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ABSTRACT 
The perception of wound healing within the current decade goes beyond the straightforward 
assertion of the three phases assembling the wound healing cascade. Healing of wounds is 
a complex process that involves a dynamic series of interactions and reactions and requires 
a collaboration of the many cell pedigrees, mediators and different tissues. The skin is the 
largest organ of the body and serves as a protective barrier against foreign objects therefore 
a loss in its veracity may lead to a decrease quality of life or even death.  
 
The primary goal for wound care and treatment is an aesthetically pleasing scar with close to 
complete functionality at the wound site and rapid wound closure. Attainment of these 
features requires incorporation of various characteristics such as a moisture retention, 
absorption and debridgement amongst others. A huge variety of wound dressings are 
available however not all of these meet the specific requirements of an ideal wound healing 
device to cover every aspect within the wound healing cascade. Highlighted within this thesis 
is the design and development of a Bioresponsive transdermal delivery system (BTDS) for 
wound healing that aims at the incorporation of the significant characteristics for optimal 
wound management and treatment. 
 
Nanobiotechnology is an interdisciplinary field that combines many avenues to revolutionise 
the development of drug delivery systems specific to wound healing. Delivery systems 
produced on the nanoscale can encourage the promotion of biologically active new 
molecular entities that were previously considered underdeveloped by the enhancement of 
the therapeutic efficacy of wound healing materials. Recent research interest has focused on 
the development of smart biomaterials. Combining biomaterials that are crucial for wound 
healing will provide opportunities to synthesize matrices that are inductive to cells and that 
stimulate and trigger target cell responses crucial to the wound healing process. Stimuli 
responsive systems provides an attractive, novel and alternate approach to the process of 
healing by offering an advanced alternative to simple wound dressings as they have the 
ability to adapt to the surrounding wound environment and regulate the healing process by 
thermal, chemical, biochemical, electrical and mechanical means on exposure to an external 
stimulus that triggers the effect. 
 
The research focused on the development and characteristic analysis of a complete 
prototyped device for wound healing incorporating a nanofibrous mat as well as a 
bioresponsive component to inflammation which could be the first novel prototype developed 
as an inflammation bioresponsive device for superior wound healing incorporating a 
nanofibrous mat. The BTDS was synthesized by the attainment of a statistically derived Box-
viii 
 
Behnken Design Template, whereby 15 formulations were generated to fabricate a wound 
healing nanofibrous mats as well as a lyophilized inflammatory dependent matrix. The 
technique entailed the process of electrospinning for nanofiber formation as well as blending 
and lyophilization for the inflammatory responsive component. Elucidation of the various 
polymeric and crosslinker concentrations greatly influenced the properties and characteristics 
of the system.  An endorsement in intensity and conjugation is noted by the FTIR spectra 
whereby greater shifts in wavelengths from 3260.11cm-1 to 3278.79cm-1 is noted when 
enhancements in crosslinking bridges is undertaken. Structural morphological analysis 
revealed the synthesis of smooth, cylindrical, uniformly aligned nanofibres without the 
presence of nanobeads as well as the formation of a lyophilized matrix having a tough 
backbone structure at higher concentrations. Upon nanotensile mapping, variation in Young‟s 
Modulus was observed at 4.25MPa providing flexibility whereas a higher Young‟s Modulus 
provides rigidity and stiffness to the structure. Determination of the bioresponsive nature was 
carried out in a stimulated inflammatory environment by utilisation of the Fentons reaction: 
Fe2+ + H2O2 → Fe
3+ + OH∙ + OH- . Results amongst the experimentally derived formulations 
revealed the reliance of bioactive release on the hyaluronic acid concentration and 
degradation by hydroxyl radicals present. MDT results obtained depicted a value at 42.39 at 
a higher hyaluronic concentration and degree of crosslinkage whereas at lower 
concentrations, MDT values at 33.21 and 35.76 were depicted. In vivo histological 
examination revealed the healing progression whereby the presence of the nanofibrous mat 
illucidated a close to complete re-epithelisation and remodelling of the wound site 
represented by thick, vascular granulation tissue dominated by fibroblasts and extensive 
collagen deposition. 
 
The approach of introducing a topical device for wound management containing both 
nanotechnology and stimuli responsive techniques provide an innovative and encouraging 
proposal for wound care to the pharmaceutical industry.  
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CHAPTER 1 
INTRODUCTION AND RATIONALE OF THE STUDY 
 
“The measurement of greatness in a scientific idea is the extent to which it stimulates thought 
and opens up new lines of research” 
 
- „Paul A.M Dirac‟ 
 
1.1. Background to the study 
The perceptive understanding of cutaneous burns and wound healing requires thorough 
comprehension and knowledge with regards to the function of the skin, its anatomy and 
physiology (Mihm et al., 1976). The skin serves as the largest organ of the body portraying 
many physiological functions thus playing a pivotal role in the maintenance of normal body 
function and homeostasis. Primarily the skin is structured by three main layers namely the 
epidermis, dermis and hypodermis as indicated in Figure 1.1. The skin serves as the bodies‘ 
first line of defence against foreign obstacles in that it is in direct contact with the outside 
environment. It serves protection as a physical barrier mostly owing to the presence of the 
epidermis and its rich availability of keratinocytes arranged in a scaffold-like lattice and a 
lipid-rich matrix that serves as a robust and waterproof barrier. Furthermore mechanical, 
sensory, metabolic and structural functions are maintained by the skin under physiological 
conditions and stresses (Venus et al., 2010) 
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Figure 1.1: Structure and function of the skin (obtained from Venus et al., 2010) 
 
A wound can be described as a break or defect in the skin tissue whereby its integrity may 
be compromised due to physical, thermal or chemical factors (Boatang et al., 2008). They 
can be classified as traumatic, surgical and pathological malignancies whereby these injuries 
may result in a declined function of the skins native physiological functions. There are seven 
major categories of wounds of interest, distinct from each other, by the manner in which the 
skin or tissue is broken and its general appearance as described in Table 1.1. Of significant 
interest to this research are burn wounds and the healing process of burns. Burn wounds 
may be described as injury to the skin caused by thermal, chemical, and electrical sources 
that may be distinguished by the appearance and burn depth of the skin layers. Thermal 
burns such as scalds tend to cause superficial dermal burns whereas flame burns and 
contact burns cause deep dermal injury to the full thickness of the skin. Electrical burns are 
caused by tangenial exposure of skin tissue to varying degrees of current. Chemical burns 
are caused by both alkali and acidic sources. These wounds tend to be deep, as corrosive 
agents may cause coagulative necrosis until the full thickness of the skin is removed. Table 
1.1 provides a depiction of the various wound types and their occurrence as follows: 
(Hettiaratchy and Dziemulsky, 2004; Mallefet and Dweck, 2008). 
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Table 1.1: Categories of wounds  
 
Wound Category Description 
Abrasions Caused by rubbing or scraping of the skin  
Incisions Clean cut wounds which tend to bleed freely 
Lacerations Ragged wounds with irregular edges and 
masses of torn tissue beneath 
Punctures Created when sharp objects enter the skin 
and penetrate the tissue leaving a small 
surface opening 
Avulsions Tearing of tissue from a body part with heavy 
bleeding 
Contusions/closed wounds (bruises) Result of forceful trauma that injures an 
internal structure without breaking the skin 
Burns:  
1. Themal 
2. Chemical 
3. Electrical 
Distinguished by the appearance and burn 
depth of the skin layers: 
Scalds: superficial dermal burns, flame 
burns/contact burns, deep dermal injury to 
the full thickness of the skin, 
Deep corrosive with coagulative necrosis 
caused by alkali and acidic sources, 
Tangenial exposure of skin tissue to varying 
degrees of current 
 
Wound treatment and management has proven to be challenging due to the fact that various 
extrinsic and intrinsic factors govern significant roles during the healing process (Gethin, 
2007). Wounds occur on a daily basis and can result in a declined quality of life depending 
on the severity. Wound healing involves three interlapping and dynamic phases that work 
hand in hand; namely the inflammatory, proliferation and remodelling phases. Thus an 
advanced delivery system is required to ensure adequate and optimal treatment (Li et al., 
2012). Numerous wound dressings have been marketed in the past. However, the majority of 
these systems lack the necessary therapeutic effects required to target all factors associated 
with the process of adequate healing. These include natural and synthetic bandages, cotton 
wool, lint and gauzes with varying degree of absorbency and efficiency (Lock et al., 1980).  
 
Many of the available systems lack the adequate fundamentals for effective wound healing 
such as poor fluid absorption capabilities, low gas transmission and water vapour rates as 
well as poor tensile strength (Archana et al., 2013). An effective wound healing device should 
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possess both desirable clinical and pharmaceutical properties for optimal treatment such as 
a moist wound environment, which allows for rehydration of desiccated tissue which 
enhances angiogenesis and connective tissue proliferation, debridement for the removal of 
necrotic tissue and foreign bodies which have the ability to promote the inflammatory phase 
and serve as a medium for microbial growth. Absorption promotes the removal of excess 
exudates which hinders cell activity and proliferation. Gaseous exchange allows 
management of the healing process stimulating fibroblasts and promoting angiogenesis. 
Minimal adherence to the wound site will ensure convenient removal as well as minimal 
tissue damage and pain affliction to the user. Microbials produce an unpleasant wound odour 
and tend to induce tissue damage thus the ideal wound healing device would prevent this 
and promote collagen synthesis and tissue repair. Extended usage features and a low 
frequency of dressing change ensure cost effectiveness (Boateng et al., 2008). In addition, 
durability, tensile strength and the desired film thickness need to be considered. 
 
1.2. Rationale and Motivation of the study 
A single assembled device that has the ability to incorporate the many required features as 
discussed, of an advanced wound healing delivery system that will have the potential to 
advance drug delivery with regards to afflicted burns and wound healing. This research 
focuses on overcoming the many challenges associated with effective wound healing, by the 
development of a smart device composed of various components that have the potential to 
stimulate advanced wound healing synergistically when incorporated as a single system.  
 
Burn wounds in particular occur at varying levels and can be termed as 1st, 2nd and 3rd 
degree depending on the severity. First degree burns are associated to burn wounds 
occurring only on the epidermal surface with no blister formation, 2nd degree burns involve 
partial thickness of the skin such as the epidermis and superficial dermal layers whereas 3rd 
degree burns involve the full thickness of the skin giving it a white leathery look. The device 
described aspires to effectively target and ensure healing of burn wounds at all wound 
depths associated with burns. To accomplish this efficiently the single assembled device will 
incorporate an intelligent crosslinked nanofibrous system that has the ability to mimick the 
extracellular structures of the native skin thereby forming ‗pseudoskin‘ accelerating the 
healing process with regards to regeneration, proliferation, epithelisation, and furthermore 
resulting in a scarless healing artefact together with a stimuli (inflammatory) responsive 
component ensuring prolonged and targeted release. The emergence of applications 
surrounding stimuli-responsive technology in drug delivery may provide as a promising 
technique for wound healing allowing responses to specific chemical or physical changes at 
the wound site such as that of inflammation, improving the therapeutic response and 
ensuring targeted and prolonged bioactive release. Challenges that are currently faced which 
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include factors such as drug accumulated toxicity and side effects, indefinite delivery as well 
as unpredictable release can be overcome by application of these systems (Cabane et al., 
2012).  
 
The above mentioned system is a step forward from other wound healing systems in that it 
combines the innate structures, such as biopolymers presenting with wound healing 
properties in a nano-based system together with the bioresponsive nature of the natural 
healing cascade as depicted in Figure 1.2. The device composes of a backing layer, 
lyophilized inflammatory dependent matrix as well as a nanofibrous mat incorporated into the 
lyophilized matrix and is termed a ‗Bioresponsive transdermal delivery system (BTDS)‘. This 
allows and ensures specified release of the bioactives in correspondence to the inflammatory 
mediators released through the wound healing cascade ensuring aligned levels of bioactive 
with the presence or absence of inflammation experienced by any individual person. In 
addition, the various biopolymers and bioactives will be combined by employing the 
interpenetrating polymer network (IPN) technique explained in greater detail in Chapter 3, 
that allows the crosslinking or semi crosslinking of polymers by ionic, covalent or hydrogen 
bonding thus endowing advantageous properties to the system. The combinatory delivery 
system will employ the use of various technology strategies as outlined in Figure 1.3 which 
also depicts the advantageous of each, to develop a single healing device with multiple 
properties. As a comparison to the device, a bioactive film as described in Chapter 3 is 
synthesized to determine the efficacy of the device in terms of in vivo analysis carried out on 
a burn wound. 
 
Figure 1.2: Mechanism of action of the BTDS on exposure to inflammation at a wounded 
skin site. 
Lyophilized 
inflammatory 
dependent matrix 
Inflammatory 
infiltrates and 
hydroxyl radicals 
Skin Cells 
Backing 
Layer 
Nanofibrous Mat 
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Figure 1.3: Technology applied in the development of the BTDS to ensure bioresponsive 
release of nanofibrous mats 
1.3. The Mechanism of Action of the Combined Bioresponsive Topical Delivery System 
(BTDS)  
The research focuses on the fabrication of a bioresponsive transdermal delivery system 
(BTDS) that integrates a wound healing system with an inflammation responsive system. 
This is achieved by the inclusion of a stimuli-responsive system that ensures a two-way 
communication between the delivery system and the body so that a prompt therapeutic 
intervention occurs upon recognition of biochemical responses. This is achieved through the 
targeted release of a nanofibrous polymeric mat designed to mimic the extracellular matrix of 
the natural skin whilst simultaneously promoting healing in all stages of the healing process 
(Alvarez-Lorenzo and Concheiro, 2004).  
 
The proposed BTDS composing of smart polymeric materials serves as an application for a 
smart stimuli-responsive system that has the capability to deliver nanofibrous wound healing 
mats at controlled therapeutic levels on exposure to inflammation at the pathological wound 
site as depicted in Figure 1.4. Inflammatory molecules such as neutrophils, macrophages 
and hydroxyl radicals inherent to the healing process will be the intrinsic factor that the BTDS 
responds to. The wound healing process comprises of three main phases, namely: the 
inflammatory, proliferative and remodelling phase. Of particular interest, is the inflammatory 
phase that occurs immediately post injury to establish homeostasis. During this stage several 
mediators for wound healing, such as platelet derived growth factors, chemotactic factors, 
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macrophages and neutrophils are secreted that adhere to the extracellular matrix of the skin 
to promote metamorphosis and reparative functions (Singer and Clark, 1999). Furthermore, 
hydroxyl radicals are generated during the inflammatory process (Darzynkiewicz and Balazr, 
1971) and thus will serve as the main target of the BTDS to ensure bioresponsive behaviour. 
 
Figure 1.4: Schematic conceptualisation of bioresponsive stimulization of the BTDS showing 
a response on exposure to an inflammatory stimulus 
Incorporated within the BTDS, is a lyophilized matrix that will serve as a drug reservoir, 
incorporated with a nanofibrous mat comprised of natural polymers that have the capacity to 
accelerate re-epithelisation and remodelling at the wound site. Advantageous features such 
as mimicking the ECM of the native skin together with possessing wound healing 
characteristics that can be additively combined and in addition properties such as 
biodegradability, biocompatibility, bioadherence and non toxicity can be established within 
the system thus ensuring minimal to no scarring of tissue at the wound site. These 
nanofibrous mats enhance healing and are composed of natural polymers such as chitosan 
and hypromellose crosslinked with a natural crosslinker genipin and in addition include a 
bioactive curcumin, have been proven to be effective through both in vitro and in vivo studies 
in the promotion and enhancement of the healing process throughout all the interlapping 
phases as shown in Figure 1.5 and described in Table 1.2. The BTDS incorporating the 
nanofibrous mat will further serve as a delivery platform having the potential to mimic the 
extracellular matrix as described and deliver selected nanofibrous polymeric material with 
wound healing properties in a prolonged controlled manner. The formation of a BTDS will 
enhance this by ensuring prolonged and direct release at the wound site at a specific 
interphase within the healing process. Inclusion within the BTDS design criteria is the use of 
biopolymers such as hyaluronic acid and sodium alginate that have the ability to act in a 
bioresponsive manner to inflammation in addition to having wound healing characteristics.
     
 
BTDS 
Inflammatory 
cells and 
hydroxyl radicals 
Wound Site 
Inflammatory Stimulus 
Release of 
Bioactives 
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Figure 1.5: Schematic conceptualisation depicting the integration of the Bioresponsive 
transdermal delivery system (BTDS) with the nanofibrous mat and release of the various 
biopolymeric components upon degradation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Causes accumulation of 
phagocytic cells that result in the 
release of hydroxyl radicals 
which cause the 
depolymerisation of hyaluronic 
acid thus promoting an 
inflammation dependent delivery 
system (BTDS). 
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Table 1.2: Wound healing characteristics of the various biopolymers 
Phase Inflammation Proliferation Remodelling References 
Chitosan Homeostasis Differentiation, 
re-
epithelisation 
and 
fibroplasia 
during 
granulation 
Decreased 
hypertrophic 
scar 
formation 
Howling et al.,  
2001; Ishihara 
et al.,  2002; 
Alemdaroglu 
et al., 2006  
Citric Acid Decreased 
microbe 
infestation 
and exudates 
excretion 
Laying of 
granulation 
tissue and 
epithelisation 
 
       ___ 
Naqoba et al., 
2011 
Genipin  
 
       ___ 
Epithelisation 
and 
proliferative 
activity 
Promotion of 
new collagen 
formation 
and 
remodelling 
Mi et al., 
2002; 
Muzarelli, 
2009 
Hypromellose  
 
        ___ 
Angiogenesis  
 
       ___ 
Braund et al., 
2002;Topham, 
2002 
Curcumin Anti-
inflammatory, 
anti-oxidant, 
TGF-β1 
formation. 
Cellular 
proliferation, 
induction of 
growth factors 
and 
granulation 
tissue 
formation 
 
 
 
       ___ 
Pachence, 
1996; 
Gopinath et 
al., 2004 
Hyaluronic 
Acid 
(BTDS) 
Interaction 
with hydroxyl 
radicals, 
water 
attracting 
properties, 
absorption of 
exudates  
Promotion of 
proliferation 
and 
regeneration. 
proteolytic 
degradation 
of provisional 
matrix to 
increase cell 
migration 
and tissue 
remodelling 
Perttila et al., 
1990; 
Anilkumar et 
al., 2011 
 
1.4. Novelty of the Study 
The use of a bioresponsive system comprising of hyaluronic acid, a biological component of 
the skins natural extracellular matrix, in combination with a nanofibrous mat composed of 
purely natural polymers having wound healing properties, will result in a synergistic system to 
enhance wound healing. The concurrence of nanotechnology and stimuli responsive systems 
serves as a unique technique whereby properties of both systems may be combined to 
enhance system performance thus accelerating the healing process and promoting scar free 
closure. Innovative incorporation of the various technologies such as a bioresponsive system 
ensures effective action of the device only upon recognition of the wound site through 
distinguished mediators. At the same time incorporation of the nanofibrous mat will ensure 
the formation of ‗pseudoskin‘ whereby the various components of the natural ECM can be 
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mimicked further advancing the healing process. In addition the employment of the various 
biopolymers in combination serves as a novel blend for fabrication of the device having 
wound healing attributes and properties thus providing advantageous characteristics 
throughout the wound healing cascade. 
 
1.5. Possible Therapeutic Applications of the Study 
 Foot ulcers occur in approximately 5-10% of the population and are on the increase in 
majority of the population affected with diabetes. Lower limb amputation is primarily due 
to ulcerative wounds and requires appropriate management. The use of an inflammatory 
responsive topical wound healing system will assist in prevention of infection, bacterial 
colonisation as well as aid the healing process. 
 Wounds and lesions associated with AIDS conditions such as Kaposis Sarcoma, oral and 
orofacial lesions and contraction of bacterial infections such as Staphylococcus aureus 
and Salmonella, can be prevented and maintained by the use of a wound healing device 
that promotes the healing process and prevents the occurrence of bacterial infestation 
and disease. 
 Enhanced healing therapy through targeted and prolonged delivery of nanofibrous mats 
will enhance the therapeutic effect of lesions, avulsive wounds, ulcerations, burn wounds 
and incisions thus promoting scar free and optimal healing. 
 
1.6. Aim and Objectives of the Study 
The aim of this research is to develop a device that will efficiently and effectively accelerate 
the healing process of wounds. This can be undertaken by the fabrication of a device known 
as the Bioresponsive transdermal delivery system (BTDS) that employs the use of innovative 
technologies. The device can be set in a componential manner whereby the various 
components comprises of a nanofibrous mat employing nanotechnology and electrospinning 
as well as an inflammatory responsive component employing stimuli-responsive techniques, 
in addition to the use of biopolymers having influential wound healing qualities. 
 
For pragmatic fulfilment of the aim, the following objectives will be undertaken:  
1. Identification of potential polymeric biomaterials in terms of their biocompatibility, 
wound healing significance and stimuli responsive behaviour to inflammation to be 
used in the synthesis of the BTDS which will consist of the lyophilized matrix, 
nanofibrous mat and backing layer. 
2. Generation of a three factor Box-Behnken Design obtained from preliminary 
mathematical feasibility studies that involve the procurement of upper and lower limits 
for synthesis of the device.  
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3. Optimization of the BTDS acquired from computational collaboration and 
conceptualisation of the Box-Behnken Design template.  
4. Analysis of the BTDS in terms of its physicomechanical and physicochemical 
characteristics by performance of Fourier Transform Infrared Spectroscopy 
(FTIR),Nanotensile Analysis (NA), Scanning Electron Microscopy (SEM) and 
Differential Scanning Calorimetry (DSC) amongst other characterisation tests. 
5. In vitro analysis for responsiveness to inflammation on exposure to chemical 
mediators such as hydroxyl radicals. 
6. Ex vivo analysis to determine the biological characteristics in terms of adhesion and 
release through biological tissue 
7. In vivo analysis to determine the biological and preclinical prospection in terms of its 
wound healing capacity 
 
Successful conclusions of the above objectives, may lead to establishment of the feasibility 
of the system in humans. 
 
1.7. Overview of the Thesis 
Each chapter in this thesis is based on the aim and objectives as outlined in Section 1.6. A 
summary will be provided whereupon Figure 1.6 will further provide a straightforward and 
pragmatic overview of the processes undertaken in pursuing the origin of the BTDS system.  
 
Chapter 1 of this thesis provides a background that portrays a brief description of the native 
skin as well as a general indication of wounds and wound healing. It also describes wound 
management and the strategies employed in this work to overcome the challenges faced 
with treatment. A brief synopsis is also provided illustrating the architectural structure of the 
proposed prototype device. Further a rationale and motivation, novelty of the study is also 
provided. A list of objectives and an aim is presented. 
 
Chapter 2 of this thesis provides a comprehensive review on delivery systems for wound 
healing. It ushers in an introduction of wound healing and the mechanisms involved there 
forth outlining the physiology, mechanism of actions, wound types and wound management. 
Further revealed in this literature survey, is a detailed depiction that focuses on wound 
management aids, both advanced and traditional as well as the use of smart polymeric 
materials, bioactives and biopolymers in wound healing devices. The chapter concludes with 
an illustration of modern day techniques employed to fabricate wound healing devices.  
 
Chapter 3 of the thesis describes the synthesis of a bioactive film. The role of the various 
biopolymers and the semi interpenetrating polymer network (s-IPN) technique is depicted. 
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The synthesis of the films by preparation of the various variants followed by the construction 
of a 3 factor Box-Behnken design template is discussed. Optimization is then pursued and 
the applicability of the respective design is analysed. Furthermore, the physicochemical and 
physicomechanical characteristics are evaluated to determine design feasibility.  
 
Chapter 4 of the thesis introduces the process of electrospinning and the characteristics of 
nanofibres. The challenges faced during the electrospinning process to optimise the fibres 
are also included. Following on from the theoretical basis established, novel methodology 
was accomplished for electrospinning of the nanofibrous mats. The 3 factor Box-Behnken 
experimental design was used originating from a set of variables whereby upper and lower 
limits were established. Physicomechanical, physicochemical and in vitro characteristics 
were scrutinised to confer an in-depth acquaintance to system properties and performance. 
 
Chapter 5 of this thesis focuses on the optimization of the nanofibrous mats established via 
the successful design as described in Chapter 4. The nanofibrous mat optimization is 
undertaken by employing a Response Surface Methodology. Characterisation of bioactive 
release kinetics, property dynamics in terms of chemical transitions and mechanical 
properties were further investigated.  
 
Chapter 6 describes the synthesis of the stimuli responsive component of the BTDS. This 
chapter focuses on the experimental investigation by employment of the 3 factor Box-
Behnken Design template for formulary analysis whereby fifteen formulations are obtained. 
The selection of responsive polymers and novel methodology for the design is presented.  
 
Chapter 7 of this thesis portrays the optimization of the stimuli responsive component of the 
BTDS obtained from evaluation of the fifteen formulations described in Chapter 6. 
Furthermore, the chapter focuses on the assemblance of the prototype device which consist 
of the backing layer, optimized stimuli responsive lyophilized matrix discussed in greater 
detail in this chapter and the nanofibrous mat (discussed in Chapter 4 and 5) incorporated 
within the stimuli responsive lyophilized matrix. Further detailed analysis is characterised on 
the BTDS followed by in vitro and ex vivo bioactive release kinetics. Of significant interest is 
the elucidation of the hydroxyl radical effect on the inflammatory behaviour of the device 
when a simulated pathological state is created. 
 
Chapter 8 of this thesis demonstrates the in vivo performance of the device and provides a 
comparative analysis between the experimental groups, control, placebo and conventional 
systems. A detailed description of the methodologies undertaken to inflict a burn wound and 
the healing progression is presented on the selected Sprague Dawley Rat model. Highlighted 
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in the chapter are the nanofibrous mat and BTDS compatibility as well as the various intrinsic 
methods employed for wound healing determination. 
 
Chapter 9 of this dissertation provides an overall conclusion of the inclusive outcome of this 
research. Future recommendations and outlook is also provided. 
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Figure 1.6: Schematic of the breakdown of each chapter in this thesis. 
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1.8. Concluding Remarks 
In this chapter a description of the novel system developed is provided in terms of 
conceptualisation, structure and functionilisation of the various components of the 
Bioresponsive Transdermal Delivery System (BTDS). The chapter highlights the 
fundamentals of wound healing, challenges and difficulties needed to be overcome in order 
to ensure effective and enhanced healing. The chapter sought to provide a rationale for 
effective wound dressings and devices whilst the appropriate stimulus was selected for 
targeting bioactive delivery at the wound site (In particular delivery of the nanofibrous mat). 
The focus of the chapter was a description of the BTDS, with particular emphasis on the 
functioning and architectural structure of the various componential layers.  
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CHAPTER 2 
A COMPREHENSIVE REVIEW OF ADVANCED BIOPOLYMERIC WOUND 
HEALING SYSTEMS 
 
2.1. Introduction 
The formation of creative ideas for the use and modification of delivery systems which will 
influence complex wound healing behaviours, such as proliferation, migration and 
differentiation of cells will promote novel opportunities for tissue regeneration and repair in 
the wound healing process. Many agents are pivotal and multifunctional, that is they are 
potent within the different stages of wound healing to ensure repair and regeneration (Shi et 
al., 2010) Synthetic polymer delivery systems that can control and sustain release are 
particularly promising as materials for enhancing tissue regeneration (Biondi et al., 2008) 
This review discusses the processes involved in skin regeneration and the state of the art in 
nanotechnology and polymer drug-delivery systems and their potential application for wound 
healing. The interdisciplinary field of nanobiotechnology, which combines biology, chemistry, 
engineering and medicine is revolutionising the development of drug-delivery systems and 
devices. Research in the area of drug delivery, tissue engineering and wound healing has 
provided unlimited potential to improve human health (Goldberg et al., 2007). Within the field 
of tissue engineering, drug delivery and wound healing, new dimensions can be envisioned 
with regards to enhancing the therapeutic effect and at the same time reducing risks and 
adverse effects. Developments in the field of nanotechnology involving nanomedicine, 
nanopharmacy, production of nanofibres, nanotubes and nanorods may promote novel 
opportunities for delivering wound dressings with efficient drug delivery (Broudriot et al., 
2006; Patzke et al., 2002). Nanoscale delivery vehicles can enhance the therapeutic efficacy 
and enable new classes of therapeutics by encouraging the promotion of biologically active 
new molecular entities that were previously considered underdeveloped (Shi et al., 2010). 
 
2.2. Physiology and Mechanism of Action of the Native Skin 
The skin is the largest organ of the body which comprises about 8% of the human body mass 
and covers the entire external body surface. The surface area varies from person to person 
because of the variation in weight and height; skin thickness may also range from 1.5 to 4.0 
mm (Chong et al., 2007). The skin plays a crucial role in many functions such as sensory 
detection and fluid homeostasis. It serves as an effective barrier against microbial invasion, 
and enables formation of a self-repairing and self renewing interface between the body and 
its environment. It is capable of protecting the body against thermal, chemical, mechanical 
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and osmotic damage, and has properties which allow for adsorption, selective permeability to 
chemicals and excretion (Chong et al., 2007). 
 
The main skin components of interest for wound healing comprises of the epidermis, dermis 
and sub-dermal layers (Figure 2.1). The epidermis has a thin and highly cellular structure 
that forms the superficial layer of the skin. It is the outermost barrier having high 
impermeability, thus controlling water loss and serving as a barrier against external harmful 
stimuli. Underlying and separated from the epidermis by a basement membrane is the 
dermis. The dermis composes of collagen-rich extracellular matrix (ECM), elastin, fibroblast 
and glycosaminoglycans (Zhong et al., 2010). It provides flexibility and physical strength to 
the skin and supports the extensive vasculature, nerve bundles and lymphatic system. 
Throughout the dermis is a network of nerve fibres that serve a sensory role in the skin and 
influence immune and inflammatory responses (Chong et al., 2007). The hypodermis is the 
layer beneath the dermis and contains a large amount of adipose tissue that is well 
vascularised and contributes to both the thermoregulatory and mechanical properties of the 
skin (Cohen. 1983). 
 
 
 
Figure 2.1: Image displaying the cross-section of skin (http://www.infovisual.info/0./0.36-
en.html) (Access Date: 04/06/2014) 
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2.3. Wound Types and the Wound Healing Cascade 
A wound can be described as a defect or a break in the skin which could be due to physical, 
chemical or thermal damage or as a result of an underlying physiological or medical 
condition which would then result in a disruption of the normal anatomical structure and 
function of the skin (Boatang et al., 2008). Figure 2.2 classifies the various forms of wound 
occurrence, furthermore wounds may be classified as acute or chronic on the basis of the 
wound healing process. Acute wounds are usually healable within a period of time and are 
caused by traumas that would result in abrasions, avulsions, incisions, contusions and 
lacerations. These categories of wounds are likely due to by mechanical damage or 
exposure to extreme heat, irradiation, and electrical shocks or corrosive chemicals. Chronic 
wounds occur as a result of a specific disease such as diabetes, which could lead to ulcers, 
severe physiological contaminations and tumours. Unlike acute wounds, these wounds could 
take a long period of time usually exceeding 12 weeks to heal and reoccurrence is not 
uncommon (Shanmagasundaram et al., 2005). Trauma to the skin is subsequently followed 
by the beginning of a regime of an organised and predictable sequence of events that has a 
cascade effect until the wound is bridged by scar tissue regeneration that binds and holds 
the wound in stasis (Mallefet and Dweck, 2008). The cascade of events initiated by skin 
trauma, involves three phases that is immediate and works towards repair as shown in 
Figure 2.3. 
 
 
 
 
Figure 2.2: Classification of wound types 
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Figure 2.3: Infiltration of various factors for the process of wound healing. Reproduced with 
permission from Elsevier BV Ltd©_ 2012.16 
 
Wound healing is a dynamic interactive process that involves parenchymal cells, ECM, blood 
cells and soluble mediators. The three phases involved in wound healing can be classified as 
the inflammatory, proliferative and the tissue remodelling phase which is outlined in Figure 
2.3 (Madhumathi et al., 2010).The healing cascade begins when the inflammatory phase 
prepares the area of injury for healing by immobilising the wound and causing it to swell and 
become painful (Mellefet and Dweck. 2008). Bleeding occurs at the injury site to ensure 
removal of toxic waste and activation of homeostasis begins which is initiated by exudate 
components. The clotting mechanism is elicited by platelets and this results in coagulation 
and the formation of a fibrin network. The inflammatory phase also results in vasodilation and 
phagocytosis whereby histamine and serotonin is released. Phagocytes enter the wound and 
engulf dead cells and platelets are liberated and form aggregates as part of the clotting 
mechanism (Boatang et al., 2008). 
 
The proliferative phase involves the proliferation of epidermal cells at the wound margin 
behind the actively migrating cell (Singer et al., 1999) whereby cells travel about 3 cm from 
the point of origin in all directions. This process usually occurs 2 days to 3 weeks following 
injury and results in the formation of granulation tissue at the wound space. Granulation is 
the effect of fibroblasts and macrophages providing a continuing source of growth factors 
necessary to stimulate angiogenesis and fibroplasias (Singer et al., 1999). This result in a 
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bed of collagen that helps fill the defect whereby wound edges pull together and new 
capillaries are produced. The final stage is known as the remodelling stage and usually 
begins three weeks post injury up to 2 years. Remodelling of dermal tissue to produce 
greater tensile strength whereby new collagen is formed is the main aim of this phase. The 
principle cell involved is the fibroblast. Collagen molecules begin to form whereby it 
undergoes further modification and molecules begin to form in a characteristic triple helical 
structure. Collagen is released in the extracellular space whereby stable cross-links are 
formed. As collagen matures at the wound site more and more intra-molecular and 
intermolecular cross-links are formed. Cross-linking gives collagen its strength and stability 
over time; however, the tissue will never regain the properties of uninjured skin (Sibbald et 
al., 2003) Figures 2.4 and 2.5 briefly illustrate the process of healing associated with the 
wound healing cascade (Dulmovits et al., 2012; Stein and Kutcher. 2013). 
 
 
Figure 2.4: The major stages undertaken by the body‘s defence mechanism during the 
process of wound healing 
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Figure 2.5: Cell mediator‘s interactions at the wound site to promote proliferation and 
remodelling of skin tissue. Reproduced with permission from Elsevier BV Ltd© 2013. 
 
2.4. Wound Care and Management Aids 
The objective of wound management is to heal the wound in the shortest period of time that 
is possible with minimum pain, discomfort and scarring to the patient (Jannesari et al., 2011). 
The successful treatment of a wound should ensure that the formation of scar tissue is 
minimal, the amount of necrotic tissue produced is reduced and microbial invasion is 
prevented. In the past, wound management involved simple principles such as ‗to cover and 
conceal'. Materials used for wound management such as simple gauze materials were 
passive products that did very little to encourage the wound healing process, as limited 
attention was given towards the requirements of a wound healing environment or the 
functional performance of wounds. In recent years, the treatment of wounds has been 
revolutionised because of a greater understanding of the underlying molecular and cellular 
abnormalities that prevent the wound from healing. An approach to ensure that the 
pharmacological, mechanical and pharmacokinetic requirements of wound healing are met 
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will provide a novel approach, to remove these barriers to natural healing and enhance the 
effects of advanced therapies (Schultz et al., 2009). 
 
The ability of the skin to repair itself after a minor injury is a remarkable process; however, 
when the damage is severe or occurs in large amount of skin area, appropriate and 
immediate coverage of the wound area with an optimal device or adequate dressing is 
essential to protect the wound and accelerate wound healing. Ultimately, immediate wound 
coverage and protection is the principle goal of wound care management (Bindu et al., 
2010). To promote and ensure effective wound management many factors involved in the 
wound healing process need to be taken into account. The introduction of the ‗TIME concept' 
provides the basis to which appropriate wound management can be effectively understood. 
 
T—deficient and non-viable tissue can physically impede the migration of wound cells across 
the wound bed and act as a focus for infection. 
I—uncontrolled inflammation and infection may perpetuate a cycle of repeated injury and 
insult to the wound area. This needs to be corrected in order for cellular migration to proceed 
during the wound healing process. 
M—both, excess moisture and wound desiccation may impede the wound healing process. 
Desiccation may impede cellular migration and wound contraction, whereas excess moisture 
may result in maceration of the wound bed and surrounding tissue. 
E—the formation of a migrating epithelial edge is a visible sign that healing is taking place, 
whereas a non-migrating edge is a signal showing poor healing properties (Granick et al., 
2006). 
 
This concept provides a systemic approach to assessing and treating wounds with the aim of 
restoring the biochemical environment that stimulates healing and it provides the necessary 
concepts required for the design of advanced wound healing devices. 
 
Wound management aids are available in a variety of physical forms such as hydrogels, 
xerogels, tissue engineering, hydrocolloids, skin scaffolds, films, lint and gauzes (Lloyd et al., 
1998; Boatang et al., 2008). The various type of wounds require different environments and 
properties for effective healing thus the physicochemical and clinical properties of various 
wound healing dressings and devices must be designed in order to suite the requirements of 
the TIME philosophy mentioned above. The functions and desirable characteristics of wound 
healing devices and dressings are summarised in Figure 2.6 include debridement of the 
wound area, as this clears the wound of necrotic tissue and bacteria, to maintain a clean 
surface that will heal relatively easy. Debridement plays a critical role in wound healing as 
devitalised, necrotic tissue provides a focus for infection, impedes re-epithelisation, prolongs 
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the inflammatory phase and mechanically obstructs contraction of the wound surface. 
Debridement using mechanical methods such as application of the appropriate wound 
dressing is all that may be required to promote the first step of wound healing as assisted 
debridement accelerates the wound healing process(Schultz et al., 2003).Clinically the 
effects of wound healing dressings have a profound effect on the rate of healing. Moisture 
retentive dressings may accelerate the wound healing process as a moist wound/dressing 
environment facilitates the recruitment of vital host defences and the necessary cell 
population, such as macrophages which help promote wound healing. An amazing number 
of growth factors are elaborated by these cells creating a milieu characterised by increased 
fibronolysis, accelerated angiogenesis and connective tissue synthesis, prevention of cell 
desiccation and death, and an accelerated rate of healing which is promoted by the autolytic 
properties of a moist environment that rejuvenates and rehydrates desiccated skin and 
tissue. An added benefit of moist wounds and dressings is decreased pain at rest, during 
ambulation and patient convenience during dressing changes (Parsons et al., 2005). 
Removal of blood and excess exudates is an important factor affecting wound healing. 
Absorption of exudates is a significant characteristic of dressings and wound healing devices 
as excess exudates contain tissue degrading enzymes that block the activity and proliferation 
of cells and break down extracellular materials and growth factors thus delaying the wound 
healing process. The body tends to function optimally in an environment that mimics or is 
similar to its own environmental conditions, thus normal tissue temperature improves the 
blood flow to the wound bed promoting epidermal migration (Boatang et al., 2008). Insulation 
characteristics is a significant property of wound management aids, as maintenance of body 
temperature will be optimised thus accelerating the healing process under normal body 
conditions. 
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Figure 2.6: Functions and desirable characteristics of wound dressings and devices related 
to treatment clinical significance 
 
Wounds often provide a favourable environment for the colonisation of microorganisms 
(Chambers et al., 1962; Brook. 1996; Adam et al., 1999; Bowler and Davies, 1999). In order 
to improve the process of wound healing, conditions that are unfavourable for microorganism 
growth is essential and thus an environment that is favourable for the host repair mechanism 
must be implemented (Canal et al., 2009). For more than a century, one of the major 
rationales for the prevention of infection was the application of a dressing to the wound site. 
Theoretically, dressings can protect the wound from gross microbial contamination and acts 
as a barrier between the wound and the outside world. The composition and properties of the 
wound dressing or device itself can play a major role in modifying the wound 
microenvironment (Falanga, 1988). An infected wound may give of an unpleasant odour and 
delay collagen synthesis, the inflammatory phase is also prolonged in the presence of 
microbials and epidermal migration is inhibited which results in further damage to the tissue 
(Boatang et al., 2008).Oxygen delivery is a critical element for the healing of wounds as the 
formation of wound granulation tissue is increased, epithelisation and fibroblast formation as 
well as wound contraction and secondary closure is accelerated (Kallaiinen et al., 2003). 
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Oxygen is an essential nutrient for cell metabolism, thus under hypoxic conditions wound 
healing is delayed as a result of reduced granulation and epithelisation processes. Therefore, 
a desirable characteristic of wound dressings and devices is effective gaseous exchange of 
both water and air, whereby exudates can be effectively managed by the permeability of 
wound dressings to water vapour. In addition to the above, wound management aids should 
also ensure low adherence to the wound site, thus preventing trauma, pain and further injury 
to the wound site. Adherent dressings can result in further tissue damage at the injury site 
and can be agonising and difficult on removal. The economical factors also need to be 
considered, to ensure cost effectiveness and a low frequency of change (Boatang et al., 
2008). In addition, an acceptable shelf life, acceptable mechanical properties that are 
compatible to topical application of dressings and at the same time the variation in 
degradation should be compatible with the healing process, that is, inflammation, 
regeneration and remodelling therefore matching the timeline for the healing process. When 
in contact with the skin surface, the material should not cause a toxic or inflammatory 
response, should provide permeability, convenience and be able to be easily metabolised 
and cleared from the body (Lloyd. 2002). 
 
2.5. Components of Wound Management Aids 
Wound healing and dermal substitution are areas in medicine where there have been many 
recent advances. The main component of every wound is the connective tissue matrix, thus 
there is an overall consensus that in order to effectively heals wounds, it is necessary to 
ensure the effective substitution of the main component (Ruszczak. 2003). Wound dressings 
are an essential part of wound management and care to ensure the enhancement of the 
natural wound healing process, thus new material technologies are evolving in this field. The 
development of new intelligent dressings is underway, that promise to play an active role in 
modifying and promoting healing of both acute and chronic wounds (Atiyeh et al., 2002). 
Wound dressings are usually classified according to their nature of action as: (i) passive 
products, (ii) interactive products and (iii) bioactive products. Gauze and other traditional 
dressings such as Tulle are passive products, whereas polymeric films and foams which 
feature transparency, permeability to water vapour and oxygen and in some cases 
biodegradability are termed as interactive products. Advanced dressings that have the ability 
to transport active substances to the wound site by the design of dressings composed of 
materials having endogenous activity or by the delivery of active substances in wound 
healing are regarded as bioactive products. These products include collagen, proteoglycans, 
chitosan and alginates (Paul and Sharma. 2004). There has been transitions from simple 
wound management aids to advanced specialised devices with specific characteristics, such 
advanced wound dressings are infused with various components in optimised proportion, 
which may include polymers and hydrocolloids. 
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2.5.1. Polymers 
When choosing a material for application in treatment of wounds, it must meet specific 
requirements. Of utmost importance is the biocompatibility of the material, as the material 
chosen must induce the appropriate response within the host organism. Current research 
has suggested the incorporation of bioactive materials as opposed to those that are inert, 
since the bioactive material can interact with the biological environment and influence 
activities such as the cells function (Paul and Sharma., 2004). A large variety of materials 
can be used, which may be classified as (i) natural, (ii) synthetic or (iii) hybrid. Within these 
subdivisions, in particular synthetic materials, one can further delineate materials as 
degradable and non-degradable materials. The degree of degradability within materials can 
be controlled by altering parameters such as polymer compositions and variation as well as 
the ratio of amorphous to crystalline segments (Kim and Park. 2006). Polymers are 
considered as potential material due to their amenability to chemical modification, resulting in 
defined chemical composition, potential for defined 3D structures and customised surface 
functionality (Sill and von Rectum. 2006). Several polymers are clinically used as 
therapeutics: synthetic polymers such as (poly(ethylene glycol), N-(2-hydroxypropyl) and 
methacrylamide co-polymers, natural polymers such as (dextran (α-1,6 polyglucose), dextrin 
(α-1,4 polyglucose), hyaluronic acid and chitosan, others include linear polyamidoamines and 
pseudosynthetic polymers [(the man-made poly (amino acids) poly(L-lysine), poly(L-glutei 
acid), poly(malic acid) and poly(aspartamides)] (Duncan. 2003). Polymers are suitable for 
drug delivery as they offer effective unlimited diversity in topology, dimensions and chemistry 
(Brocchini and Duncan. 1999). A vast range of polymer architecture is available such as 
graft, linear, branched, cross-linked, multivalent, dendronised and star-shaped polymers 
(Goldberg et al., 2007). Within particular interest for the management of wounds, polymers 
that can be used as skin culture substitutes may be tissue derived or synthetic. 
 
2.5.1.1. Natural Polymers 
Natural polymers can be classified as those obtained from natural sources such as animal, 
microbial and vegetable sources. They usually are of protein or polysaccharide nature (Qiu 
and Bae. 2006; Moura., 2013). Natural origins of these polymers make them suitable 
substitutes of the ECM and original cellular environment of the native skin. However, 
limitations to their applications are improvised as when isolated from animal and vegetable 
tissues, batch to batch variability and large heterogeneity are seen in addition to their high 
costs (Tabata. 2009; Sell et al., 2010). Disadvantages associated with the use of natural 
polymers, such as a high biodegradability can be overcome by modification with synthetic 
polymers. Natural polymers such as chitosan, collagen and gelatin can be successfully 
implemented to fabricate wound dressings with desirable properties, as polymers such as 
chitosan and similar substrates are the principle structural component of natural ECM 
27 
 
(Malafaya et al., 2007). Commonly used natural polymer is collagen that promotes healing by 
allowing attachment and migration. It is commonly used in medical devices as a coating or 
an implant. Other important natural biopolymers of increasing interest are hyaluronic acid 
which assists in providing scarless wound healing (Livesey et al., 1995; Balakrishan et al., 
2006). Chitosan is one of the most abundantly found natural polymers suitable for the use in 
wound dressings as it not only aids the healing process but is biodegradable, biocompatible, 
non-toxic, bioadhesive, bioactive, non-antigenic, anti-microbial and at the same time 
possesses haemostatic effects (Duo et al., 2001; Qiu and Bae. 2006; Melcafe and Ferguson. 
2007). 
 
2.5.1.2. Synthetic Polymers 
Synthetic polymers offer the advantage of overcoming many of the shortcomings seen in 
natural polymers as they can be synthesised and modified in a controlled manner according 
to specific requirements needed to produce constant and homogenous physical and 
chemical properties as well as stability (Zhong et al., 2010). However, they are biologically 
inert thus do not offer a therapeutic advantage as is seen in natural polymers. Commonly 
used synthetic polymers for wound dressings include polyvinyl alcohol (PVA), which has the 
capability of being favourably moulded in many dressing forms such as foams, films, 
particles, sponges and fibres. Additionally PVA can also provide excellent water absorption, 
mucoadhesion and oxygen permeability (Bourke et al., 2003; Perez et al., 2012). Other 
commonly used synthetic polymers include polyethyleneoxide (PEO) and polyethyleneglycol 
which serve an advantageous purpose in the healing process as they are non-toxic, 
biocompatible, non-immunogenic, hydrophilic and flexible and can further be used to 
incorporate mediators such as growth factors to assist the healing process (Lee and 
Mooney., 2001; Kim et al., 2008; Zhong et al., 2010). Tissue regeneration and wound healing 
applications can further be promoted with other beneficial synthetic polymers such as 
polycaprolactone which is biodegradable and compatible and reduces inflammatory infiltrate, 
polyurethane (PU), poly lactic acid, poly vinyl pyrrolidone polyglycolic acid (PGA), poly(lactic-
co-glycolic acid) (Qiu and Bae. 2006). 
 
2.5.1.3. Interpolymer Complexes 
Novel polymer combinations can be used to form scaffolds, wound healing meshes and films 
with improved mechanical, biological and chemical characteristics by hybridising polymers of 
natural origin with those that are synthetic and biodegradable (Slaughter et al., 2009). 
Combination of polymers allows for the integration of both polymer types thus exhibiting the 
advantages of both polymers, as ideally the most important features that polymers and 
biomaterials possess can be combined in a delivery systems for wound healing. Because of 
the range and complexity of polymer substances currently used, an ideal system cannot be 
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considered as one polymeric system. In order to achieve this, a wide range of biodegradable 
materials with specific and unique characteristics need to be developed (Kim et al., 2001). 
Current research efforts have focussed on the development of tailor made and custom 
designed biodegradable materials for specific applications with novel resorbable biomaterials 
by attempting computational and combinatorial approaches, development of biomimetic 
polymer structure with unique chemistries thus increasing diversity (Nair and Laurencin., 
2007). Tsao and co-workers (2011) reported the use of a polyelectrolyte complex which 
consists of chitosan and γ-poly (glutamic acid) (γ-PGA) as a wound dressing material. This 
complex combination allowed the exhibition of good mechanical properties, suitable moisture 
content and favourable removal without the damage of regenerated tissue. Kim and co-
workers (2003) also reported the use of chitosan with polyxamer to form a suitable wound 
dressing. In addition, a semi-interpenetrating polymer network was further introduced to 
provide enhanced compatibility and mechanical strength. Novel wound dressing applications 
have been improvised by novel bioprocesses and advances in organic chemistry, thus 
enabling the development of novel enhanced smart polymers as candidates for specialised 
and unique wound dressings that elicit favourable, biological, physical and chemical 
responses (Nair and Laurencin., 2007). 
 
2.5.2. Hydrocolloids 
Hydrocolloid dressings are amongst the most widely used dressings and are based on the 
modern dressing technology principle of creating and maintaining a moist wound 
environment. The term ‗hydrocolloid' describes the family of wound management products 
obtained from colloidal materials that are gel forming agents combined with other materials 
such as elastomers, gelatine, pectin, carboxymethylcellulose and adhesives. These agents 
may be bonded together to produce a thin film, sheet or foam with the properties of 
hydrocolloids, whereby a gel is formed on the wound surface to promote moist wound 
healing. Hydrocolloids are useful clinically because unlike other wound healing dressings, 
they adhere to both the moist and dry sites (Boatang et al., 2008). Cross-linkage of materials 
used in dressings influences the viscosity of the gel formed. Hydrocolloids are virtually 
impermeable to water vapour and air as they contain an occlusive outer covering that 
prevents water vapour exchange between the wound and it‘s surrounding; however, as the 
gel forms, they become progressively more permeable to air. Their properties of 
impermeability made them effective dressings for rehydration and autolytic debridement in 
the past; however, recent research suggests dressings with good water vapour permeability 
and gaseous exchange are characteristics for optimal wound healing. Pain associated with 
wounds may be reduced by the use of hydrocolloid dressings as their barrier and non-
adherent properties at the wound site allow patients to bath shower and maintain their daily 
activities without the risk of wound contamination. Hydrocolloid dressings are also available 
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as fibres in the form of a non-woven flat sheet that is hydrophilic. On exposure to moist 
surfaces such as wound exudates, they tend to form a soft coherent gel sheet from the 
previously dry dressing, thus making them effective dressings for wounds that produce a 
large amount of exudates. These dressings are referred to as hydrofibre dressings (Jones et 
al., 2006). 
 
2.5.3. Bioactives and Drugs 
Topical wound treatment aids are designed to overcome and rectify both structural and 
physiological imbalances, thus promoting a homeostatic environment at the wound site. 
Novel complex biodegradable systems can be modified to incorporate many active 
compounds to facilitate the provision of homeostasis and these features by incorporating 
actives agents such as anti-biotics, anti-inflammatories, anti-septics, antibodies and other 
bioactives. In the treatment of wounds caused by ulcers, Rayment and co-workers (2008) 
reported the use of tetracycline, doxycycline, bisphosphonate and hydroxamic acid as a 
protease inhibitor to inhibit high levels of excessive proteolytic activity namely MMP activity 
found in chronic wound fluid that have a negative impact on the influx of growth factors which 
positively influence the healing process. Curcumin which is a natural product derived from 
the rhizomes of curcuma longa has widely been used in the treatment of inflammatory 
conditions for centuries in indigenous medicine. Li and co-workers (2001) have shown the 
use of curcumin as an anti-oxidant and anti-inflammatory agent loaded into a 
nanoformulation of methoxy poly (ethylene glycol)-graft-chitosan composite film. Combined 
therapy which allows the use of drugs with different therapeutic outcomes and 
pharmacological actions ensures the inflammatory response is to the minimum and optimum 
allowing rapid healing. Combinational treatment using antibiotic drugs such as streptomycin 
prevents and treats infection whilst the concurrent administration of anti-inflammatory drugs 
such as diclofenac can relieve the swelling and pain associated with injuries and wounds by 
targetting the inflammatory phase of wound healing (Pawar et al., 2013). 
 
Inherent in the process of normal wound healing is the involvement of endogenous growth 
factors. Insulin-derived growth factors, platelet-derived growth factor (PDGF), epidermal 
growth factor (EGF) and transforming growth factor (TGF) amongst others contribute to the 
process of homeostasis regulation, cytokine attraction, restoration and repairment of tissue 
and remodelling of the wound site (Miller. 2009). To improve the healing outcome, a 
foundation for therapeutic intervention must be instilled. For successful healing, the cell–
matrix and cell–cell interactions are fundamental whereby a balance is maintained by 
cytokines and growth factors, thus regulating cellular migration, adhesion and proliferation to 
a large extent (Kiwanuka et al., 2012). Within the clinical practice, growth factors are been 
employed to accelerate the healing process and to ensure rapid and full recovery that is 
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clean and scar free (Judith et al., 2010; Bao et al., 2009; Pawar et al., 2013). Growth factors 
can be integrated in wound healing delivery systems as the healing cascade involves 
continuous and dynamic processes in a step by step manner. Accelerated or retarded tissue 
repair can be influenced by various factors and cells. Some of these include growth factors 
such as epidermal growth factors (EGF), TGFs, fibroblast growth factors (FGFs) and PDGFs. 
These growth factors play a crucial role as critical modulators that have the capacity to 
orchestrate all events occurring within the wound healing cascade. 
 
Epidermal growth factors have successfully been used in the process of wound healing by 
enhancing proliferation, cell motility as well as mesenchymal and epidermal regeneration 
(Hardwicke et al., 2008). However, with regards to superficial wounds, a limitation exists with 
the use of EGF in that they have a limited transdermal permeability, which does not allow for 
further distribution to the stratum corneum and underlying dermal stem cell layers thus 
compromising optimal healing (Cohen. 1983; Tolino. 2011). This is largely due to their large 
size and hydrophilic nature. Choi et al (2012) prepared a system by employing recombinant 
technology whereby a low-molecular-weight protoamine (LMWP) was conjugated to EGF 
thus allowing enhanced transdermal properties. LMWP is an arginine-rich cell penetrating 
peptide that has the capacity to deliver large molecules such as proteins and gene products 
into the cells (Park et al., 2005; Gurther et al., 2008). TGFs and PDGFs display chemotactic 
and mitogenic properties during the inflammatory phase whereby they mediate chemotaxis of 
neutrophils, fibroblast and macrophages at the wound site. Both TGF and PDGF can be 
incorporated into wound dressing systems simultaneously in order to provide an additive 
therapeutic effect (Pierce et al., 1991; Robson. 1991).  To determine the effects of growth 
factors, a wound model was designed by Mustoe and co-workers (1992) by creating an 
excisional defect measuring 6 mm on a cartilage of a rabbit. A PDGF-BB system composed 
of a PDGF-B dimer was applied to the wound area to determine healing progress. The 
influence of the growth factor system resulted in an increased volume of granulation tissue at 
the wound site comprising greater deposition of both glycosamine and hyaluronic acid. The 
addition of TGF showed a further increase in granulation tissue together with the formation of 
new and increased collagen. Thus, it can be deduced that growth factors such as TGF play 
an active role in stimulating inflammation and angiogenesis, whereas other factors such as 
FGFs ensure the presence of fibroblast within the collagen matrix at the wound site to 
promote homeostasis. In addition, PDGF play a chemotactic role for fibroblast and allow 
mutagenesis of mesenchymal cells (Cromack et al., 1990; Mustoe et al., 1991).  
 
However, many factors need to be taken into account when designing delivery systems 
incorporating growth factors as they may significantly affect the therapeutic efficacy. Most 
growth factors in their native form are susceptible to degradation on administration and have 
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low membrane permeability. In addition on manipulation, these proteins are easily denatured 
and may cause multiple side effects if administered in high or multiple doses to reach a 
desirable therapeutic concentration. Wound healing is a dynamic and complex process 
whereby many intricate processes involved may overlap. Thus, it is essential to ensure that 
the precise growth factors are elected when designing a delivery system. Chen and co-
workers, 2010 have reported the possible inhibitory effects of growth factors on wound 
healing when delivered in combination or alone. In vivo models on spontaneous bone healing 
have shown the reduction of bone formation in comparison with controls when treated with 
TGF-β and BFGF. Thus, the efficacy of recombinant human TGF-β1 delivery can also be 
challenged as it is found to have proliferative effects only on cells already involved in the 
osteoblastic lineage. This suggests that inhibitory effects may be induced on osteoblast 
formation in vivo. Combined growth factor delivery such as BMP-2 and IGF-1 has also 
demonstrated inhibitory effects on bone healing and osteoblast differentiation under in vivo 
and in vitro conditions. Thus, it can be seen that critical considerations need to be taken into 
account when designing a growth factor incorporated delivery system or recombinant 
delivery systems as these findings are due to adverse combinations. Thus, inappropriate 
growth factor combinations can lead to undesirable outcomes when erroneous stimulations 
causing signalling of multiple cascades occur (Chen et al., 2010). Regulation of cutaneous 
healing has been extensively researched with regards to their cellular and molecular 
function. However, the cell to cell communication and intracellular systems involved in the 
effective repair of cutaneous wounds have not been established. Thus, all aspects of the 
wound healing response cannot be effectively mediated by a single exogenous agent; 
therefore combinational drug therapy is required. 
 
The platelet is a rich source of a complex group of growth factors. Moreover, they have the 
ability to assist in clot formation warranting cessation of local lymph and blood loss together 
with recruiting crucial cytokines and growth factors that induce and accelerate the healing 
process. Recruitment of growth factors as active healing agents from platelets occurs upon 
its degeneration caused by proteins (Carter et al., 2003). The use of a platelet gel will infer 
significant advantages to the process of wound healing. A platelet gel is a hemocomponent 
that can be obtained by associating cryoprecipitates and activated hyper-concentrated 
platelets. Within a platelet gel, growth factors can be released to procure clinical healing 
processes whereby homeostasis and tissue regeneration can be restored (Crovetti et al., 
2004). Kazakos and co-workers (2009) have shown a platelet gel to be effective as a drug-
delivery system that promotes homeostasis, angiogenesis and remodelling by sensitivity to 
growth factors. Platelet-rich gels have been reported to be effective in chronic non-healing 
wounds and acute soft tissue wounds. Patients treated with platelet-rich gels initiated 
adequate tissue regeneration and faster healing rates (Kazakos et al., 2009).Platelets serve 
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as specialised secretory cells that have the ability to release a large number of biologically 
active substances such as growth factors upon activation thus modulating the healing 
process (Sandri et al., 2011). Growth factors influence many processes involved in tissue 
repair which include chemotaxis, cellular proliferation, angiogenesis as well as the synthesis 
of the ECM (Sandri et al., 2013).Of paramount importance is the development of a suitable 
therapeutic vehicle that will allow the release of growth factors according to the wound 
healing requirements. This is of great significance as the efficacy of hemoderivate growth 
factors critically depends on the way they are made available to the injury site. Platelet-rich 
plasma can be employed to provide a therapeutic effect by activation and preparation of a 
‗lysate'. This process involves the destruction of platelets by freeze–thawing and the 
attainment of bioactive molecules, which begins in a platelet-rich plasma sample in the 
presence of anticoagulant agents. Platelet lysate can be prepared from donors (allogenic) or 
from the patients themselves (autologous) (Sandri et al., 2013). Clinically, platelet lysate has 
been shown to be effective in the healing of oral mucositis and occipital decubitus ulcers. 
Furthermore platelet lysate has been proven capable in promoting the healing process in 
corneal and buccal lesions (Caramella et al., 2011). Rossi and co-workers (2013) 
successfully demonstrated the use of a sponge-like dressing to deliver platelet lysate in the 
treatment of chronic wounds and concluded that platelet-rich preparations have the capacity 
to release their complete pool of biologically active substances. 
 
Many challenges are faced when designing a delivery system or wound dressing that will 
ensure adequate and optimal therapeutic effects. These challenges include high viscosities, 
over adhesion and phase separation. In addition, many physiological factors can impose an 
undesirable effect when dealing with wound healing. One such factor would be fibrosis and 
excessive wound contraction of injured skin that may result in a fibroproliferative state 
causing limited or suboptimal use of the site infected together with the presence of 
hypercontractile scars. Mast cells, released during the healing process, regulate the healing 
process; however, when in excessive amounts, can result in hypercontractility, fibrosis and 
fibrotic scars. Thus, Gallant-Behm and co-workers (2008) introduced the use of a stabiliser 
known as ketotifen at wound healing sites, thus decreasing the rate of wound contraction and 
avoiding unwanted fibrosis. Other stabilisers that are shown to be medically useful include 
Lewis acids such as nitric oxide, sulphur dioxide and boron triflouride (Gallant-Behm et al. 
2008).  Another class of stabilisers include free radical stabilisers such as catechol, 
hydroquinone, monomethyl ether hydroquinone, monoethyl ether hydroquinone and 
nitrhydroquinone. Sulphonic acid and sulphur dioxide have also been shown to display 
anionic stabilising effects when in combination (Asbill and Mickmack. 2000). 
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Anti-oxidants, anaesthetics, analgesics and preservatives are other incorporates that can be 
included in wound healing dressings. The addition of such substances may enhance the 
overall therapeutic outcome of wound dressing delivery systems. Li and co-workers (2002) 
have stated the use of anti-oxidants such as alkaloids, triterpenes and flavanoids as an 
application to prevent oxidative stress that may result in further pathogenesis due to lipid 
peroxidation and free radical scavenging. Anaesthetics such as lidocaine and bupivacaine 
can be used at the wound site either incorporated within wound dressings or injected at the 
injury site to reduce the pain associated with open wounds. Minor dermal lacerations can be 
treated with an anaesthetic known as tetracaine–epinephrine [adrenalin]–cocaine (TAC) 
topically. Anti-inflammatory agents such as NSAIDS and corticosteroids can be used in 
dressings to prevent progressive inflammatory damage thus promoting speedy healing 
(Shah. 1994). 
 
2.6. Employment of Cell Based Therapies for Wound Healing 
 
2.6.1. Gene Therapy in Cutaneous Wound Healing 
Advances in cell biology have led to the identification of various factors such as growth 
factors and their receptors and genetic therapy. Recent research interest has found the skin 
to be a significant target for gene therapy. Gene therapy involves the insertion of a gene into 
the recipient skin cells that acts as a vehicle. Possible application of gene therapy is made 
simpler by the cultivation and harvesting of fibroblasts and keratinocytes. There are two basic 
strategies that can be implied for the introduction and expression of foreign DNA and genetic 
material into host cells. These strategies include genetic medicine whereby short-term 
expression of a gene product is transformed and permanent insertion of genetic material 
such as DNA at the target site (Khavari et al., 2002). The delivery of genes can be conducted 
under either in vivo or ex vivo conditions. Ex vivo delivery involves a technique whereby 
transplantation of genetic material to the host can be done upon cultivation and isolation of 
selected cells with their transfection in vitro. In vivo techniques employ a direct introduction to 
genes to the target tissue (Sprugel at al., 1987). 
 
Classification of gene delivery systems employs two procedures namely viral or non viral 
vectors. Viral techniques involve the use of viruses as natural vehicles for gene delivery. The 
technological strategy involved in this technique is to generate a replication-defective particle 
by replacement of some viral genes with the gene of interest conveying the desired 
therapeutic effect (Kootstra and Verma. 2003). ‗Packaging cells' are specialised cell lines 
which may be engineered to restore recombinant viruses when a viral gene is removed. The 
development of therapeutical gene vectors can be can be approached by the modification of 
several types of viruses. These include retroviruses and lenti viruses as non-lytic replicators. 
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Lytic receptors are also employed such as the herpes simplex virus, adeno-associated 
viruses and human adeno viruses. Non-lytic replicators leave the host cell relatively intact 
and are created from the cellular membrane of infected cells, whereas lytic replicators 
involve the release of a virion upon the collapse of a host cell after infection (Branski et al., 
2009).  Several authors have described the successful use of viral vectors in cutaneous 
wound healing. Platelet-derived growth factor B (PDGF-B) was transferred to an adenoviral 
vector in a chronic wound of a rabbit ear by Liechty and co-workers (1999). Findings showed 
accelerated and rapid re-epithelisation of the wound site on comparison with control groups 
(Galeano et al., 2003). Furthermore epithelisation regeneration and neo-angiogenesis can be 
accelerated by a gene–vector combination of vascular endothelial growth factor A (VEGF-A) 
and serotype 2 of Adeno-associated viruses as reported by Deodato et al., 2002; Galeano et 
al., 2003 and Branski et al., 2009. Viral vectors play a significant role in gene therapy as they 
are the most established and original. Successful applications for cutaneous wound healing 
have been made possible by the use of viral vectors. However, of particular concern with the 
use of virus-mediated gene transfer models is the risk of both systemic and local infections 
and transfection efficacy. The production of viral vectors is also cost and time consuming 
(Branski et al., 2009). 
 
An alternative approach employed is the use of non-viral vectors whereby genes are injected 
directly into the skin. However, employment of the native DNA constructs show low 
transfection efficacy, undergo degradation easily and have limited penetration into cells due 
to their electrical charge and large size (Vogel. 2000). Advantages of this type of therapy 
include the delivery of genes to target cells without the repeated exposure to viral vectors 
and cellular damage. In addition, prevention of recombination with wild-type viruses is also 
avoided. On a large scale, non-viral vectors are easier to manufacture employing plasmids 
constructs grown with existing fermentation technology (Ortiz-Urda, 2002). Modification of 
these vectors are required due to their drawbacks as discussed above, thus techniques such 
as ‗micro-seeding', ‗gene-gun', extrapolation and the use of cationic liposomes can be 
employed. ‗Micro-seeding' involves the use of solid needle mounted on a modified tattooing 
machine to directly transfer the desired gene to the target cell. However, transfection using 
this method was only observed in superficial layers (Eriksson et al., 1998). The ‗gene-gun' 
method infers gene propellation into skin cells via the use of tungsten or gold-coated 
particles. This method has reported successful transfection results whereby significant 
improvement in wound healing was noted when gene gun particle mediated transfection of 
different PDGF isomers utilised (Eming et al., 1999). Cationic liposomes are surrounded by 
negatively charged DNA strands that offer protection. These complexes are synthetically 
prepared and contain a positively charged surface. Uptake of these complexes occurs by 
endocytosis when the net positive charge of liposomes binds to the negatively charged cell 
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surface (Felgner and Ringold. 1989). Thus, genes encapsulated in liposomes may be applied 
by direct injection or topically. Studies utilising IGF-I cDNA transfected in animals revealed 
increased basal skin proliferation in wounded tissue (Jeschke et al., 2000). The extrapolation 
technique utilises electrical field induction with simultaneous administration of growth factors 
and plasmid DNA. Lee and co-workers (2004) reported the use of electropolation in 
combination with tissue growth factor β1 in diabetic mouse wound models. An increased rate 
of re-epithelisation, angiogenesis and collagen formation was reported (Lee et al., 2004; 
Branski et al., 2009). 
 
2.6.2. Stem Cells and Wound Healing 
Wound healing is a dynamic process that integrates complex molecular and biological events 
during the healing cascade involving inflammation, proliferation and remodelling. The 
creation of a complex viable skin substitute is of significance, however, is difficult and 
challenging to reconstitute. A complex structure can be created by the use of stem cells as 
they have the ability to differentiate into various tissue types by asymmetrical replication. 
Moreover they can prolong their self-renewal capacity. Stem cells can be isolated from a 
variety of sources which include the bone marrow, adipose tissue, umbilical and peripheral 
blood as well as skin and hair follicles (Branski et al., 2009). These cells have the ability to 
modulate healing responses in both acute and chronic wounds. Stem cells show promising 
results in cutaneous wound healing as studies have shown the persistence of stem cells 
originated for eleven months post grafting (Flowers. 1990). Furthermore, these stem cells 
initiated from male cells show potential effects in female hosts thus suggesting that stem 
cells have the ability to differentiate in a variety of tissues and exist in all tissues (Cairns. 
1975). Furthermore, they have a very long life. Han (2005) have reported the acceleration of 
wound healing on application of human bone marrow stromal cells in vitro. Dermal 
reconstitution was achieved by the development of new elastic fibres of treated wounds by 
Falanga (2005) Human autologous bone marrow-derived cultured cells were applied to non-
healing and acute wounds. Thus, it can be seen that stem cell therapy has made a significant 
contribution to the study of the basic mechanisms of cell proliferation, differentiation and 
remodelling. Stem cells thus offer an alternative approach to reconstitute wounded structures 
as they have been proven effective in the development of cellular therapy. 
 
2.6.3. Gap Junction and Connexin 43 Mimetic Peptides in Wound Healing 
Research and development in drug-based therapies have led to the introduction of diverse 
pathways with dynamic complex mechanisms that promote the healing processes. Recent 
studies have indicated that targetting of gap junctional connections in wound healing 
pathways may provide an unexpected breach to scar free healing. Between cell gap 
junctions couplings are formed by aggregates of protein that form intercellular channels and 
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are encoded by the connexion multigene family. A significant aspect influencing cutaneous 
injury response are intercellular communications mediated by gap junctions. Functions of 
connexions specific to wound healing include wound closure and scar tissue formation after 
injury, inflammatory response co-ordination and propagation of injury signals between cells 
(Wei. 2004). Connexion 43 (CX43) peptides can potentially be targeted at wound sites to 
influence the healing progression as they have been found to be expressed in both the 
epidermis and dermal layers (Goliger and Paul. 1995). Throughout the process of wound 
healing, CX43 communication and expression has been found to decrease transiently in 
epidermal cells, thus decreasing intercellular coupling and gap junctional communication 
levels (Richards. 2004).  Transient knockdown of the CX43 protein in a wound bed by the 
employment of an antisense oligodeoxynucleotide shows promising results in the early 
stages of wound healing. Qiu and co-workers (2003) reported a single application of the 
antisense dramatically improved the rate of healing and the macroscopic wound appearance 
in a wound healing model. Another study conducted by Qiu and co-workers (2003) revealed 
the use of CX43 antisense oligonucleotides reduces infiltration of inflammatory cells and the 
overall area of granulation tissue formation post injury. Wound healing processes were 
accelerated as well. Furthermore, it has been shown that CX43 antisense treatment 
significantly increases the level of TGF-β1 mRNA thus further promoting the wound healing 
process. It can be deduced that by transiently disrupting one signalling pathway through the 
knockdown of a specific type of gap junction channel CX43, responses involved in the 
process of inflammation can be dampened. This allows for enhancements in the rate of re-
epithelisation by positively targetting the early stages of wound healing. The mechanism 
involved with the down regulation of transient CX43 causes a decrease in the recruitment of 
cytokines such as neutrophils and macrophages subsequently dampening their 
amplifications and further blocking the exuberant influx of leukocytes that lead to scarring 
(Kapoor. 2005).  In addition, CX43 down regulation can be employed as a safe and effective 
technique in wound healing therapy approaches as they can further enhance epidermal 
closure in the early stages of wound healing (Rhett et al., 2008). 
 
2.7. Classification of Wound Dressings 
There are many classification criteria used for the classification of wound dressings. These 
include classification by the physical form of the dressing such as gels, ointments, creams, 
films and scaffolds (Buyuktimkin. 1997).  Further, classification may depend on the function 
of the dressing in the wound, namely debridgement, adherent, antibacterial, occlusive or 
absorbent (Morghimi et al., 2009) or by the type of material employed to produce the 
dressing such as alginate, chitosan, hydrocolloid and collagen (Quintero. 2003). Yet another 
classification criterion include traditional wound dressings, advanced modern wound 
dressings, wound healing devices and skin replacement products. Primary and secondary 
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dressings distinguish between those that make direct contact with the wound surface and 
those dressings that are used as a cover on primary dressings respectively. In addition, 
island dressings are those dressings that contain an outer adherent portion with an inner 
absorbent centre (Bolton and Fattu. 1994; Boateng et al., 2008). The discussion that follows 
classifies the various wound management aids according to the physical form of the 
dressings discussed.  
 
2.7.1. Traditional Wound Dressings 
Wound dressings have been used widely for at least the past two millennia; however, germ 
theory and its treatment are only about a century old. Cotton wool, natural and synthetic 
bandages and gauze were used as absorbent wound dressing material to absorb exudates 
and provide physical protection (Falabella. 2006). These dressings are dry and do not 
provide a moist environment. They may be used to perform a specific function in conjunction 
with other wound dressings such as hydrogels and colloids whereby each dressing 
component plays a pivotal role in the wound healing process. Traditional dressings are 
functional as both primary and secondary dressings. These traditional wound healing agents 
have largely been replaced by modern technologically advanced devices with the ability to 
provide a moist environment, ensure effective gaseous exchange, prevent bacterial 
contamination and colonisation as well as prevent maceration of the wound and 
accumulation of exudates as discussed above. Traditional dressings such as gauze and 
cotton wool have limited effectiveness with regards to these functions and further have the 
tendency to become adherent to the wound site as the fluid content diminishes, thus making 
it painful to remove. Gauze dressings allow evaporation thus causing dehydration of the 
wound site resulting in a delayed wound healing process (Boateng et al., 2008). In addition, 
gauze dressings are made of interwoven fibres of cotton and polyester which may become 
loose and embed within the skin at the wound site causing great patient discomfort. Other 
traditional agents include topical formulations such as ointments, gels and creams which may 
be in the liquid-gel phase as well as suspensions, solutions and emulsions in the liquid 
phase. Many formulations are available that included the following: chlorhexidine, used for 
the irrigation of wounds as it has antibacterial properties, lack of toxicity and enhancement of 
the healing phase, povidine iodine, which is available commercially in several formulation 
forms (solution, cream and ointment) and is used in wound management for its antiseptic 
properties and wound cleansing thus preventing or treating localised infections. Other agents 
include hydrogen peroxide for its antiseptic and disinfectant properties as well as cadexomer 
iodine available as an ointment (Purner and Babu. 2000).  Because of the low viscosity of 
many topical formulations such as those found in the solution form, they have the 
disadvantage of having a short residence time at the wound surface especially at high 
exudating wound sites thus limiting their activity as wound management aids. Agents such as 
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gels and ointments have a longer residence time due to their semi-solid state, however a 
high degree of exudation and wound fluid will be absorbed when applied to a highly 
exudating wound. Semi-solid preparations are not very effective as they lose their rheological 
characteristics and flow easily away from the wound site thus hindering their wound healing 
capabilities. 
 
2.7.2. Lyophilized Wafers and Drug Incorporation 
Lyophilised wafers have potential as drug-delivery systems for suppurating wounds, as they 
can be applied directly to the wound surface. Freeze dried wafers made from polymeric 
solutions or gels to yield solid porous structures can be used to incorporate drugs promoting 
wound healing and applied to the wound surface. Their physical architecture resembles 
those of foam dressing sheets which are made of PU, sometimes with adhesive borders 
(Queen et al., 2004).  Wafers have the capacity to absorb fluid such as excess exudates and 
revert to its gel form in order to allow the diffusion of the contained drug. With conventional 
products such as gels and creams, the amount of drug applied to the wound surface is 
unpredictable and difficult and there is often a high degree of fluid been discharged from the 
wound site. The use of dried wafers addresses a major hurdle with regards to drug 
incorporation, as the wafer relies on the presence of discharge from the wound site to form a 
viscous gel allowing targeted drug delivery, whereas in contrast gels and other conventional 
therapies are diluted by discharge, thus reducing its viscosity, causing the gel to run from the 
target area together with the active drug essential for treatment. Therapeutic agents such as 
antibiotics and growth factors may be incorporated into lyophilised wafers to ensure 
sustained release of drug particles (Van Rijswijk.2006). 
 
2.7.3. Hydrogels 
Rosiak and co-workers (1989) invented hydrogels as the basic material used for 
manufacturing of wound dressings in 1989. Since then, many modifications have been 
undertaken to improve their physical and chemical properties. Hydrogels are hydrophilic, 
insoluble, and swellable dressings made mostly from synthetic polymers such as 
polyvinylpyrrolidine and methacrylates. Hydrogels contain water molecules of up to 80%–
90%, thus allowing them to maintain a moist environment at the wound site by the donation 
of water molecules. Unlike hydrocolloids, hydrogels cannot absorb much exudate and are 
thus not suitable for wounds producing a high amount of exudates. Maceration of the skin 
may result due to fluid accumulation and poor absorption properties, this may then lead to 
bacterial proliferation and the production of a foul odour from an infectious wound site. One 
of the major problems associated with the application of hydrogels, is their poor mechanical 
strength. The plasticising effect of water held within the polymer network is the underlying 
cause of their poor tear strength and limited resistance to mechanical deformation. Ironically, 
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it is this same structural feature that dominates permeability, selectivity and surface 
properties thus giving hydrogels their interesting and unique properties such as improved 
transmission of moist vapour and oxygen (Lawrence. 1994).  Hydrogels with greater 
mechanical strength and elastic properties were then thus formulated by the incorporation of 
hydrofibres and reinforcing agents such as small scale inorganic particles (Cooper. 2005; 
Matthews et al., 2005; Boatang et al., 2013). Hydrogels rehydrate non-viable tissue thus 
promoting wound debridement and facilitating the natural autolysis process. In addition, they 
reduce the pain at the wound site as they are non-adherent and cool the surface of the 
wound. They are considered as the standard treatment form for the management of necrotic 
and sloughy wounds. Amorphous gels that usually are in the form of thick, viscous gels are 
the most commonly used hydrogels (Rosiak., 1989)  Properties of hydrogels include: 
 Supply moisture to wounds with low to medium exudates 
 May cause macerations 
 Useful in flat wounds, sinuses and cavities 
 Suitable for necrotic and sloughy wounds 
 Need secondary dressing 
 May stay in place for several days 
 Examples include: Aquaform, Intrasite, Granugel, Nu-Gel, Purilon, Sterigel   
 
Gels may also be formed i-situ upon contact the skin surface. A natural polymer alginate is 
an example whereby application of alginate dressing at the wound site results in the 
exchange of ion from the alginic fibres with those of the exudate and blood thus forms a 
protective coating of gel which maintains optimal healing temperature and moisture content. 
The gelation properties of the alginates are attributed to cross-linking in the presence of 
calcium ions which help to form a polymeric cross-linked gel with low degradability 
properties. The formation of cross-linking between calcium ions and the alginic polymer 
make it the ideal material for scaffold formation for tissue engineering (Corkhill. 1989; Kokabi. 
2007).  Polymer alginate gels are highly absorbent and need to be changed daily, need 
secondary dressings, are for all wound types with high exudates and are useful for sinuses, 
cavities and undermining wounds. Examples of alginate dressings include Tegagen, 
Urgosorb, Sorbsan SA, Algisite and Algosteril (Rosiak. 1989). 
 
2.7.4. Wound Healing Films 
A film may be described as a homogenous structure with uniform properties and may include 
co-polymers, homopolymers and plasticised polymers (Churochkinaet al., 1998). Films 
dressings have been used tremendously in the past for the management of wound healing 
and are currently still used in day-to-day clinical practice. They may be used as a primary or 
secondary dressing and are also often incorporated into other dressings such as hydrogel 
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sheets, composite dressings, foams and hydrocolloids (Matthews et al., 2005). These 
dressings were originally manufactured from nylon derivatives and supported in an adhesive 
polyethylene frame, thus making it occlusive (Gao et al., 1993; Lansown et al., 2003). 
However, these dressings did not allow for absorption of exudates thus creating a favourable 
environment for bacterial contamination. They also contained limited exchange of water 
vapour and gases which delayed the healing process. Modern films dressings are semi-
permeable adhesive sheets made by drying polymeric solutions or gels of acrylic derivatives, 
nylon (Queen et al., 2004) or natural polymeric materials such as chitosan. They are 
transparent and may be modified, thus making them permeable to oxygen and moist water 
vapour yet waterproof. Because of their semi-permeable nature they help maintain a moist 
wound environment by trapping moisture at the wound surface, they facilitate cellular 
migration and promote autolysis of the necrotic tissue. They also provide a barrier thus 
preventing bacterial contamination. Films are used for superficial wounds and wounds with 
light exudates. They may be also used as a retentive for primary dressings; in addition semi-
permeable films are relatively economical (Guncem et al., 2009). 
 
Semi-permeable films are formulated from various individual polymers, biomaterials, 
copolymers and block polymers but in addition are highly modified to suit the purpose of 
semi-permeability, thus allowing specified entry and release of gases and moisture. 
Interpenetrating (IPN) or semi-interpenetrating polymer network (s-IPN) formation serves as 
a method to produce semi permeability. IPN can be defined as a system comprised of two or 
more polymers that are combined where one of the polymers is cross-linked or in the 
immediate presence of the other. A novel property profile is introduced by the advancement 
in multi-component polymeric systems and these semi-permeable films include the following 
properties (Van Rijswijk. 2006): 
 Promote a moist environment 
 Allow visual checks and adhere to healthy skin but not to the wound 
 Are suitable for flat shallow wounds with low to medium exudates 
 Are not for infected or heavily exudating wounds 
 Useful as secondary dressings 
 May be left in place several days and provide no cushioning 
 Marketed examples include Bioclusive Mefilm, Opsite and Opsite plus, Tegaderm, 
Flexigrid. 
 
2.7.5. Wound Healing Foams 
Foams are structures that contain a large fluid binding capacity and are processed in the 
form of a sponge or foam (Churochkina. 1998). A sponge may be defined as a solid matrix 
characterised by the dispersion of gas particles which is usually air. Within the 
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pharmaceutical and biomedical arena, there has been great interest for the use of sponges 
and foams for wound dressing applications, controlled drug delivery, and within the tissue 
engineering field, as a matrix for cell growth (Queen et al., 1987).  Advanced pharmaceutical 
formulations such as foam dressings, scaffolds, hydrogels and films have been designed in 
order to distribute therapeutic substances to exudating wounds in a controlled release 
manner. These formulations may contain pain-relieving, anti-bacterial and anti-inflammatory 
therapeutic agents. Drug-delivery systems such as foam dressings have high exudate 
absorbing properties and thus can be used effectively for exudate wounds, as it has been 
shown to have advantages in treating chronic low-to-high exudating wounds in comparison 
with dressings of poor absorbing properties (Sussman. 2010). The use of natural polymers 
and polysaccharides have developed unfound interest for the design of foams and sponges 
due to their favourable characteristics such as low toxicity, biodegradability, favourable 
mechanical properties and bioresorption ability of the constituent materials. One such 
example is alginate which is derived from brown algae and is an anionic linear 
polysaccharide composed of 1,4-linked β-d-mannuronates residues and 1,4-linked α-l-
guluronates in varying proportions (Debra and Cheri. 1998). Alginate has widely been used 
in the medical field as a wound dressing application, scaffolds, surgical and dental 
impressions as it is hydrophilic, relatively economical and biocompatible (Weller and 
Sussman, 2006). Its use as dressings for wound treatment stems primarily from the ability to 
form gels on exposure to wound exudates thus giving them high absorbent properties thus 
minimising microbial contamination and limits wound secretion. Alginate dressings occur 
either in the form of freeze dried porous sheets (foams) or as flexible fibres. 
 
2.7.6. Multi-Layered Wound Dressings 
Wound healing is an intricate and complex process that requires many favourable biological 
processes in order to ensure optimal healing. As discussed above some of these 
characteristics include a moist wound environment, adequate gaseous exchange, absorption 
of wound exudates and infection prevention. In order to promote all of these characteristics, 
multi-layered wound dressings can be developed. Lee and co-workers (2012) have 
discussed the formation of multi-layered wound dressings of various properties such as the 
combination of an adhesive layer with an absorbent layer for highly exudating wounds. More 
sophisticated dressings can also be implemented such as the development of a dressing 
which consists of a transmission layer; a core that is absorbent and a contracting wound 
layer which limits the lateral extend of exudates in the dressing to the region of the wound 
(Saltzmann and Olbricht., 2002). Lee and co-workers (2012) further developed a hydrogel 
multi-layered dressing whereby a base layer was formed to provide mechanical support lined 
by an absorbent top layer. Optimal healing can be achieved by incorporation of the various 
characteristics into a multi-layered wound dressing. 
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2.7.7. Nanofibrous Scaffolds and Mats for Wound Healing 
Research in this field include many areas such as biomaterial sciences, design aspects 
involving engineering for the creation of both 2D and 3D cell expansions and tissue growth, 
biology whereby cell proliferation and differentiation occur. Other aspects include 
biomechanical and informatic properties of design. Deep open wounds are unable to 
regenerate by themselves in some cases thus the creation of a scaffold will promote the 
natural sequence of healing events by providing mechanical support to the development of 
neotissue (Lutolf and Hubbell. 2005). A Scaffold is a network that supports and holds 
together living tissue. They are produced by the body naturally after injury or when a wound 
occurs, but they may also be engineered as a tissue substitute to speed up the healing 
process. Synthetic and natural polymers which are biodegradable and compatible have been 
used for the development of scaffolds for tissue engineering. Scaffolds of optimal activity 
should mimick the biological function as well as the structure of the bodies ECM, thus 
regulating cellular activity and maintaining mechanical support (Chung and Park. 2007).  
Cellular activity may be induced to ensure tissue regeneration by the engineering of scaffolds 
that provide biological function. Functionalisation of the surface of a 3D scaffold will promote 
cell adhesion by specific cell matrix interactions (Langer and Vacanti. 1993). In addition, 
many growth factors and other immunologically active substances may be interdispersed 
within a scaffold. Growth factors have the ability to signal molecules thus inducing tissue 
repair, in particular proliferation, differentiation, cell migration and organisation within a 
functional tissue (Steven. 1996).  Biodegradable polymeric scaffolds for tissue engineering 
promote cellular and tissue growth by providing a spatial and temporal environment. 
(Hutmatcher. 2000; Kenawy et al., 2002, Khil et al., 2003; Vachon and Yager., 2006). 
Scaffolds that are formulated by electrospinning from materials such as collagen (Khil et al., 
2003), poly ethylene-co-vinyl alcohol (Thakur et al., 2008) PU (Peter et al., 1998) and 
collagen-PEO (Queen. 1987) may be potential applications in the treatment of wounds, as 
such substrates have the ability to accommodate high amounts of exudates due to their high 
void volumes. They may also have the ability to improve the breathability and permeability of 
the applied wound dressings (Diegelmanns and Evans. 2004). The ideal scaffold requires 
several chemical and structural features: (i) the desired shape, mechanical strength and 
volume contained within a three dimensional architectural structure,( Hutmatcher. 2000; Khil 
et al., 2003)  (ii) minimisation and prevention of immune and inflammatory responses by the 
insurance of a biodegradable and compatible chemical composition of products and at the 
surface of the wound site, (iii) a well interconnected open pore structure and highly porous 
scaffold that allows for optimal tissue in-growth and high cell seeding density and (iv) 
provision of sufficient support to impaired tissue until its full re-growth by a finely tuned in 
pattern of the degradation rate of polymeric scaffold. (Hutmatcher. 2000; Senet. 2004). 
Techniques such as the application of nanotechnology will ensure the fabrication of a 
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biodegradable scaffold for directing a series of tissue regeneration processes in a more 
active manner promoting faster wound healing. 
 
2.8. Recent Research Focus: Healing from a Molecular and Structural Perspective 
The underlying principle for the treatment of wounds is that dissociated cells should have the 
ability to reassemble into a structure that resembles the original skin infrastructure. Native 
ECM is a dynamic and hierarchically organised nanocomposite that interacts, promotes and 
regulates cellular functions such as adhesion, proliferation, migration, morphogenesis and 
differentiation in addition to providing mechanical support (Mallefet and Dweck., 2008). A 
stable multifunctional matrix is created by the linkage of supramolecular structures by 
multiple binding domains. The typical skin structure contains structural protein fibres such as 
elastin fibres and collagen fibres which naturally have dimensions ranging from 10 to several 
hundred nanometres. These protein fibres that are nanoscaled entangle with each other in 
order to form a non-woven mesh that provides the skin with its elasticity and tensile strength. 
Within the ECM, adhesive proteins that are also nanoscaled such as fibronectin and laminin 
exist that provide specific binding to ensure cell adhesion. Native ECM contains less than 1% 
solid material, yet still has the capacity to provide diverse functionality and remain 
mechanically robust. Thus, it can be observed that nature tends to assemble structures with 
the minimal amounts of material as necessary and the optimal solution is building 
hierarchically organised structures from the molecular level up to macroscopic scale. The 
mechanical properties of biological tissue are modulated by nature by adjustments of the 
tissues composition with a perceivable alteration to its nanoscale organisation (Goldberg et 
al., 2007).  
 
The skin has a unique biochemical composition, viscoelastic properties and structural 
organisation thus an attainment of the understanding of its hierarchical tissue organisation 
and function from a molecular level to microscopic level will more than likely provide a 
rational guide for the design of films, scaffolds etc that offer synthetic ECM substitutes. With 
the use of nanotechnology, biodegradable polymers can be modified to recapitulate the 
hierarchical organisation of natural ECM thus, artificial substitutes in the form of scaffolds, 
films etc can be engineered that mimick the morphological features of the skin (Goldberg et 
al., 2007; Steffensen and Herping. 2008). 
 
2.9. Nanotechnology 
The field of nanotechnology relates to structures like nanofibres, nanoparticles, nanorods 
and nanotubes with unique chemical, mechanical and optical properties. New dimensions 
can be envisioned for areas such as wound healing and tissue engineering drug delivery with 
regards to enhancing the therapeutic aspect whilst reducing side effects and risks when 
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introducing novel concepts such as nanotubes, nanofibres, nanorods and branched 
nanoobjects (Miyoshi et al., 2006). Several amazing characteristics can be observed, when 
the diameters of polymer fibre materials are shrunken from micrometers to submicrons or 
nanometers. These characteristics include a very large surface area to volume ratio, the ratio 
of a nanofibre in comparison with that of a microfibre may be as much as 103 greater. It even 
provides greater mechanical support relating to functionalities such as tensile strength and 
stiffness as well as improved flexibility within the topology as compared with any other known 
form of the same material. A polymer nanofibre is the optimal candidate to promote and 
ensure effective wound healing due to the outstanding properties mentioned above (Kumar 
et al., 2014). Based on the requirements for optimal wound healing agents as described 
above, materials used for wound healing devices formulated via electrospinning is currently 
the state of art in pharmaceutical wound healing technology. Electrospun nanofibres have 
been applied in many fields including optical sensor fields, filtration and biomedical sciences. 
In the field of biomedical sciences, they can be used as a means of drug delivery in wound 
dressings and in the production of tissue engineering scaffolds and films (Horber and Miles. 
2003; Bishop et al., 2010). The useful properties of electrospun nanofibres such as variable 
pore size distribution, oxygen-permeable high porosity, and morphological similarity to the 
body's natural ECM thus promoting wound healing processes involving cell adhesion, 
migration and proliferation (Horber and Miles. 2003). In addition, nanofibres have a high 
surface to volume ratio thus making it an appropriate agent for the use in wound dressing 
materials. For wound dressing applications, nanofibres are made from polymers that are 
biocompatible, biodegradable, have a low toxicity and promote the process of wound healing 
(Dersch. 2005). 
 
2.9.1. Nanoparticle-Based Delivery Systems for Wound Healing 
The process of wound healing consist of three different phases whereby various 
characteristic progressions occur during each phase to ensure optimal curative therapy thus 
low changing frequency dressings are of favourable preference (Wolf et al., 2009). Of 
increased interest is the synthesis of stable nanoparticles, as they have unique 
physicochemical characteristics such as optical properties, antibacterial properties, catalytic 
activity and magnetic properties (Bhuveneshwari et al., 2014). Nanoparticles are complex 
mixtures whereby they may be defined as particulate matter having at least one dimension 
that is less than 100 nm. The behaviour of nanoparticles differs from that of other matter in 
that the properties of the different components need to be considered. Nanoparticles have an 
exceptionally high surface to volume ratio contributing to their unusual properties and 
behaviour. Furthermore, because of its high surface area, its surface structure will also differ 
from that of the core. Specific and suitable functional groups can be attached to the surface 
of a nanoparticle to meet its target such as interactions with biological systems. Thus, 
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nanoparticles can be modified to suit the purpose intended (Christian et al., 2008). As a 
therapeutic agent in wound healing and acceleration of the healing process nanoparticles 
can be utilised as a carrier system for sustainable delivery of therapeutic agents (Losi et al., 
2013). Hendi (2011) reported the use of silver as a wound healing therapeutic agent that 
promotes the therapeutic process and reduces scar appearance, however its use has been 
restrained due to its many toxic effects. The emergence of silver nanoparticles is a form of 
nanotechnology that provides a means of reducing the percentage of pure silver thus 
reducing the rate of potential side effects. Application of nanoparticles allows for the 
synthesis of particles with varying shape, size, chemical composition and mono-dispersity. 
Wolf and co-workers (2009) also reported the use of a nanoparticulate carrier system to 
release opiod analgesics at a wound site thus minimising pain at a wound site (Wolf et al., 
2009). Nanoparticles as a delivery system allow the loaded drug to be released in a slow 
manner and increase its skin penetration by several folds. Various intrinsic factors and 
characteristics need to be considered when designing a wound healing therapeutic agent, 
therefore the use of metals provide essential characteristics as antimicrobial agents. 
Integration of nanotechnology and biology can bring the use of metals such as copper, silver 
and zinc to the forefront in the form of metallic nanoparticles (Gopal et al., 2014). These 
agents may serve as excellent antimicrobial agents owing to their large surface area to 
volume ratio and their nanoscale structure in comparison with their metal bulk form (Wu et 
al., 2014). Thus, the formation of nanoparticles by the application of nanobiotechnology, 
combined with the acquaintance to wound healing cellular and subcellular events offers great 
opportunities for improving wound care (Gopal et al., 2014). 
 
2.9.2. Nanohealing: Techniques Employed 
The combined use of two techniques namely electrospraying and spinning is made use of in 
a highly versatile technique called electrospinning (Wu et al., 2014). Recent years has shown 
a growing interest in the exploration of electrospinning technology. This technique may be 
used to produce nanoscale fibres especially so, for the fabrication of nanofibrous scaffolds 
and films for tissue engineering and wound repair. Non-woven membranes can be produced 
by the application of the electrospinning technique whereby individual fibre diameters may 
range from a few nanometres to hundreds of nanometers. In addition the fibres may be 
modified to form a porous structure that is ideal for gene, drug as well as cell delivery (Huang 
et al., 2003; Luu et al., 2003; Agarwal et al., 2008). The process of electrospinning utilises a 
high voltage source to inject charge of a known polarity into a polymer melt or solution, which 
acts as one of the electrodes. This is then accelerated towards a collector of opposite 
polarity. A Taylor Cone is formed when the electrostatic attraction between the opposite 
charges and the electrostatic repulsion between like charges in the liquid become stronger. 
The formation of continuous fibres occur when a fibre jet travels through the atmosphere 
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causing the solvent within the polymer solution to evaporate, thus resulting in the deposition 
of solid polymer fibres on the collecting disk. The process of fibre jet formation occurs when 
the electric field strength exceeds the surface tension of the liquid. Notably, this technique 
may be applied to fabricate filaments on the nanometer scale (Yoshimoto et al., 2003; 
Mattews et al., 2002., Pillay et al., 2013). During the process of electrospinning, many factors 
may be manipulated in order to produce the optimal filament for healing. These factors 
include parameters such as the electric field strength, the length and radius of the spinneret, 
the distance of the electric field generated, solution parameters such as conductivity, 
viscosity, concentration and ionic strength. In addition the solution flow rate should also be 
considered (Chow et al., 2002). By the alteration of these parameters, properties such as the 
kinetic, biological and mechanical may be manipulated in order to produce the desired 
fabrication. Electrospinning also has the advantage of producing a non-woven nanofibrous 
structure which has similarities such as morphological, topographical and architectural 
features that are similar to the natural ECM of the skin, thus enabling it to mimic the natural 
environment of the body thus playing an important role in proliferation and adhesion of cells 
during wound healing (Green et al., 1994; Flemming et al., 1999; Chow et al., 2002; Chong 
et al., 2007). Non-woven fibrous mats composed of nanofibres have the ability to interact 
with cells as they have a very high fraction of surface available to interact with cells, thus 
making them ideal candidate for cell attachment. Additionally, they may aid in nutritional 
support due to the porosity within electrospun mats (Figure 2.7) (Su et al., 2006). 
 
Figure 2.7: Nanofibres fabricated by electrospinning, elucidating different nanofibres 
diameters 
 
2.10. Concluding Remarks 
Considering the variation in the rate of production of wound exudates and the variation in the 
appearance of the wound surface, no single wound dressing can significantly influence all 
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wound types, thus the challenge is to develop novel wound healing drug-delivery 
formulations that have the capacity to positively influence all or most wound types. It thus 
then seems ideal to fabricate a composite wound healing device that incorporates the 
different characteristics of all current technologies available thus overcoming challenges that 
remain with current devices available (Table 2.1 and Figure 2.8). With the advancement and 
emergence of tissue engineering technologies individual therapy options can be explored in 
order to target specific wound types and ensure its effective treatment. In addition, the 
emergence of novel polymers that can be modified to mimic the skin environment, conditions 
and structure play a pivotal role in the treatment and management of various wound types. 
Furthermore, the incorporation of active agents, growth factors and drugs can stimulate 
wound healing responses thus further promoting optimal treatment and management. Such 
advanced approaches may aid in the treatment of both acute and chronic wounds in a 
clinically efficient manner. There are many requirements that's need to be ensured when 
designing and developing a wound healing device and techniques such as electrospinning 
can be employed to ensure this. This review aimed at providing an insight to the 
development of an idealised wound healing device that has the capacity to overcome all 
current challenges. 
 
Figure 2.8: Different forms of polymeric scaffolds for tissue engineering and repair. 
Reproduced with permission from Elsevier BV Ltd©2007. 
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Table 2.1: Classification of various wound dressings and their properties. 
Form Biomaterials Bioactives Application References 
 
Traditional 
dressings 
 
Cotton wool, gauze 
and cotton 
bandages 
 
Can be used in 
conjunction with 
hydrogels and 
hydrocolloids 
 
Primary and secondary 
dressings 
 
Asbell and 
Mickmack. 
2000 
 
 
 
Lyophilised 
wafers 
 
Synthetic polymers: 
Polyurethane 
 
Antibiotics and 
growth factors 
 
Adhesive and absorptive 
dressings 
 
Morghimi et 
al., 2009; Li et 
al., 2011; 
 
 
Hydrocolloids 
 
Gel forming agents: 
elastomers, 
gelatine, pectin 
 
Active agents 
such as local 
anaesthetics 
 
Clinically useful due to 
adhesion to either moist or 
dry sites. Provides an 
optimal moist wound 
environment 
 
Boatang et 
al., 2008 
 
Hydrogels 
 
Synthetics and 
natural polymers: 
polyvinylpyrrolidine 
and methacrylates 
 
Anti-
inflammatory 
antimicrobials 
and local 
anaesthetics 
 
Primary dressing having 
swellable and hydrophilic 
properties 
 
Kootstra and 
Verma. 2003 
 
Films and 
semi-
permeable 
films 
 
Co-polymers, 
homopolymers and 
plasticized 
polymers both 
natural and 
synthetic 
 
Wound healing 
bioactive 
includes growth 
factors, 
stabilisers and 
antimicrobials 
 
Primary and secondary 
dressings, in conjugation 
with foams, hydrogels or 
hydrocolloids. Semi-
permeable films promote 
enhanced gas exchange 
and moisture 
 
Eming et al., 
1999 
Rossi et al., 
2013 
 
 
Foams 
 
Natural polymers, 
polysaccharides, 
solid matrices with 
gas particles 
 
Pain relieving, 
antibacterial 
and anti-
inflammatory 
agents 
 
Controlled drug delivery 
and as a matrix for cell 
growth 
 
 
Galeano et 
al., 2003; 
Quintero. 
2003;Falanga. 
2005 
 
 
Multi-layered 
dressings 
 
Natural and 
synthetic polymers 
 
Bioactives: local 
anaesthetics, 
antimicrobials, 
anti-
inflammatory 
 
Multi-characteristic 
dressings that provides 
adhesion, absorption, 
mechanical support, 
strength and moisture 
 
Wei. 2004 
 
Electrospun 
nanofibres 
mats and 
scaffolds 
 
Natural, 
electroconductive 
and synthetic 
polymers: chitosan, 
polyvinylalcohol, 
surfactants 
 
Bioactives: anti-
inflammatory, 
antibiotics and 
antiseptics 
 
Primary and secondary 
dressings mimicking the 
properties of the skin and 
may form pseudoskin 
 
Lawrence. 
1994;Boatang 
et al., 2013 
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CHAPTER 3 
DESIGN, CHARACTERIZATION AND OPTIMIZATION OF THE BIOACTIVE 
CURCUMIN FILM SYNTHESIZED BY THE INTERPENETRATING 
POLYMER NETWORK TECHNIQUE EMPLOYING AN EXPERIMENTAL 
DESIGN STRATEGY 
 
3.1. Introduction 
This chapter aims at introducing techniques, biomaterials and progressions made in this 
investigation to overcome the many challenges and complex processes faced during the 
wound healing cascade. The employment of novel practical ideas and the use of forward-
thinking approaches are essential to establish outstanding outcomes in the therapeutic field. 
The overall outcome of this chapter elaborates on the use of a simple technique 
demonstrating a significant interest to the use of biomaterials and the semi interpenetrating 
polymer network (s-IPN) technique.  
 
Currently there are numerous wound healing products available for the treatment of burns, 
lacerations, incisions, chronic and decubitus ulcers (Suzuki et al., 1997; Tanihara et al., 
1998; Kanokpanont et al., 2012). However there is a growing need for novel initiatives in the 
treatment of burn wounds and excessive skin loss (Kim et al., 2012). Novel wound dressing 
applications can be produced by the modification and synthesis of biocompatible materials. 
Biomaterials play a pivotal role in the wound healing process as they are biodegradable, 
biocompatible, bioadherent and bioabsorbable thus augmenting the healing process. In 
addition, they contribute inductive, instructive, stimulating and triggering effects to the skin 
cells and tissues. Numerous synthetic and natural polymers have been used for wound 
dressing applications: natural polymers include alginate (Hashimoto et al., 2004; Thu et al., 
2012), gelatine (Choi et al., 1999; Kanokpanont et al., 2012), collagen (Ma et al., 2003) and 
chitosan (Muzzarelli et al., 2005; Li et al., 2012) and the synthetic polymers such as poly 
(ethylene glycol) (Kim et al., 2000), silicone rubber (Crowder and Gooding, 1997) and poly 
(amino acid) (Hwang and Stupp, 2000) have also shown to be useful for wound healing 
applications. 
 
Interpenetrating polymer network (IPN) structures can be described at the molecular level as 
two or more polymer components interlaced in order to form a network that cannot be broken 
unless the individual entities can be chemically separated and considered a viable option 
(Zhang et al., 2004; Liu et al., 2006; Yao et al., 2010). The formation of an interpenetrating 
polymer network (IPN) allowing intermolecular bondage between various components such 
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as genipin, chitosan and hypromellose, ensures that the components remain interlaced and 
there is a resistance to phase separation (Saimani et al., 2010). 
 
Considerable interest has been focused on the use of an IPN based drug delivery system as 
application of this technique will open up new avenues for the combination of natural and 
synthetic polymers. The use of an s-IPN offers many benefits in that it allows the 
coalescence of synergistic properties of both polymers, thus avoiding limitations present by 
the use of single polymer entities. The IPN technique involves the merging of two or more 
polymers exhibiting diverse characteristics by the process of crosslinking in the presence of 
the other polymer. Semi-IPN occurs when one polymeric component of the system is left in 
the linear form whilst the other is crosslinked. (Bhardwaj et al., 2012) 
 
In this study the formation of a semi interpenetrating polymer network was implemented as 
illustrated in Figure 3.1 in order to form films with the use of natural biopolymers, crosslinkers 
and bioactives. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Proposed mechanism for the formation of an s-IPN (Adapted from Muzarelli, 
2009) 
 
3.2. Biopolymeric Components employed in the Synthesis of an s-IPN Bioactive Film 
Selection of biopolymers plays an important role as they should beable to adequately 
influence the physiological and biological environment of the wound site and cooperate within 
the electrospinning process with regards to their capabilities and essential potential usage to 
produce nanofibres as will be discussed in Chapter 4 and 5. Of key importance when 
selecting a polymer is its profound ability to produce biodegradable, biocompatible, 
bioresorbable, bioadherent and bioactive activity at the designated site of need (Ishihara et 
al., 2001; Ueno et al., 2001). 
Introduction of 
a crosslinker 
Uncrosslinked 
chitosan 
Crosslinked 
bridges forming 
an s-IPN 
51 
 
Chitosan (CS) is a natural polymer and a derivative of chitin which has many positive facets 
in the wound healing process such as biodegradability and excellent biocompatibility 
properties that are native to the body constituents (Dash M et al., 2011; Li et al., 2012). In 
addition, it is non toxic and plays an imperative role in the wound healing process due to its 
versatile biological activity which includes the induction of the healing process within the 
regenerative and inflammatory phase and its ability to promote tissue growth and 
differentiation within skin tissue (Datta et al., 2011) thus playing a major role in large wound 
areas due to its function in granulation and organisation as it has an adaptable property to 
the wound (Ishihara et al., 2001; Ueno et al., 2001). Howling and co-workers (2001) have 
found chitosan to be influential during all stages of wound healing when carrying out an in 
vivo study. Homeostatic ability by chitosan has been pronounced within the inflammatory 
phase whereby re-epithilisation and fibroplasia have been accelerated avoiding further 
complications by foreign bodies, and at the same time promoting the granulation phase 
(Howling et al., 2001; Ishihara et al., 2002; Alemdaroglu et al., 2006). Studies carried out in 
dogs and cats have also shown an advantage of decreased scar formation as excessive 
hypertrophic scar formation was prevented by the use of chitosan (Ueno et al., 1999). In 
addition chitosan exhibits gelation and film forming characteristics, is non toxic and 
biocompatible (Ishihara et al., 2001; Alemdaroglu et al., 2006).  
 
Citric acid, a chemical agent is beneficial in the treatment of wounds as it is convenient, 
inexpensive, non-toxic and highly effective against organisms thus preventing the 
development of infection by manifestation of microbes in open wound sores. It has also been 
found to enhance the wound healing process by promoting the laying of granulation tissue 
and epithelisation while at the same time exudates excretion is minimised (Naqoba et al., 
2011). In studies carried out citric acid was found to be effective in wounds of humans 
against various bacteria (Nagoba et al., 1998; Nagoba et al., 2010). In addition citric acid 
serves to create an acidic environment when dissolving chitosan within an aqueous medium.  
 
Hypromellose a natural polymer is known for its advantageous hygroscopic properties thus 
ensuring lubrication and providing an essential moist wound environment during the wound 
healing process. Hypromellose also promotes angiogenesis at the wound site, is non-toxic, 
highly viscous thereby registering sustained release of biopolymers by acting as a viscous 
barrier and controlling the rate of hydration and diffusion (Topham, 2002).  
 
Throughout the tropical regions such as South East Asia, Africa, India and China, the 
cultivation of Curcuma Longa has been widely established. C. Longa also known as turmeric 
belongs to the Zingeberace family and is a perennial herb known to humankind for over 6000 
years (Kurrup and Barrios, 2008). Within the biological and medical field, of particular interest 
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are the phytochemical constituents such as curcuminoids and curcumin for their wide 
spectrum of biological activities. ―Tumeric‖ or curcumin is a yellow rhizome which is 
extensively used in the food industry as a colouring and flavouring agent, condiment and 
spice (Adaramoye et al., 2009). Furthermore, traditional medical practitioners of the tropical 
regions utilized curcumin to treat inflammation, urinary tract infections, hypertension and 
eczemas (Dao et al., 2012), in addition to being used as an antioxidant and anticancer agent 
(Sidhu et al., 1998). Current extensive studies and understanding of the phytochemical 
constituents of curcumin has lead to the discovery of biological activities associated to 
appropriate wound healing such as anti-inflammatory and antioxidant properties. 
Furthermore, studies conducted in various animal models have proven curcumin to be 
nontoxic at even high doses (Ponnusamy et al., 2012). Curcumin moreover has been shown 
to play an important role in wound repair by ensuring the induction of TGF-β1 within the 
wound thus significantly enhancing the healing process (Sidhu et al., 1998; Mani et al., 2002; 
Li et al., 2012). 
 
Many polymers including the natural polymers have major drawbacks such as poor 
mechanical properties and rapid degradation which limits their application in the skin and 
tissue engineering field. Interest in the use of genipin as a crosslinker is on the increase due 
to the many toxic effects of other chemical crosslinkers such as glutaraldehyde (Beppu et al., 
2007), glyoxal (Pauliukaite et al., 2009), epichlorohydrin (Singh et al., 2006), and 
formaldehyde (Machado et al., 2009). Genipin is extracted from the Gardenia jasminoides 
fruit and is an iridoid glucoside that has been used by the food industry and Chinese 
traditional medicine as a blue colorant. It can crosslink macromolecules such as 
polysaccharides and proteins and is a well-known crosslinker of chitosan, a natural polymer 
consisting of many amino groups. The degree of crosslinking by genipin is mainly dependent 
on the availability of free amino groups to which it can react under mild conditions and can 
clearly be noted by the blue colour change that occurs upon crosslinking (Pujana et al., 2013; 
Gao et al., 2014). In comparison to other potent crosslinkers as mentioned above, genipin 
can produce crosslinked materials with comparative degradative and mechanical properties 
(Gao et al., 2014). Within the field of biotechnology and biomaterials, genipin is widely 
employed in studies related to tissue engineering, regeneration, and fixation. In addition, it 
has been used in the formation of interpenetrating polymer networks (IPN), nanocomposites, 
nanoparticles, as well as microspheres and macrogels (Pujana et al., 2013). Furthermore, in 
a study carried out by Chang and co-workers (2003) it has been shown that genipin exhibits 
great cell compatibility and wound coverage by epithelisation as this is further enhanced by 
the presence of genipin as a crosslinker (Bigi et al.,2002). Proliferative activity of cells at 
wound sites showed greater outcomes in comparison to other crosslinking agents such as 
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glutaraldehyde thus making it a well suited agent for clinical usage (Sung et al., 2002; 
Muzarelli, 2009). 
 
A combination of these biopolymers can serve as a potential application throughout the 
process of healing as collectively they may induce an additive complementary therapeutic 
effect that has the capability to accelerate the healing process as well as optimize the 
beneficial effect of each individual entity.  
 
3.3. Part 1: Preliminary Investigation of the Biopolymeric Films 
 
3.3.1. Determining the Upper and Lower Variables for Formulation Preparation 
required for Input into the Box-Behnken Design 
The merit of attempting a preliminary study permits an understanding of the various system 
characteristics, whereby establishment of an optimized candidate can be achieved. 
Preliminary studies involve selection and evaluation of the various biopolymers significant to 
the wound healing process as well as advantageous for film formation. The identification of 
variables incorporating upper and lower limits is of paramount importance when considering 
further experimentation and optimization. Various factors in this investigation were 
considered and include the following (Lloyd et al., 1998): 
 Protection of the wound from the outside environment 
 Storage conditions and shelf life 
 Flexibility and toughness 
 Homeostatic, biodegradable, microbial invasion, exudates absorption 
 Restoration of normal function and appearance 
 Convenient and easy removal, patient compliance 
 
The variable upper and lower levels of the various formulations analysed were as follows: 
 
Table 3.1: Template exhibiting Upper and lower limits derived from preformulation 
experimentation 
Polymer/Active 
Crosslinker 
Chitosan 
(%w/v) 
Hypromellose  
(%w/v) 
Genipin 
(%w/v) 
Citric acid 
(%w/v)  
Curcumin 
(%w/v) 
Upper Level 1 0.4 0.1 5 1 
Lower Level 3 1.6 0.5 5 1 
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3.3.2. The Influence of Crosslinking with Genipin on Film Formation and the Effect of 
Variable Polymer Concentrations 
Within this investigation, of interest is the use of genipin as a natural crosslinker to form a 
semi-interpenetrating polymer network (s-IPN) whereby it also provides further advantageous 
therapeutic benefits relating to wound healing such as anti-inflammatory properties (Gao et 
al., 2014). The addition of a cross-linker such as genipin can greatly improve upon or 
overcome many physicomechanical drawbacks. Furthermore, genipin is nontoxic and 
biocompatible, thus it has been shown to be an effective crosslinking agent of biomaterials 
such as chitosan which contains a large amount of amino groups and the natural cellular 
tissue (Huang et al., 1998; Mi et al., 2002; Yan et al., 2010).  
 
Chitosan is a highly biodegradable polymer thus needs to be crosslinked in order to 
modulate its properties enhancing bioavailability and mechanical properties. Genipin, a 
crystalline substance with a highly defined structure serves as a desirable crosslinker due to 
its natural origin and low cytotoxicity. The mechanism of crosslinking is pH dependent and 
within an acidic environment the olefinic carbon atom at C3 undergoes a nucleophilic attack 
by the amino groups of chitosan. This is followed by the opening of the dihydropyran ring 
whereby an attack occurs by the secondary amino groups on the newly formed aldehyde 
group. Condensed genipin having short chains perform as crosslinking bridges whereby 
genipin acts as a dialdehyde (Muzzarelli, 2009). In this manner, the structural composition of 
chitosan is modified introducing supplementary bonds greatly impacting the 
physicomechanical properties of the polymer as illustrated in Figure 3.2. According to a study 
conducted by Mi et al., 2005, chitosan in the presence of genipin undergoes crosslinking at a 
neutral pH whereby heterocyclic amines are formed associated to crosslinked networks 
whereby short chains of dimmer, trimer and tetramer bridges are formed. 
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Figure 3.2: Illustration of the crosslinked reaction between genipin and chitosan (Chen et al., 
2004) 
 
In this investigation, variable concentrations of genipin were introduced to determine the 
crosslinking potential of chitosan ranging between 0.1%w/v and 0.5%
w/v. The illustrations in 
Figure 3.3 depict the crosslinking effects on the chitosan films observed by the colour 
change. Crosslinking with genipin results in the formation of a blue pigmentation viewed as 
green in this instance (due to presence of curcumin) formed via the reaction of amino groups 
with genipin in the presence of oxygen (Butler et al., 2003). As can be noted the films 
presented with a darker pigmentation as the concentration of genipin was increased thus 
advocating greater formation of crosslinking bridges. The impact of crosslinking was then 
determined by analysing various characteristic properties. Furthermore it was observed that 
when very high concentrations of genipin was used as a crosslinker, the mechanical 
properties of the films decreased due to elevated molecular bonding making the films brittle 
and fragile. Additionally using higher concentrations of biopolymers such as chitosan lead to 
an increase in solution viscosity further diminishing the tensile properties of films and forming 
films of irregular and uneven textural constitutes as observed in Figure 3.4 
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Figure 3.3: Chitosan films crosslinked with genipin at various concentrations. (a): 0.1%w/v, 
(b): 0.2%w/v, (c): 0.3%
w/v, (d): 0.4%
w/v, (e): 0.5%
w/v 
 
Figure 3.4: Crosslinked film constituting of high crosslinker and polymer concentration  
(b) 
(c) (d) 
(e) 
(a) 
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The crosslinking reaction could further be noted by the FTIR spectra analysis. Upon 
crosslinking a shift in the wavelength to the left is noted from 3260.11cm-1 in Figure 3.5b to 
3278.79cm-1 in Figure 3.5a and 2049.97cm-1 in Figure 3.5b to 2164.10cm-1 in Figure 3.5a. 
This strongly suggest an increase in conjugation and bond intensity due to greater 
intermolecular forces occurring due to the presence of the crosslinker as is illustrated in the 
FTIR spectra (demarcated in Figure 3.5). A shift in wavelength is seen and absorbance is 
also further augmented. Wavenumbers at 1634 and 1636cm-1 were examined and upon 
analysis it is seen that that an increase in conjugation and bond intensity is seen at 1636cm-1 
in Figure 3.5a due to a shift to the left in wavelength from 1634cm-1  in Figure 3.5b thus 
augmenting the crosslinking intermolecular bondage. The slight peak depicted in Figure 3.5 
at 2164.10 cm-1 and 2049.97 cm-1 are representative of an alkyne stretch due to conjugation 
which is more prevalent in Figure 3.5a. 
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Figure 3.5: Chemical transitions depicted by the FTIR spectra in (a): genipin crosslinked 
chitosan films, (b): Uncrosslinked chitosan films 
 
Upon formation of films of varying concentrations obtained from the variable data, of 
paramount interest was the determination of the physicomechanical properties by texture 
analyses (illustrated in Figure 3.6) to analyse the tensile strength (N.mm2) by varying polymer 
concentration. Upon close examination it was noted that an increase in tensile strength 
occurred as the crosslinker genipin concentration was increased up to 0.4%W/V at 
0.187N.mm2.  
 
A further increase in crosslinking such as 0.5%W/V rendered a decrease in tensile strength as 
depicted in Figure 3.7 at 0.134N.mm2, making the films brittle and more prone to tearing and 
breakage. This phenomonan can be attributed to the Young‘s modulus. as the concentration 
of genipin was increased so to did the mechanical characteristics of the films exhibiting a 
greater Young‘s modulus. An increase in the Young‘s modulus reveal greater strength, 
toughness and rigidity to the films. However, at higher concentrations the strong 
intramolecular and intermolecular bonding results in decreased elasticity and flexibility to the 
films rendering them brittle and easy torn.  
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Figure 3.6: Image displaying the texture analysis process when a strain is applied to the 
films to determine its tensile strength 
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Figure 3.7: Graph depicting the influence of varying concentrations of genipin on the tensile 
strength of films 
 
Further analysis was conducted to establish the influence of polymeric concentration and 
crosslinking on the bioavailability and bioactive delivery at the wound site. A swelling test 
was conducted whereby the various films with differing polymer and crosslinker 
Probe 
providing 
upward 
force 
% w/v 
Tension 
force 
induced to 
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Strip 
Provision of 
downward 
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concentration was immersed in buffer of neutral pH over a period of 1 hour and the weight 
was taken before and after immersion to determine the swelling capacity.  From the results 
obtained it was noted that at higher crosslinker concentrations the swelling capacity was 
lowered, such as 36.16%w/v at 0.2%
w/v  genipin compared to 8.92%
w/v at 0.4%
w/v allowing a 
controlled release of bioactive and greater bioavailability. In addition when the polymeric 
concentrations of chitosan were increased, the percentage swelling capacity decreased. 
Addition of 1% w/v chitosan revealed a % swelling capacity of 43.62%
 w/v whereas at 2.5%
 w/v 
a swelling capacity of 7.47%w/v was noted. This could be attributed to the increase in solution 
viscosity as well as greater availability of amino groups for crosslinkage with genipin.   
 
Thus from the investigation carried out, a conclusion to the most appropriate variable 
concentrations with regards to the upper and lower limits could be made as depicted in Table 
3.1 to produce the most desirable characteristics in terms of film formation and wound 
treatment. From theses variable obtained a three factor Box-Behnken design template was 
implemented as portrayed in section B of this chapter. 
 
3.4. Part B: Experimental Synthesis and Statistical Optimization of the Films for 
Wound Healing 
 
3.4.1. Materials and Methods 
3.4.1.1. Materials 
Chitosan (CS) (medium Mw poly (D-glucosamine) deacetylated chitin), hypromellose-
hydroxymethylcellulose 2910, citric acid (ACS reagent ≥99.5%, Mw=192.12g/mol), genipin 
(≥98% HPLC grade) powder (Mw=226.23g/mol), and curcumin as well all other reagents of 
analytical grade used were procured from Sigma-Aldrich Chemie GmbH (Steinheim, 
Germany). 
 
3.4.1.2. Synthesis of a Semi-Interpenetrating Network Polymer Film 
Semi-interpenetrating network (IPN) polymer blends were prepared using the sequential IPN 
method. Various concentrations of chitosan (CS) ranging from1 to 3%w/v were added to a 
5%w/v (5 g/100 mL) solution of citric acid. This was then allowed to stir using a magnetic 
stirrer until a homogenous solution was formed. Next, the crosslinker genipin was dissolved 
in deionized water to make an aqueous solution of varying concentrations between 0.1 and 
0.4%w/v. This was then added to the CS solution to allow crosslinking. Thereafter, various 
concentrations of hypromellose solution ranging between 0.4 and 1.6%w/v added to a 1%
w/v 
curcumin solution were mixed with the above blend. Lastly, 1 mL of glycerol was added to 40 
mL of the s-IPN formulation consisting of all polymers, including the bioactive curcumin and 
crosslinker genipin and allowed to stir overnight to form a homogenous semi-IPN blend. The 
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optimum quantity of each blend (10 mL) was poured into a rectangular mold composed of 
Parafilm (710×260 mm) and cast in film form by solvent evaporation at room temperature 
with the use of a fume hood under the influence of continuous airflow. After drying, semi-IPN 
films were removed from the fume hood and placed in a petri dish until further use under 
Parafilm. A three-factor Box-Behnken experimental design as shown in Table 3.2 (acquired 
from preformulation studies) was generated to obtain optimal concentration combinations of 
biopolymers in order to perceive optimal parameters from the design to acquire a semi-IPN 
film with superlative therapeutic and formulation outcomes. Preformulation experiments led 
to the search of variables that enabled an upper and lower limit of all factors necessary as 
discussed in part A of this chapter, to be established in order to run an accurate design. 
Furthermore, characterization of the design formulations lead to the establishment of an 
optimized semi-IPN film of optimal concentrations that is adequate as a wound dressing on 
which further in vitro and ex vivo studies were conducted. 
 
Table 3.2: Box-Behnken design template for statistically derived semi-IPN film formulations 
Formulation 
No. 
Chitosan 
(%w/v) 
Genipin 
(%w/v) 
Hypromellose 
(%w/v) 
Curcumin 
(%w/v) 
1 1 0.25 0.4 1 
2 3 0.1 1 1 
3 2 0.1 1.6 1 
4 1 0.25 1.6 1 
5 2 0.25 1 1 
6 2 0.4 0.4 1 
7 3 0.25 0.4 1 
8 2 0.25 1 1 
9 3 0.4 1 1 
10 1 0.4 1 1 
11 1 0.1 1 1 
12 2 0.4 1.6 1 
13 2 0.1 0.4 1 
14 2 0.25 1 1 
 
3.4.1.3. Chemical Structure Analysis by Fourier Transform Infrared Spectroscopy 
ATR-FTIR analysis which identifies absorption bands based on vibrational molecular 
transitions was conducted to characterize complex interactions occurring within bioactive 
polymer exchanges. A PerkinElmer® Spectrum 100 Series FT-IR Spectrometer fitted with a 
universal ATR Polarization Accessory (PerkinElmer Ltd., Beaconsfield, UK) was employed 
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and Spectra  over the range 4000-625cm-1, with a resolution of 4cm-1 and 32 accumulations 
was recorded for all semi-IPN film samples. 
 
3.4.1.4. Thermodynamic Property Analysis by Differential Scanning Calorimetry 
Studies 
Differential scanning calorimetry (DSC) measurements were taken for semi-IPN film samples 
weighing 7–10 mg using an advanced DSC (TMDSC/ADSC) (Mettler Toledo DSC-1 STARe 
System, Schwerzenback, ZH, Switzerland) at a heating rate of 10°C/min from −10 to 350°C 
under a nitrogen atmosphere. Weighed samples were placed in a covered aluminum sample 
holder with a central pin hold. Calibration of the DSC modulus was done in respect to 
enthalpy and temperature. Thermoanalysis of the samples was carried out with regard to the 
glass transitions, melting points, chemical reactions, and phase change temperatures of the 
polymeric system. 
 
3.4.1.5. Surface Morphological Analysis by Scanning Electron Microscopy Imaging 
Surface topographical structure of the dry semi-IPN films was analyzed by scanning electron 
microscopy (SEM; Phenom ™, FEI Company and Hillsboro, OR, USA) for porosity, surface 
roughness, and particle size of films. Samples were cut from films and mounted into metal 
stubs whereby samples were gold coated with an in-house SPI-Module Sputter Coater (SPI 
Supplies, Division of Structure Probe Inc., West Chester, PA, USA) prior to analysis. 
 
3.4.1.6. Determination of the Physicomechanical Properties of the Films by Textural 
Profile Analysis 
Semi-IPN film samples were subjected to texture analysis using a highly sensitive texture 
analyzer (TA.XT plus Texture Analyser, Stable Microsystems, Surrey, UK) fitted with a 50- kg 
load cell. The physicomechanical properties of the film was measured by fixating film 
samples between two brackets placed 3 cm apart and a tension force of 0.5mm/s applied to 
the system to determine the force at breaking point. This approach was employed to 
generate force-distance profiles to determine the tensile strength and work of extensibility 
which can be computed from the peak tensile force required and using Equation 3.1. The 
parameters marked for textural analysis are presented in Table 3.3. Tensile strength was 
measured using the Young‘s modulus. 
 
𝐸 =
𝑇𝑒𝑛𝑠𝑖𝑙𝑒  𝑠𝑡𝑟𝑒𝑠𝑠
𝑇𝑒𝑛𝑠𝑖𝑙𝑒  𝑠𝑡𝑟𝑎𝑖𝑛
=
𝛿
𝜀
=
𝐹𝐿𝑜
𝐴𝑜∆𝐿
                                                                                   [Equation 3.1]         
 
Where, E= Young‘s modulus (modulus of elasticity), F= force applied to the object; A0= 
original cross-sectional area (πr2) through which the force is applied, ΔL= quantity by which 
the length of the object changes and L0=original length of the object. 
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Table 3.3: Parameters employed for textural analysis 
 
 
 
 
 
 
 
 
 
3.4.1.7. Durability Testing of the Films by Nano-Tensile Mapping 
The tensile properties (at a nano-sensitivity level) of the semi-IPN films were evaluated using 
a nano-Tensile Analyser (nanoTensileTM 5000, Hysitron Inc., MN, USA). Samples were 
mounted within nano-tensile brackets that were held rigidly together by a frame thus aiding in 
sample alignment and positioning. An accurate measurement of the width, thickness and 
length of all film samples were taken using a digital calliper prior to mounting of samples. To 
determine the Young‘s Modulus, brackets were made to move apart at a constant rate of 
5μms-1 until a breaking force was established. 
 
3.4.1.8. Determination of the Swelling Capacity and Equilibrium Water Content 
Pre-weighed samples of the semi-IPN films were dispersed in 15mL of phosphate buffer 
solution (PBS; pH 7.4) and allowed to equilibrate at room temperature (37,1°C) for 24 hours. 
Samples were then removed periodically at 1 hour intervals, excess buffer was removed and 
samples were reweighed. The swelling capacity (%) and equilibrium water content was 
determined using Equations 3.2 and 3.3 (Bindu et al., 2010). 
 
%  𝑆𝑤𝑒𝑙𝑙𝑖𝑛𝑔 𝐶𝑎𝑝𝑎𝑐𝑖𝑡𝑦 =
𝐹𝑖𝑛𝑎𝑙  𝑊𝑒𝑖𝑔𝑕𝑡−𝐼𝑛𝑖𝑡𝑖𝑎𝑙  𝑊𝑒𝑖𝑔𝑕𝑡
𝐼𝑛𝑖𝑡𝑖𝑎𝑙  𝑊𝑒𝑖𝑔𝑕𝑡
× 100                             [Equation 3.2] 
 
%  𝐸𝑞𝑢𝑖𝑙𝑙𝑖𝑏𝑟𝑖𝑢𝑚 𝑊𝑎𝑡𝑒𝑟 𝐶𝑜𝑛𝑡𝑒𝑛𝑡 =
𝑊𝑠−𝑊𝑑
𝑊𝑑
× 100                                           [Equation 3.3]                                              
 
Where, Ws = weight of film in the swollen state when dispersed in deionised water and Wd= 
weight of film in the dry state after been dispersed in deionised water (hourly). 
 
 
 
 
Parameter                   Settings 
Test mode                    Tension 
Pre-Test speed             0.50mm/sec 
Test speed                   0.50mm/sec 
Post test speed            5.0mm/sec 
Trigger type                  Auto 
Trigger force                 5kg 
Contact time                 5sec 
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3.4.1.9. Analysis of the Water Vapor Transmission Rate into the Semi-IPN Films 
Water vapor transmission rate (WVTR) tests were performed. Film samples were placed on 
the top of glass polytops having an area of 144mm2 and containing 10mL of phosphate buffer 
solution of pH of 7.4. This set up was pre-weighed and then placed in an oven at 35°C for 24 
hours. Samples were then re-weighed at regular intervals and a plot of weight loss due to 
Vapor Transmission vs. Time was deduced. The transmission rate was determined using 
Equation 3.4. 
 
𝑊𝑉𝑇𝑅 = 
𝑤𝑖−𝑤𝑡
𝐴
× 106 𝑔/𝑚2𝑑𝑎𝑦−1                                                                 [Equation 3.4]              
 
Where, WVTR is expressed in g2 h, A=area of the polytop opening (mm2), wi and wt = the 
weight of the polytop before and after been placed in the oven, respectively (Kim et al., 
2007). 
 
3.4.1.10. Measurement of the Rheological Properties of the Semi-IPN Polymer Blends 
A Haake Modular Advanced Rheometer System (MARS) (ThermoFisher Scientific, 
Karlsruhe, Germany) was used to determine the rheological parameters of the polymer 
solution blends employed for formulating the semi-IPN films. Samples were placed on a 
sample stage whereby a C35/1° titanium rotor was immersed in the polymer solution at a 
temperature maintained at 24°C, shear rate at 100s-1 and a time period of 360s (Shaik et al., 
2012). Stress-Strain rheological parameters were then obtained for all samples quantified. 
 
3.4.1.11. In Vitro release of Bioactive 
The release of bioactive curcumin from the semi-IPN films was performed in a modified 
Franz Diffusion Cell (FDC) apparatus study setup. Films were cut in a circular section and 
placed on the receptor compartment to allow diffusion, which had a surface area of 
approximately 1.8cm2. Each receptor compartment was filled with 12mL of isotonic 
phosphate buffer solution and was further thermo-regulated at 37°C by a water jacket 
throughout the study. Receptor compartments were constantly stirred using a magnetic 
stirrer. At time periods 0.5, 1, 2, 3, 4, 6, 8, 10 and 12 hours, 0.1mL of solution was withdrawn 
from the receptor compartment and replaced by an equal quantity of fresh PBS buffer 
immediately after each sampling. Samples were then evaluated using a nanophotometer 
(Implen, GmbH, Munich, Germany) at a wavelength of 425nm. 
 
3.4.1.12. Ex Vivo Permeation Studies through the Sprague Dawley Rat Skin Model 
Permeation studies were undertaken using full thickness skin excised from Sprague Dawley 
rats. Rats were euthanized using pentobarbitone intraperitoneally (i.p) and the skin was 
carefully removed. Rat skin was stored in isotonic phosphate buffer solution (pH 7.4) at -
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80°C until further use. Prior to experimental procedures skin was removed and thawed by 
placing in water at 37°C. The dorsal region was shaved and further subcutaneous and 
adipose tissue was carefully removed (Amnuaikit et al., 2005). Skin sections were excised to 
fit receptor compartments having a surface area of approximately 1.8cm2. To ensure that the 
integrity of the full thickness skin samples was maintained throughout the study, electrical 
resistance was measured across the skin membrane before and after permeation studies. 
This was performed by passing a fixed current across the skin specimen sample using a 
Mettler Toledo Seven Multi GmbH, Analytical CH-8603 (Schwerzenbach, Switzerland) 
connected to an electrode that was adjusted to isotonic environments by placing the probe 
into isotonic PBS solution before insertion with skin sections. Thereafter the resistance and 
conductance measurements were recorded as shown in Table 3.4 at a temperature of 37°C 
(Davies et al., 2003). 
 
Table 3.4: Resistance and conductivity of skin preparations to determine skin integrity before 
and after ex vivo permeation studies 
 
Skin preparation Resistance (Ώ/cm) Conductivity (μs/cm) 
Before 0.37×103 18 
After 0.86×103 68 
 
The prepared skin was then placed between the donor and receptor compartment of the 
Franz Diffusion Cell apparatus. Semi-IPN films having a surface area of approximately 
1.8cm2 was then placed over the skin and covered by the upper compartment of the FDC. 
Experimental procedures were performed as outlined for the in vitro bioactive release 
studies. The concentration of permeated curcumin was then determined using a 
nanophotometer (Implen, GmbH, Munich) whereby the extent of bioactive permeation across 
the membrane was evaluated by computing the drug flux. The flux (mg.cm-2.hr-1) of curcumin 
across the skin tissue was calculated per unit area by linear regression analysis of 
permeation data using Equation 3.5. 
  
𝐽𝑠 =
𝑄𝑟
𝐴×𝑡
                                                                                                       [Equation 3.5] 
 
Where, Js= the flux, Qr (mg) = the quantity of drug within the receptor compartment that has 
diffused through the skin, A (cm-2) = the effective cross-sectional area that is available for 
permeation and t (h) = the time of drug exposure to the skin tissue.   
 
3.5. Results and Discussion 
The film cast method was used to synthesize films of various polymeric concentrations and 
degree of crosslinking obtained from the Box-Behnken design template. From experimental 
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observations it was noted that films of yellow to green color were produced due to the 
presence of curcumin and crosslinkage by genipin. When lower polymeric concentrations 
were used and the degree of crosslinking was minimal, films tend to have weaker 
mechanical properties, are more yellow in color and highly adhesive to skin tissue. Upon an 
increase in polymeric concentration and crosslinker a greenish colour is more dominant in 
films and mechanical properties are improved. Further increases in concentration lead to 
greater rigidity of films and decrease in flexibility. The addition of glycerol also played a 
significant role in improving the texture and mechanical properties of the films. Formulary 
optimizations lead to the production of films having transitional Young‘s modulus values and 
swelling capacity thus revealing advanced film characteristics as to be discussed. 
Experimental characterization lead to the acquisition of an optimal formulation containing 
3%w/v  chitosan, 0.1%
w/v genipin and 0.4%
w/v  hypromellose. 
 
3.5.1. Chemical Structure Stability and Vibration Transitional Analysis 
Physical and chemical interactions involved in IPN formation of various polymer blend 
concentrations were evaluated using FT-IR. This determined the degree of alteration within 
the native polymers. The crosslinking within the films were characterized by the change in 
color from yellow (due to bioactive incorporation) to a dark deep green colour when 
crosslinked with genipin as depicted in part A of this chapter. Furthermore, the 
disappearance of a peak, at 1223.62cm−1 as seen in the uncrosslinked structure, 
representative of C-O stretching within the aromatic ring, upon crosslinking indicated the 
formation of a crosslinking bridge at the aromatic site of genipin with chitosan (CS) 
supporting the formation of a crosslinked network. Furthermore, O-H stretching indicated by 
the large broad band at 3260.11cm−1 was observed shifting to 3278.79cm−1 and absorbance 
from 0.34–0.35A when crosslinked suggesting an increase in conjugation and intensity, 
impacting improved stability and physicomechanical properties to the film. It was further 
deduced that a change in polymer concentrations resulted in a slight change within the 
spectra. A broad strong band representing hydrogen bonding for O-H stretching within the 
range of 3200 and 4000 cm−1 was observed with all semi-IPN films. A shift within the 
spectrum varied with the degree of crosslinking. Film 9 displayed a wavelength at 
3923.54cm−1, whereas a wavelength of 3289.37 and 3268.02cm−1 was present in Films 1 
and 2, respectively (annotated in Figure 3.8), characteristic to the bioactive curcumin 
indicating that an increase in crosslinker concentration resulted in a shift to a greater 
wavelength thus promoting conjugation and bond formation. In addition, the absence of a 
peak at the wavelength of 1281.98cm−1, representative of the presence of an additional 
amino group in Film 1, indicated no presence of free amino groups as seen with Films 2, 5, 
9, and 10. This was due to low CS concentration and more crosslinker, thus the formation of 
steric hindrance ensuring no presence of free amino groups. Film 5 showed the presence of 
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a band at 1980.69cm−1 (demarcated in Figure 3.8), which was not characteristic of any 
polymer entity but representative of the formation of C=C conjugation asymmetrical stretch 
and occurs when an intermediate amount of polymer entities are used thus the formation of 
intermolecular bonds. Semi-IPN formation resulted in significant differences in infrared 
absorption frequencies of the final product in relation to the original compounds. Network 
formation resulted in a change in the vibrational energy and frequency thus the presence of 
skeletal vibrations at wavelengths of 2937.54 and 2881.46cm−1 which were characteristic of 
C-H stretching and at 1712.30cm−1 characteristic of C=O stretching was noted. C-H bending 
within the aromatic ring was seen at wavelengths 921.85, 808.96, and 621.69cm−1 related to 
the incorporation of a C-N group in place of the C-O group within the ring due to crosslinking. 
C-N stretching is also present at the wavelengths of 1318.16 and 1280.60cm−1. These peaks 
occur at higher vibrational frequencies and are associated to the degree of polymer network 
formation as well as crosslinking resulting in a change within the structural environment. As 
the concentration of crosslinker increased so did the intensity of the band formation as is 
indicated in the FTIR spectra, resulting in stretching and conjugation within the structure and 
bending between CH bonds in the aromatic ring. Formulations displaying greater band 
intensities corresponded to a higher degree of crosslinking. Hence, it can be deduced that 
the degree of semi-IPN film formation was affected largely by the polymers and crosslinker 
concentration. 
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Figure 3.8: Fourier transform infrared spectroscopy of semi-IPN films: a: film 1, b: film 2, c: 
film 5, d: film 9 and e: film 10 
 
3.5.2. Assessment of the Thermodynamic Behaviour of the Semi-IPN Films 
The DSC thermograms of the various films showed a glass transition temperature (Tg) 
ranging between 28 and 30°C as shown in Figure 3.9. This was related to a change in heat 
capacity when a transition occurred due to network formation and crosslinker concentration. 
Film 1 presented with the greatest Tg value due to the presence of amino groups capable of 
crosslinking at the temperature of curing. Film 1 also exhibits semicrystalline behavior, 
therefore affecting the mobility of the amorphous region influencing a higher Tg value. In 
addition, the degree of crosslinking affected the amorphousity of the structure; the highest Tg 
was thus observed in Film 1 that had amino groups within the structure capable of 
crosslinking at the temperature of curing. A decrease in the degree of crosslinking due to 
crosslinker concentrations lower than the optimum was seen in Film 2, which resulted in a 
lower Tg value, thus was likely to display a quicker onset of degradation. Film 10 which had 
the highest recorded crystalline temperature (Tc) of 213.96°C (displaying a more ordered 
4000 3500 3000 2500 2000 1500 1000 650 
cm-1 
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molecular arrangement) resulted in decreased molecular motion, whereas Film 9 
(demarcated in Figure 3.9b) has a lower degree of crystillinity with a Tc at 128.19°C. These 
observations are attributed to lower polymer concentration in Film 10 while higher polymeric 
concentrations were present in Film 9, thereby varying the degree of crosslinking. This 
suggested that Film 10 had a greater degree of regular molecular arrangements due to the 
formation of inter- and intramolecular bonds when lower polymeric concentrations are used, 
therefore a well-defined structure was obtained. Furthermore, Film 10 also displayed the 
lowest degree of decomposition at a high-temperature range of 213.96°C which was 
attributed to its crystalline state. Film 9 on the other hand displayed a lower degree of 
crystallinity that was related to the random orientation of molecules displaying amorphous 
behaviour due to free non-crosslinked groups within the structure with a poor polymer 
backbone. In addition, the amorphous form of Film 9 was linked to the lack of crosslinking 
(curing) as displayed by the exothermic peak which preceded the endothermic melting 
transition phase present in all films (Film 6) showing semicrystalline behavior. Furthermore, 
the data obtained from the differential scanning calorimetry profiles reveal that all 
formulations degrade between a temperature rate of 230 and 300°C; this is largely due to the 
known fact that natural polymers are highly biodegradable due to properties such as their 
hydrophilic nature, they are easily swellable and water wettable as well as greatly sensitive to 
temperature changes, thus they tend to degrade easily on thermal exposure. Sarasam and 
Madihally (2005) suggest that chitosan, degrades at a temperature of 270°C prior to melting. 
Thus, it can be deduced that a temperature of 350°C will greatly impact the stability of natural 
polymers as the temperature range from 230 to 300°C already causes decomposition of 
polymeric material. 
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Figure 3.9: Differential scanning calorimetry of semi-IPN films: (a): film 1, (b): film 9, (c): film 
2, (d): film 10, and (e): film 6 
 
3.5.3. Structural Morphological Analysis of the Semi-IPN Films 
Figure 3.10 a–g demonstrates the SEM images of the semi- IPN films and the difference in 
surface morphologies of the films prepared using various polymer and crosslinker 
concentrations. Zhao and co-workers (2009) and Bhuvaneshwari and co-workers (2000) 
have reported that the surface morphology of pure CS films is relatively smooth, nonporous, 
flat, and homogenous. However, with the introduction of a polymer IPN, the addition of 
bioactives and crosslinking modification to the surface revealed a slightly rough surface 
texture with the existence of pores and cracks in some instances, confirming a porous 
network microstructure which is one of the essential features required to optimize gaseous 
exchange at the wound site. Porous structures were clearly observed in all micrographs of 
films but the pore size and shape differed as shown in Film 6 (Figure 3.10e) which had a 
slightly more rough surface topology with pores that were elongated and small in shape, 
whereas Film 10 (Figure. 3.10 g) showed a surface morphology with a more fibrous like 
structure, pores tend to be long, larger, and rod-like in shape. Film 9 (Figure. 3.10 f) showed 
pores that are much larger and clearly hollow with a definite border, whereas Film 1 (Figure. 
3.10c) and Film 2 (Figure 3.10d) showed a similar surface morphology with randomly 
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orientated pores that are indefinite in size, shape, and structure with the presence of a few 
cracks on the film surface. These differential surface features were attributed to the different 
polymer concentration and degree of crosslinking in the respective films. Film 9 (Figure 
3.10f) and Film 10 (Figure 3.10g) have the highest quantity of crosslinker relating to the 
greatest degree of crosslinking. However, distinguishing features of pores of the various films 
such as those in Film 9 (Figure 3.10g) and Film 10 (Figure 3.10f) could be accounted to a 
lower concentration of CS at 3% and higher CS concentrations of 1% being used in Film 9 
(Figure 3.10g) and Film 10 (Figure 3.10f), respectively. A lower degree of crosslinking results 
in cracks within the surface due to poor tensile properties as observed for Film 2 (Figure 
3.10d). When both the crosslinker and CS were used in intermediate quantities in films, the 
pores were notably smaller and the surface topology was rougher relating to the percentage 
crystallinity as observed in Film 5 (Figure 3.10e). 
 
 
 
Figure 3.10: Scanning electron micrographs of semi-IPN films: (a), (b): optimized film, (c): 
film 1, (d): film 2, (e): film 5, (f): film 9, and (g): film 10 
 
(a) (b) (c) 
(d) (e) (f) 
(g) 
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3.5.4. Textural Profile Analysis and Young’s Modulus Determination of the Semi-IPN 
Films 
The tensile and mechanical properties of all films were investigated by textural and 
nanotensile analysis. Figures 3.11 and 3.12 revealed that an increase in polymer 
concentration yielded a greater Young‘s modulus (YM) and tensile strength values as 
presented by Film 12. A greater degree of rigidity and stiffness is observed in Film 12 as an 
increase in crosslinking and polymeric concentration affects the polymer backbone formation 
and polymer chain flexibility which inevitably have an impact on the stress–strain relationship 
of the film. Semi- IPN films with a smaller Young‘s modulus value showed defined flexibility 
and thus a limited amount of stress was required to produce a relatively high amount of 
strain. Figure 6 illustrates the linear portion of the slope showing linear elastic deformation at 
this point thus an optimized, fairly flexible film will have a relatively small Young‘s modulus 
value as it is representative of both the rigidity and stiffness of the films. Interestingly, when 
an intermediate quantity of crosslinker was used (0.25%w/v), the ultimate strength (σu) was 
the greatest among all films as was seen in Films 4, 5, 7, 12, and 14, represented by the 
highest point on the stress–stain curve (Figure 3.13). However, films with a high σu value 
were also likely to have a high Young‘s modulus value as ultimate strength and Young‘s 
modulus are directly proportional and thus have poorer flexibility and elastic properties. Thus, 
the degree of crosslinking and polymer concentration has a distinct effect on elasticity and 
flexibility of films as ultimately a higher percentage causes a distinct increase in film rigidity 
and stiffness. Giovino and co-workers (2012) and Boatang and co-workers (2013) reported 
on the use of glycerol in films as a plasticizer to improve film properties and prevent a 
fracture, therefore the addition of glycerol also greatly improves the flexibility and elasticity 
index of films. Improved flexibility properties were impacted by the formation of H-bonding of 
glycerol with CS and at the same time ensuring the semidestruction of hydrogen network 
formation by the breakage of both intramolecular and intermolecular bonds. 
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Figure 3.11: Tensile strength (N.mm2) of the various semi-IPN Films 
 
 
Figure 3.12: Young modulus E (MPa) for various film formulations via nano-tensile analysis 
 
Film No. 
Film No. 
74 
 
 
Figure 3.13: Stress–strain nano-Tensile profile and Young‘s modulus 
 
3.5.5. Swelling Capacity and Equilibrium Water Content Analysis of the Semi-IPN Films 
The swelling capacity, water absorption, and equilibrium water content are important factors 
when considering the rate of absorption of polymeric films when in contact with the skin 
surface. Thus, the swelling capacity (%) and equilibrium water content (%) was evaluated in 
phosphate buffer solution (37°C; pH 7.4) (Figures 3.14). Plots clearly revealed that Film 11, 
Film 13, followed by Film 2 had the greatest swelling capability occurring within the first hour 
after immersion. This can be directly attributed to the low crosslinker concentration, thus 
covalent bond formation between polymers and polymer chains occur to a lesser extent 
providing enhanced hydrodynamic free volume to accommodate more water molecules, 
therefore exhibiting a greater swelling capacity. Poor crosslinking resulted in an increase in 
porosity which leads to fast initial rates of liquid uptake and a higher extent of equilibrium 
swelling. This suggests that a faster onset, degree and rate of bioactive absorption will occur. 
When the concentration of crosslinker was increased as in Films 2, 6, 8, 9 and 14, the 
swelling capacity and water content decreased, due to greater covalent bond formation 
overcoming porous sites, thus allowing penetration and absorption to occur at a reduced 
rate. This ensured sustained release of the bioactive (curcumin) throughout every stage of 
the wound healing phase (i.e. inflammation, granulation, proliferation, and remodelling). 
Thus, it can be deduced that the overall delivery rate was dependent on the rate of swelling 
as a decrease in the swelling rate promoted prolonged and controlled release of bioactive. 
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Figure 3.14: Profile of swelling capacity of the semi-IPN films 1–14 and the optimized film 
 
3.5.6. Water Vapour Transmission Rate Analysis 
Figure 3.15 represents the effects of various polymer concentrations on the water vapour 
transmission rate (WVTR). In the case of wounds, particularly burn wounds, the WVTR plays 
a key role with regard to moisture balance as it needs to be maintained throughout the 
repairing process. A low WVTR value could lead to numerous clinical challenges due to the 
build-up of exudates, whereas a very high value can lead to wound dehydration that 
decelerates the healing process. Furthermore, Sung and co-workers (2010) and Queen 
(1987) stated that a transmission rate between 2,000 and 2,500 g/m2 per day would yield the 
adequate moisture environment required for optimal healing. In this study, it was deduced 
that the highest WVTR value was seen in Film 12 where a high concentration of polymer and 
crosslinker was used, thus promoting wound dehydration. Furthermore, it was noted that the 
WVTR value increased with an increased quantity of CS rather than hypromellose. Thus, it 
can be deduced that the WVTR value was directly proportional to the CS concentration and 
therefore for optimal gaseous exchange, an intermediate quantity of polymer and crosslinker 
was required as observed in Film 5a and b. 
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Figure 3.15: Profile of the rate of water vapour transmission within the semi-IPN films 1–14 
and the optimized formulation 
 
3.5.7. Rheological Characterization of the Semi-IPN Film Polymer Blends 
Table 3.5 represents the rheological characteristics, in particular viscosity and yield stress, of 
formulation blends. From the results obtained, Films 3, 11, and 13 have the lowest shear 
viscosity rates and this was attributed to low-percentage crosslinking, suggesting weaker 
bonds due to lower chemical interactions between the amine groups of CS and genipin. 
Interestingly, it was noted that the degree of shear rate was directly proportional to the 
concentration of CS and the quantity of crosslinker used. At higher concentrations of CS (as 
in Film 2) where 3%w/v CS was used, hydrodynamic volume expansion occurred, which 
resulted from the protonated NH3 groups caused by repulsive forces thus increasing the 
shear rate (Pakravan. 2011). Furthermore, when higher concentrations of crosslinker was 
used, such as 0.025%w/v (Films 1, 4, 5, 7, 8, and 14), the viscosity shear rate increased. 
Stronger interactions due to a greater extent of crosslinking resulted in a remarkable 
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increase in shear viscosity. The yield stress under experimental conditions can be defined as 
that stress under which no flow can be observed and is related to the polymer viscosity 
(Barnes and Walter. 1985). From Table 3.5, it is observed that lower viscosity rates such as 
those in Films 9-11 resulted in a weaker yield. Thus, semi-IPN films are able to exhibit 
greater strain results when a stress is applied in the presence of a high yield stress. This 
directly influences the elasticity of the films which is an important property regarding wound 
dressings for topical use. From the results obtained, it was noted that the best rheological 
and mechanical properties are observed in Films 2, 4, 12, 14, and the optimized film. Post 
characterization of semi-IPN films generated through the Box-Behnken experimental design 
lead to an ultimate optimal formulation of 3%w/v CS, 0.1%
w/
v genipin, and 0.4%
w/
v 
hypromellose. This optimized formulation was further subjected to in vitro and ex vivo 
studies. 
Table 3.5: Effects of various concentrations of polymer and crosslinker on the formulation 
viscosity and yield stress 
Formulation no: Viscosity at a shear 
rate of 100s-1 (MPa) 
Yield Stress  
(Pa) 
F1 742.51 20.97 
F2 605.36 38.55 
F3 32.93 38.46 
F4 529.48 38.59 
F5 578.53 38.52 
F6 219.67 38.63 
F7 516.38 38.62 
F8 579.62 38.62 
F9 115.27 29.65 
F10 40.92 32.29 
F11 6.51 25.03 
F12 46.85 38.51 
F13 1.24 9.97 
F14 578.32 38.57 
F optimized 62.53 38.59 
 
3.5.8. Bioevaluation of the Curcumin-loaded Semi-IPN Film 
A transdermal permeation and release study was undertaken on the optimum candidate 
formulation obtained. Bioactive release and permeation studies of curcumin are depicted in 
Figure 3.16 a, b. Interestingly; an initial burst release is observed within both systems at 
1.1mg (bioactive release) and 2.23μg (bioactive permeation) within the first hour but is more 
pronounced during the permeation study. The first phase of the healing process is 
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inflammation and begins within a few minutes of injury and may last up to 24 hours or longer 
(Pawar et al., 2013), thus an initial burst release as seen initiates the delivery of curcumin at 
the wound site thus potentiating a therapeutic anti-inflammatory and antibacterial therapeutic 
effect at the wound site in association to inflammation. Furthermore, throughout this study, it 
was noted that bioactive release occurs at a fine rate when permeated through the skin. This 
can be directly attributed to the hydrophobic nature of curcumin, thus enhanced release rates 
were observed when in contact with skin tissue as preferential interactions occur with lipid-
based membranes such as the phospholipid bilayer present in the skin. Therefore, this 
directly impacts the major barrier associated with curcumin release improving its 
bioavailability and clinical efficacy (Zhao et al., 2013).  
 
The stratum corneum of the skin only allows moderately lipophilic molecules that are small to 
partition across it passively, into the deeper layer of the skin (Zhao et al., 2013). The stratum 
corneum is not an inert structural material and behaves as a reactive medium that may alter 
in response to changes in the sorption or desorption of penetrant molecules, thus deviation 
to Fick‘s law occurs (Scheuplein. 2011). Between 4 and 6h, an intermediate second burst 
release was seen in Figure 3.16b from 3.39 to 6.19μg, thus further potentiating a deviation 
from Fick‘s law. The flux rate of permeated bioactive release reveals substantial deviation, 
thus revealing that steady-state release profiles are not maintained throughout the study. 
Therefore, curcumin-loaded IPN films will serve as a dressing with ideal characteristics 
intended to be applied topically to wounds. Variation to steady-state release profiles 
potentiating wound healing is further supported by Seetharaman et al. (2011) whom also 
state that ideal characteristics for wound healing is potentiated by this type of release. When 
considering factors that affect the permeation rate across skin tissue, evaluation of 
characterization studies such as the FTIR analysis discussed in text, it can be seen that 
introduction of crosslinking by genipin resulted in the formation of crosslinking bridges at the 
aromatic site thus supporting the formation of a crosslinked network. This brought about an 
increase in intermolecular conjugation. Augmentation of crosslinking resulted in greater 
mechanical properties such as an elevated Young‘s modulus which could be seen as the 
crosslinking increased thus forming stiffer and more rigid films. Therefore, an increase in 
crosslinking decreases the permeation ability as a denser network structure occurs. Rana 
and co-workers (2005) also state that stronger crosslinking of chitosan by increasing the 
crosslinker concentration seems to restrict the permeation of drug. 
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Figure 3.16: (a): Drug release profile of curcumin-loaded semi-IPN films and (b): drug 
release permeation through the Sprague-Dawley rat skin. 
 
3.6. Concluding Remarks 
Preliminary studies led to the rational identification of the formulation variables most suited 
for film formation. Further studies were then conducted to ensure development and 
optimization of the novel semi-IPN film composed of CS and its derivatives, crosslinked and 
incorporated with a bioactive (curcumin). Medium molecular weight CS was dissolved in citric 
acid and successfully crosslinked with genipin before the incorporation of biopolymers such 
as hypromellose and curcumin in a stepwise manner to structure an IPN that ensured the 
bioactive can be gradually diffused through the Sprague-Dawley rat skin model. The films 
have shown the potential to swell and release the bioactive to stimulate proliferation, 
differentiation, and remodelling of the targeted skin tissue.Outstanding release and 
permeation rates were noted when the system was in contact with the skin tissue thus 
suggesting that topical application of the films at a wound site would augment bioactive 
release. An important outcome of this chapter was to identify variable polymer concentrations 
to obtain an optimal formulation bearing the most advantageous characteristics in terms of 
bioactive release, flexibility, toughness and the ideal rheological properties. 
 
The attainment of a design of experiments (DoE) from the statistically derived Box-Behnken 
design and mathematical conceptualisation lead to the attainment of optimal concentrations 
(a) 
(b) 
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of biopolymers for synthesis of the ideal film. Inclusion of genipin was thus shown to be 
beneficial as the mechanical properties of the film were improved greatly. This chapter 
served to identify the candidate formulation which led to the identification of three variables 
with their corresponding upper and lower limits for input into the Box-Behnken Design as 
described. Formation of the films serves as an ideal comparative constituent when compared 
against the nanofibrous mat as will be discussed in Chapter 4 and 5. Attainment of the 
optimal candidate formulation also aids the fabrication of nanofibres. 
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CHAPTER 4 
FABRICATION AND CHARACTERISATION OF THE CROSSLINKED 
NANOFIBROUS MAT AS A WOUND HEALING DELIVERY SYSTEM 
 
4.1. Introduction 
Wound healing is a dynamic process (Said et al., 2011) that involves a complex sequential 
cascade that may occur simultaneously involving mediators such as parenchymal cells, 
blood cells and the extracellular matrix (ECM) of the skin (Moura et al., 2013). These 
mediators may be activated to synergistically restore healing integrity thus preventing 
organism homeostatic deregulation (Jayakumar et al., 2011) throughout the phases of 
inflammation, proliferation, re-epithelisation and remodelling,(Moura et al., 2013) the main 
phases that occur during healing. To ensure optimal and accelerated healing of a wound 
area, coverage of the wound site is a requirement for provision of a protective environment 
(Gu S-Y et al., 2009). As also mentioned in previous work (Mayet et al.,2014) and stated in 
Chapter 2 the native skin serves as the perfect wound dressing thus the ideal artificial 
dressing should be designed in such a way as to replicate its essential properties and 
functions(Morin et al., 2007; Moura et al., 2013). Some of the ideal properties that should be 
incorporated in a wound healing dressing include protection from bacterial invasion, moist 
wound environment, gaseous exchange, debridgement, non toxic, non adherent, non 
allergenic (Jayakumar et al., 2011) and mimicking the essential functions of the skin tissue 
(Boatang et al., 2008; Mayet et al., 2014). Thus the goal in producing an optimal dressing 
would be to ensure these functions are incorporated together as a porous dressing structure, 
suitable wound barrier that has the capacity to mimic the extracellular matrix (ECM) of the 
skin. 
 
Structures that are nanofibrous based are of increasing interest in the wound healing field as 
they can be applied in biomedical applications in the form of dressings, scaffolds etc. 
Materials based on nanofibres enable architectural, structural and morphological similarities 
to the extra cellular matrix of the native skin to be obtained (Pinho et al., 2009). 
Nanobiotechnology provides opportunities that enable these features to be improvised as it is 
incorporated in the field of research, molecular biotechnology, nanosciences and materials. It 
is a novel interdisciplinary field that utilises the use of biopolymers and materials, both of 
organic and inorganic nature to fabricate devices on the nano-metre scale, that possess 
mesoscopic architectural properties (Niemeyer, 2006). Of interest in this chapter is an 
advanced innovative novel system synthesized by the process of electrospinning of 
biomaterials to form nanofibres as a wound healing application, as our published study 
indicated and explicated in Chapter 3, the use of biomaterials in the form of a wound healing 
film (Mayet et al., 2014). Electrospinning involves the use of a unique approach to fabricate 
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nanofibres by the use of electrostatic forces. A high potential is applied to a polymeric 
solution to produce a jet whereby nanofibrous webs can be collected on the surface of the 
collecting end of the foil (Taylor, 1969; Reneker and Chun., 1996; Zahedi et al., 2010). 
Nanofibrous wound dressing applications produced by the process of electrospinning have 
many more unique qualities as compared to dressings produced by other conventional 
methods (Zhang et al., 2005; Zahedi et al., 2010) such as: semi-permeability which allows for 
high gaseous exchange and provision of a moist environment due to the many small pore 
size between fibres. Further homeostasis is maintained as the nanofibres structure has the 
ability to mimic the extracellular matrix of the skin (ECM), thus no further homeostatic agent 
need be even included (Zahedi et al., 2010). A scar free recovery can be obtained as normal 
tissue growth is encouraged, in particular by the use of biomaterials that are biodegradable 
and biocompatible encouraging tissue self repair and promoting blood flow and good cell 
conductivity which facilitate the wound healing process (Martindale. 2000). Nanofibres 
possess a 3D conformity due to their structure and morphology thus allowing an increase in 
flexibility and resilience at the wound site, in addition they also provide for greater 
absorbability in comparison to conventional dressings as their structure allows for a high 
surface area to volume ratio, thus capable of absorbing increasing amounts of exudates 
(Dabney et al., 2002; Zahedi et al., 2010).  
 
4.2. The Technique of Electrospinning 
Within the tissue engineering community, electrospinning has gained much interest due to its 
ability to mimick the biological and structural features and functions that ensure a replica of 
the native extracellular matrix. Furthermore, it has gained much attention as an attractive 
feature for scaffolding and nanofibre formation due to its inexpensive setup nature and 
simplicity (Pham et al., 2006). This technique allows the configuration of fibres on the 
nanoscale meter ranging from few nanometres to hundreds of nanometres. In addition, a 
porous nanofibrous structure can be generated to ensure incorporation of gene factors, 
bioactives and drugs (Chong et al., 2007).  
 
The process of electrospinning involves the use of an apparatus that consists of a high 
voltage source, syringe pump and collecting disc as illustrated in Figure 4.1. Electrospinning 
expresses the use of a high-voltage electric current which runs through the polymer solution 
inducing a charge in the polymer which results in a charge repulsion. The solution is held at 
the needle tip by surface tension which is opposed by the electrostatic forces induced by the 
electric field charges. Over time, charge repulsion within the polymeric solution overcomes 
the surface tension due to the applied high-voltage source. This results in the creation of a 
polymeric solution jet. Solvent evaporates from the jet, as the jet travels to the appropriate 
collecting disc whereby polymeric nanofibres can be collected (Pham et al., 2006).  
84 
 
 
 
Figure 4.1: (a) The electrospinning apparatus with significant elements to fabricate the (b) 
nanofibrous mat.  
 
In addition, in order to ensure the fabrication of optimal nanofibres the stability of the 
polymeric jet is of significant importance. Pham and Sharma (2006) classify polymeric jets 
into four varying regions as follows: 
 
 Base Region: This specifies the formation of a cone known as the ‗Taylor Cone‘ 
which occurs upon the emergence of the polymeric jet from the needle. Electric field 
forces applied as well as the surface tension occurrence denote the shape of the 
base. 
 The Jet: Jet formation is dependent upon the surface tension and the electric field 
force. A higher conductivity will prevail in greater jet formation and strong electrostatic 
forces will allow jet formation from flat surfaces. Jet formation transpires upon the 
application of electric forces which cause acceleration and stretch of the jet 
consequently decreasing the diameter and increasing the length. Furthermore when a 
Rotating 
Drum for 
Nanofibre 
Collection 
Solution Jet 
Syringe Pump 
High Voltage 
Power Supply 
Nanofibre 
formation to 
form a mat 
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solvent of high vapour pressure is utilised, jet velocity as well as fibre diameter is 
further decreased (Reneker and Chun, 1996). 
 The Splay: This occurs upon radial charge repulsions which produce nanofibres of 
approximately equal charge and diameter per unit length (Reneker and Chun.1996). 
Splaying dominates when a solitary swift whipping jet transpires due to the use of 
high electric fields and frequency when the jet is travelling a short distance. Instability 
occurs resulting in bending and stretching of fibres (Shin et al., 2001; Shin et al., 
2001).  
 The Collection: The collection surface plays a significant role in the collection of 
nanofibres. The nature of composition and material signifies the type of fibres to be 
collected for example; metal surfaces would obtain smooth fibres whereas water 
surfaces would result in shrinkage of fibres. The uniformity and alignment of fibres 
also depend on the geometry of the collecting surface. Parallel plates, frame 
conductors as well as rings have been used (Huang et al., 2003). 
 
4.3. Limitations Pertaining to the Degree of Successful Nanofibre Formation utilizing 
the Bioactive Polymeric Solution 
In the last few decades, electrospinning has become a popular revenue for polymeric 
nanofibre formation due to its electrohydrodynamical phenomena launching broader realms 
of material science and nanotechnology. Nanofibre formation has now been altered to 
include large scale production and processes, low cost, environmentally and economically 
friendly as well as involving a high capital intensive (Reneker and Yarin., 2008).  However, 
there are many limitations and challenges faced when considering the electrospinning 
process as the production of nano-scale dimension materials is no trivial task. Hydrodynamic 
instabilities and mechanical constraints are the main intrinsic physical limitations pertaining to 
electrospinning (Kowalewski et al., 2005). The production of nanofibres via the 
electrospinning technique produced many notable limitation characteristics as follows 
(Thompson et al., 2007): 
 Diameter distribution as well as as-spun nanofibres diameter predictions is unreliable. 
 Aligned orientation of fibres is difficult to produce. Production of non-woven mats is 
much simpler and easier to produce as opposed to orientated nanoropes, crossbars 
and nanofibres arrays. 
 Many models have been generalised for the process of electrospinning and multiple 
jet formation, however precise process control has not reached the desirable level. 
 Relatively low production rates are produced when electrospinning, however Yarin 
and co-workers (2004) have reported that a 12 fold increase in production is possible. 
  Nanofibrous bead formation due to capillary instabilities as well as nanofibre 
diameter uniformity and morphology is multifarious to control. 
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 A characteristic of electrospinning such as elongation behaviour with regards to 
extremely strong uniaxial elongation flows as well as elemental aspects regarding 
rheological properties and behaviour of concentrated and semi-dilute polymeric 
solutions is absent. 
 
According to Sarkar and co-workers (2010) electrospinning is known to be the most 
successful way of nanofibre production for commercial use. Nonetheless due to its many 
limitations as discussed, many researchers have aimed at modifying the traditional 
electrospinning method to enhance the electrospinning process to overcome the inherent 
challenges faced with using a traditional electrospinner and the polymeric solution. Of 
significant importance when undergoing the electrospinning procedure is the jet stability. 
Rutledge and co-workers (2000) provided a model to display the instabilities of the jet. Jet 
instabilities were classified as Rayleigh instability and two ‗conducting‘ modes. Rayleigh 
instabilities which are axisymmetric involve the use of high electric fields and charge 
densities whereby the instability is dominated by surface tension. In contrast to this, the 
conducting modes are independent of surface tension and are dominated by electric forces 
whereby one mode produces a ‗whipping instability‘ known to be non axisymmetric and one 
conducting mode that is axisymmetric(Shin et al., 2001).  
 
In order to overcome these limitations and challenges, the various parameters affecting the 
electrospinning process needs to be taken into account. Table 4.1 depicts the various 
parameters, their effect on electrospinning as well as resolutions to be undertaken to 
overcome this (Haghi and Akbari, 2007; Pham et al., 2006). 
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Table 4.1: Parameters pertaining to limitation occurrence during the electrospinning process  
 Consequence 
on 
electrospinning 
Parameters Resolution 
Solution 
Properties 
   
Viscosity/ 
Concentration 
Fibre diameter 
size and 
morphology, 
nanobead 
formation 
 ↑viscosity, ↑fibre 
diameter size,↓ 
nanofibre formation 
↑polymer concentration 
Conductivity Jet formation, 
nanobead 
formation, 
diameter size 
↑conductivity, ↑jet and 
nanofibres formation, 
↓bead formation and 
diameter size, ↑fibre 
uniformity 
Addition of ethanol, NaCl (salt), 
Electroconductive agents: 
Polyethylene Oxide (PEO) and 
Polyvinyl Alcohol (PVA) and charged 
surfactants 
Surface 
Tension 
Nanofibre size 
and morphology, 
Electrospinning 
process, 
nanobead and 
droplet formation 
↓surface tension,↑ 
nanofibre formation, 
↓bead formation 
Addition of PVA and PEO, Choice of 
solvent 
Polymer 
Molecular 
Weight 
Morphology and 
nanofibres 
diameter size, 
nanobead 
formation 
↑molecular weight;↑ 
uniformity,↓ nanobead 
and droplet formation 
Polymers with ↑ molecular weight 
Controlled 
Variables 
   
Flow Rate Fibre diameter, 
nanobead 
formation 
↑↑ flow rate:  
nanobeading due to 
↓evaporation 
time,↓↓rates: fibres with 
smaller diameters 
Alter flow rate accordingly 
Electric Field 
Strength 
Fibre diameter 
size, junction and 
bead formation, 
Jet and Taylor 
cone formation 
↑voltage: receding 
Taylor cone, 
↑nanobead formation, 
jets with 
↑diameters.↑↑voltage, 
no visible Taylor cone. 
↓voltage: jets with 
Taylor cone forming 
bead free spinning  
Alter or ↓voltage accordingly 
Distance Fibre size and 
morphology 
Varies according to 
polymers used, effect 
on bead formation and 
electrospraying. 
Alter distance between tip and 
collector accordingly. 
Collector 
Composition/ 
Geometry 
Fibre texture, 
packing density 
and alignment 
Conductive collectors 
influence the packing 
density of 
fibres.↓conductivity:↑ 
porous structures. 
Metal collectors 
produce smooth fibres 
whereas water surface 
collectors cause fibre 
Choice of collector according to 
desired outcome 
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shrinkage.  
Ambient 
Parameters 
   
Temperature Fibre diameter ↑temperature,↓diameter ↑temperature accordingly 
Humidity Porous surface 
on fibres 
↑humidity,↑pore 
formation 
↓humidity accordingly 
 
4.4. Selection of Optimal Parameters for Advantageous Nanofibre Formation 
During the electrospinning process many drawbacks had been noted such as minimal to no 
jet formation thus poor to no nanofibre formation, electrospraying as well as nanobead 
formation. Thus, many steps were undertaken to improve the spinning process.  
 
To reduce toxicity and augment the natural nature of the system, the solvent of choice was 
deionised water. An attempt was made to electrospun nanofibres using the polymeric 
solution, but failure to obtain fibres was noted. Thus many challenges were identified such as 
poor conductivity properties, low viscosity and weak charge density which lead to the 
instability of the polymer jet solution. To overcome this many progressions were implemented 
to improve the solution properties. This included advancing the conductivity and charge 
density to overcome surface tension at the jet and Taylor cone by the addition of PEO (Fong 
et al., 1999). The addition of a PEO solution gave rise to a higher viscosity due to 
intermolecular and intramolecular interactions thus reducing nanobead formation; 
furthermore absorption of PEO molecules at the solution surface facilitated a decrease in the 
surface tension (Duan et al., 2004). To enhance this phenomena ethanol was added to make 
a PEO solution at a ratio of 2:3 of ethanol: deionised water respectively. Addition of 
ethanol/alcohol to the solvent augments the conductivity of the polymeric solution resulting in 
the formation of smoother fibres and amplifying the stability of the jet formation (Pham et al., 
2006). Furthermore it was noted that addition of a PEO solution on its own did not 
successfully enhance nanofibre formation and thus a second electroconductive agent was 
needed to be introduced. PVA was the conductive polymer of choice, further reducing 
surface tension by increasing available electrostatic charges. The addition of both PEO and 
PVA solutions simultaneously allowed for the successful configuration of nanofibres together 
with the addition of other auxiliary excipients. The addition of other agents such as non ionic 
surfactants, Polyoxyethylene Sorbitan Monooleate (Tween 80) in small amounts, further 
augments nanofibre formation by minimising bead formation enhancing the effects of formed 
nanofibres. Enhancement of fibre fabrication is expanded by the addition of salt (NaCl) in 
minute amounts which increases the solution conductivity and charge density ensuring 
optimal nanofibre formation (Pham et al., 2006).  
 
Nanofibre morphology, uniformity and diameter size are also largely dependent upon the 
processing parameters or variables that can be controlled such as flow rate, distance and 
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voltage supply. Trial and error using variable parameters regarding the above was 
undertaken to optimize the process. With regards to distance it was noted that a very short 
distance lead to electrospraying where nanofibres were not obtained. Increasing the distance 
allows for evaporation and drying of the solvent therefore maximising fibre formation. 
Increasing the distance further lead to unwanted bead formation.  Applied voltage has an 
effect on both fibre diameter and bead formation. A lower voltage will produce fibrous mats 
with minimal bead formation and larger diameters. Higher voltages produce fibres of smaller 
and greater bead formation (Haghi and Akbari. 2007). Upon investigation using the polymeric 
solution an optimal voltage rate was attained. 
 
Lastly viscosity plays a significant role in the fibre formation process as well as the eminence 
of the fibres formed. Low solution viscosities lead to minimal and poor nanofibre fabrication 
as well as electrospraying and nanobead formation. Thus, improvision of the ideal viscosity is 
of significant importance as a very high viscosity will lead to no Taylor cone formation at all. 
Based on this and various other characteristics required a Box-Behnken design template was 
implemented to optimize fibre synthesis as discussed in the sections to follow.  
 
Design of the Biopolymeric Nanofibrous Mat employing a Design Strategy 
 
4.5. Materials and Methods 
4.5.1. Materials 
All experiments conducted employed the use of chitosan, medium molecular weight poly (D-
glucosamine) deacetylated chitin, hypromellose (hydroxymethylcellulose 2910), citric acid 
(ACS reagent ≥99.5%, Mw=192.12 g/mol), genipin (≥ 98% (HPLC) powder (Mw= 226.23 
g/mol) and curcumin, all obtained from Sigma Aldrich Chemie GmbH, Steinheim, Germany. 
PVA- mowiol® 4-88 with a Mw=31000 g/mol and PEO-Polyox™, WSR 303 obtained from 
Sigma Aldrich Chemie GmbH, Steinheim, Germany as well as Tween 80 obtained from 
uniLAB®(Merck Chemicals (Pty) Ltd, Wadeville, Gauteng, RSA) was utilised 
 
4.5.2. Preparation of Crosslinked Nanofibrous Mats 
Solution A: A1+A2+A3+A4 (to 100ml) 
Chitosan (CS) (A1) solution is prepared by dissolving in an aqueous acidic solution 
comprising of a 5%w/v (50 mg/mL) citric acid as a solvent medium. The chitosan used is of 
medium molecular weight and varies in concentration between 1%w/v (10 mg/mL) to 3%
w/v 
(30 mg/mL). Aqueous solution of Hypromellose (A2) ranging between 0.4%w/v (4 mg/mL) to 
1.6%w/v (16 mg/mL) was then added. Crosslinking and the formation of a semi 
interpenetrating polymer network were obtained by the addition of genipin (A3) at 
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concentrations ranging from 0.01%w/v (10mg/10mL) to 0.05%
w/v (50mg/10mL). Lastly the 
bioactive curcumin (A4) [1%w/v (10 mg/mL)] was added. 
 
Where A1: Chitosan 
          A2: Hypromellose 
          A3: Genipin 
         .A4: Curcumin 
 
Solution B: Electroconductive agents polyvinyl alcohol (PVA) at a concentration of 10%w/v 
dissolved in deionised water (10.0g of PVA dissolved in 100ml deionised water) 
 
Solution C: 2%w/v polyethylene oxide (PEO) dissolved in 40% ethanol and 60% deionised 
water (2.0g dissolved in 100ml 40:60 – ethanol: deionised water) 
 
Final Formulation: 
Solutions A+B+C was added at a ratio of 1:1:1 (300ml) together with a surfactant 
Polyoxyethylene Sorbitan Monooleate (5ml) and a net charge density enhancer NaCl 
(7.5mg). The solution was left overnight to stir before electrospinning. 
 
Figure 4.1 describes the electrospinning process, parameters and setup which involves the 
application of a voltage of 20kV supplied by Glassman high voltage inc,(high bridge NJ USA) 
to the biosolution via a pipe attached at one end to a 10mL syringe that is inserted in the slot 
provided by the pump (Chemyx Inc syringe infusion pump). The solution was fed into the 
syringe and allowed to run whereby nanofibres were collected on an aluminium foil attached 
to the collecting surface whereby a nanofibrous mat was formed. 
 
4.5.3. Strategic employment of the Box-Behnken Experimental Design for Optimization 
of the Nanofibrous System 
For the most favourable development of the wound healing system, statistical formulation 
optimization has to be undertaken. This is achieved by employing a systemic design of 
experiments (DoE) that led to the utilisation of a three factor Box-Behnken Design template 
which consist of 15 formulations indicating the optimal formulatory components indicated in 
Table 4.2. The Box-Behnken design template was based on three variables which 
determined formulary characteristics in terms of the release and physicomechanical 
properties of the system. 
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Table 4.2: Box-Behnken Design Template for statistically derived s-IPN Nanofibrous Mats 
Formulation 
No. 
Chitosan 
(%w/w) 
Genipin 
(%w/w) 
Hypromellose 
(%w/w) 
1 3 0.25 1.6 
2 1 0.25 0.4 
3 3 0.1 1 
4 2 0.1 1.6 
5 1 0.25 1.6 
6 2 0.25 1 
7 2 0.4 0.4 
8 3 0.25 0.4 
9 2 0.25 1 
10 3 0.4 1 
11 1 0.4 1 
12 1 0.1 1 
13 2 0.4 1.6 
14 2 0.1 0.4 
15 2 0.25 1 
 
4.5.4. Determination of the Molecular Vibrational Transitions of the Nanofibrous Mats 
by Fourier Transform Infrared Spectroscopy 
A PerkinElmer® Spectrum 100 Series FT-IR Spectrometer fitted with a universal ATR 
Polarization Accessory (PerkinElmer Ltd., Beaconsfield, UK) was employed and Spectra  
over the range 4000-625cm-1, with a resolution of 4cm-1 and 4 accumulations was used in 
order to determine molecular transitions by the identification of absorption bands that occur 
at various wavelengths due to bioactive polymer interactions. 
 
4.5.5. Surface Morphology and Nanofibre Density by Scanning Electron Microscopy 
A SEM (Phenom™, FEI Company, and Hillsboro, Oregon, USA) was used to conduct 
analysis of nanofibre samples. The surface morphology of the nanofibrous mats were 
evaluated for nanofibre size range, diameter and bead formation. 
 
4.5.6. Determination of the Thermal Analysis by Advanced Differential Scanning 
Calorimetry 
Thermoanalysis of samples were carried out using an Advanced DSC (TMDSC/ ADSC) 
(Mettler Toledo DSC-1 STARe System, Schwerzenback, ZH, Switzerland) whereby factors 
such as glass transition and phase change temperature, melting points as well as thermal 
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degradation could be identified and compared. Samples were weighed and prepared by 
placing then in aluminium crucibles with a central pin hole in ambient nitrogen conditions at a 
heating rate of 10°C/min from -10 to 350°C. 
 
4.5.7. Determination of the Tensile Properties of Nanofibrous Mats by the application 
of Texture Analysis 
A texture analyser (Ta.XT.plus texture analyser, stable microsystems, surrey, UK) that is 
fitted with a 50kg load cell and is highly sensitive was used to evaluate the 
physicomechanical properties of nanofibrous mats by inserting mats within brackets that 
were calibrated at a distance of 30 mm/sec and a return speed of 5mm/sec. A pre-test speed 
of 0.5mm/sec was used to apply a tension force in order to obtain the peak force required to 
establish the breaking point. Work of extensibility and tensile strength of the mats were then 
obtained by computing the peak tensile force into the following equation (equation 3.1): 
Settings employed using the texture analysed to depict tensile strength and work of 
extensibility as well as to generate force-distance profiles are shown in Table 3.3 in Chapter 
3. 
 
Tensile strength was measured using the Young‘s Modulus equation as follows: 
𝐸 =
𝑇𝑒𝑛𝑠𝑖𝑙𝑒  𝑠𝑡𝑟𝑒𝑠𝑠
𝑇𝑒𝑛𝑠𝑖𝑙𝑒  𝑠𝑡𝑟𝑎𝑖𝑛
=
𝛿
𝜀
=
𝐹𝐿𝑜
𝐴𝑜∆𝐿
                                                                                  [Equation 3.1]                                           
Where: E is the Young‘s modulus (modulus of elasticity); F is the force applied to the object; 
A0 is the original cross-sectional area (πr
2) through which the force is applied; ΔL is the 
amount by which the length of the object changes; L0 is the original length of the object. 
 
4.5.8. Determination of Young’s Modulus and Tensile Properties by the Application of 
Nano Tensile Analysis 
Various tensile properties as well as Young‘s Modulus was determined by the application of 
a nano tensile analyzer (nanoTensile® 5000 Hysitron Inc. Nanomechanical Test Instrument, 
Minneapolis, MN). Samples cut to size were placed and securely held by a cardboard frame 
into specially designed mounting brackets as indicated in Figure 4.2. A digital calliper was 
used to accurately determine the length, thickness and width of samples after they were 
cured. Samples were gripped between the upper and lower brackets and the system was run 
at a constant rate of 5μms-1 until a stress-strain profile was established. 
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Figure 4.2: Schematic representation of mounted nanofibres secured on template for 
nanotensile mapping. 
 
4.5.9. Electrospun Polymer Solution Elucidation of Pertinent Rheological 
Characteristics and Properties 
The rheological properties of biopolymer based solutions were determined using a Haake 
Modular Advanced Rheometer System (ThermoFisher Scientific, Karlsruhe, Germany). The 
electrospinning process is influenced by properties related to rheological stress and strain 
parameters. These factors are important when considering electrospinning as optimized 
characteristics are required in order to obtain electrospun polymer blends. Of particular 
interest, changes in viscosity, yield stress, stress and frequency sweep were evaluated. 
Samples were analysed by placing polymeric solution blends onto a sample stage whilst 
immersing the C35/1° titanium rotor into the solution. Parameters employed are displayed in 
Table 4.3 
 
 
 
 
 
 
Cardboard 
Template 
Metal 
Brackets 
attached to 
Template 
Insertion of fibre 
using tape and 
secure fibre to 
metal plate using 
glue 
Removal of 
access 
cardboard from 
template 
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Table 4.3: Parameters employed to carry out varies rheological analysis on polymer 
solutions for electrospinning. 
Test Performed Parameters Employed 
Viscosity Temperature: 24°C 
Shear Rate: 100s-1 
Time: 360s 
Yield Stress Temperature: 24°C 
Ƭ: 200Pa 
Time: 30s 
Stress Sweep Temperature: 24°C 
Frequency: 0.1Hz 
Oscillatory Ƭ: 0.1pa 
70pa 
Frequency Sweep Temperature: 24°C 
Frequency: 0.964 Hz 
Ƭ= based on result from stress sweep 
 
4.5.10. Bioevaluation of Nanofibrous Mats as a Wound Healing Platform 
 
4.5.10.1. In vitro Release of Bioactive  
At time periods of 0.5,1,2,3,4,6,8,10 and 12 hours the release of curcumin, a bioactive was 
investigated using a modified Franz Diffusion Cell. Nanofibrous mat were cut into sections of 
approximately 1.8cm2 and placed on the receptor compartment of the Franz Diffusion cell 
whereby it was kept in contact with Phosphate Buffer solution (PBS) of pH 7.4, at a 
temperature of 37°C that was thermoregulated by a water jacket. The cell was filled with 12 
mL of isotonic buffer, stirred constantly using a magnetic stirrer and periodically during the 
study as stipulated above 0.1mL was removed for evaluation. Immediately an equal amount 
of fresh PBS was replaced into the compartment and allowed to stir. Sample PBS removed 
was then evaluated using an Implen nanophotometer GmbH, Munich, at a wavelength of 
425nm. 
 
4.5.10.2. Ex Vivo Bioadhesivity Testing of the Nanofibrous Mats 
Excision of skin tissue from the Sprague Dawley rat skin model 
Sprague Dawley Rats weighing between 200-250g were euthanized using pentobarbitone 
intraperitoneally (i.p) and the skin was carefully removed. Rat skin was stored in isotonic 
buffer solution in an airtight jar at -80°C until further use. Prior to experimental procedures 
skin was taken out and thawed by placing in water at 37°C. The dorsal region was shaved 
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and further subcutaneous and adipose tissue was carefully removed. Skin sections were 
then cut to fit the head of the probe.  
 
Textural Profiling Analysis to determine the bioadhesivity of the nanofibrous mats 
A TA.XT plus texture analyzer was utilised to evaluate the bioadhesivity of the mats. Excised 
skin tissue was secured to the probe using bioadhesive tape. The bioadhesivity 
characteristics was determined at 37°C whereby the attached excised skin tissue was 
lowered onto the surface of the nanofibrous mats at a constant speed of 0.1mm.s-1 and a 
contact force of 0.5N. The probe was then vertically removed upward at the same constant 
speed after a contact period of 120s. A plot of force against distance was procured and the 
area under the curve obtained to determine the work of mucoadhesion per square centimetre 
(mJ. cm2) 
𝑊𝑜𝑟𝑘 𝑜𝑓 𝑚𝑢𝑐𝑜𝑎𝑑𝑕𝑒𝑠𝑖𝑜𝑛 (𝑚𝐽. 𝑐𝑚−2) =  
𝐴𝑈𝐶
𝜋𝑟2
                                                   [Equation 4.1] 
Whereby πr2: Surface area of the skin tissue which is in contact with the mats 
 
4.6. Results and Discussion 
Following generation of the experimental design formulations, the formation of fibres by 
electrospinning was endeavoured. However many factors pertaining to the process of 
nanofibre formation as discussed herein this chapter had to be taken into account which lead 
to the optimization of these parameters as indicated in Table 4.4. Upon observation it was 
noted that polymeric concentrations at a lower range tend to provide lower tensile strength 
and are easily degradable when exposed to an aqueous medium whereas at a higher 
concentration range, they show enhanced physico-mechanical properties that tend to 
degrade at a much slower rate. Furthermore concentrations of the crosslinking agent at or 
above 0.04%w/v result in tearing and rapid degradation of the nanofibrous mats or no 
nanofibres formation at all. In addition solution and electrospinning parameters are of crucial 
importance. The synthesis of nanofibres involves a polymeric solution of paramount 
viscosity, electroconductivity, charge density and polarity as well as an optimal voltage 
supply as discussed. A deviation from this results in subordinate, minimal or no nanofibre 
formation. Table 4.5 indicates the outcome from the experimental design. 
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Table 4.4: Parameters pertaining to optimal nanofibres formation 
Parameters Nanofibrous Mat 
 
Solution Parameters and properties  
Electroconductive agent-PVA  10%w/v 
Electroconductive agent-PEO  2%w/v 
Solvent for PEO, decrease in bead formation 
and surface tension 
40% ethanol 
Surfactant Polyoxyethylene Sorbitan Monooleate (1ml) 
Net charge density enhancer NaCl (1.5mg) 
Electrospinning Parameters  
Supply of Voltage 20 Kv 
Distance 31-39.5cm 
Flow Rate 1500μl/h 
 
Table 4.5: Representation of nanofibre fabrication from the Box-Behnken experimental 
design 
Formulation 
No. 
Chitosan 
(%w/v) 
Genipin 
(%w/v) 
Hypromellose 
(%w/v) 
Nanofibre 
Formation 
1 3 0.25 1.6 ᵪ (High Viscosity) 
2 1 0.25 0.4    ̸ (with beads) 
3 3 0.1 1     ̸ 
4 2 0.1 1.6     ̸ 
5 1 0.25 1.6      ̸ (Dense) 
6 2 0.25 1      ̸ (Dense) 
7 2 0.4 0.4 ᵪ(↑[crosslinker]) 
8 3 0.25  0.4 ᵪ 
9 2 0.25 1       ̸ (Dense) 
10 3 0.4 1 ᵪ(↑[crosslinker]) 
11 1 0.4 1 ᵪ(↑[crosslinker]) 
12 1 0.1 1 ᵪ (↓ Viscosity) 
13 2 0.4 1.6 ᵪ (↑[crosslinker]) 
14 2 0.1 0.4 ᵪ(↓ Viscosity) 
15 2 0.25 1     ̸ (Dense) 
 
4.6.1. Chemical Vibrational Analysis of the Nanofibrous Mats 
FTIR analysis was conducted to determine structural and chemical modifications occurring 
upon crosslinking and electrospinning. Of particular interest is the electrospinning process of 
aqueous based solutions and to what extent the nature of native polymers are modified. 
Figure 4.4 illustrates the FTIR spectra of various nanofibrous mats. A broad band indicative 
of O-H stretching is present in all formulations. This also represents the presents of PVA in 
the structure. This peak occurs at 3294.23cm-1 in F2 where weaker band intensity is seen 
and shifts to 3310.52cm-1 and 3329.67cm-1 in F4 and F15 (demarcated in Figure 4.3) thus 
suggesting greater band intensity when the degree of crosslinkage is increased. Crosslinking 
with genipin occurs by its linkage to free amino groups within the structure, mostly present in 
chitosan. F2 contains a lower percentage of chitosan (1%w/v) thus limiting the amount of 
amino groups available for crosslinkage weakening network formation and encouraging 
steric hindrance, in comparison to F4 and F15 where greater rigidity is observed. An increase 
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in the wavelength results in greater conjugation and intensity, thus showing greater stability 
and physicomechanical properties in F3 and F7.  
 
Further a second broad band is seen at 2891.95cm-1 in F4 and F15 due to C-H vibrational 
stretching occurring within the structure. A shift in the band intensity occurred from 
2891.95cm-1 to 2906.55cm-1 in F15 and 2909.36cm-1 in F6 (demarcated in Figure 4.3). This 
further suggests that when an increase in crosslinking occurs, band intensity and conjugation 
strengthens. When crosslinking occurs to a greater degree and the percentage concentration 
of hypromellose is larger, additional O-H interactions are allowed to occur between molecular 
chains. PVA in its semi-crystalline state interacts with polymeric chains by hydrogen 
chemical binding between available hydroxyl groups thus greater linkage occurs (Han et al., 
2009) and broader bands between the 1300-1400cm-1 spectrum is observed. Furthermore 
absorbance was observed shifting from 0.09A in F5 to 0.12A and 0.13A in F4 and F6. Thus it 
can be deduced that a shift in absorbance is directly related to the degree of crosslinkage 
occurring when electrospinning, as when lower concentrations of chitosan are used such as 
that in F5, crosslinkage is limited. Thus an increase in conjugation and intensity providing 
greater stability to the structure will be enhanced in F4 and F6 as crosslinkage occurs to a 
greater extent.  
 
Another important infrared band observed in the spectrum is that of PEO observed at 
1373.74cm-1. The C-H vibrational group is sensitive to intermolecular changes and the 
environmental changes. When the percentage crosslinker is increased from 0.01%w/v to 
0.025%w/v as is seen in F9 and F12, a shift in the spectra is observed from 1359.84cm
-1 to 
1373.74cm-1 strengthening the band intensity thus reinforcing conjugation properties. 
Crosslinking occurring at a higher degree results in greater intermolecular interaction thus 
symmetric deformation of C-H band vibrations signifying the presence of PEO in its 
amorphous state (Su et al., 2002). A weak peak of 1061.12cm-1 is found in F2 only 
(demarcated in Figure 4.3) and a peak at 960.06cm-1 in all formulations, signifies the 
presence of C-H bending in the structure most likely due to the presence of supplementary 
amorphous PEO. 
 
In addition the presence of a peak at 1341.82cm-1 and 1241.83cm-1 indicated the presence of 
free amino groups in all formulations thus no crosslinking occurring by genipin at these 
structural sites, most likely due to the domination of hydroxyl intermolecular interactions 
occurring due to PVA and PEO and a lower concentration of crosslinker used. Nanofibre and 
semi-IPN formation resulted in significant differences in the infrared spectrum absorption 
frequencies of the final product in relation to the original compounds. The presence of 
polymeric compounds in amorphous or crystalline state further impacted the structural 
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crosslinking ability as well as the peak intensities of wavelengths. Minimal crosslinkage 
resulted in smaller band intensity formation resulting in bending of the C-H groups within the 
aromatic ring and stretching and conjugation within the structure which is further impacted by 
intermolecular interactions occurring between hydroxyl groups. Formulations displaying 
greater band intensities correspond to a higher degree of crosslinking hence it can be 
deduced that molecular transitions occurring within the structure leading to semi-IPN and 
nanofibres formulation is greatly affected by intermolecular interactions, the degree of 
crosslinking and the amorphous state of the polymers involved. 
 
Figure 4.3: Fourier Transform Infrared Spectroscopy of Nanofibrous mat (a) F6, (b) F15, (c) 
F2, (d) F4, (e) F9, (f) F5 
 
4.6.2. Determination of Surface Morphology and Network Density of Polymeric 
Nanofibrous Mats 
Profiles obtained by scanning electron microscopic evaluation revealed the presence of 
fibres that were randomly orientated, cylindrical, solid and varying in diameter. Furthermore 
fibres presented with a porous surface structure and characteristics were dependent on both 
polymer and crosslinker concentrations. A porous surface morphology is required for the 
process of wound healing and will be necessary for skin reconstitution. This is favourable for 
the process of homeostasis, adequate nutrient and gaseous exchange as well as aiding the 
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process of proliferation and cellular infiltration. The generation of porous sites are made 
possible for cellular in growth by the formation of nanofibres orientated in a random loose 
manner as can be clearly seen in the images displayed in Figure 4.4. The presence of 
nanofibres loosely located over one another in a arbitrary manner provides an overall 
network architecture that best mimics the native extra cellular matrix (ECM) of the skin thus 
potentiating cellular regenerative effects (Chong et al., 2007).  
 
The formation of nanofibres by electrospinning has gained much attention, however several 
challenges are faced as various systematic parameters need to be considered. Uniformity, 
size and diameter of nanofibre morphology are greatly affected and dependent on 
parameters such as the solution viscosity. A solution with a higher viscosity results in 
nanofibres with a larger diameter, prevents the formation of beads and beaded fibres as well 
as the presence of junctions and bundles which indicate wet fibres on reaching the collector 
(Pham et al., 2006; Haghi and Akbari., 2007). Figure 4.4b reveals the presence of 
nanobeads (demarcated in the figure) that are large and spherical in shape and are due to 
low polymeric chitosan and hypromellose concentrations used, crosslinked to a lesser 
degree thus depicting Rayleigh instability with regards to solution viscosity. As polymeric 
concentrations are increased (i.e.: chitosan from 1-3%w/v and hypromellose from 0.4-1.6%
w/v) 
so does the instability decrease thus resulting in fibres that demonstrate uniformity, larger 
diameters as well as the absence of nanobeads as can be seen in Figure 4.4a, Figure 4.4c 
and Figure 4.4g. Increasing polymeric solution viscosity also results in a larger diameter size. 
F3 reveals a diameter size of 28.32 as opposed to 37.93 and 62.61nm seen in F4. 
  
The effect of increasing polymeric concentration is clearly illustrated in Figure 4.4a, c and d. 
Furthermore it can be seen that the polymeric solution viscosity as well as the diameter size 
is greatly influenced by the concentration of chitosan from 1-3%w/v. As the concentration of 
chitosan was increased, so too did the viscosity and diameter size increase. The addition of 
a crosslinker contributed to an adjustment within the nanofibrous morphology thus 
substantiating the physicomechanical properties of the system. Crosslinking within 
nanofibrous mats resulted in a dense, narrowly packed structure seen in Figure 4.4d, Figure 
4.4e and Figure 4.4f due to the contraction of nanofibres by genipin. In addition to improving 
physicomechanical properties of the system, crosslinking also prolongs the release of 
bioactives due to the change brought about to the structure morphology decreasing surface 
area and the fusion occurring between individual fibres (Shaikh et al., 2012) as a result of 
crosslinking as is clearly depicted in Figure 4.4e. 
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Figure 4.4: Scanning electron microscopic profiles of (a) F3, (b) F2, (c) F4, (d) F5, (e) F9, (f) 
F6 and (g) F15. 
 
 
(a)  (b) 
(c) (d) 
 (e)   (f) 
 (g) 
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4.6.3. Thermodynamic Evaluation of the Nanofibrous Mat 
Differential Scanning Calorimetry (DSC) is associated with the transitions that occur in 
materials influenced by temperature and heat flow as a function of time in a controlled 
environment whereby physical and chemical changes associated to changes in the heat 
capacity can be measured. Figure 4.5 depicts the DSC profiles of the various nanofibrous 
mats. A glass transition occurred in all samples and varies between the range of 20°C and 
45°C. In addition a change in inclination between the Tg of the various mats occurred 
resulting in a second phase transition where an increase in heat capacity occurs, whereby 
Figure 4.5b and Figure 4.5d show the broadest inclination (Demarcated by the red arrows in 
the figure) indicating the greatest bond formation in the structure. The small change in 
inclination between peaks representing the Tg of various mats can be directly attributed to 
chitosan which is a semi-crystalline polymer and due to the small specific volume of the rigid 
chains by network formation caused by crosslinking, that are formed (Dong et al., 2004). 
Glass Transition Temperature is directly related to network formation and the concentration 
of crosslinker used. These factors influence transitions to occur which affects the 
amorphosity of the structure thus altering the heat capacity resulting in a glass transition to 
occur. Crosslinking by genipin occurs when free amino groups are present such as those 
present in chitosan allowing crosslinkage to occur at the temperature of curing. When an 
increased amount of crosslinker is used such as 0.025% as in Figure 4.5b and Figure 4.5d, 
then broader Tg inclinations are seen whereas lower Tg transitions are seen when the 
concentration of crosslinker used is decreased (0.01%), thus is more likely to undergo a 
quick onset of degradation. A narrower and sharper inclination is observed such as that in 
Figure 4.5a (demarcated by the blue arrow in the figure).  
 
All nanofibrous mats exhibited an endothermic peak following the glass transition. This can 
be attributed to a melting phase occurring upon heating whereby fusion occurs and the 
structure converts to the polymer liquid phase. This indicates the presence of non-perfect 
crystals or impurities that cause the melting point to drop and polymorphism occurs. The 
endothermic peak occurs at 65.90°C in Figure 4.5e, 69.94°C in Figure 4.5a and 294.22°C in 
Figure 4.5d. This strongly indicates that the rate of endothermic transition upon heating is 
related to the degree of crosslinking and the concentration used. Figure 4.5a and 4.5e have 
a 0.01%w/v concentration of genipin whereas in Figure 4.5d, 0.025%
w/v crosslinker is used. 
Crosslinking results in stronger network formation thus enhanced regularly arranged 
molecules in a well defined structure that are able to withstand transitions at greater 
temperatures. The presence of co-polymers and semi-crystalline polymers are strongly 
indicated by the presence of an exothermic peak subsequent to a fusion endothermic peak 
as discussed above. Furthermore literature has revealed that chitosan is a partially 
crystalline polymer (Dong et al., 2004) and PEO occurs in the amorphous state (Su et al., 
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2002). This strongly suggests that the exothermic peak present is a result of cold 
crystallisation. Cold crystallisation occurs in semi-crystalline polymers that have been 
quenched into a highly amorphous state. Figure 4.5d shows the greatest crystallisation at 
140.82°C, whereas Figure 4.5a has a cold crystallisation at 137.63°C (annotated by the black 
block). Thus it can be deduced that greater crosslinkage results in a higher temperature 
requirement to cause a transition of both endothermic and exothermic peaks to occur. A 
transition occurred displaying an endothermic melting transition proceeding the cold 
crystalline state at a higher temperature due to its kinetic nature. This represents semi-
crystalline behaviour of the structures.  
 
Curing (crosslinking) was observed to occur at higher temperatures when the endothermic 
peak preceding it transpire at lower temperatures as in Figures 4.5a and 4.5b at a 
temperature of 145.10°C and 140.89°C. Thus it can be deduced that Figures 4.5a and 4.5b 
display a lower degree of crystillinaty that is related to random orientation of molecules due 
to free non-crosslinked groups available in the structure having a poor polymer backbone. 
Figure 4.5d displays a higher temperature requirement to produce an endothermic peak thus 
representing a greater crystalline state and more ordered arrangement of molecules. 
 
Figure 4.5: Differential Scanning Calorimetry profiles of nanofibrous mats (a): F4, (b): F5, 
(c): F15, (d): F9, (e): F6 
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4.6.4. Young’s Modulus Analysis of Nanofibrous Mats to determine Mechanical 
Characteristics 
The tensile strength and mechanical properties of nanofibrous mats were investigated and 
evaluated by Young‘s Modulus. Young‘s Modulus is a measure of the ratio of stress to strain 
when a force is applied to the cross-sectional area of a specimen or sample in a tension test 
(Govindjee and Sackman, 1999). A sturdy but flexible delivery system is required to be 
applied topically as a wound healing platform thus the stress-strain relationship of a sample 
plays a major role when characterising topical systems. The strength of the materials used 
and the flexibility of polymeric chains determine the stress-strain relationship of the materials 
used. A material will be considered flexible when a relatively small Young‘s modulus, which 
is the slope of the linear portion of a stress-strain curve as illustrated in Figure 4.6 is 
observed such as that depicted by F3 in Figure 4.8b.  
 
Figure 4.7 depicts the profile of a nanofibrous sample whereby area under the curve A 
resembles the resilience of the sample to break and A+B shows the toughness of the 
nanofibre sample, thus the ultimate strength which is the maximal quantity of stress that can 
be applied to cause total deformation at rupture (maximum amount of strain endured) can be 
derived from this curve. Therefore the area under the curve gives a indication of the tensile 
strength of the sample tested whereby the energy or work required to break through the 
sample can be measured, which constitutes the measure of toughness of brittleness of the 
samples. Resilience (A) is the property of a material to endure a load that does not exceed 
the elastic limit when a tension is induced and toughness (A+B) indicates the energy that is 
absorbed when an average force and maximum tension is applied in order to cause a 
fracture or break in the sample (Lee and Moon, 2003). Thus it can be deduced that samples 
with higher tensile strengths such as F4, F5 and F6 as shown in Figure 4.8a have a larger 
area under the curve and require a greater amount of energy for deformation to occur. This 
can be directly attributed to the degree of crosslinkage and the density and alignment of 
nanofibres networks. As depicted in the scanning electron micrographs of nanofibres in 
Section 3, crosslinking resulted in more densely and narrowly arranged nanofibres thus 
substantiating the physicomechanical properties of the nanofibrous mats as the strength of 
samples is dependent on the architectural arrangement, size and number of nanofibres.  
 
F2, F9 and F15 show considerable strength as they have the maximum ultimate strength as 
depicted in Figure 4.8d. Figure 4.8b to Figure 4.8f illustrates the Young‘s Modulus (E), yield 
stress (σy) (the magnitude of stress on the stress–strain curve at which appreciable 
deformation takes place without any appreciable increase in the stress), ultimate strength 
(σu) (the maximum stress a material can withstand), ultimate strain (εu) and toughness 
(J.cm3). Thus it can be deduced that an increase in the % crosslinker resulted in a greater 
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Young‘s Modulus and thus a decrease in the elasticity of the sample such as that in F4, F5 
and F6, therefore tend to be more brittle. When an intermediate amount of crosslinker is 
used such as that in F2, a smaller Young‘s Modulus of 4.25MPa is seen and a greater 
ultimate strength occurs as is illustrated in Figure 4.8d. Furthermore F2 also shows the 
greatest toughness of 0.20J/cm3 in contrast to all other nanofibres samples as depicted in 
Figure 4.8f. Variations in the degree of crosslinking led to deviation in the elastic modulus of 
samples and thus the ultimate strengths. Samples crosslinked to a lesser degree such as F3 
and F15 where a Young‘s modulus of 0.63 and 1.97 MPa shows greater elastic properties in 
contrast to those with greater Young‘s modulus of 10.32 and 14.74MPa as in F4 and F5 
resemble a lesser degree of elasticity. Differing fibre diameters contribute to the variation in 
elasticity. When a greater degree of intermolecular crosslinked bonds are formed between 
nanofibres, a greater degree of rigidity and stiffness is noted between the nanofibres within 
the nanofibrous mat. However, when a lower degree of intermolecular crosslinked bonds are 
formed, fibres tend to align along the tensile pull axis and slip pass one another thus 
substantiating the elastic modulus (Shaikh et al., 2012).  
 
Figure 4.6: Stress-Strain relationship profile of nanofibrous mats where (a) is the linear 
portion of the slope from which Young‘s Modulus can be derived and (b) represents the 
fracture point of the sample   
a 
b 
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Figure 4.7: Force versus distance curve whereby the tensile strength can be derived. Area A 
resembles the resilience and Area A+B the toughness of measured samples. 
 
 
 
 
 
 
 
 
 
 
Force (N)
Distance (m)
123
A B 
106 
 
Formulation
1 2 3 4 5 6 7
T
e
n
s
ile
 S
tr
e
n
g
th
 (
N
.m
m
2
)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
Tensile Strength (N.mm2) 
Nanofibre Mats
1 2 3 4 5 6 7
Y
o
u
n
g
s
 M
o
d
u
lu
s
 E
(M
P
a
)
0
2
4
6
8
10
12
14
16
 
Nanofibre Mats
1 2 3 4 5 6 7
Y
ie
ld
 S
tr
e
s
s
 (
M
P
a
)
0.0
0.1
0.2
0.3
0.4
0.5
0.6
Yield Stress (MPa) 
Nanofibre Mats
1 2 3 4 5 6 7
U
lti
m
a
te
 S
tr
e
n
g
th
 (
M
P
a
)
0.0
0.2
0.4
0.6
0.8
Ultimate Strength (MPa) 
 
Nanofibre Mats
1 2 3 4 5 6 7
U
lti
m
a
te
 S
tr
a
in
0.0
0.1
0.2
0.3
0.4
Ultimate Strain 
Nnaofibre Mats
1 2 3 4 5 6 7
T
o
u
g
h
n
e
s
s
 (
J
/c
m
3
)
0.00
0.05
0.10
0.15
0.20
0.25
Toughness (J/cm3) 
 
Figure 4.8: Vertical Bar outlining the variations between nanofibrous mats of (a) Tensile 
Strength (N.mm2), (b) Young‘s modulus (E; MPa), (c) yield stress (σy; MPa), (d) ultimate 
strength (σu; MPa), (e) ultimate strain (εu) and (f) toughness (uf; J cm−3) of nanofibrous 
mats 1–7 (where 1: F2, 2:F3, 3:F4, 4:F5, 5:F9,6:F6,7:F15). 
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4.6.5. Rheological Characterisation of the Nanofibrous Mats 
The ability of a polymeric hydrogel solution to electrospin, its physical integrity and retentive 
behaviour are significant measures when synthesising nanofibres with bioactive incorporates 
as topical delivery systems, thus its mechanical strength and viscoelastic properties should 
be measured (Anumolu et al., 2010). Viscosity plays a significant role in transforming a 
polymer solution into nanofibres. Changing of polymeric solution concentrations directly 
impacts the viscosity of the solution and is found to be one of the greatest factors influencing 
morphology and fibre diameter size when electrospinning polymeric solutions. Fibre diameter 
is one of the most important quantities related to the process of electrospinning and is 
primarily dependent on the polymer contents within a jet to be electrospun as well as the size 
of the jet. When a solution of higher viscosity is obtained, larger fibre diameter is observed, 
thus the solution concentration is directly proportional to nanofibres diameter size (Huang et 
al., 2003).  
 
Table 4.6 depicts the solution viscosity of the various nanofibrous solutions. F6 reveals a 
viscosity of 216.66MPa when crosslinked thus forming cylindrical, more uniform nanofibres of 
slightly larger diameters as seen in Figure 4.4f and g. It can thus be deduced that an 
increase in polymer concentrations used results in greater diameter size and thus can be 
described as a power law relationship as deduced by Deitzel and co-workers. When lower 
polymer concentrations are used, lower viscosities are obtained as is pragmatic to F2 where 
a viscosity of 71.23MPa is seen and defects in the system are observed in the form of beads 
and droplets such as those distinguished in Figure 4.4b. This is directly attributed to 
electrospraying rather than electrospinning. Furthermore the presence of bundles and 
junctions within a nanofibrous mat is also observed and this can be directly attributed to wet 
fibres hitting the collection disk (Pham et al., 2006), thus suggesting inadequate evaporation 
of solvent due to lower concentrations of polymer used. Therefore when polymer 
concentrations increased thus increasing the viscosity, uniform fibres with minimal junctions 
and beads are yielded. Thus it can be observed that morphological changes occurring upon 
electrospinning are directly related and dependent on the variation of viscosity of the 
polymeric solution been electrospun. Additionally when solutions of very high viscosities are 
used, electrospinning did not occur such as that in F1 and F8 where viscosities of 
252.38MPa and 231.13MPa occur upon crosslinking forming huge droplets at the jet site that 
tend to dry out not allowing optimal jets for electrospinning to be maintained. 
 
In addition, crosslinking plays a significant role in the determination of solution viscosity as is 
depicted in Table 4.6. Addition of crosslinker such as genipin led to greater intermolecular 
forces occurring between the molecules thus increasing the viscosity. Polymeric solutions 
crosslinked to a greater extent resulted in nanofibres with a more uniform alignment that 
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were densely packed and narrower nanofibres that are interlaced decreasing the surface 
area thus promoting prolonged release such as those resembled in Figure 4.4 c,d and e.  
 
The yield stress is a measure of the stress required to initiate measurable flow. Yield stress 
measurements are significant to determine the pharmaceutical shelf life of a product. When 
low stresses are applied, formulations tend to be very viscous. However, as the shear stress 
applied increases breakdown of the structural network of hydrogels occurs as macroscopic 
flow begins to occur and is known as the dynamic yield stress. Macroscopic flow begins to 
occur when the viscosity drops by several orders of magnitude over a very narrow stress 
range. Table 4.6 outlines the yield stress measurements of formulations, whereby it can be 
seen that all formulations depict a comparable yield stress range. Thus it can be deduced 
that the ―apparent‖ yield stress is designated as a single point and the critical stress range is 
very small (Saak et al., 2001). 
 
Topologically a gel can be defined as a three dimensional network system that mechanically 
is soft in nature having both liquid and solid like characteristics. On application of a force gels 
tend to deform to an extent and take an infinite time to reach equilibrium, thus they tend to be 
viscoelastic in nature. Dynamic moduli can be applied to distinguish gels from sols. This can 
ideally be evaluated by the application of oscillating small strains, namely the storage 
modulus G‟ which is a measure of the elasticity of a material and the loss modulus G” which 
represents the viscous components, when an oscillatory frequency ω is given. Ideally a solid-
like mechanical spectrum should be exhibited by gels whereby G‘>G‖ (Ikeda and Nishinari, 
2001). Figure 4.9 represents the oscillatory stress ramping obtained from stress and 
frequency sweep data obtained for the various formulations. From the profiles obtained it can 
be seen that in Figure 4.9b and e, the storage modulus G‘ dominated thus suggesting that 
these hydrogels are more elastic then viscous within the investigated frequency range thus 
more structural systems will be obtained. These systems will have a greater ability to resist 
structural changes when a stress or strain is applied (Diez-Sales et al., 2007). This can be 
attributed to higher polymeric concentrations used as well as the influence of crosslinking. 
 
Diez-Sales and co-workers (2007) state that when increased concentration of chitosan was 
used, dynamic moduli was also increased. Figure 4.9a, d and c demonstrate a low G‘ 
modulus that exhibits an elastic region only below a frequency of 60pa. This suggest that 
these hydrogels show greater viscous properties then elasticity as G‖>G‘ and correspond to 
the characteristic behaviour of solutions whereby a non structured system is prevailing. This 
can be attributed to lower concentrations of polymer been used. Furthermore it can be 
perceived that the effect of crosslinking has a immense impact on the dynamic moduli of the 
solutions as all uncrosslinked solutions represented by figure 4.9f to j depict a greater G‖ 
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modulus suggesting a less structured system whereby nanofibres with insufficiencies such 
as nanobeads and electrospraying will occur. Thus crosslinking plays a pivotal role in 
providing a polymeric solution that can be electrospun to form uniform, cylindrical fibres with 
no to minimal defects such as nanobeads ensuring an optimal nanofibrous mat. The 
rheological data show that hydrogels with a greater G‘ value are more elastic in nature, 
having enhanced viscoelastic properties, thus serving as appropriate mediators that may 
prolong transdermal bioactive residence time thus providing a longer  pharmacological effect 
(Anumolu et al., 2010).  
 
Table 4.6: Viscosity and Yield Stress of the various hydrogel formulations for nanofibre 
synthesis 
Nanofibre Mat 
Formulation # 
Viscosity  
(MPa) 
[crosslinked] 
Yield Stress 
(Pa) 
[crosslinked] 
Viscosity (MPa) 
[uncrosslinked] 
Yield Stress 
(Pa) 
[uncrosslinked] 
1 
 
252.38 40.23 246.35 39.74 
2 71.23 
 
38.54 
 
68.92 38.51 
5 140.57 
 
38.57 
 
136.58 37.69 
8 
 
231.13 39.12 224.52 38.89 
6 216.66 
 
38.60 
 
208.87 38.58 
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Figure 4.9: Dynamic Modulus G‘ and G‖ of [crosslinked] (a) F1, (b)F2, (c) F5, (d) F6, (e) F8; 
[uncrosslinked] (a) F1, (b) F2, (c) F5, (d) F6, (e) F8   
Crosslinked nanofibrous solutions: 
Uncrosslinked nanofibrous solutions:  
G‘: 
G‖: 
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4.6.6. In Vitro Release Kinetics of Curcumin 
Figure 4.10 shows the curcumin release profiles from chitosan/hypromellose nanofibrous 
mats fabricated at different concentrations. It was observed that curcumin release is 
increased within the first six to ten hours of the study in all formulations. This can be 
attributed to diffusion of the bioactive curcumin as well as the mechanism of polymer erosion 
(Charernsriwilaiwat et al., 2012) when in contact with phosphate buffer solution (PBS). 
Furthermore it was observed that crosslinked nanofibrous mats with genipin to a lower 
degree had a greater initial release rate of bioactive as compared to those nanofibrous mats 
crosslinked to a greater degree. However crosslinking supported sustained release of 
bioactive over a longer period of time thus improving its therapeutic activity. Nanofibrous 
mats crosslinked with genipin at higher concentrations such as 0.025% exhibited minimal 
swelling and release rates over the 24 hour period. This is ascribed to the intermolecular and 
intramolecular bonds occurring between molecules of the structure due to crosslinking. In 
addition, when decreased concentrations of genipin are used resulting in subordinate linkage 
formation, weak intermolecular and intramolecular bonds are formed thus encouraging faster 
bioactive release (Rana et al., 2005). This phenomenon is exhibited by F3 and F4, whereby 
the greatest release of drug is seen reaching a peak of 0.243 mg/mL at 12 hours and 0.229 
mg/mL at 10 hours respectively, when the percentage crosslinker used is 0.01%w/v. 
Furthermore F2, F5 and F15 exhibited poorer release at 0.150 mg/mL, 0.151 mg/mL and 
0.208 mg/mL, respectively at 8 hours and can be accredited to the greater network formation 
occurring due to crosslinking thus impeding the bioactive release. Thus it can be deduced 
that the in vitro drug release across the nanofibrous mats were significantly influenced by the 
concentration and degree of crosslinking occurring within the structure.     
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Figure 4.10: Release profile of curcumin of the various nanofibrous mats, (a): F2-5, (b): F6, 
9, 15 
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4.7. Mucoadhesive Characteristics of the Nanofibrous Mats 
The ability of biopolymers both synthetic and natural to attach to biological tissue can be 
termed as mucoadhesion. Wound dressings that possess a mucoadhesive attribute upon 
topical application have the capability of sustaining bioactive release and thus increasing the 
bioavailability of the active compound therefore ensuring controlled release to the wound 
site. Mucoadhesion occurs upon direct interaction between biopolymers and the tissue 
causing a chemical reaction to occur that results in the swelling of polymers allowing 
interpenetration to occur (Cevher et al., 2008). Figure 4.11 depicts a force-distance profile 
whereby the pertinent adhesion force was obtained, thus from the results obtained it was 
noted that the adhesive properties of the mats increased as the concentration of the 
biopolymer chitosan increased from 1% to 3%. Furthermore an increase in crosslinkage 
resulted in declined mucoadhesive ability. F6 disclose a work of adhesion of 0.182 mJ cm-2 
when a chitosan concentration of 3% is used. Employment of 1% chitosan as that used in F2 
and F5 revealed a work of mucoadhesion of 0.0631mJ cm-2 and 0.0748mJ cm-2 respectively. 
The mucoadhesive ability of chitosan can be directly attributed to its ability to adhere to 
biological tissue, hence making its use an optimal candidate for site specific delivery. Work of 
adhesion is based on a mechanism of action that involves ionic interactions, hydrogen 
bonding and swelling upon direct contact with the tissue. Positively charged amino groups 
present within the chitosan chemical structure interact with the negatively charged particles 
within biological tissue at a molecular level allowing an attraction to occur via electrostatic 
forces (George and Abraham., 2006). Thus increasing the molecular weight of chitosan 
improves and results in stronger mucoadhesion that is clearly detected in the study carried 
out. 
 
Figure 4.11: Force-distance textural profile employed to compute work of adhesion and the 
peak adhesion force  
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4.7. Concluding Remarks 
The development of nanofibrous mats using natural polymers and deionised water as a 
solvent was successfully attained by exploration and investigation exercising the various 
parameters as discussed. Furthermore it was noted that a modification to these parameters 
could significantly influence the fibre morphology such as diameter, porosity, strength, 
bioactive release and fibre functionality. Generation of a Box-Behnken template signified a 
design of experiments whereby 15 formulations were generated and characterised in terms 
of the physico chemical, mechanical and biological release properties. Various polymer 
concentrations were investigated in order to develop optimal nanofibrous mats whereby it 
was noted that an increase in polymeric concentration lead to higher viscosities which greatly 
impacted the nanofibre morphology. Higher solution viscosities lead to the fabrication of 
nanofibres with a greater diameter, more cylindrical in shape with uniform alignment. 
Reducing the viscosity lead to poorer mechanical properties, greater droplet and nanobead 
formation as well as substandard fibre alignment. However at very high viscosities jet 
formation was unattainable and mechanical properties in terms of flexibility and elasticity 
declined substantially. The rates of crosslinked bridge formation between polymers as well 
as the extent of inter and intramolecular forces also greatly impact the fibre characteristics as 
well as bioactive release. Increasing crosslinkage and genipin concentration resulted in 
sustained and greater control release of bioactive. Thus it could be deduced that a 
successful optimal polymeric formulation can be obtained from the detailed characteristic 
analysis carried out as is discussed herein within the chapter to follow. Chapter 5 provides a 
detailed portrayal of an optimized formulation for nanofibre formation mathematically attained 
for a response methodology as is described in greater detail in the chapter to follow. 
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CHAPTER 5 
STATISTICAL OPTIMIZATION OF THE CROSSLINKED NANOFIBROUS MAT 
AND THE INFLUENCE OF CROSSLINKING ON DYNAMIC CHARACTERISTICS 
OF THE SYSTEM AS A CONSTITUENT OF A MULTI-COMPONENT STIMULI 
RESPONSIVE PROTOTYPE DEVICE 
 
5.1. Introduction 
The successful development of wound delivery systems require approaches that lead to 
statistical formulary optimization. This can be achieved by the employment of a design 
strategy enclosing an outline of the most proficient experiments. The use of this strategy 
allows for efficiency in terms of cost, time and accuracy. The step wise methodology 
employed a design of experiments (DoE) employing the Box-Behnken design strategy and 
response surface methodology. The DoE encompassed 15 formulations on a varying scale 
of low, medium and high and is in accordance with the various variable parameters identified 
for the most favourable characteristics. 
 
Criterion followed for assertion of statistical optimization of the nanofibrous delivery system 
followed a series of events that included:  
 Formulary component identification of the natural biopolymers and crosslinker for 
employment in the experimental factorial design 
 Recognition of significant characteristics through the employment of various variables 
leading to the assibilation of the design strategy 
 Modulation of the three factor Box-Behnken design  
 Characterisation and analysis of the design formulations utilising identified reactions  
 Design implementation using the Response Surface Methodology (RSM) aiding 
statistical optimization 
 Coefficient evaluation using regression analysis 
 Validation and prediction of responses for optimization 
 Statistical optimization of the nanofibrous system in accordance to a required  
protocol 
 
Nanoscale fibres composed of natural biopolymers serve as successful candidates for 
various applications which include drug delivery, mimicking the extracellular matrix, tissue 
engineering, and wound dressings as is described in more detail in Chapter 4. Nanofibres 
produced by electrospinning of natural origin have many advantageous properties that 
include biodegradability, non-toxicity, biocompatibility and are economically friendly. 
However, there are many drawbacks related to this which include its high degradability 
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limiting its long-term biomedical application, furthermore the shelf life is also shortened 
amongst others. Thus, in order to improve these properties, the electrospun mats were 
crosslinked improving its thermomechanical performance as well as advancing the water-
resistant ability of the fibres (Zhang et al., 2006). The investigation to follow in this chapter 
will provide a pointer on the fibre characteristics of the nanofibrous mats upon crosslinking.     
 
A Box-Behnken (B-B) statistical design template was employed to generate desirable 
formulary components, in order to devise an optimal, economical and efficient formulation 
appropriate for fabricating a biopolymeric nanofibrous mat of natural origin that would 
ultimately serve as an optimized healing device. The design template generated 15 
multifactorial experimental formulations to establish the measured responses which 
ultimately lead to the innovation of a distinct optimal formulary composition preserving 
desirable results which is the main focus of this chapter. The optimization process involves 
the attainment of optimal stability, biological responses and physicomechanical validation as 
is described above.  
 
5.2. Materials and Methods 
 
5.2.1. Materials 
Fabrication of nanofibres employed the use of chitosan, medium molecular weight poly(D-
glucosamine) deacetylated chitin, hypromellose(hydroxymethylcellulose 2910), citric acid  
(ACS reagent ≥99.5%, Mw=192.12 g/mol), genipin (≥ 98% (HPLC) powder with an Mw= 
226.23 g/mol) and curcumin, all obtained from Sigma Aldrich Chemie GmbH, Steinheim, 
Germany. PVA- mowiol® 4-88 with an Mw=31000g/mol and PEO-Polyox™, WSR 303 were 
used as electroconductive agents and was obtained from Sigma Aldrich Chemie GmbH, 
Steinheim, Germany. Tween 80 was obtained from uniLAB® (Merck Chemicals (Pty) Ltd, 
Wadeville, Gauteng, RSA). 
 
5.2.2. Fabrication of the Optimized Nanofibrous Mat 
An optimized polymeric solution was prepared under ambient room conditions from 
statistically derived superlative concentrations as indicated in Table 5.1 for solution A and 
shown in Figure 5.1.The optimised formulation was prepared by: 
 
Solution A: A1+A2+A3+A4 (to 100ml) 
Chitosan (CS) (A1) solution is prepared by dissolving in an aqueous acidic solution 
comprising of a 5%w/v (50 mg/mL) citric acid as a solvent medium. The chitosan used is of 
medium molecular weight with an optimised concentration of 3%w/v (30 mg/mL). Aqueous 
solution of Hypromellose (A2) with a concentration of 0.4%w/v (4 mg/mL) was then added. 
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Crosslinking and the formation of a semi interpenetrating polymer network were obtained by 
the addition of genipin (A3) at a concentration of 0.01%w/v (10mg/10mL). Lastly the bioactive 
curcumin (A4) [1%w/v (10 mg/mL)] was added. 
Where A1: Chitosan 
          A2: Hypromellose 
          A3: Genipin 
         .A4: Curcumin 
 
Solution B: Electroconductive agents polyvinyl alcohol (PVA) at a concentration of 10%w/v 
dissolved in deionised water (10.0g of PVA dissolved in 100ml deionised water) 
 
Solution C: 2%w/v polyethylene oxide (PEO) dissolved in 40% ethanol and 60% deionised 
water (2.0g dissolved in 100ml 40:60 – ethanol: deionised water) 
 
Final Formulation: 
Solutions A+B+C was added at a ratio of 1:1:1 (300ml) together with a surfactant 
Polyoxyethylene Sorbitan Monooleate (5ml) and a net charge density enhancer NaCl 
(7.5mg). The solution was left overnight to stir before electrospinning. 
 
Thus, the final polymer ratios per 100ml in the final optimised formulation were chitosan: 1%, 
genipin 0.03%, Hypromellose 0.13%, curcumin 0.33%, citric acid 1.67%, PEO 0.67% and 
PVA 3.33%. The polymeric solution was then processed through a pump (Chemyx Inc 
syringe infusion pump) attached to the electrospinner (Glassman high voltage Inc, (high 
bridge NJ USA)) and a voltage of 20kV was applied. Nanofibres were collected on a 
collecting surface employing the parameters indicated in Table 5.2. 
 
Table 5.1: Statistically derived superlative concentrations for crosslinked and uncrosslinked 
nanofibres 
 Chitosan (%w/v) Genipin (%
w/v) Hypromellose 
(%w/v) 
Optimized 
Formulation 
3 0.1 0.4 
Optimized 
Formulation 
(uncrosslinked) 
3 - 0.4 
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Figure 5.1: Schematic conceptualization of nanofibre production comprising of s-IPN 
formation and electrospinning 
 
Table 5.2: Depicting parameters and properties related to nanofibre solution and 
electrospinning  
Parameters Nanofibrous Mat 
Solution Parameters and properties  
Electroconductive agent-PVA  10%w/v 
Electroconductive agent-PEO  2% w/v 
Solvent for PEO, decrease in bead formation 
and surface tension 
40% ethanol 
 
Surfactant 
Polyoxyethylene Sorbitan Monooleate (1mL) 
Net charge density enhancer NaCl (1.5mg) 
Electrospinning Parameters  
Supply of Voltage 20 Kv 
Distance 31-39.5cm 
Flow Rate 1500μl/h 
 
 
 
Step 1:IPN formulation 
comprising of Chitosan in citric 
acid solution and HPMC. 
Step 2: Addition of 
curcumin
Step 3: Addition 
of chromium 
ascorbate
Layer 1: crosslinked CHT/HPMC
Layer 2:multi-step 
crosslinkage,incorporation of 
curcumin(IPN formation)
c
Taylor Cone
High voltage 
supply
Grounded
Collector
Nanofibre formation by 
electrospinning,using +ve and  -ve
charges(electrostatic attraction and 
repulsion for enhancement of 
nanofibre alignment)
Nanofibrous film for 
wound healing
Step 3: 
Addition of 
Genipin 
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5.2.3. Characteristics of the Optimized Nanofibrous Mat 
 
5.2.3.1. Evaluation of the Polymeric Vibrational Frequency and Structural Properties 
Changes in vibrational frequencies and absorbance occur upon chemical interactions 
between polymers, bioactives and crosslinking agents. This was investigated upon bioactive 
crosslinked and uncrosslinked bioactive free samples using a PerkinElmer® Spectrum 100 
Series FT-IR Spectrometer fitted with a universal ATR Polarization Accessory (PerkinElmer 
Ltd., Beaconsfield, UK). FTIR Spectra was recorded over a range of 4000-625cm-1, with a 
resolution of 4cm-1 and 32 accumulations 
 
5.2.3.2. Evaluation of Surface Morphology and Topography 
PhenomTMMicroscope (FEI Company, Hillsboro, Oregon, USA) was used to analyse the 
surface morphology of the nanofibrous mat. Samples were sputter coated after been 
mounted on aluminium stubs. Coating employed the use of argon gas at a pressure of 0.1 
torr using a SPI-ModuleTMSputter Coater and SPI-ModuleTMControl (SPI Supplies, Division of 
Structure Probe Inc., West Chester, PA, USA) for a time period of 90 seconds. The prepared 
sample was then analysed in terms of surface morphology, nanofibre density, size and range 
under the PhenomTMscanning electron microscope. 
 
5.2.3.3. Evaluation of Thermodynamic Transitions occurring over a Specified Heating 
Range 
Weighed samples prepared in aluminium crucibles were evaluated to determine 
thermodynamic behaviour in terms of crystalline, semi-crystalline, melting points, chemical 
reactions, glass transition and degradation analysis. An Advanced DSC (TMDSC/ADSC) 
(Mettler Toledo DSC-1 STARe System, Schwerzenback, ZH, Switzerland) at a heating rate of 
10°C/min from -10°C to 350°C under a nitrogen atmosphere was employed. 
 
5.2.3.4. Determination of the Young’s Modulus and Tensile Properties of the 
Crosslinked and Uncrosslinked Fibres 
Tensile strength, Young‘s Modulus and other pertinent physicomechanical properties were 
evaluated employing both a nanoTensile®5000 (Hysitron Inc. Nanomechanical Test 
Instrument, Minneapolis, MN) and a Texture Analyzer (TA.XTplus Texture Analyzer, Stable 
Microsystems, Surrey, UK) fitted with a 50kg load-cell. Both apparatus, the nano tensile and 
texture analyser was calibrated prior to sample testing to ensure accuracy. Thereafter 
samples cut to approximately 20×5mm strips were mounted as indicated in Figure 5.2 and 
allowed to run until a fracture point was established. Texture analysis was employed using 
the parameters as indicated in Table 3.3. The tensile strength was analyzed using equation 
3.1. 
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Figure 5.2: Schematic illustrating the textural analysis procedure employed to cause a break 
or fracture in the nanofibrous strip so that a force against distance plot could be generated to 
determine the tensile strength 
 
5.2.3.5. Analysis of the Pertinent Rheological Properties of the Polymeric Formulations 
A Modular Advanced Rheometer System (ThermoHaake MARS Rheometer, Thermo Fischer 
Scientific, Karlsuhe, Germany) was used to determine the rheological properties of the 
polymeric formulation. Stress-strain rheological parameters play a vital role upon 
electrospinning as these factors greatly influence the electrospinning process. Of particular 
importance is the viscosity and yield stress of the polymeric solution to form nanofibres. 
Samples were mounted on a C35/1° titanium rotor and maintained at a temperature of 37°C. 
Samples were then analyzed for their pertinent rheological characteristics. Table 4.4 as 
depicted in Chapter 4 reveals the parameters employed to conduct rheological analysis. 
 
5.2.3.6. Determination of the Degree of Crystallinity by X-Ray Diffraction 
An X-Ray Diffractometer (Rigaku Miniflex 600, Rigaku Corporation, Matsubara-cho, 
Akishima-shi, Tokyo, Japan) was utilised at room temperature to determine the degree of 
crystallinity and amorphosity chemical composition present in the biopolymeric system within 
the atomic plane. Samples were prepared by loading the prepared nanofibres on a glass 
sample holder and quantitative X-ray diffraction patterns were obtained. 
 
5.2.3.7. Determination of In vitro Bioactive Release and the Effect of Crosslinking on 
Release Kinetics 
An in vitro drug release study was conducted using a modified Franz Diffusion Cell type 
apparatus to determine the release of the bioactive curcumin. The nanofibrous mat was cut 
into sections of approximately 1.8cm2. Samples were then placed into the receptor 
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compartment exposed to phosphate buffer of pH 7.41 and kept at a constant temperature of 
37°C thermoregulated by a water jacket. Cells containing the buffer were constantly stirred 
using a magnetic stirrer and loaded with 12mL of the isotonic buffer. At periodic time intervals 
0.1mL was removed for analysis followed by direct insertion of the same amount of buffer 
into the cell. Samples removed for analysis were evaluated using an Implen nanophotometer 
GmbH, Munich, conducted at a wavelength of 425nm. 
 
5.2.3.8. Release Kinetics by Ex Vivo Studies using a Franz Diffusion Cell Type 
Apparatus 
Excised skin of full-thickness obtained from Sprague Dawley Rats was used to conduct the 
permeation study. The excised skin was carefully removed and stored in isotonic buffer at -
80°C following euthanasia of the Sprague Dawley Rats using pentobarbitone 
intraperitoneally (i.p.). Preceding the experimental procedure skin samples were cut to a 
desired area of approximately 1.8cm2. This was prepared subsequent to thawing at room 
temperature utilizing water and shaving of excess hair and elimination of adipose and 
subcutaneous tissue on the dorsal region of the skin. Prepared skin was then placed on the 
receptor compartment of the Franz Diffusion Cell type apparatus followed by application of 
the nanofibrous mat and held in place by aluminium clamps. The sample was kept in contact 
with isotonic phosphate buffer in the cellular compartment filled to 12mL and stirred 
continuously using a magnetic stirrer. At specified periodic interval 0.1 mL was removed and 
immediately replaced with isotonic buffer. A removed sample was then evaluated for 
bioactive release employing an Implen nanophotometer GmbH, Munich, conducted at a 
wavelength of 425nm. 
 
Skin integrity maintenance throughout the study was ensured by measurement of the 
electrical resistance across the skin sections before and after ex vivo evaluation. This was 
performed by passing a fixed current across the skin preparation using a Mettler Toledo 
Seven Multi GmbH, Analytical CH-8603 Schwerzenbach, Switzerland connected to an 
electrode that was adjusted to isotonic environments by placing the probe into isotonic PBS 
solution before insertion with skin sections. Table 5.3 reveals the conductance and 
resistance measurements. 
 
Table 5.3: Resistance and conductivity of skin preparations to determine skin integrity before 
and after ex vivo permeation studies 
Skin preparation Resistance (Ώ/cm) Conductivity (μs/cm) 
Before 0.37×103 18 
After 0.86×103 16 
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5.3. Results and Discussion 
 
5.3.1. Characteristic Analysis of the Optimized Nanofibrous Mat 
5.3.1.1. Attainment of an Optimized Nanofibrous Wound Healing System by Residual 
Analysis and Surface Plot Evaluation 
Derivation of an effective optimal formulation was obtain and originated from results generated 
from the B-B design of statistically diverse formulations that varied in concentrations of biopolymer, 
i.e.: chitosan (1-3%w/v), hypromellose (0.4-1.6%
w/v) and a crosslinker genipin (0.010-0.040%
w/v) as 
indicated in Chapter 4. Results attained in terms of the investigated responses (i.e.: Young‘s 
modulus, ultimate strength, swelling capacity and water vapour transmission rate) consigned to 
phenomenal potential in terms of elastic behaviour and potency, stability as well as distension and 
conduction capability when generated within specific polymeric concentration arrays. Thus this 
outcome deduced the polymeric composites of the optimized candidate for formulation. 
 
In order to determine the relationship between the predictor variables and the response variables a 
full ANOVA analysis was conducted as depicted in this section of the measured formulation 
responses. Data used for the optimization of the experimental design entailed nanotensile analysis 
to determine the strength and flexibility of the nanofibres, as well as percentage swelling capacity 
to determine the capacity of exudate absorption and biopolymeric release. Analysis of the model 
was employed by the attainment of residual plots as seen in Figure 5.3. Analysis of the normal 
probability plots reveal normal to regular distribution as all points are in close propinquity to the 
straight line as indicated in the figure (Figure 5.3A-D) with no evidence of underlying variation. 
Residual analysis of the response surface design (Figure 5.3) disclose significant response data 
that generally showed random scatter on either side of the zero line indicating the absence of 
trends thus assumptions relating to the multiple regression analysis were not grossly violated. 
Amid the consecutive point displayed in the residual vs. the order of data, a random distribution 
alternating between positive and negative points is distinguished (Figure 5.3 M-P) further 
validating the assumptions. This is further convoluted by the histogram of residuals (Figure 5.3 I-L) 
where constant variation with normal distribution is observed. Table 5.4 depicts a full ANOVA that 
was carried out. 
 
To establish the level to which the model fitted the data, the coefficient of regression R2 was 
determined for all responses whereby it was noted to be above the 50% mark for all. Young‘s 
Modulus displayed a value of 84.7%, Water Vapour Transmission Rate (WVTR) 76.8%, % 
Swelling Capacity 77.9% and Ultimate Strength 61.8% indicating a superior fit. 
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Regression equations regenerated for the responses are specified in Equation 5.1 a-d: 
𝑌𝑜𝑢𝑛𝑔𝑠 𝑀𝑜𝑑𝑢𝑙𝑢𝑠 = 53.44 +  −51.84 [𝐻𝑃𝑀𝐿] +  −25.79 [𝐶𝑆] +  −50.64 [𝐺𝐸𝑁] +
 11.93  𝐻𝑃𝑀𝐿 ∗ 𝐻𝑃𝑀𝐿 +  3.13  𝐶𝑆 ∗ 𝐶𝑆 +  −9088.89  𝐺𝐸𝑁 ∗ 𝐺𝐸𝑁 +  11.40  𝐻𝑃𝑀𝐿 ∗ 𝐶𝑆 +
9233.33) 𝐻𝑃𝑀𝐿 ∗ 𝐺𝐸𝑁 +  90.83 [𝐶𝑆 ∗ 𝐺𝐸𝑁]  [Equation 5.1a] 
 
𝑊𝑎𝑡𝑒𝑟 𝑉𝑎𝑝𝑜𝑢𝑟 𝑇𝑟𝑎𝑛𝑠𝑚𝑖𝑠𝑠𝑖𝑜𝑛 𝑅𝑎𝑡𝑒 =
13.441 +  5170  𝐻𝑃𝑀𝐿 +  −6345  𝐶𝑆 +  −356661  𝐺𝐸𝑁 +  −2902  𝐻𝑃𝑀𝐿 ∗ 𝐻𝑃𝑀𝐿 +
 577  𝐶𝑆 ∗ 𝐶𝑆 +  1993285  𝐺𝐸𝑁 ∗ 𝐺𝐸𝑁 +  422  𝐻𝑃𝑀𝐶 ∗ 𝐶𝑆 +  −10570  𝐻𝑃𝑀𝐿 ∗ 𝐺𝐸𝑁 +
 105543 [𝐶𝑆 ∗ 𝐺𝐸𝑁][Equation 5.1b]       
 
% 𝑆𝑤𝑒𝑙𝑙𝑖𝑛𝑔 𝐶𝑎𝑝𝑎𝑐𝑖𝑡𝑦 =
426 +  −307  𝐻𝑃𝑀𝐿 +  −125  𝐶𝑆 +  −9023  𝐺𝐸𝑁 +  104  𝐻𝑃𝑀𝐿 ∗ 𝐻𝑃𝑀𝐿 +  38  𝐶𝑆 ∗
𝐶𝑆+254540𝐺𝐸𝑁∗𝐺𝐸𝑁+19𝐻𝑃𝑀𝐿∗𝐶𝑆+3240𝐻𝑃𝑀𝐿∗𝐺𝐸𝑁+−2738[𝐶𝑆∗𝐺𝐸𝑁][Equation 5.1c] 
 
𝑈𝑙𝑡𝑖𝑚𝑎𝑡𝑒 𝑆𝑡𝑟𝑒𝑛𝑔𝑡𝑕 = 1.0290 +  −0.8944  𝐻𝑃𝑀𝐿 +  −0.2412  𝐶𝑆 +  −18.5278  𝐺𝐸𝑁 +
 0.4097  𝐻𝑃𝑀𝐿 ∗ 𝐻𝑃𝑀𝐿 +  0.0150  𝐶𝑆 ∗ 𝐶𝑆 +  88.8889  𝐺𝐸𝑁 ∗ 𝐺𝐸𝑁 +  0.0375  𝐻𝑃𝑀𝐿 ∗
𝐶𝑆+0.8333𝐻𝑃𝑀𝐿∗𝐺𝐸𝑁+5.000[𝐶𝑆∗𝐺𝐸𝑁][Equation 5.1d] 
 
Table 5.4: ANOVA analysis of the measured responses 
 
Response Variable 
 
                           P Value 
YM WVTR Swelling US 
Hypromellose 0.011 
 
0.342 0.137 0.11 
Chitosan 0.03 
 
0.109 0.324 0.464 
Genipin 0.927 
 
0.131 0.249 0.362 
Hypromellose*Hypromellose 0.069 
 
0.196 0.188 0.074 
Chitosan*Chitosan 0.152 
 
0.447 0.18 0.828 
Genipin*Genipin 0.321 
 
0.55 0.067 0.773 
Hypromellose*Chitosan 0.012 
 
0.722 0.644 0.736 
Hypromellose*Genipin 0.292 
 
0.893 0.272 0.91 
Chitosan*Genipin 0.479 
 
0.065 0.142 0.287 
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Figure 5.3: Summary of Residual plots for Young‘s Modulus, Ultimate Strength, Swelling 
Capacity and Water Vapour Transmission Rate 
 
Further analysis was conducted and explicated by the use of surface plots to optimize the product 
design and processing whereby significant components and interactions within the nanofibrous 
system were highlighted. Interactions between the polymers and crosslinker were analysed and 
addition of a crosslinker at low concentrations of 0.01%w/v was found to significantly influence the 
characteristics and design properties of the system formulation. Addition of the crosslinker to 
chitosan considerably enhanced the mechanical properties of the nanofibrous mat by decreasing 
the Young‘s modulus and increasing its ultimate strength as discussed in this study and can be 
microscopically visualised in Figure 5.10. When a larger amount of crosslinker was used by 
increasing crosslinker concentration, flexibility and elasticity of the system decreased until 
brittleness was noted. Furthermore increasing the polymer volume resulted in an increase in the 
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fibrous bulk volume augmenting the mechanical attributes to a certain degree thereafter 
influencing its elasticity and flexibility for topical application. Figure 5.4 and Figure 5.5 represents 
the surface plots and contour plots obtained that provides valuable data regarding the responses 
obtained from the 3 factor Box-Behnken design for optimization. 
 
 
 
 
 
 
Figure 5.4: Contour and Response Surface Plots depicting the interactions between polymers and 
crosslinker on mechanical characteristics resembled by Young‘s Modulus 
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Figure 5.5: Contour and Response Surface Plots depicting the interactions between polymers and 
crosslinker on mechanical characteristics resembled by Ultimate Strength 
 
Figure 5.6 and Figure 5.7 depict the contour and surface response to swelling and water vapour 
transmission upon the influence of varying polymer concentration. Minimal swelling is indicated 
upon utilisation of low volume of polymer from 1-1.6%w/v hypromellose and 2-3%
w/v chitosan as 
depicted in the figures thus sustaining and prolonging the bioactive release. The degree of 
crosslinking also greatly influenced the swelling and transmission rate as greater intermolecular 
forces and bonds provides superior control over the rate of swelling and erosion when applied to 
skin tissue. Furthermore Figure 5.7 depicts the greatest transmission rate when a high degree of 
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chitosan polymer is used up to 9000g/m2. The use of lower concentrations provides a lower more 
suitable transmission rate as is predicted in Figure 5.7. 
 
 
 
 
Figure 5.6: Response surface and contour plots depicting the effects of chitosan, 
hypromellose and genipin on swelling. 
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Figure 5.7: Surface and contour plot analysis depicting the influence of swelling and water 
vapour transmission. 
 
5.3.1.2. Response Optimization 
Nanofibre optimization was obtained using the measured responses for the reverent factors as 
discussed i.e.: Young‘s Modulus, Ultimate Strength, Water Vapour Transmission Analysis and 
Swelling Capacity. The procedure was performed (MINITAB®, V15, Minitab, USA) to attain the 
adjusted levels of polymer and crosslinker incorporated into the nanofibres to prepare an ideal 
formulation to give flexible yet robust fibres suitable for topical administration from the 
experimentally derived value as indicated in Figure 5.8 and analysed as discussed in Chapter 4. 
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Figure 5.8: Optimization plot for the definition of the optimum nanofibrous system 
 
5.3.2. Stability Analysis in Terms of Chemical Structural Transitions by Fourier 
Transform Infrared Spectroscopy 
Chitosan, a natural polymer and thus highly biodegradable needs to be crosslinked in order 
to conserve bioactive delivery and controlled release. Crosslinking involves chemical 
interactions occurring to form a bond between polymer chains that will enhance the general 
properties by improving both the physicochemical and physicomechanical properties to 
modulate and control sustained bioactive release. Genipin a natural crosslinker with a low 
cytotoxicity profile and encompassing wound healing activity is the crosslinker of choice 
(Muzarelli et al., 2009) as stated before. Figure 5.9 demonstrates the FTIR profile revealing 
the effects of crosslinking. A wavelength of 1341.74cm-1 was eminent in Figure 5.9a(a) which 
embodied the presence of aromatic C-N stretching representing an amine group due to the 
presence of genipin. Furthermore a shift in the various wavelengths was seen from 2892.99 
in uncrosslinked nanofibres to 2907.16cm-1 in crosslinked nanofibres (1), 1416.06 to 
1429.29cm-1 (2) and 1341.77 to 1373.12cm-1 (3) in crosslinked nanofibres representing 
alkanes C-H bending. This shift in wavelength to the left indicated an increase in conjugation 
and bond intensity thus establishing an increase in stability and physicomechanical 
properties to the nanofibrous system. This enhancement assists in sustaining controlled and 
long lasting bioactive release. In addition, due to improved physicomechanical properties, 
topical application will be made convenient and durable. 
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Figure 5.9: FTIR spectra of (a): Crosslinked nanofibrous mat and (b): Uncrosslinked nanofibrous 
mat 
 
5.3.3. Surface Topographical and Morphological Evaluation by Scanning Electron 
Microscopy 
Morphological analysis of the SEM profiles revealed the influence of crosslinking on 
nanofibre eminence. Figure 5.10 disclosed the presence of nanofibre structures that were 
solid, cylindrical, uniform in some instances and of random orientation. The absence of 
crosslinker resulted in the formation of a nanofibrous mat with nanofibres that vary in 
diameter as can be seen in Figure 5.10b and 5.10c. Nanofibre diameter was seen ranging 
between a scale of 22.68nm and 75.43nm. Furthermore it was noted that nanofibres were 
deposited upon the aluminium collecting surface in a disorganized manner whereby they 
accumulated in a coiled and tangled fashion, diameter was of varying size and the presence 
of nanobeads and kinks was clearly distinguished in Figure 5.10c. The incorporation of 
crosslinker resulted in the formation of a nanofibrous mat with more evenly orientated 
nanofibres in a structured fashion. Furthermore, crosslinking caused contraction of 
nanofibres thus endorsing a denser structure with narrowly packed nanofibres (Figure 5.10d, 
e, f). Crosslinked nanofibrous mats displaying this orientation prolong the release of 
bioactives thus promoting sustained release due to a decrease in surface area when 
nanofibre compaction occurs. In addition, the nanofibrous surface demonstrates the absence 
4000 3500 3000 2500 2000 1500 1000 650 
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of pores which can be attributed to the use of water as a solvent. Water encompasses a 
relatively low volatility thus preventing surface pore formation (Sheikh et al., 2012).  Porous 
sites were seen occurring between individual nanofibres within the mat which encourages 
the regenerative process during wound healing due to its close architecture to the native 
extracellular matrix (ECM) of the skin. Moreover, the addition of a crosslinker improved the 
physicomechanical properties of the nanofibrous system preventing ruptures and breakage 
from occurring as seen in Figure 5.10a. Crosslinking provided a nano structure with relevant 
vapour transmission and swelling thus controlling bioactive release promoting prolonged 
healing at a much more efficient rate. 
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Figure 5.10: Morphological representation of(a), (b), (c): Uncrosslinked nanofibres; (d), (e), (f): 
Crosslinked Nanofibres 
 
(a) (b) 
(c) (d)
 
 C 
(f) (e) 
133 
 
5.3.4. Thermodynamic Behaviour of the Nanofibrous Mats in terms of Differential 
Scanning Calorimetry 
Figure 5.11 displays the DSC transitions occurring upon exposure to heat variation.  A glass 
transition (Tg) was seen in both curves but was more prevalent in the crosslinked nanofibrous 
mat at 75.13°C whereas when uncrosslinked a glass transition occurred at 30.54°C and was 
superimposed by an endothermic peak at 101.72°C. This suggests that the provision of a 
polymer backbone upon crosslinking increased the glass transition therefore allowing 
decomposition to occur at a decreased and slower rate. A low glass transition of 30.54°C 
superimposed by the broad endothermic peak revealed melting and the presence of eutectic 
impurities, thus the uncrosslinked nanofibrous mat subsist in a more defined polymorphic 
state. An exothermic peak was observed at 148.64°C in Figure 5.11a and 144.63°C in Figure 
5.11b indicating crystallization. An elevated crystalline temperature of 148.64°C seen in the 
crosslinked nanofibrous mat demonstrated a further ordered molecular arrangement thus a 
decreased molecular motion between molecules due to the intramolecular and intermolecular 
bonding occurring upon crosslinking. An endothermic melting transition phase was seen in 
both DSC profiles. However, Figure 5.11b revealed the presence of an exothermic peak 
arising upon melting as indicated in the figure. This suggested the occurrence of melting with 
decomposition which could be attributed to the uncrosslinked nanofibrous structure been in 
an amorphic state with randomly orientated molecules more prone to degradation. Lastly an 
exothermic peak occurring at 283.96°C in the crosslinked nanofibrous structure and 
264.45°C in the uncrosslinked nanofibrous structure disclosed a decomposition event. From 
the temperatures obtained it was seen that crosslinking improved the stability of the 
structure, thus slowing down the process of degradation.  
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Figure 5.11: Differential Scanning Calorimetry Thermograms of (a): Crosslinked nanofibrous 
mat, (b): Uncrosslinked nanofibrous mat 
 
5.3.5. Determination of the Young’s Modulus and Tensile Properties of the Crosslinked 
and Uncrosslinked fibres 
To investigate the mechanical properties as well as the influence of crosslinking on nanofibre 
formation, tensile properties were evaluated to determine the tensile strength and Young‘s 
Modulus. Figure 5.12 and Table 5.5 reveals the results obtained from nano tensile mapping. 
Young‘s Modulus provides a means by which the ratio of stress to strain can be depicted to 
determine the nanofibrous elasticity. From the stress-strain graphs obtained in Figure 5.12 it 
was seen that Figure 5.12a displays an irregular pattern of deformation as demarcated in the 
figure, to finally produce a breaking point. This suggest that a deviation from linear-elastic 
behaviour occurs thus causing permanent deformation to take place and the uncrosslinked 
nanofibrous mat exhibits poor elastic properties. The introduction of genipin as a crosslinker 
to produce an optimum formulation resulted in the formation of a polymer backbone 
enhancing polymer chain flexibility. From the results obtained in Table 5.5 it was noted that 
the crosslinked nanofibrous mat displays a greater tensile strength of 0.195N.mm2 in 
comparison to the uncrosslinked mat displaying a value of 0.035N.mm2. It was further seen 
that the crosslinked nanofibrous mat displays a lower Young‘s Modulus thus portraying 
defined flexibility, whereas uncrosslinked nanofibrous mats with elevated Young‘s Modulus 
portray a greater degree of rigidity and stiffness promoting the configuration of a brittle 
structure that is inconvenient for topical application. Furthermore from the table it was seen 
that crosslinked nanofibrous mats depict a greater ultimate strength, ultimate stress and yield 
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stress.  
 
Figure 5.12: Nanotensile mapping depicting comparisons in mechanical strength of (a): 
Uncrosslinked nanofibrous mat, (b): Crosslinked nanofibrous mat [a: Linear portion depicting 
Young‘s Modulus, b: Fracture point]  
 
Table 5.5: Experimental values obtained from the nanotensile mapping of crosslinked and 
uncrosslinked nanofibrous mats 
 Tensile 
Strength  
(N.mm2) 
Young’s  
Modulus 
E (MPa) 
Yield Stress 
(σy) 
Ultimate 
Strength 
(σu) 
Ultimate 
Strain 
(εu) 
Uncrosslinked 
Nanofibrous 
Mat 
0.035 5.96 0 0.07 0.009 
Crosslinked 
Nanofibrous 
Mat 
0.195 7.56 0.13 0.14 0.019 
 
5.3.6. Analysis of the Pertinent Rheological Properties of the Polymeric Formulations 
For the process of optimal electrospinning, polymeric hydrogel integrity and retentive 
behaviour assessment is required by evaluation of their viscoelastic properties and 
mechanical strength. This was conducted by the application of stress sweep and frequency 
sweep experimentation. Figure 5.13 displays the outcome obtained from both crosslinked 
and uncrosslinked formulations by means of the frequency sweep. When a hydrogel displays 
exceptional physicomechanical properties, its integrity is maintained thus preventing physical 
drug loss, preserving and prolonging drug delivery in vivo. Furthermore hydrogels 
demonstrating excellent physicomechanical characteristics, endorse the process of 
electrospinning allowing the formation of uniform, cylindrical and orientated nanofibres which 
can be observed in Figure 5.10. Evaluation by stress sweep analysis, revealed the linear 
viscoelasticity range providing a strain value which is employed to conduct a frequency 
sweep evaluation. G‘ (elastic or storage modulus) and G‖ are pertinent rheological 
(a) (b) 
a 
a 
b b 
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parameters obtained upon the conductance of a frequency sweep test under non- destructive 
conditions. G‘ computes how well structured a hydrogel will be and signifies the elastic 
storage of energy. G‖ displays the viscous energy of a hydrogel and adjusts in accordance to 
the viscosity of the hydrogel. From the results obtained it was seen that G‘ dominates in the 
crosslinked formulations therefore suggesting the hydrogel is more elastic then viscous 
within the investigated frequency range (Anumolu et al., 2010).  
 
Illustrations of the frequency sweep of the uncrosslinked hydrogel solution, whereby G‖ 
dominates displayed that the hydrogel exist in a greater viscous state. The results can be 
further supported by the yield stress obtained whereby the crosslinked hydrogel revealed a 
yield stress of 36.57Pa and the uncrosslinked hydrogel showed a yield stress of 38.60Pa 
disclosing that the uncrosslinked hydrogel will cease to behave elastically prior to the 
crosslinked hydrogel. This was attributed to the introduction of a crosslinker supplying a 
polymer backbone with the formation of a stronger crosslinking network. The crosslinked 
hydrogel where G‘ is dominant displays a greater mechanical strength suggesting its ability to 
resist any structural changes when an increased strain is applied. Furthermore the 
crosslinked hydrogel produced nanofibres that were more uniform in diameter producing an 
organised nanofibrous mat. Nanofibres fabricated from the uncrosslinked hydrogel confirmed 
the presence of nanobeads and nanofibres of varying diameters as depicted in Figure 5.10. 
 
Figure 5.13: Depiction of pertinent rheological parameters affecting nanofibres formation (a): 
Crosslinked hydrogel, (b): uncrosslinked hydrogel 
 
5.3.7. Determination of the Degree of Crystallinity by X-Ray Diffraction 
For the establishment of the crystallographic interactions occurring in the nanofibrous mats 
upon crosslinking, XRD patterns have been determined. Figure 5.14 portrays the x-ray 
diffraction patterns both, upon crosslinking and uncrosslinked over a 2θ range of 0-80°.From 
the profiles obtained it was noted that crosslinked nanofibrous systems reveal symmetrical 
and narrow peaks that are dominated at 38°, 43°, 78° and 81°. A broader peak preceeds 
(a) (b) 
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composed of narrow symmetrical peaks, arising prior to 20° 2θ advocating that the 
nanofibrous character shifts from a polycrystalline state to a more crystalline state. Absence 
of crosslinking bridges produce a diffraction pattern dominated by broader peaks throughout 
the diffractogram. Broad asymmetrical peaks were intensified between 60° and 80° 2θ. 
Irregular stereoregularity detected by the broad peaks in uncrosslinked nanofibrous systems 
demonstrate a structure that is dominantly amorphous in nature thus containing a randomly 
orientated entanglement of polymer chains, therefore easily degradible with poor tensile 
properties. Introduction of crosslinking provides greater stereoregularity to the structure in a 
crystalline configuration thereby promoting sustained and controlled release of bioactives as 
well as enhanced mechanical properties. 
 
 
Figure 5.14: XRD profiles of (a): Crosslinked nanofibrous mat, (b): uncrosslinked 
nanofibrous mat 
 
5.3.8. Evaluation of In Vitro and Ex Vivo Bioactive Release Kinetics 
To determine the release kinetics of the optimum nanofibrous delivery system across 
permeated skin and in contact with a dissolution buffer medium of pH 7.4, a Franz Diffusion 
Cell Type Apparatus was used. Samples were removed at 0.5,1,2,3,4,6,8,10,12 and 24 
hours during experimentation to determine the cumulative release rate. Figure 5.15a reveals 
the bioactive and permeated release rate over time. From the outcome obtained it was noted 
that there was a burst release obtained within the initial two hours of the study in both 
instances. At 2 hours a release rate of 0.9457mg and 2.1016μg was observed for bioactive 
release and permeated release rates respectively. The release rate of curcumin was 
observed to steadily increase for the initial 8 hours and was pronounced in the permeated 
release profile at 3.1641μg and 1.3193mg in the bioactive release profile. Subsequent to 8 
hours, the release rate in both instances seemed to take on a greater equilibrium state 
thereby commencing a more defined steady state release profile. Curcumin is a yellow to 
orange crystalline powder with the chemical formula C21H20O6 and is insoluble in water thus 
(a) 
(b) 
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highly hydrophobic (Bharat et al., 2008). Due to its hydrophobic nature, release rates were 
potentiated across the skin tissue when in contact with the lipophillic phospholipid bilayer, a 
lipid based membrane present within the skin. Thus accelerated release rates were seen in 
the permeated bioactive release of curcumin throughout the study advancing the clinical 
efficacy as shown in Figure 5.15. These results comply with earlier studies carried out in 
curcumin films (Mayet et al., 2014).  
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Figure 5.15: in vitro bioactive release and ex vivo permeated release profile of the optimum 
nanofibrous mat  
 
5.4. Concluding Remarks 
The nanofibrous mats composed of natural biomaterials was successfully developed, 
optimized and characterised for topical wound administration. Employment of the response 
surface methodology lead to the development of an optimized formulation by mathematical 
derivation. Furthermore regression and correlation analysis was used to analyze the dataset 
thus confirming the statistical adequacy of the models proposed. Optimization of the 
formulation leads to the expansion of an optimized nanofibrous mat with fine biological and 
mechanical characteristics. Furthermore the chapter also demonstrated the direct effects of 
crosslinking on the formation of the nanofibrous mat. To further enhance the system and 
provide a complete prototype device a novel component was introduced to the system known 
as the BTDS. Chapter 6 to follow will provide a greater insight to this advancement. 
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CHAPTER 6 
DESIGN OF THE LYOPHILIZED INFLAMMATORY DEPENDENT MATRIX OF THE 
MULTICOMPONENT STIMULI RESPONSIVE PROTOTYPE DEVICE 
 
6.1.1. Introduction of Advancements to the Bioactive Delivery System 
This chapter aims at illustrating the incorporation, design and development of the lyophilized 
inflammatory dependent matrix to serve as a component of the Bioresponsive transdermal 
delivery system (BTDS). It explores the mechanism of the device that demonstrates two way 
communications between the delivery system and biological tissue. Of particular interest is 
the invention of a biopolymeric network, that when designed may provide an unique 
opportunity to interact chemically or physically with specific biological mediators for 
recognising biological processes that pertain to a specific disease state such as wound injury 
and healing, consequently releasing bioactives upon exposure.  
 
The field of stimuli responsive delivery systems has undeniably gained much insight in the 
last decade at multi-scaled lengths involving biological systems that govern many living 
functions. ―Stimuli Responsive Systems‖ can be classified as a polymers response or 
reaction upon exposure to a specific stimulus and can be categorized in various ways. 
Responsive polymers, as components in the system may react to a chemical or physical 
interaction leading to the beginning of diverse events such as acid-base reactions, 
destruction or configuration of forces both intermolecular and intramolecular involving 
hydrogen bonds, electrostatic interactions as well as the degradation of various delivery 
systems such as hydrogels, implants, wafers amongst others upon the application of a 
particular stimulus. This consequently causes alterations in the polymeric structure which 
include irreversible or reversible bond breakage of crosslinked groups, polyelectrolyte 
complexes or the polymer backbone ultimately resulting in the release of the desired active. 
Application of these smart delivery systems hold great promise in the electronics, biomedical, 
sensing and drug delivery fields (Roy et al., 2010).   
 
Stimuli responsiveness can be acquired through an array of techniques, both physical and 
chemical by the employment of heterogeneous polymer networks using smart healing 
materials. These stimuli techniques include (Liu and Urban, 2010): 
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 Temperature 
 Mechanical                                
 Light                                          Physical 
 Electric 
 Magnetic 
 pH 
 Biological                                  Chemical 
 Electromechanical 
 Ionic Strength 
 
Of significant interest to this research as an advancement and way forward approach is by 
overcoming challenges faced, by the design of a combinatory bioactive wound healing 
delivery system. This is done via using a chemical biological stimulus, in particular 
inflammation as a response. The development of a safe, non toxic and effective matrix that 
can passively target inflammatory cells at the desired site ensuring controlled and prolonged 
release and at the same time enhance the anti-inflammatory components of the delivery 
system was under investigation.    
 
6.1.2. Inflammation as a Stimulus Employed for Controlled Topical Bioactive Delivery 
A potentially inflammatory sensitive polymeric device was introduced as an augmentation to 
the nanofibrous wound healing bioactive system designed as conferred in Chapter 4 and 5. 
The aim of this ensuing investigation was to build on to the existing nanofibrous system by 
introducing an inflammatory responsive component thus employing a combinatory delivery 
system that encompasses the potential to regulate bioactive release from the nanofibrous 
system and enhance the wound healing impediment of the device. 
 
Wound healing is a dynamic interactive process involving many stages, the first been 
inflammation. Inflammation presents immediately upon tissue injury whereby extravasation of 
blood constituents collectively with blood vessel disruption occurs (Singer and Clark, 1999). 
Inflammation involves the transpiration of manifold events upon exposure to a particular 
‗stimulus‘ and is not an entity of a solitary event (du Toit, 2013). Of great significance to the 
process of inflammation is the re-establishment of homeostasis upon injury which 
materializes as a blood clot or fibrin matrix at the site as a provision of an extracellular matrix. 
Recruitment of many infiltrates transpire such as macrophages, neutrophils, natural killer 
cells (NK), monocytes, interleukins (IL), growth factors and platelet plugs as seen in Figure 
6.1 (Gurtner et al., 2008). Amongst these there are also chemical mediator‘s oxygen 
metabolites, arachidonic acid metabolites and proteolytic enzymes which are the main 
perpetrators in establishing tissue damage (Du Toit, 2013). Of pertinent significance to this 
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investigation was the focus on the above mentioned mediators that lead to the fabrication of 
the lyophilized matrix. 
 
Figure 6.1: Illustration revealing influx of infiltrate mediators to the wound site that will serve 
as an inflammatory stimulus for the delivery system (Obtained from Singer and Clark, 1999) 
 
6.1.3. Polymeric Components of the Lyophilized Matrix 
Hyaluronic acid (HA), a natural constituent that serves as the only non-sulphated 
glycosaminoglycan (GAG) component within the native extracellular matrix (ECM) of the skin 
is structured as a linear polysaccharide and comprises of β-1,4-linked D-glucoronic acid (β-
1,3) N-acetyl-D- glucosamine disaccharide units (Luo et al., 2000). Hyaluronic acid has been 
found practical for therapeutic use in many delivery systems, in particular tissue engineering 
as it is biodegradable and biocompatible. Furthermore, it boasts many advantageous 
properties clinically for wound healing in a variety of tissues as it provides the required 
structural organisation of the extracellular matrix (ECM) regulating the morphological 
structure and promoting cell differentiation and regeneration (Kim and Park, 2002). In vitro 
and in vivo application of HA derived biomaterials in delivery systems have shown improved 
in vivo residence time and at the same time retaining natural biodegradability and 
biocompatibility upon chemical modification. In addition to its superior therapeutic attributes, 
HA exhibits profound pharmaceutical merits whereby chemical modifications allows tailoring 
of the polymer bonds to suit desired specifications. Functional modifications, drug-polymer 
conjugates and crosslinking can be applied to progress tissue engineering and controlled, 
targeted drug release (Luo et al., 2000). The significance of incorporation of HA for the 
Inflammatory 
Stimulus 
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course of wound healing disclose improved tissue regeneration in the connective tissue ECM 
by mimicking the native HA found in tissue. Furthermore, HA provides indications that direct 
responses to improve the superiority of regeneration such as reduced scar tissue formation. 
Cell adhesion, migration and proliferation are promoted by HA via signalling, both 
biochemical and biophysical mechanisms (Kreger and Voytik-Harben, 2009).      
 
Sodium alginate was used as a component of the lyophilized matrix. It is a natural algal 
polysaccharide that is effective as a wound management aid. Attained from the cell walls of 
the brown algae species seaweeds (Ascophyllum sp and Laminaria sp) (Lloyd et al., 1998). 
Alginate is an anionic linear polysaccharide composed of 1, 4 linked β-D-mannuronates and 
1, 4 linked α-L-guluronates in varying proportions (Kim et al., 2008). Fan and co-workers 
have reported the extensive use of alginate in wound management devices and applications 
due to its many advantageous properties such as non-toxicity, biocompatibility and 
bioactivity. Above all it possesses haemostatic function, thus is able to absorb exudates from 
the wound site endowing an elevated absorption capacity and promotion of a moist wound 
environment. Attainment of a physiologically moist microenvironment promotes the formation 
of granulation tissue as well as healing (Kim et al., 2008). In addition, alginate dressings 
serve as one of the most versatile dressings available currently as they demonstrate an 
eminence to activate macrophages at the wound bed generating pro-inflammatory signals to 
initiate resolving inflammatory characteristics of wound healing (Fan et al., 2006). 
 
Amongst mammalian species, the structural moieties of hyaluronic acid (HA) have shown 
great conservation as it is also a naturally occurring biopolymer (Price et al., 2007). Tissue 
engineering and drug delivery systems can be exceedingly endorsed by the use of HA due to 
its immunoneutrality properties providing excellent building blocks for synthesis (Prestwich et 
al., 1998). However, due to its innate nature it is highly biodegradable thus lacking optimal 
physicomechanical properties. Thus the focus on HA as a major element in drug delivery 
devices, has brought to attention the addition of partner molecules also possessing 
advantageous properties to the healing process such as those in alginate to improve on 
these concerning areas. The use of versatile chemical methodology will allow careful 
combination of these materials ultimately altering the pharmacokinetic properties diverging its 
biophysical nature. The use of hydrazides such as adipic acid dihydrazide (ADH) as a 
crosslinker allows attachment and combination of therapeutic bioactives by covalent 
attachment of glucuronic acid moieties of HA to the carboxylic acid functions found in 
hydrazides as shown in Figure 6.2. This allows the availability of amino group arrays along 
the backbone of HA originating from the attached hydrazides thus improving its biostability 
and physicomechanical properties, allowing affixment to alginate and encouraging prolonged 
and controlled release of bioactives (Prestwich et al., 1998).    
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Stimuli responsive polymer erosion as a drug delivery system has become a superlative 
route for drug delivery. To a large extent, attention has been focused on this form of drug 
delivery based on its immense potential when applied in vivo.  Smart drug delivery systems 
are able to carry, protect, deliver and then release the active by matching the desired kinetic 
release by a sequence of complex responses. Employment of a stimuli responsive system to 
inflammation serves as an ideal contrivance to enhance the efficacy of the bioactive system 
only when in contact with inflammation allowing activation by degradation of the desired 
polymeric components (Stuart et al., 2010). As discussed previously in Chapter 1 and in this 
chapter hyaluronic acid (HA) plays a pivotal role in several physiological functions which 
include angiogenesis and differentiation, controlled permeation as well as the scavenging of 
hydroxyl radicals released during the inflammatory process. When used as a therapeutic and 
responsive agent, HA reacts in the body by two applications: 
 Enzymatic degradation by hyaluronidase 
 Degradation by hydroxyl radicals as a source of active oxygen 
 
For the purposes of this investigation in terms of a stimuli responsive system, degradation by 
hydroxyl radicals was further investigated. Affliction of a wound at the tissue site causes the 
activation of inflammation which results in enhanced capillary permeation. Activation of 
immune complexes to inflammation causes the release of phagocytic cells, 
polymorphonuclear leukocytes and macrophages amongst others causing a release of 
hydroxyl radicals, which in excess may result in tissue damage. The application of an 
inflammatory responsive system can be understood by the degradation of HA on exposure to 
these hydroxyl radicals occurring when an acute inflammatory event ensues allowing the 
development of a stimuli sensitive drug delivery system for wound healing that exhibits 
inflammation regulated degradation (Yui et al., 1992). 
 
Bearing these considerations in mind, the use of crosslinked hyaluronic acid jointly with 
alginate in the preparation of an inflammatory dependent lyophilized matrix wherein the 
bioactive nanofibrous mat is suspended serves as a means to persuade controlled, targeted 
and prolonged release at the wound site. 
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Figure 6.2: Functionalisation of HA with amino groups by the use of ADH 
 
6.2. Materials and Methods 
 
6.2.1. Materials 
Glycerol and Tween 80 obtained from Associated Chemical Enterprises Pty Ltd. (South 
Africa), Alginate (TICA-algin® 400 Powder, medium viscosity) was purchased from Texture 
Innovation Center® (White Marsh, MD, USA), polyacrylic acid, hyaluronic acid (sodium salt 
from streptococcus equi (MW= 8000-15000 g/mol), adipic acid dihydrazide (ADH) Mw= 174.20 
≥ 98% tritration were purchased from Sigma Aldrich Chemie GmbH, Steinheim, Germany. All 
other materials used were of analytical grade and used as received. 
 
6.2.2. Preparation of Bioresponsive Lyophilized Matrix Component of the BTDS 
A three-factor Box-Behnken Design (B-B) was generated by Minitab®, V15 (Minitab® Inc, 
Pennsylvania, USA) depicted in Table 6.1 in order to derive an efficient, effective and 
economically favourable end-product. The design comprised of 15 formulations acquired by 
the input of independent factors based on upper and lower limits as seen in Table 6.2 of the 
various polymeric concentrations and their responsive impacts. Formulatory component 
characteristics were based on the acquisition of dependent variables: Bioactive release on 
exposure to a stimulus represented by a plot of release against time, mechanical and 
formulary components such as viscosity (mPas) over a period of time at increasing speed 
and Young‘s Modulus E(MPa) whereby the attainment of a stress-strain relation curve was 
established. 
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Table 6.1: Box-Behnken Design Template of the 15 statistically derived formulations for the 
design of an inflammatory responsive lyophilized matrix of the BTDS 
 
Experimental 
Formulation 
No.  
Alginate 
(%w/v) 
 Hyaluronic  
Acid (%w/v) 
Adipic Acid 
Dihydrazide(%w/v) 
1 2.75 0.5 0.13 
2 2.75 0.7 0.16 
3 4.5 0.5 0.16 
4 4.5 0.3 0.13 
5 2.75 0.5 0.13 
6 2.75 0.3 0.16 
7 1 0.3 0.13 
8 2.75 0.5 0.13 
9 2.75 0.7 0.1 
10 1 0.5 0.1 
11 1 0.7 0.13 
12 4.5 0.5 0.1 
13 2.75 0.3 0.1 
14 4.5 0.7 0.13 
15 1 0.5 0.16 
 
Table 6.2: Depiction of upper and lower limits of independent variables: polymer and 
crosslinker concentration  
 
Independent Factors Lower Level Upper Level 
Polymer concentration (X1) 
Alginate 
1% 4.5% 
Polymer concentration (X2) 
Hyaluronic acid 
0.3% 0.7% 
Crosslinker Concentration (X3) 
Adipic acid dihydrazide 
0.16%        (1:3 of 
hyaluronic acid at 0.5%) 
0.1%       (1:5 of hyaluronic 
acid at 0.5%) 
 
6.2.3. Formation of a Stimuli Responsive Topical Delivery System (BTDS) 
incorporating the Nanofibrous Mat 
Formulations were prepared in concentrations according to those specified by the Box-
Behnken Design template discussed. A hyaluronic acid hydrogel was made by solution 
polymerisation using deionised water as the solvent. The hyaluronic acid solution was 
crosslinked by preparation of a hyaluronic acid-adipic dihydrazide complex to form a 
hydrazide-functionalised HA hydrogel under continuous stirring using a magnetic stirrer (Luo 
et al., 2000). Sodium alginate dispersed within deionised water was then added to the HA-
ADH functionalised hydrogel to form a multifaceted hydrogel. Wound healing nanofibrous 
mats were then suspended in the hydrogel allowing polyionic complexes to occur to structure 
a polyelectrolyte complex. Suspended nanofibrous formulations were immediately subjected 
to freezing at -80°C (Ultra-low freezer, Sanyo VIP™ Series, Sanyo North America 
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Corporation, Wood Dale, IL, USA) for a period of 48 hours to maintain stability and prepare 
formulary samples for the lyophilization process. The prepared samples were then subjected 
to lyophilization over a period of 24 hours to eliminate entrapped solvent. The system 
prepared formed a stimuli responsive matrix reservoir that was capable of been adjoined to 
the backing layer as described in Chapter 7 to form a BTDS system. 
 
6.2.4. Chemical Transitional Analysis through Fourier Transform Infrared 
Spectroscopy 
Evaluation of the chemical compositions and molecular vibrational transitions of the BTDS 
lyophilized matrix were carried out to determine the degree of crosslinking. FTIR was 
employed to obtain absorption band spectra using a PerkinElmer® Spectrum 100 Series FT-
IR Spectrometer fitted with a universal ATR Polarization Accessory (PerkinElmer Ltd., 
Beaconsfield, UK). Spectra over the range 4000-625cm-1, with a resolution of 4cm-1 and 4 
accumulations was utilised as FTIR parameters to determine the degree of crosslinkage 
occurring between hyaluronic acid and adipic acid dihydrazide by evaluation of the molecular 
vibrational transitions. 
 
6.2.5. Thermodynamic Analysis through Differential Scanning Calorimetry 
An advanced DSC (TMDSC/ADSC) (Mettler Toledo DSC-1 STARe System, Schwerzenback, 
ZH, Switzerland) was employed for thermal analysis. This was undertaken on the BTDS 
lyophilized matrix to determine thermal analysis with regards to chemical reaction transitions, 
glass transition temperatures (Tg), phase change and melting points of the BTDS samples as 
well as maximal thermal strain until degradation occurs. DSC measurements were taken at a 
heating rate of 10°C/min from -10-300°C under nitrogenatmosphere. Weighed samples were 
placed in a covered aluminium sample holder with a central pin hold. 
 
6.2.6. Analysis of Physicomechanical Properties by Textural Profiling 
To determine the tensile strength and force required to cause a defect or break in the 
system, textural analysis was employed to the BTDS lyophilized matrix. This was done by 
the use of a texture analyser (TA.XT. plus Texture Analyzer, Stable Microsystems®, Surrey, 
UK) fitted with a 50kg load-cell to determine physicomechanical properties of the system and 
in particular tensile strength from the generated force-distance profiles computed from the 
peak tensile force required and using Equation 6.1 given below. The parameters marked for 
textural analysis are presented in Table 6.3. Tensile strength was measured using the 
Young‘s Modulus equation as follows: 
𝐸 =
𝑇𝑒𝑛𝑠𝑖𝑙𝑒  𝑠𝑡𝑟𝑒𝑠𝑠
𝑇𝑒𝑛𝑠𝑖𝑙𝑒  𝑠𝑡𝑟𝑎𝑖𝑛
=
𝛿
𝜀
=
𝐹𝐿𝑜
𝐴𝑜∆𝐿
                                                                                   [Equation 6.1]                                           
147 
 
Where: E is the Young‘s modulus (modulus of elasticity); F is the force applied to the object; 
A0 is the original cross-sectional area (πr
2) through which the force is applied; ΔL is the 
amount by which the length of the object changes; L0 is the original length of the object. 
Table 6.3: Parameters employed for Texture Analysis 
 
 
 
 
 
 
6.2.7. Determination of Young’s Modulus by Nano Tensile Analysis 
A Nano Tensile Analyser (nanoTensile®5000 Hysitron Inc. Nanomechanical Test Instrument, 
Minneapolis, MN) was employed to determine Tensile Strength and Young‘s Modulus. This 
was employed on nanofibrous mats to determine the nanomechanical properties of the 
nanofibres to ensure optimal mechanical properties of the nanofibrous mats. In advancement 
it was then utilised to measure the durability of the BTDS system on a whole at a nano 
sensitive level. Samples were measured using a digital calliper, pretesting and mounted until 
a breaking force was established at a velocity of 5μms-1. Stress-Strain curves were then 
procured to further determine the ultimate strength, strain and toughness of the BTDS 
system. 
 
6.2.8. Determination of Water Content and Erosion by Analysis using a Kaarl Fisher 
Volumetric Tritrator 
Hydrogel samples of the lyophilized system was analysed using Kaarl Fisher (Mettler Toledo 
V30 Volumetric KF Tritrator, Mettler Toledo Instruments Inc., Greifensee, Switzerland) 
whereby water content and swelling ability were evaluated. This was undertaken to evaluate 
the degree of hydration of crosslinked hydrogel BTDS samples for further correlation to be 
made with regards to in vitro and in vivo biocompatibility studies. The study allows for 
analysis of the wettability of the system. 
The Equilibrium swelling ratio was then calculated employing the following equation: 
𝐸𝑆𝑅 =
(𝑊1−𝑊0)
𝑊0
                                                                                                [Equation 6.2] 
Where W1 is the weight of samples after immersion and W0 is the weight of samples in the 
dried state. 
 
Parameters                   Settings 
Test mode                    Tension 
Pre-Test speed              0.50mm/sec 
Test speed                    0.50mm/sec 
Post test speed             5.0mm/sec 
Trigger type                   Auto 
Trigger force                  5kg 
Contact time                  5sec 
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6.2.9. Identification of Surface Topographical Structure and Morphology Employing 
Scanning Electron Microscopy 
The surface topographical structure and morphology of design samples were evaluated 
using a scanning electron microscopy (SEM) (Phenom™, FEI Company, and Hillsboro, 
Oregon, USA) whereby bulk characteristics such as pore size, texture, roughness and 
brittleness amongst others were identified in order to evaluate the structural morphology of 
the system and to analyse the most suitable configuration for suspension of the nanofibres 
mats within the lyophilized matrix.   
 
6.2.10. Measurement of the Transient Rheological Characteristics of the Bioresponsive 
transdermal delivery system 
A Haake Modular advanced Rheometer system (MARS) (ThermoFisher Scientiofic, 
Karlsruhe, Germany) was used to evaluate rheological properties of polymer hydrogels used 
to fabricate the lyophilized matrix in order to ensure an optimal end product with the most 
advantageous flexibily toughness and strength. Samples were placed on a sample stage 
whereby a c35/1° titanium rotor was immersed in the polymer solution blends at a constant 
temperature of 24°C, shear rate of 100s-1 and a time interval of 360s. Stress-Strain 
rheological parameters were then obtained for quantified samples and an evaluation was 
made with regards to viscosity and yield stress. These parameters play a vital role in shaping 
a lyophilized matrix that is able to suspend nanofibrous material. 
 
6.2.11. Evaluation of the Stimuli Responsiveness of the Bioresponsive transdermal 
delivery system to an Inflammatory Stimulus through In Vitro Release Studies 
To ascertain inflammatory dependent behaviour of the BTDS, an inflammatory favourable 
environment was created. This was undertaken by formulating Fenton‘s reagent that has the 
ability to mimick the constituents of a natural inflammatory response. In vitro degradation of 
the crosslinked BTDS was analysed by employing the Fenton‘s reaction. Fenton‘s reagent 
was used as a stimulus resulting in the release of hydroxyl radicals as stipulated below in 
equation 6.3. Degradation of the BTDS matrix leading to the release of nanofibrous mats was 
then evaluated on exposure to the liberated radicals (Yui et al., 1992). 
 
    Fe2+ + H2O2 → Fe
3+ + OH∙ + OH-                                                                                           [Equation 6.3]
  
 
The BTDS was immersed in phosphate-buffered saline (PBS) set at physiological pH (7.4), 
and in an appropriate in vitro stimulus (Fenton‘s reagent) at a pH of 5.5 to correlate with the 
pH of inflammation. Samples were placed in dialysis tubing with a molecular weight of 12 000 
in a closed vial and placed in an oscillating laboratory incubator (Labcon® FSIE-SPO 8-35, 
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California, USA), set to 25 rpm (du Toit et al., 2008). At predetermined periods samples were 
removed and subjected to analysis for bioactive release using a nanophotometer (Implen 
nanophotometer GmbH, Munich,) at a wavelength of 425nm to determine maximum 
absorption 
 
6.3. Results and Discussion 
Within the field of controlled drug delivery or bioactive delivery, a significant field of interest is 
stimuli-responsive polymeric drug delivery systems. They function by allowing a controlled 
amount of drug/bioactive to be released as according to the physiological need of the 
significant disease state. They have the capacity to undergo swift modifications in their 
microstructure as well as in their macrostructure on activation of changes in the environment 
making the system more adaptable to the therapeutic requirements of the disease state in 
question (Bawa et al., 2009). The selection and employment of hyaluronic acid (HA) a natural 
biopolymer plays a significant role in inflammatory responsive systems as it plays a 
significant role in in vivo physiological functions that include angiogenesis, differentiation, 
controlled permeation and significantly scavenging of hydroxyl radicals which plays an 
important role in its responsiveness to inflammation (Yui et al., 1992). The present 
investigation provides an insight to the prototype BTDS device and its function to 
inflammatory responses. 
 
6.3.1. Determination of the Chemical Stability and Transitions of the Lyophilized 
Component 
HA has been portrayed to possess many advantageous properties for the utilization in tissue 
engineering applications which include soft tissue augmentation and adhesion formation 
(Kwang et al., 2007). In order to investigate the chemical composites of the structure as well 
as the reactions involving crosslinked bond formation and back bone structure FTIR spectra 
were obtained as indicated in Figure 6.3. Figure 6.3a reveals the spectra of uncrosslinked 
HA which demonstrates four main peaks at a specified wavelength. A broad peak was seen 
at 3257.06cm-1 (as demarcated) indicating C-H stretching due to the presence of an aromatic 
compound with possible weak to moderate bonds. The peak also indicated hydrogen 
bonding and an O-H stretch. The formation of a hydrogel with HA crosslinked to ADH and 
alginate showed a broad more defined peak with a shift in the spectra to a greater 
wavelength. This can be directly attributed to the introduction of a crosslinking agent which 
resulted in a break in the aromatic structure of hyaluronic acid as indicated in Figure 6.2, 
whereby hydrogen bonding and the hydroxyl groups of the aromatic ring is replaced with 
aliphatic molecular fragments. F8 revealed a peak of 3292.76cm-1 whereas F2 and F14 
revealed a peak at 3254.55cm-1 and 3246.58cm-1 respectively. This analysis revealed that as 
the degree of crosslinking was increased, the wavelength was shifted to the left. A shift in the 
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wavelength suggests an increase in conjugation and bond intensity. An intermediate quantity 
of crosslinker and polymer was used in F8 thus the rate of crosslinked bond formation was 
shown to be the highest. As polymeric concentrations were further increased whilst 
maintaining the ADH concentration, bond intensity and conjugation decreased as shown by 
the wavelength in the FTIR spectra of Figure 6.3f. The addition of a bi-functional crosslinker 
ADH revealed the appearance of a peak to the spectra at 2049.76cm-1 which is attributed to 
the introduction of amine groups from ADH that interacts with the aldehyde groups of HA. 
The double bonded nitrogen groups, such as the amino groups tend to exhibit absorption 
bands close to the carbonyl (C=O) and alkene (C=C) double bond stretching region as can 
be seen in Figure 6.2. Furthermore, a breakage in the aromatic ring and crosslinkage by 
ADH resulted in the formation of conjugated ketones at 1634.54cm-1 in the formulations 
depicted in the figure which is not a characteristic peak of HA. The peak was also seen at 
1634.26cm-1 in F5 and 1635.04cm-1 in F10. Distinct peak formations at 1605.68cm-1 and 
1021.08cm-1 in HA (illustrated in the figure) was seen to disappear due to aromatic ring 
breakage and ADH backbone formation in the crosslinked formations. In addition 
disappearance of the peak at 1021.08cm-1 is attributed to the consumption of the aldehyde 
groups found in HA to form an imine bond between HA and ADH. Incorporation of alginate to 
the modified HA lead to the formation of intra- and intermolecular chains by ionic bonding 
with divalent cations. Alginate could be linked to ADH and HA by covalent linkages between 
carboxylic acid groups in alginate chains and the amine groups of ADH (Liu et al., 2013). 
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Figure 6.3: Chemical vibrational transitions of (a): Hyaluronic Acid, (b): F2, (c): F5, (d): F8, 
(e): F10, (f): F14  
 
6.3.2. Identification of the Thermodynamic Properties of the Bioresponsive 
Transdermal Delivery System 
The thermal behaviour of the various lyophilized formulations was investigated to determine 
the degree of thermal degradation by differential scanning calorimetry (DSC). The DSC 
thermograms of the various formulation composites are shown in Figure 6.4. Upon analysis it 
was noted that all formulations exhibited an endothermic and exothermic peak. Endothermic 
peaks were surveyed at temperatures ranging from 77°C to 120°C. The presence of an 
endothermic peak reveals a phase transition to melting and the presence of polymorphism. 
Furthermore it was noted that the endothermic peak present was superimposed upon the 
glass transition (as demarcated in the figure) due to gradual enthalpy changes. F2 depicts a 
broad endothermic peak at a temperature range of 113°C representing the temperature of 
melting Tm whereas F5 depicts an endothermic peak at a Tm of 102.70°C. A very low melting 
temperature is seen in F7 at a Tm of 77.94°C. This observation deduces that the energy of 
heat required for phase transition and decomposition is directly attributed to the degree of 
crosslinking. Su and co-workers (2010) reported that crosslinking density is greatly 
influenced by the concentration of adipic-acid dihydrazide (ADH/crosslinker) which further 
affects the degradation of the system. Hydralyzation and degradation tends to be slower 
when higher concentrations of ADH is used in comparison to lower concentrations as further 
depicted in Section 6.3.1. From the Tm temperatures obtained it was depicted that when low 
ADH concentrations are used such as in F7, a %w/v concentration of 0.13% is used, energy 
for transition required is minimal in comparison to a greater concentration such as 0.16%w/v 
ADH in F2, energy required for enthalpy transitions is greater. Thermodynamic kinetics was 
seen at elevated temperatures whereby the thermal profiles exhibit the presence of a sharp 
exothermic peak. Exothermic peaks were seen ranging between temperatures (TC) of 210°C 
and 255°C. The sharp exothermic peaks represent a phase transition whereby an altered 
polymer microstructure occurs associated to the configuration of a polymeric crystalline 
structure. F15 exhibited the highest TC of 250.23°C in comparison to F13 depicting a TC of 
(f) 3246.58cm
-1 
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214.82°C. The crystalline temperature (TC) is a measure of the exothermic transition that 
occurs upon cooling from liquid to a crystalline state and is a measure of both time and 
temperature. Analysis of the TC revealed that increasing ADH concentration had a direct 
effect on the rate of phase transition and cleavage of bonds to render a crystalline state. A 
greater degree of molecular bonding and the formation of a crosslinked backbone requires 
greater enthalpy energy to exhibit the transition to a crystalline state as F15 encloses an 
ADH concentration of 0.16%w/v in comparison to F13 depicting a concentration of 0.1%
w/v. 
Intermediate amounts disclose a TC of 225.55°C and 244.38°C in F5 and F7 respectively. 
This was attributed to the intermediate crosslinker volume of 0.13%w/v and an intermediate 
polymeric concentration of 0.5%w/v. Furthermore Luo and co-workers (2000) report that 
uncrosslinked hydrogels of hyaluronic acid exhibits a sharp exothermic peak with a relatively 
small TC indicating that the gel exist primarily in an amorphous rather than a crystalline state. 
This observation indicates that bondage and the formation of an HA-ADH structure provides 
greater stability (Liu et al., 2007) and bondage of the two polymers clearly produces a novel 
material with properties that are distinguished from both the original components utilised (Luo 
et al., 2000). 
 
Figure 6.4: DSC analysis illustrating the thermal behaviours of the various formulations: (a): 
F7, (b): F5, (c): F15, (d): F13, (e): F2 
 
6.3.3. Determination of Tensile Strength and Young’s Modulus by Textural Profiles 
Dynamic mechanical analysis of wound dressings and devices are of utmost importance for 
biomedical applications. Young‘s Modulus can be described as a 1 dimensional tensile test in 
which the Young‘s modulus is the ratio of the normal stress (θ) to the normal strain (ε) 
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(Govindjee and Sackman, 1999). Figure 6.5 depicts the stress-strain curve of the lyophilized 
matrix whereby the fracture point and Young‘s modulus can be detected. From the data 
obtained it was seen that a very high yield stress and Young‘s modulus was presented by 
F13 and this can be attributed to the greater crosslinkage degree between HA and ADH. 
Interactions between HA and ADH resulted in the formation of a network structure that 
provided a polymeric backbone to the configuration as seen in the topographical images and 
described by the FTIR spectra, thus increasing its rigidity. However, as seen in Figure 6.5c 
the ultimate strength of F13 was considerably lower at 0.01θ μ (MPa). For topical 
applications such as wound dressings, a significant requirement is a device that entails 
physical characteristics such as toughness yet flexibility as described in greater detail in 
Chapter 4. F13 enclosed a Young‘s modulus of 2.14 E (MPa) thus disclosing a high Young‘s 
modulus which is not ideally suitable for wound dressings. A very high Young‘s modulus 
would provide a dressing structure that is tough, rigid and prone to brittleness. Thus, the 
ideal dressing should be of a lower Young‘s modulus providing greater elasticity and 
flexibility to the system. A greater ultimate strength was seen when a lower Young‘s modulus 
is produced such as that of F9 and F14 whereby an ultimate strength of 0.03 θμ (MPa) is 
depicted when a Young‘s modulus of 0.38 and 0.53 E (MPa) is noted. It was deduced that 
the mechanical properties of the structure is attributed to the concentration of HA. When the 
concentration of HA was increased to 0.07%w/v such as in F9 and F14, so too did the 
ultimate strength of the system. Furthermore it was also noted that the viscosity of the 
hydrogel solutions increased with an increase in the HA concentrations as will be discussed 
in more detail in the section to follow herein the chapter. F3 and F7 depicts a very low tensile 
strength and Young‘s modulus at 0.07E (MPa) and 0.05E (MPa) respectively thus no 
ultimate strength was noted and very low ultimate strains are deduced. It was noted that in 
these formulations obtained from the Box-Behnken design, lower concentrations of HA is 
used at 0.05%w/v and 0.03%
w/v respectively. Mechanical properties such as the tensile 
strength, elastic modulus and viscosity are important attributes when considering the 
bioactive release rates on response to a stimulus, as the rate of degradation and erosion are 
dependent upon the breakdown of the system.  
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Figure 6.5: Stress-Strain relationship profile of the lyophilized matrix where (a) is the linear 
portion of the slope from which Young‘s Modulus can be derived and b resembles the 
fracture point of the sample 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) 
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Figure 6.6: Vertical bar charts outlining the variations in mechanical properties amongst the 
various formulations where (a): Young‘s modulus (E; MPa); (b): yield stress (σy; MPa); (c): 
ultimate strength (σu; MPa); (d): ultimate strain (εu) and (e): Tensile Strength (N.mm2) 
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6.3.4. Water Content Determination of the Bioresponsive Transdermal Delivery System 
The swelling behaviour, kinetics, water content and erosion is linked to the polymeric 
hydrophilicity and nature, crosslinkage forces, as well as the diffusion process.  From the 
results obtained as is depicted it was seen that F13 had the lowest water content and thus 
can be directly attributed to the low crosslinker and polymeric concentration. As the 
concentration of adipic acid dihydrazide (ADH) was increased to 0.13% in F4 and 0.16% 
such as those in F2, F3 and F6 the water content percentage decreased making the 
lyophilized matrix less viable to swelling and erosion. These phenomena can be attributed to 
the degree of crosslinking which results in the formation of stiffer and dense three 
dimensional structures as elaborated in the FTIR spectra which prohibit or minimise the 
diffusion and transport of water molecules. Furthermore it was noted that slightly lower water 
content was generated when the polymeric concentrations were decreased thus making the 
device more susceptible to the diffusion of water molecules due to minimal intermolecular 
bonding and greater free space availability due to the less dense structure of the  molecules. 
Increasing the polymeric concentration influenced the total monomer concentration of the 
device which directly impacted on the swelling capacity and gel content of the system. 
Pourjavadi and co-workers (2007) state that sodium alginate is widely used in commercial 
products due to its biodegradable, renewable and natural nature; furthermore it has a high 
gelatinization capacity. Thus increasing the monomer concentration of alginate led to an 
increase in gel content and water absorbency. In addition, increasing the polymeric 
concentrations provides a gel formation of greater viscosity and a denser matrix which 
results in a more augmented chance of chain transfer to monomer molecules as well as the 
hindering of free radical movement and monomer molecules (Pourjavadi et al., 2007). The 
low water content values obtained were attributed to the lyophilization process undertaken, 
thus leaving more free space for exudates uptake upon application to a wound site. The 
degree of crosslinking also greatly impacts upon the swelling capacity of the system. As 
discussed at elevated crosslinker concentrations, the system would be less viable to water 
uptake thus the ideal system would have an intermediate amount of crosslinker thereby 
augmenting the system mechanical characteristics and ensuring absorption of exudates. 
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Figure 6.7: Percentage water content analysis of formulation 1-15 
 
6.3.5. Identification of Surface Topographical Structure and Morphology employing 
Scanning Electron Microscopy 
Scanning electron microscopic images were obtained in order to determine the morphologies 
and microstructure of the lyophilized matrix at different sample angles. Figure 6.8 reveals the 
various topographic morphologies of the various formulations. Samples were prepared by 
freeze drying to remove access water particles after been frozen at -80°C. According to 
Zhang and co-workers (2011), the process of freeze drying also greatly influences the 
morphology of the microscopic images obtained due to the formation of ice nuclei, thus in 
order to preserve better morphology, hydrogel samples were first frozen at -80°C. From the 
morphologies obtained, Figure 6.8 revealed the topographical structures on different scales. 
Crosslinking of HA to ADH resulted in the formation of porous sites where interconnecting 
pores can conspicuously be observed as illustrated in Figure 6.8 a, b and e. In addition, 
Figure 6.8c and f demonstrated a greater domain of fibrillogenesis with the presence of a 
slight fibril structure as demarcated. This was attributed to interactions occurring between 
water molecules and hydrophobic groups in the structure. From the figures illustrated it was 
noted that the pore size decreased significantly with an increase in ADH. Introduction of ADH 
causes the addition of an amino group as discussed in detail in Section 6.3.1 which leads to 
the formation of a polymeric backbone in the structure improving the mechanical properties 
by the introduction of molecular bonding. Figure 6.8c clearly demarcates the impact of 
crosslinking on the surface structure. The various reactions and interactions results in a 
surface morphology of a more coarse character which was attributed to the formation of 
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clusters of molecular entanglements and ionically associated domains, a characteristic trait 
by the presence of alginate. Figure 6.8e revealed a highly porous structure with pores 
ranging in the domain of approximately 2.5μm with absence of a backbone structure. The 
figure represents F9 whereby a very low ADH concentration is used with a high HA polymeric 
concentration. Significantly low crosslinker concentration leads to minimal intermolecular 
bondage formation thus a greater porous site in contrast to F15 or F2 represented by Figure 
6.8a and c respectively. A higher concentration of ADH was employed (0.16%w/v) thus the 
structure is more rigid with a perceived backbone structure as can be seen. The surface 
topography also portrayed minimal pores with a pore size ranging at 0.5μm to 1.5μm. At very 
low concentrations of ADH and a higher concentration of alginate, the surface matrix also 
appeared to be more brittle with irregular pore sites as seen in Figure 6.8g representing F12 
illustrated in the figure whereby 0.1%w/v of ADH is used and 4.5%
w/v alginate is employed. 
Lyophilization and freeze drying lead to the formation of layers in the matrix as clearly 
demarcated in Figure 6.8d, and with the presence of interconnecting pores, making it 
suitable and beneficial for cell survival in a 3D environment, advantageous for waste and 
nutrient transport (Su et al., 2010). The surface topography of the various lyophilized 
samples provided a representation of the degradation of the HA-ADH models and the 
approximate behaviour in terms of degradation and bio erodible behaviour in-vivo and on 
exposure to an inflammatory stimulus.  
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Figure 6.8: Topographical imagery by scanning electron microscopy of (a): F15, (b): F3, (c): 
F2, (d): F8, (e): F9, (f): F11, (g): F12 
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6.3.6. Measurement of Transient Rheological Characteristics of the Bioresponsive 
transdermal delivery system 
To determine the flow behaviour and mechanical characteristics of the various crosslinked 
hydrogel formulations, rheological analysis was carried out in accordance with the procedure 
as described above in this chapter. Furthermore, this analysis was carried out as a 
complementary technique in order to assess the crosslinking characteristics of the 
crosslinked HA hydrogel. Table 6.4 provides the viscosity measurements obtained from the 
various formulations attained by means of the Box-Behnken design. Viscosity provides a 
measurement of the flow characteristics of the hydrogel when an applied stress is applied. 
The formation of molecular entanglements and ionically associated domains as seen in the 
topographical imagery greatly influences the visco behaviour of the hydrogel upon a shear 
stress. Figure 6.9 provides an illustration of the characteristics pertaining to viscosity, flow 
and deformation properties of the hydrogel matter. From the figure it was seen that dilatant 
flow is exhibited initially due to the high concentrations of small deflocculated particles. Under 
zero shear conditions, the hydrogel behaves in a manner whereby particles are closely 
packed and interparticulate voids are minimum. Consequently as the shear rate is increased 
over a longer period of time, the slope of the curve gradually decreases as depicted in Figure 
6.9 and the HA hydrogel begins to exhibit Newtonian behaviour whereby thixotrophy is 
observed. Increase in shear rate resulted in a decrease in the apparent viscosity due to 
energy exhibited disrupting the bonds (Schnaare et al., 2005) thus dilatant flow is observed 
at low to moderate shear rates and pseudoplastic flow at higher shear rates (Schnaare et al., 
2005). Furthermore, Table 6.4 illustrates the impact of varying polymeric concentration and 
crosslinker on the rate of viscosity. From the table it was seen that the viscosity is directly 
attributed to the polymeric concentrations and crosslinker, thus the degree of crosslinking. It 
was further seen that at low HA concentrations the viscosity was minimal. F13 revealed a 
viscosity of 212.319MPa when HA revealed a low concentration of 0.3%w/v and a low ADH 
concentration of 0.1%w/v. As the concentration of HA increased to 0.7%
w/v such as that in F9, 
a viscosity of 1888.028MPa is seen. In addition, this pattern was observed with all the 
formulations, as the degree of crosslinking was increased due to higher concentrations the 
viscosity values depicted were greater. Lower values were seen at lower concentrations. The 
yield stress can be defined as the resistance of a material to flow, i.e.: the minimal amount of 
shear stress required to initiate a flow. From the results obtained in Table 6.4 it was seen that 
the yield stress was directly proportional and dependent upon the viscosity. As the viscosity 
increased so too did the yield stress. Furthermore, it was detected that the ―apparent‖ yield 
stress is designated as a single point and the critical stress range is very small. The yield 
stress of the hydrogels could also be directly related to the Newtonian flow properties of the 
gels. As the shear stress applied increased so too did the yield stress as the 3D structure 
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incorporating inter and intramolecular forces break down as a consequence of the energy 
induced. 
 
 
Figure 6.9: Depiction of flow behaviour of a crosslinked HA hydrogel upon an applied shear 
stress over time 
 
Table 6.4: Viscosity and Yield Stress values of the various formulations 
Formulation Viscosity (MPa) Yield Stress (Pa) 
1 1308.091 38.57 
2 1819.196 38.54 
3 1294.021 38.61 
4 864.686 38.58 
5 1270.786 38.57 
6 963.528 38.43 
7 850.622 22.73 
8 1265.171 38.57 
9 1888.028 38.6 
10 1105.243 29.58 
11 1532.955 32.21 
12 1192.109 38.56 
13 212.319 32.21 
14 953.712 38.59 
15 1151.313 29.61 
 
6.3.7. Evaluation of the Stimuli Responsiveness of the Bioresponsive Topical Delivery 
System to an Inflammatory Stimulus through In Vitro Release Studies  
On exposure to pathological conditions (i.e.: hydroxyl radicals created by Fenton‘s Reagent), 
bioactive release profiles were generated for the experimentally derived formulations 
whereby the bioresponsive potential was evaluated. Figure 6.10 reveals the bioactive release 
profiles of the various experimentally derived formulations on exposure to the inflammatory 
stimulus. A general pattern was seen whereby the degree of release was dependent upon 
the concentration of HA and thus the degree of crosslinking. This analysis correlates to the 
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results obtained by the mechanical strength evaluation as well as the rheological 
examination whereby similar traits are seen. Both viscosity and physicomechanical 
characteristics increased with HA concentration. As can be seen by the drug release profiles, 
a greater release is seen at lower concentrations, thus increasing polymeric HA 
concentrations lead to prolonged bioactive release. The bioactive release mechanism under 
the influence of a stimulus operates by the degradation of HA under the influence of hydroxyl 
radicals. Stimuli dependent degradation occurs upon the rapid autooxidation of Fe2+ to Fe3+. 
A release of hydroxyl radicals caused a reaction to occur with HA whereby glycosidic 
cleavage occurs. This involves the abstraction of hydrogen on the carbon adjoining the 
carboxyl group in the D-glucoronic acid unit. Thus, the degree of degradation of HA depends 
upon the generation of hydroxyl radicals in the presence of oxidising agent‘s therefore 
promoting pulse or responsive release of the bioactive by degradation and erosion (Yui et al., 
1993). From the profiles obtained, further analysis as depicted in Figure 6.10a revealed that 
a greater release profile is seen with F3 then F1 and F2 with the greatest cumulative release 
rate been at 4 hours at 0.15mg in F3 and 0.062mg and 0.0295mg in F1 and F2 respectively. 
This was attributed to the lower concentration of HA present in F3 leading to a lower 
crosslinking degree, thus interactions leading to degradation by hydroxyl radicals are of a 
greater extent. Furthermore, it can be deduced that the release profile of F3 been greater 
then F1 is greatly influenced by the presence and polymeric concentration of alginate. As 
discussed in Section 6.3.4 alginate has a high gelatinization capacity thus a great tendency 
to absorb fluid and cause swelling and erosion of the polymer matrix thus leading to a greater 
bioactive release profile as in F3 where a polymeric concentration of 4.5%w/v is utilised in 
contrast to the 2.75%w/v concentration used in F1. Additionally a greater release profile is 
also seen in F12 whereby a release rate at 24 hours is seen at 1.95mg in contrast to F10 and 
F11 depicting release rates at 0.098 and 0.086mg respectively where a greater concentration 
of alginate (4.5%w/v) is used in F12 then F10 (0.1%
w/v) and F11 (0.13%
w/v). A similar 
prototype is distinguished with F14 when a higher concentration of alginate is used.  
 
Table 6.5 lists the various MDT release rates of the experimentally derived formulations. F14 
revealed a higher MDT release profile at 42.39 whereas a lower rate is surveyed in F12 and 
F13 at 33.21 and 35.76 respectively. The use of a lyophilized HA matrix serves as an auto-
feedback drug delivery system in response to inflammation. Lui and co-workers (1992) state 
that rapid in vitro degradation of an HA matrix occurs upon the incorporation of FeSO4 to the 
system, thus causing rapid as conferred above. Hydroxyl radicals produced have a short 
lifespan thus disappear rapidly therefore the matrix can be tailored to the biological needs 
based on the unique characteristics of the HA structure. Experimentation and analysis of the 
various derived formulation revealed that the use of a crosslinker ADH at intermediate 
amounts (0.13%w/v) modified the HA structure in an approach to delay the release of 
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bioactive and the degradation of the HA matrix on exposure to the hydroxyl radicals. F14 
showed a high concentration of HA crosslinked by ADH thus protracting degradation by 
hydroxyl radicals. As depicted by the FTIR spectra a shift in the wavelength is also seen in 
F14 to the left thus displaying greater bond intensity and conjugation lowering the rate of 
degradation. MDT results obtained from Table 6.5 depicted lower values for F12 and F13, 
thus greater hydroxyl degradation of the matrix resulting in a more rapid bioactive release 
rate. This can be attributed to a very low ADH concentration of 0.1%w/v been used forming 
weaker and less covalent bonding thus making the system more prone to degradation. 
Furthermore low polymeric concentrations of HA were also used at 0.5%w/v for F12 and 
0.3%w/v for F13 respectively. The value obtained further illustrates the effect of HA on 
bioactive release as a greater release is seen in F13 then F12 as well. Thus, it can be 
deduced that release rates is dependent upon the concentrations of all polymers and 
crosslinker as well as the rate of degradation by hydroxyl radicals upon exposure. 
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Figure 6.10: Bioactive release profiles based on an inflammatory stimulus of (a): F1-3, (b): 
F4-6, (c): F7-9, (d): F10-12, (e): F13-15 
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Table 6.5: MDT bioactive release profiles of formulation 1-15 
Formulation 
Stimuli Responsive 
Bioactive Release (MDT) 
F1 36.54 
F2 34.01 
F3 35.91 
F4 52.09 
F5 36.98 
F6 34.43 
F7 35.72 
F8 36.83 
F9 41.67 
F10 37.95 
F11 37.02 
F12 33.21 
F13 35.76 
F14 42.39 
F15 41.42 
 
6.4. Concluding Remarks 
This chapter described the formation of the bioresponsive matrix by utilisation of hyaluronic 
acid and alginate lyophilized polymer blends. The results demonstrated using three 
variables, namely the concentration of HA, alginate and ADH in order to derive a Box-
Behnken design template containing superior combinations whereby 15 formulations were 
obtained. Various characteristic analysis was conducted in terms of the chemical, 
mechanical and bioactive release properties whereby it was clearly noted that the relative 
ratios as well as polymeric concentrations significantly affect these properties, with the 
greatest been the HA concentration.  
 
The chapter to follow will describe the derivation of a single optimal formulation based on the 
results obtained in order to formulate a device with enhanced characteristics. Further 
characterisation in terms of the physicochemical and physicomechanical properties will be 
evaluated and described in the chapter to follow as a step to determine the efficacy of the 
design and development of the BTDS for eventual in vivo studies. 
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CHAPTER 7 
CONCEPTUALIZATION AND STATISTICAL OPTIMIZATION OF THE SMART 
INFLAMMATORY RESPONSIVE MATRIX AS A COMPONENT OF THE 
PROTOTYPE DEVICE 
 
7.1.1. Introduction  
The main outcome of this study was to develop and design a novel prototype as an 
inflammation bioresponsive device for superior wound healing incorporating a nanofibrous 
mat. This Chapter will provide insight to the smart device as a complete prototype providing 
prospection and facilitating advanced marketing potential. Further, elaboration is provided in 
terms of interactions of the BTDS with the wound environment providing pertinent statistics to 
the bioresponsive capabilities of the device. The chapter aims at providing a detailed insight 
into the stimuli responsive function and optimization of the BTDS by demonstration of the 
pertinent rheological characteristics considerably influencing the matrix formation, 
determination of the overall BTDS architecture by carrying out the various test in terms of 
nano mapping, tensile strength, FTIR spectra, topographical imaging by SEM, alterations in 
system properties by thermal influences as well as modification impacts by nanofibre 
incorporation. In addition, this chapter aims at justifying the bioresponsive nature of the 
lyophilized component of the BTDS by conducting in detail in vitro studies and 
pharmacokinetic analysis of the optimized BTDS. The versatility and latency will also be 
evaluated for conduction of in vivo studies.  
 
As discussed in greater detail within Chapter 2 of this thesis, wound healing is a complex 
biochemical process entailing many stages that need to be adequately managed for effective 
healing, thus many factors need to be taken into account when designing a wound healing 
device. To date, very few to no single system has been implemented that provides all the 
necessary requirements for optimal healing processes. Thus, this research development 
aims at introducing a single prototype device consisting of momentous components 
introducing foremost characteristics to the wound healing process. The featured design 
focuses on innovative layered technology whereby the unique multi layered design provides 
elevated breathability and absorbency thus reducing the risk of bacterial invasion and 
maceration. Figure 7.1 depicts an illustrated schematic revealing the mechanism of the 
prototype. The BTDS prototype device will comprise of: 
 
 A Backing Layer: The incorporation of a backing layer secures the device in place, 
furthermore the mucoadhesive and adherent properties presents self adherence to 
the wound site thus facilitating patient care and convenience with enhanced 
management of everyday daily challenges of dressing change. Due to its 
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mucoadherent properties, the device will remain in place and can be easily removed 
thus making it friendly for use on fragile skin. A significant feature of its adherent 
properties is its ability to be lifted and repositioned without the loss of its adherent 
quality, furthermore disruption of healing tissue will be minimised as it will not adhere 
to the wound bed. Incorporation of a backing layer averts strikethrough and prevents 
invasion and provides protection against external bacteria and viruses. 
 
 Inflammatory responsive lyophilized matrix: Chapter 6 of this thesis provided a 
greater insight to the bioresponsive function of the lyophilized matrix as a component 
of the prototype device. To provide a brief rationalization, the lyophilized matrix will 
serve as a two way communication between the device and the biological tissue. 
Initiation of the wound healing process will occur in a stimuli responsive nature 
whereby a biological interaction will occur upon exposure to inflammation releasing 
the various bioactives.  
 
 Nanofibrous mat: Chapters 4 and 5 of this thesis provided a detailed insight to the 
many advantages of fabrication of a nanofibrous system. Incorporation of the 
nanofibrous mat as a component of the prototype device will supply the BTDS with a 
‗pseudoskin‘ feature whereby the extracellular matrix of the native skin is mimicked 
providing enhanced wound healing potential. Many of the ideal wound healing 
characteristics is also incorporated into this component such as adequate gaseous 
exchange, debridgement of wound site, moist wound environment, absorption of 
excess exudates, and minimal frequency of dressing change, infection protection and 
bacterial invasion protection. 
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Figure 7.1: Mechanism of action of the prototype device 
 
7.1.2. Formation of the Polyelectrolyte Complex  
A polyelectrolyte complex (PEC) can be defined as an electrostatic interaction between 
oppositely charged polyions (Nam and Lee, 1997). A PEC is formed within a solution when 
oppositely charged electrolytes are mixed and the resultant interaction leads to the formation 
of strong yet reversible electrostatic links altering the original assembly of links in the 
structure. These interactions lead to non-permanent structures via the formation of a 
polyelectrolyte complex network without the need to form covalent bonds. Formation of PECs 
results in structures that are more sensitive to changes in environmental conditions, show 
greater biocompatibility and are more well tolerated (Hamman. 2010). Anionic natural 
polymers such as both alginate and hyaluronic acid can form polyelectrolyte complexes with 
chitosan. PECs between chitosan and alginate occur at the guluronic and manuronic acid 
groups containing negatively charged carboxylic acids, thus interacting electrostatically with 
the positively charged amino groups of chitosan. PECs formed between these natural 
polymers still possess biodegradability and biocompatibility but are notably stronger 
mechanically (Hein et al., 2008). Composition of the complete prototype device can also lead 
to the formation of a polyelectrolyte complex between chitosan and hyaluronic acid. 
Hyaluronic acid is a natural constituent of the native extracellular matrix of the skin and the 
only nonsulphated glycosaminoglycan found in the ECM. It is a linear anionic polysaccharide 
that forms electrolyte complexes with chitosan making it less prone to enzymatic hydrolysis 
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thus improving its stability and mechanical characteristics (Denuziere et al., 1998; Hamman. 
2010). 
 
7.1.3. The Employment of Mucoadhesion to Promote Effective, Targeted and 
Convenient Topical Bioactive Delivery 
Within the field of pharmaceutical sciences, a larger interest has been focused on the region 
of mucoadhesion and mucoadhesive materials as well as polymers. Distinctiveness of 
bioadhesion can be explained as a linkage between two materials with at least one been 
biological in nature for an extended period of time by an interfacial force. When one of these 
materials conforming to the adhesive attachment is a mucus membrane or mucus, it can be 
termed as mucoadhesion (Gu et al., 1988). A mucus membrane consists of biological tissue 
in which the surface is made moist by the presence of a mucus layer. Specialised cells 
known as goblet cells amongst others are present within the tissue that secretes mucus onto 
the epithelial surface as a gel layer adherent. Glycoproteins present within the mucin are the 
major components forming the characteristic adhesive, cohesive and gel-like properties 
(Smart et al., 2005). To investigate the process of mucoadhesion there are six general 
adhesive theories that have been adapted. These include (Smart et al., 2005): 
 
 The mechanical theory: Interlocking of a liquid adhesive on a rough surface thereby 
allowing adhesion. 
 The electronic theory: Formation of an adhesive bond due to attractive forces present 
forming an electrical double bond when electronic transfer occurs at a surface 
interface due to divergence in the electronic structure. 
 The diffusion theory: Interdiffusion of polymer chains across an adhesive interface 
that is driven by a concentration gradient. 
 The wetting theory: Involves interfacial and surface energies when applied to liquid 
systems. As a prerequisite for adhesion, the liquid is required to spread 
spontaneously onto a surface. 
 The fracture theory: Adhesion in this instance is related to the detachment after 
adhesion of the two involved surfaces whereby failure to adhere usually occurs at the 
weakest point which is considered to be a cohesive failure within one of the adhering 
surfaces. 
 
For incorporation of mucoadhesive abilities within a pharmaceutical dosage form, smart 
mucoadhesive polymers can be utilised. Mucoadhesion via the use of polymers are said to 
occur upon the formation of bonds such as van der waals forces, hydrogen bonds, ionic 
interactions as well as physical interpenetration effects of mucus and polymer chains. 
Polymer chain flexibility provides a greater understanding of the mucoadhesive properties of 
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a polymer. A stronger adhesive bond will be accomplished by more flexible chains thus 
enhancing the interpenetrating effect of polymer chains and mucus to a satisfactory depth. 
Thus, in addition the use of crosslinkers and the formation of covalent strong bonds will 
decrease the flexibility of the polymer chain thus rendering the material less adhesive. 
Therefore for improved mucoadhesive characteristics, the use of low molecular weight, 
uncrosslinked polymers provide ideal properties for mucoadhesion (Leitner et al., 2003). 
Polymers comprising of a greater charge density serve as superior mucoadhesive agents. 
Furthermore, polyanion polymers serve as greater bioadhesives then non-ionic and 
polycationic polymers. Alginate serves as a prospective mucoadhesive agent owing to its 
anionic polymeric state at the carboxyl end groups. George and Abraham. (2006) have 
reported that studies have shown that alginate serves as a greater mediator for 
mucoadhesion then other natural polymers which include chitosan, poly (lactic acid), 
polystyrene and carboxymethyl cellulose. The use of alginate improves effectiveness as an 
adhesive agent and bioavailability. Incorporation of poly acrylamide (PAA) further enhances 
mucoadhesive properties due to its high charge density and polyanionic nature (Park and 
Robinson. 1987).  
 
7.1.4. Optimization of the Lyophilized Matrix in terms of its Inflammatory Responsive 
Nature of the BTDS 
The main aim of this chapter is the development of an optimum lyophilized matrix for 
incorporation within the BTDS, therefore the requisite goals of a pharmaceutical scientist is 
the expansion and design of an immaculate drug delivery system covering the indispensable 
requirements, thus casing many objectives. In order to obtain the optimum formulary design, 
many steps and objectives were put in place which include the attainment of a Box-Behnken 
design template whereby the most suitable formulations, a design of experiments (DoE) was 
statistically derived where upon in detail characterisation is undertaken as elementary 
discussed in Chapter 6 of this thesis. Subsequent to this for achievement of optimization, a 
response surface methodology (RPM) is needed to be implicated as will be discussed in this 
chapter in order to generate mathematical models that will adequately predict and describe 
the bioresponsive release behaviour, mechanical properties and rheological characteristics 
of the derived formulations leading to an optimal formulation.  
 
This chapter will focus on the optimization of the inflammatory responsive component of the 
BTDS following the generation of the RPM, under conditions simulating both inflammation at 
an inflicted wound site and normality. Consequently overall bioactive release kinetics will be 
undertaken and the assurance of the rationality and applicability of the system will be carried 
out by application of the various characteristic analysis. 
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7.2. Materials and Methods 
 
7.2.1. Materials 
Hyaluronic acid (Sodium salt from streptococcus equi, Mw=8000-15000 g/mol), adipic acid 
dihydrazide (ADH) Mw=174.20 g/mol ≥98% tritration purchased from Sigma Aldrich Chemie 
GmbH, Steinheim, Germany. Alginate (TICA-algin® 400 Powder, medium viscosity) was 
purchased from Texture Innovation Center® (White Marsh, MD, USA) and Poly (acrylic acid) 
(Carbopol 974P®) (Noveon Inc., Cleveland, USA). Glycerol and Tween 80 obtained from 
Associated Chemical Enterprises Pty Ltd. (South Africa), Silicon (BDH, VWR International 
Ltd, London, UK), and Paraffin Liquid (Saarchem Wadeville, Gauteng, South Africa). All other 
reagents used were of analytical grade. 
 
7.2.2. Synthesis and Formation of a Backing Layer to serve as a Component of the 
Prototype Device 
The film casting method was employed whereby a ratio of 3:1 was used for film formation. 
0.17g of alginate was dissolved in solvent, deionised water with 0.5g polyacrylic acid. A 
hydrogel was subsequently formulated by sequential blending of the polymer solutions, 
followed by the addition of the plasticizer glycerol at a concentration of 2:1 (polymer: 
plasticizer). Thereafter 1 drop of antifoaming agent silicon was added to the solution. 
Solution blends were then allowed to stir on a magnetic stirrer until a homogenous solution 
was formed. 10mL of each blend was poured into a mould composed of parafilm, rectangular 
in shape (710mm x 260mm) lubricated with liquid paraffin and cast in film form by solvent 
evaporation at room temperature with the use of a fumehood under the influence of 
continuous airflow. After being dried, membrane films were removed from the fumehood and 
parafilmed, this was utilised as a backing layer for the BTDS 
 
7.2.3. Formulation of the Crosslinked Bioresponsive Lyophilized Matrix incorporating 
the Entrapped Nanofibres 
An optimized formulation was prepared from the statistically derived superlative 
concentrations as indicated in Table 7.1. A hyaluronic acid hydrogel was formulated by 
solution polymerization using deionised water as the solvent. Crosslinking was then 
undertaken by preparing a hyaluronic acid-adipic dihydrazide complex as a hydrogel. The 
HA-ADH solution was then allowed to stir continuously under ambient room temperature 
conditions using a magnetic stirrer. Sodium alginate in concentrations indicated in Table 7.1 
dispersed within deionised water was then added to the HA-ADH solution to form a complex 
hydrogel whereby wound healing nanofibrous mats were then suspended in the gel and 
immediately frozen. The above system was then lyophilized to form a stimuli responsive 
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matrix reservoir that can be adjoined to the backing layer as described in Section 7.2.2 in 
order to formulate the BTDS.  
 
Table 7.1: Statistically derived superlative concentrations of the bioresponsive and non-
bioresponsive component 
 Alginate %w/v Hyaluronic Acid 
%w/v 
Adipic Acid 
Dihydrazide %w/v 
Bioresponsive 
lyophilized matrix 
2.75 0.5 0.13 
Nonbioresponsive 
lyophilized matrix 
2.75 - - 
 
7.2.4. Optimization of the Formulary Components  
A statistically derived optimized formulation was derived by mathematical modelling and 
simulations using the response surface methodology (RSM) from the statistically derived 
design of experiments (DoE) of the Box-Behnken Design as stipulated in Chapter 6. The 
response optimization procedure (MINITAB®, V15, Minitab, USA) was used to obtain the 
adjusted levels of biopolymer and bioactive to be incorporated within the lyophilized 
component of the BTDS. Cumulative bioactive release, Young‘s Modulus in terms of the 
tensile and mechanical characteristics as well as the rheological characteristics for 
simultaneous constrained optimization were identified as the most pertinent responses for 
successful operation of the bioresponsive topical wound healing delivery device. Undertaking 
simulations relating to these responses ensures the successful establishment of a nano 
incorporated system with constant stimulated bioactive release, stability and mechanical 
flexibility for topical application. An optimized level of the independent variables, predicted 
response (y), goal of the response, factor settings and desirable scores was established for 
optimization. The optimized responsive lyophilized component of the BTDS was then tested 
for various characteristics in comparison to a normality whereby the major responsive 
polymeric component (hyaluronic acid) was omitted as illustrated in Table 7.1. 
 
7.2.5. Evaluation of the In Vitro Bioresponsive Bioactive Release Behaviour by 
employing the Fenton’s Reaction 
In Vitro degradation of the lyophilized crosslinked matrix was analysed by selecting 
inflammation as a stimulus whereby chemical inflammatory mediators (production of hydroxyl 
radicals) by the generation of the Fenton‘s reaction was produced: 
 
Fe2+ + H2O2 → Fe
3+ + OH∙ + OH-                                                                     [Equation 6.3] 
 
Samples prepared were immersed in saline phosphate buffer at a pH of 7.4 and in the 
appropriate in vitro stimulus at a pH of 5.5 to correlate with the pH of inflammation. Samples 
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were placed in dialysis tubing with a molecular weight of 12 000 in a closed vial and placed in 
an oscillating laboratory incubator (Labcon® FSIE-SPO 8-35, California, USA), set to 25 rpm 
(du Toit et al., 2008). At predetermined periods samples were removed and subjected to 
analysis for bioactive release using a nanophotometer (Implen nanophotometer GmbH, 
Munich,) at a wavelength of 425nm to determine maximum absorption. A comparison to this 
was undertaken whereby samples were prepared omitting the inflammatory responsive 
component as well as the crosslinker. Samples were then placed under the equivalent 
environmental conditions and the bioactive release profiles were then taken. 
 
7.2.6. Characterisation in terms of the Hydration Dynamics Behaviour 
In order to determine the swelling capacity of the samples, a Karl Fischer Titrator (Mettler 
Toledo V30 Volumetric KF Titrator, Mettler Toledo Instruments Inc., Greifensee, Switzerland) 
was used for analysis whereby water is quantified using electrical conductivity and as a 
standard a methanol-water solution is utilised. The unreacted Karl Fisher reagent left 
determines the endpoint analysis whereby the conductivity difference is indicated. Samples 
were immersed and allowed to run until the endpoint was reached and validated. Samples 
were weighed prior and after immersion and the % swelling capacity was then calculated 
using equation 6.2 as follows: 
 
𝐸𝑆𝑅 =
(𝑊1−𝑊0)
𝑊0
                                                                                                [Equation 6.2] 
Where W1 is the weight of samples after immersion and W0 is the weight of samples in the 
dried state. 
 
7.2.7. Ex Vivo determination of Mucoadhesive Properties through Textural Profiling 
A TA-XT plus texture analyzer was utilised to conduct mucoadhesive studies. Full thickness 
excised skin tissue from Sprague Dawley rat models were sectioned at 2mm thickness and 
attached to the lower end of a probe. The mucoadhesion studies was carried out at 37°C 
whereby the attached excised skin tissue was lowered onto the surface of the BTDS at a 
constant speed of 0.1mm.s-1 and a contact force of 0.5N. The probe was then vertically 
removed upward at the same constant speed after a contact period of 120s. A plot of force 
against distance was procured whereby the area under the curve was calculated to 
determine the work of mucoadhesion per square centimetre (mJ.cm2) (Cevher et al., 2008) 
 
𝑊𝑜𝑟𝑘 𝑜𝑓 𝑚𝑢𝑐𝑜𝑎𝑑𝑕𝑒𝑠𝑖𝑜𝑛 (𝑚𝐽. 𝑐𝑚−2) =
𝐴𝑈𝐶
𝜋𝑟2
                                                      [Equation 7.1] 
Whereby πr2: Surface area of the skin tissue which is in contact with the gel formulations. 
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7.2.8. Characterisation in terms of Chemical and Vibrational Transitions 
A PerkinElmer® Spectrum 100 Series FT-IR Spectrometer fitted with a universal ATR 
Polarization Accessory (PerkinElmer Ltd., Beaconsfield, UK) was utilised in order to 
determine the molecular vibrational transitions and chemical compositions of the various 
formulations as well as the effect of crosslinker incorporation on the optimized lyophilized 
matrix component of the BTDS. Spectra over the range 4000-625cm-1, with a resolution of 
4cm-1 and 4 accumulations was utilised as FTIR parameters. 
 
7.2.9. Evaluation of the Thermodynamic Behaviour of the Matrix 
To assess the thermal behaviour of the constituents, an advanced DSC (TMDSC/ ADSC) 
(Mettler Toledo DSC-1 STARe System, Schwerzenback, ZH, Switzerland) was utilised. This 
was carried out to ascertain temperature phase change in terms of chemical reaction 
temperatures, glass transition (Tg) and melting points of the lyophilized matrix of the BTDS.  
Analysis was conducted in terms of the total heat flow (ΔH) across the samples, whereby 
variation in magnitude of the peaks were analysed in terms of the magnitude of the 
crystallisation temperature (Tc), melting temperature (Tm) and glass transition (Tg). The 
procedure was carried out whereby samples (±10mg) were accurately weighed into standard 
40μL aluminium open pans and hermetically sealed in perforated 40μL aluminium pans. 
Measurements were employed at a heating rate of 10°C/min from -10°C to 300°C under 
nitrogen atmosphere.  
 
7.2.10. Surface Structure and Morphological Analysis 
To determine the effect of crosslinking and incorporation of the responsive polymer (HA), 
surface comparisons were made by attainment of the topographical imagery using scanning 
electron microscopy (SEM) (Phenom™, FEI Company, and Hillsboro, Oregon, USA). In 
order to maintain matrix integrity the lyophilized samples were first blot-dried and submerged 
in liquid nitrogen. Samples were evaluated for bulk characteristics such as pores and pore 
size, texture and roughness. 
 
7.2.11. Determination of Young’s Modulus by Nanotensile Mapping 
A Nano Tensile Analyser (nanoTensile®5000 Hysitron Inc. Nanomechanical Test Instrument, 
Minneapolis, MN) was employed to determine the Tensile Strength and Young‘s Modulus of 
the lyophilized matrix. The mechanical characteristics were employed to measure the 
durability of the BTDS system at a nano sensitive level. Samples were first measured using a 
digital calliper, pretested and mounted until a breaking force is established at a velocity of 
5μms-1. Stress-Strain curves were procured to further determine the ultimate strength, strain 
and toughness of the BTDS system. 
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7.2.12. Physicomechanical Characterisation by Textural Profiling 
To determine the tensile strength and force required to cause a defect or break in the 
system, textural analysis was employed on the BTDS system. This was done by using a 
texture analyser (TA.XT.plus texture analyser, Stable Microsystems®, Surrey, UK) fitted with 
a 50kg load cell that was utilised to determine physicomechanical properties of the system 
and in particular tensile strength from the generated force-distance profiles computed from 
the peak tensile force required and using Equation 6.1 given below. The parameters marked 
for textural analysis are presented in Table 7.2. Tensile strength was measured using the 
Young‘s Modulus equation as follows: 
𝐸 =
𝑇𝑒𝑛𝑠𝑖 𝑙𝑒  𝑠𝑡𝑟𝑒𝑠𝑠
𝑇𝑒𝑛𝑠𝑖𝑙𝑒  𝑠𝑡𝑟𝑎𝑖𝑛
=
𝛿
𝜀
=
𝐹𝐿𝑜
𝐴𝑜∆𝐿
                                                                                   [Equation 6.1]                                           
Where: E is the Young‘s Modulus (Modulus of elasticity); F is the force applied to the object; 
A0 is the original cross-sectional area (πr
2) through which the force is applied; ΔL is the 
amount by which the length of the object changes; L0 is the original length of the object. 
 
Table 7.2: Parameters employed for Texture Analysis 
 
 
 
 
 
 
7.2.13. Evaluation of the Transient Rheological Properties 
The rheological analysis studies of the BTDS were carried out using a Thermo Scientific 
HAAKE MARS Rheometer (Thermo Fischer Scientific, Karlsuhe, Germany). The viscosity of 
the gel solutions were measured at a constant temperature of 37°C. Samples were placed on 
a sample stage whereby a c35/1° titanium rotor will be immersed in the polymer solution 
blends at a shear rate of 100s-1 and a time interval of 360s. Stress-Strain rheological 
parameters were obtained for quantified samples and an evaluation was made with regards 
to viscosity, yield stress, stress and frequency sweep. These parameters play a vital role in 
shaping a lyophilized matrix that is able to suspend nanofibrous material. 
 
 
 
 
 
Parameters                   Settings 
Test mode                    Tension 
Pre-Test speed              0.50mm/sec 
Test speed                    0.50mm/sec 
Post test speed             5.0mm/sec 
Trigger type                   Auto 
Trigger force                  5kg 
Contact time                  5sec 
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7.3. Results and Discussion 
 
7.3.1. Optimization of the Lyophilized Component of the BTDS 
The pragmatic design of the bioresponsive topical delivery system incurs superlative 
optimization in order to ensure safe, reproductive and effective drug delivery systems 
exhibiting therapeutic requirements and responses both in vitro and in vivo. In order to 
ensure this (i.e.: attainment of an optimized formulary component) a response optimization 
procedure (MINITAB®, V15, Minitab, USA) was used to attain the adjusted levels of 
biopolymer and crosslinker to be incorporated within the lyophilized component. Data used 
for the optimization of the experimental design formulations related to Young‘s Modulus and 
tensile analysis to determine the strength and flexibility of the system, bioactive release rate 
on exposure to a stimulus at a pH of 5.5 and the rheological viscosity in the hydrogel form of 
the various formulations.  
 
The residual plots for MDT indicating stimuli responsive bioactive release of curcumin, 
Young‘s Modulus and viscosity were employed for analysis of the model. This was 
undertaken in order to determine the relationship between the response variables and the 
predictor variables to measure the suitability of the multiple regression models through 
residual analysis. Figure 7.2 depicts the residual plots of the MDT, Young‘s Modulus and 
viscosity whereby it was noted, upon analysis of the normal plots of the residual reveals 
normal distribution as all plots are in close proximity to the straight line. Furthermore, 
viscosity normal residual plots depict point distribution in clusters along the straight line 
indicating strong linear relationships. The residual scatter plot where the residual was plotted 
against the fitted values or model predictions emit points around the 0 residual and generally 
show random scatter. Thus these demarcations point out that no trends are indicated thus 
underlying assumptions relating to the multiple regression analysis were not grossly violated. 
Furthermore variance within the residuals was noted indicating non constancy due to the 
presence of some fanning and outliners (du Toit. 2013). Normal distribution of data is 
represented by a bell shaped histogram (Hazel. 2011). The residual histograms for stimuli 
responsive bioactive release and viscosity reveal slight irregularities which could be due to a 
random area on the data set. The histogram residual of Young‘s Modulus revealed symmetry 
thus depicting a relatively uniform distribution. Plots depicting the residual versus observation 
data indicate the performance of the model. A non random error is indicated by points that 
remain at constant magnitude whereas fluctuation on either side of the centre line displays 
non correlated errors with one another (Hazel. 2011).A full ANOVA was carried out as 
depicted in Table 7.3. 
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Table 7.3: ANOVA analysis of the measured responses 
Response Variable/ 
Term 
P-Value 
Stimuli Responsive 
Bioactive Release 
(MDT) 
Young‘s Modulus Viscosity 
Constant 0.952 0.048 0.952 
Alginate 0.772 0.175 0.772 
Hyaluronic Acid 0.757 0.119 0.757 
Adipic Acid 
Dihydrazide 
0.955 0.067 0.955 
Alginate*Alginate 0.784 0.320 0.784 
Hyaluronic 
Acid*Hyaluronic Acid 
0.494 0.981 0.494 
Adipic Acid 
Dihydrazide* Adipic 
Acid Dihydrazide 
0.893 0.147 0.893 
Alginate*Hyaluronic 
Acid 
0.790 0.683 0.790 
Alginate* Adipic Acid 
Dihydrazide 
0.407 0.210 0.407 
Hyaluronic Acid* 
Adipic Acid 
Dihydrazide 
0.435 0.046 0.435 
 
Complete Regression equations indicated for stimuli responsive bioactive release rate 
(MDT), Young‘s Modulus and viscosity are in depicted below in equations 7.2-7.4. 
𝑆𝑡𝑖𝑚𝑢𝑙𝑖 𝑅𝑒𝑠𝑝𝑜𝑛𝑠𝑖𝑣𝑒 𝐵𝑖𝑜𝑎𝑐𝑡𝑖𝑣𝑒 𝑅𝑒𝑙𝑒𝑎𝑠𝑒  𝑀𝐷𝑇 : 113.17 − 9.15 𝐴𝐿𝐺 − 129.67 𝐻𝐴 −
640.40 𝐴𝐷𝐻 + 2.61 𝐴𝐿𝐺 ∗ 𝐴𝐿𝐺 + 183.75 𝐻𝐴 ∗ 𝐻𝐴 + 2963.89 𝐴𝐷𝐻 ∗ 𝐴𝐷𝐻 − 7.86 𝐴𝐿𝐺 ∗
𝐻𝐴−3.67𝐴𝐿𝐺∗𝐴𝐷𝐻−263.75(𝐻𝐴∗𝐴𝐷𝐻)                                                     [Equation 7.2]   
 
𝑌𝑜𝑢𝑛𝑔𝑠 𝑀𝑜𝑑𝑢𝑙𝑢𝑠: 11.613 + 0.973 𝐴𝐿𝐺 − 11.761 𝐻𝐴 − 132.211 𝐴𝐷𝐻 − 0.067 𝐴𝐿𝐺 ∗ 𝐴𝐿𝐺 +
0.115 𝐻𝐴 ∗ 𝐻𝐴 + 355.093 𝐴𝐷𝐻 ∗ 𝐴𝐷𝐻 + 0.221 𝐴𝐿𝐺 ∗ 𝐻𝐴 − 4.905 𝐴𝐿𝐺 ∗ 𝐴𝐷𝐻 +
78.750(𝐻𝐴 ∗ 𝐴𝐷𝐻)                                                                                               [Equation 7.3]  
 
𝑉𝑖𝑠𝑐𝑜𝑠𝑖𝑡𝑦: 353.7 − 235.8 𝐴𝐿𝐺 + 2557.1 𝐻𝐴 − 4251.8 𝐴𝐷𝐻 − 22.0 𝐴𝐿𝐺 ∗ 𝐴𝐿𝐺 +
4286.3 𝐻𝐴 ∗ 𝐻𝐴 + 36675.6(𝐴𝐷𝐻 ∗ 𝐴𝐷𝐻) − 179.8 𝐴𝐿𝐺 ∗ 𝐻𝐴 + 3851.4 𝐴𝐿𝐺 ∗ 𝐴𝐷𝐻 −
31605.7(𝐻𝐴 ∗ 𝐴𝐷𝐻)                                                                                              [Equation 7.4] 
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Figure 7.2: Residual plots of (a) stimuli responsive bioactive release; (b) Young‘s Modulus 
(c) Viscosity 
 
7.3.1.1. Response Surface Plot Analysis for Formulary Optimization 
For design product optimization and processing, optimization techniques such as the 
response surface methodology need to be put in place. Attainment of the response surface 
methods provides a relation between the various biopolymers and crosslinker salt 
concentration. As mentioned prior the responses tested against is the bioactive release MDT 
for curcumin, the strain the system can withstand before fracturing in terms of its tensile 
strength as well as the Young‘s Modulus and the viscosity when in the hydrogel form. 
Surface plots illustrated in Figure 7.3, 7.4 and 7.5 provide valuable data pertaining to the 
responses and the factors. 
 
The response surface plot analysis of the stimuli responsive bioactive release (MDT) 
provides information regarding the effects of interactions between the various variables on 
the release rates of the bioactive. Many factors impact on the bioactive release from 
polymeric matrices, which include polymer swelling and erosion. Swelling and erosion 
characteristics from a polymeric system can be directly attributed to the various properties of 
the system. Incorporation of alginate plays a major role in terms of swelling and erosion due 
to its gelanisation characteristics and pH dependency making it more prone to erosion 
resulting in bioactive release. To determine the functional relationship between the 
responses achieved and the experimental variables, plots were employed. Responses 
obtained from the polymers employed which include blends of alginate and hyaluronic acid is 
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depicted in Figure 7.3. Furthermore the induction of crosslinking by the incorporation of a 
crosslinker adipic acid dihydrazide (ADH) greatly influenced the bioactive release rates. To 
visualise the relationships between the variables a contour plot was included as illustrated in 
Figure 7.3. A prolonged, greater controlled release rate was seen by the addition of 
crosslinker. Furthermore it was noted that the bioactive release rate was prolonged to a 
greater extent when interactions between hyaluronic acid and the crosslinker were analysed. 
This observation provides a greater insight to the stimuli responsiveness of the system as the 
active polymeric system for stimuli (inflammation) responsiveness is the integration of 
hyaluronic acid. The formation of crosslinked bonds prolongs and minimises the degradation 
by hydroxyl radicals on exposure to an inflammatory site. Therefore the formation of covalent 
bonds by crosslinking and the concentration of crosslinker play a vital role in the release 
rates of bioactive. The interactions between polymers i.e.: hyaluronic acid and alginate 
revealed a more rapid release rate then release rates by the incorporation of a crosslinker. 
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Figure 7.3: Contour and Surface Plots of the stimuli responsive bioactive release (MDT) in 
relation to amendment in concentration of polymer and crosslinker 
 
The surface and contour plots in Figure 7.4 depict the effects of the interactions between 
variables on the Young‘s Modulus and tensile strength of the system. Crosslinking the 
lyophilized component of the BTDS provided a significantly greater Young‘s Modulus, thus 
the system exhibited greater rigidity and stiffness. Furthermore it was noted that by 
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increasing the degree of crosslinking further the stiffness and rigidity of the system was 
augmented which can lead to brittleness. Decreasing the degree of crosslinking in the 
system lowered the Young‘s Modulus thus improving the elasticity and flexibility of the BTDS. 
Interactions between polymers alginate and hyaluronic acid portrays a lower Young‘s 
Modulus as can be seen in the surface plot of Figure 7.4 thus weaker in comparison to the 
addition of a crosslinker, making the system more prone to effortless  tearing and fracturing. 
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Figure 7.4: Surface and Contour Plots depicting the effect of varying polymeric and 
crosslinker concentration on the Young‘s Modulus and tensile strength 
 
The analysis of viscosity of the system in a hydrogel form provides pertinent information 
regarding the system properties. Viscosity characteristics provide a measure in which the 
systems resistance to gradual deformation can be analysed when a shear stress or tensile 
stress is applied. In addition characteristics relating to erosion and degradation for bioactive 
release can be investigated. Varying concentrations of the polymers and crosslinker had a 
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direct attribution to the viscosity of the system. Increasing polymeric concentration lead to 
greater viscosity thus the system displayed a greater resistance to the applied forces 
consequently opposing degradation. Thus it could be deduced that increasing the viscosity 
augmented its tensile strength properties and delayed degradation thus prolonging bioactive 
release. 
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Figure 7.5: Response surface and contour plots depicting the effect of varying 
concentrations on the viscosity of the formulation 
 
7.3.1.2. Response Optimization of the Bioresponsive transdermal delivery system 
Response optimization procedure (MINITAB®, V15, Minitab, USA) was utilised in order to 
establish the favoured level of biopolymer and crosslinker formulary components. 
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Simultaneous constraint optimization of the selected responses, inflammatory responsive 
bioactive release, viscosity of the formulations and Young‘s Modulus were carried out in 
order to acquire an optimal formulation. Maximisation of these characteristics was attained to 
ensure response optimization by establishing the optimized levels of the independent 
variables and their predicted responses. Figure 7.6 depicts optimized levels of the 
independent variables, the goal for the response, the predicted response, y, at the current 
factor settings, as well as the individual and composite desirability scores. Based on the 
statistical desirability function, it was found that the composite desirability‘s for the 
formulation was 1.0.  
 
Figure 7.6: Desirability plots representing the levels of Alginate, Hyaluronic Acid and Adipic 
Acid Dihydrazide required to synthesise the optimized formulation. 
 
7.3.2. Inflammatory Responsive Bioactive Release Behaviour 
Intrinsic to evaluation of the optimized stimuli responsive formulation was its in vitro 
performance on exposure to a stimulus (Fenton‘s reagent) and under normal conditions 
(saline phosphate buffer). As described an optimized formulation was fabricated enclosing an 
active component (HA) to a stimulus and compared to a non stimuli responsive (control) 
system whereby the active component (HA) was omitted. Bioactive release profiles were 
then taken and revealed that the release rates under normal conditions portrayed a slower 
release rate of the crosslinked optimized stimuli responsive system. When exposed to the 
inflammatory conditions the release rate was enhanced. Furthermore it was noted that the 
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release rate from the non stimuli responsive system that was not crosslinked and contained 
no crosslinker portrayed a much more rapid rate of bioactive release. Enhancement of 
bioactive release under inflammatory conditions can be attributed to the prospective 
disruption of the hydrolysable linkages representing the stimulus responsive mechanism of 
the system (du Toit et al., 2013). Disruption of these linkages results in the release of the 
embedded nanofibrous component. Furthermore release rates may be prolonged due to the 
formation of a polyelectrolyte complex between components of the nanofibrous system 
embedded and components of the lyophilized matrix of the inflammatory responsive system. 
 
Figure 7.7 depicts the bioactive release rate of curcumin from the system under the various 
environmental conditions. The optimized stimuli responsive formulations depicted a release 
rate at 5 hours of 0.064mg when exposed to inflammatory pathological conditions created by 
Fenton‘s Reagent and a release rate of 0.045mg at 5 hours when exposed to normal 
conditions created by the employment of phosphate saline buffer. Enhanced release rates 
when exposed to pathological conditions is observed and is attributed to the mechanism 
entailing degradation by hydroxyl radicals as described above in this chapter. Stimuli 
responsive polymer erosion occurs when the HA matrix comes into contact with inflammatory 
stimulus releasing hydroxyl radicals which cause the degradation of HA within the lyophilized 
component of the BTDS which ultimately results in bioactive release in response to the 
stimulus signal. Addition of the crosslinker modifies the polymeric structure thus prolonging 
the release of bioactive. Within the optimized formulary component, the lyophilized matrix 
encompasses a greater backbone structure due to crosslinking with ADH whereby the 
introduction of the amine group consequently forms covalent linkages with prominent groups 
of the HA structure as depicted by the SEM images illustrated in Chapter 6 and further 
depicted in Figure 7.11 of this chapter. Furthermore incorporation of the nanofibrous mat 
lead to the configuration of a polyelectrolyte complex which further tailored the structure 
providing greater mechanical strength and modifying release rates. Furthermore, a greater 
sensitivity to changes in environmental conditions was displayed on formation of a PEC 
(Hamman. 2010). A PEC was formed between both alginate and hyaluronic acid due to their 
anionic nature with positively charged amino groups of chitosan, a polymeric component 
structuring the nanofibrous system embedded. This structural modification further alters the 
structure providing greater stability and mechanical probability modifying the release rate 
further. As depicted in Figure 7.7, the optimized stimuli responsive formulation placed under 
normal saline conditions exhibit the lowest release rates attributed to the covalent 
crosslinkages, formation of the PEC and non exposure to stimuli responsive conditions. The 
control exposed to inflammatory pathological conditions reveals the greatest release rates at 
0.067mg at 5 hours increasing up to 0.095mg at 24 hours due to the influence of active 
degradation by hydroxyl radicals and the exclusion of a PEC complex and crosslinkages by 
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ADH. No influence by hydroxyl radicals imposed a lower release rate of 0.057mg at 5 hours 
leading to 0.084mg at 24 hours. Thus it was deduced that the crosslinkage and PEC 
formation generate a positive modification on the structure by prolonging the release rates 
thus avoiding a burst bioactive providing a more constant release as is illustrated by the 
optimized (F) (stimuli responsive) release in Figure 7.7. Due to the described phenomena, it 
was seen that the release rates is primarily due to the exposure to the Fenton‘s reagent 
generating hydroxyl radicals causing degradation of HA leading to release of the bioactive 
curcumin from the modified structure thus exhibiting stimuli responsive behaviour to 
inflammation.  
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Figure 7.7: Comparative bioactive release profiles for the stimuli responsive (optimized) 
formulation and non stimuli responsive (Control) under inflammatory (F) and normal 
conditions (N). 
 
7.3.3. Water Content Analysis of the Bioresponsive Transdermal Delivery System 
The swelling ability of the formulations in the hydrogel form was titrated using a Karl Fisher 
Titrator. Swelling and water penetration is highly dependent upon the degree of crosslinking 
thus the intermolecular and intramolecular bonding forces occurring between molecules. The 
results obtained disclose a percentage water content of 16.419% in the stimuli responsive 
system and 16.826% in the non stimuli responsive system. Thus it was observed that a 
(Hrs) 
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slightly higher swelling ratio is obtained in the control system. The higher swelling ability is 
characteristic of the lack of bond formation due to the absence of crosslinking presenting a 
low crosslink density thus a greater swelling ability. Uncrosslinked control systems present 
with a structure whereby polymer chains are flexible and modifications in environmental 
conditions such as exposure to fluidic molecules may cause a breakage in secondary 
interactions resulting in more space for liquid uptake within the matrix (Rohindra et al., 2004); 
therefore the rate of swelling is less in the stimuli responsive formulation due to crosslinked 
bond formation. Furthermore, the swelling capacity of the hydrogel is largely dependent upon 
the monomer and monomer concentration used the hydrophillicity as well as the ionic density 
of the structure. As the hydrophillicity was increased so too did the swelling ability 
(Pourjavadi and Mahdavinia. 2006). Viscosity also plays a significant role in the swelling and 
erosional behaviour of the matrix. As the viscosity of the polymeric solution was increased, a 
greater resistance to swelling was attained and the swelling ratio plummeted. The addition of 
hyaluronic acid and adipic acid dihydrazide modifies the viscosity properties of the solution in 
contrast to the control containing only alginate thus rendering the formulation less swellable. 
Furthermore as mentioned the ionic nature and density directly impacts on the swelling ability 
of the matrix by the addition of ionisable functional groups such as carboxylic and amino 
groups. An understanding of the degree of hydration and swelling allows for the conception 
of transport of small molecules and bioactives through the matrix. Hyaluronic acid been a 
polyionic compound ionically reacts with various compounds within the structure which 
include chitosan and alginate. Positively anionic charges present interacts with the negatively 
charged ions present in alginate thus forming a polyelectrolyte complex, increasing the 
charge density (Cai and Gupta, 2002). This resulted in a more rigid structure with lower chain 
flexibility thus providing greater mechanical strength to the system diminishing the swelling 
ability. A decrease in swelling ability attributes to lower erosion rates thus prolonging the 
bioactive release rates over time. Effects of this phenomena is observed in the bioactive 
release profiles illustrated in Figure 7.7 whereby greater release rates over time is noted in 
the control than the optimized system. 
 
7.3.4. Evaluation of the Degree of Mucoadhesion of the Prototype Device 
Mucoadhesion can be defined as a polymers or materials ability to adhere or bind to the 
desired tissue. This is of crucial importance when developing a system for wound healing as 
topical preparations require favourable application properties to ensure patient compliance 
and optimal delivery. Furthermore mucoadhesive delivery systems are capable of increasing 
the bioavailability of the active compounds thus controlling release of the bioactive at the 
desired site whilst also extending the retentive time (Cevher et al., 2008). A TA-XTplus 
analyzer equipped with a 5kg load was employed to evaluate the mucoadhesive properties of 
the prototype device via attachment to excised Sprague Dawley rat skin. The mucoadhesive 
191 
 
tests were carried out to determine the adhesive properties of the formulations for device 
fabrication. From the work of mucoadhesion obtained from the area under the curve as 
illustrated in Figure 7.8a and Figure 7.8b, the backing layer formulation displayed a value of 
0.079 mJcm-2 and 0.031 mJcm-2 for the lyophilized matrix formulation (incorporated with 
nanofibrous mat). Thus the results obtained depicted greater adhesive strength of the gel 
formulation of the backing layer which serves as an ideal prototype for wound healing. This 
can be directly attributed to the use of a mucoadhesive polymer such as polyacrylic acid. 
Literature findings suggest that the presence of more than 90% of acidic groups in non 
ionised polyacrylic acids avert electrostatic charges and thus demonstrate lower swelling 
abilities thus enhancing its binding properties directly to proteins and polysaccharides found 
in skin tissue (El-Kamel et al., 2002). The higher mucoadhesive characteristics displayed by 
the backing layer reveals superior bioadhesive qualities due to the high molecular weight of 
incorporating alginate and polyacrylic acid, strong hydrogen bonding, greater surface tension 
properties and its hydrophillicity. Elevated hydrophilic properties of the backing layer enable 
strong bioadhesive bonding to the mucosal surface of the skin tissue which ultimately 
resulted in strong bioadhesive forces. Hydrogen bonding is favoured by the presence of OH- 
and COOH- groups present in polyacrylic acid. In addition, high surface tension 
characteristics favour the spread of the BTDS prototype over the epithelial layer of the skin 
(Ndesendo et al., 2010). 
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Figure 7.8: Area under the curve for the work of mucoadhesion of the prototype device 
where (a): Backing Layer, (b): Lyophilized matrix with incorporated nanofibrous mat 
 
7.3.5. Vibrational Transitional Analysis to determine the Molecular Transitions of the 
crosslinked structures 
Infrared spectroscopy serves as a versatile and diverse analytical technique for the 
determination of molecular vibrational transitions and fundamental absorption frequencies 
which provides an imperative key to unlocking structure-spectral relationships between 
associated molecular structures (Coates, 2000). Figure 7.9 reveals the infrared spectra of the 
stimuli responsive and non stimuli responsive systems, from the spectra attained it is noted 
that three distinct peaks are presented in both spectra whereby a broad band is observed 
representing O-H stretching due to hydrogen bonding as well as C-H stretching characteristic 
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of the presence of an aromatic compound. Figure 7.9a distinguishes the stimuli responsive 
broad band at 3258.55cm-1 and the control at 3255.77cm-1 in Figure 7.9b depicted in the 
figure. This signifies that the introduction of the stimuli responsive component (HA) as well as 
the crosslinker (ADH) provided greater stability and intensified the intermolecular and 
intramolecular bonds between the molecules. Furthermore both structures revealed a peak 
at 2165.56cm-1 and 2162.35cm-1 respectively in Figure 7.9a and 7.9b. The peak is attributed 
largely to the presence of a disubstituted medial alkyne group frequency representing C≡C 
stretching. A more intensified bond is noted in Figure 7.9a which can be attributed to the 
presence of the polymeric compounds HA as well as ADH providing greater conjugation to 
the presented bond due to the introduction of amine groups interacting with aldehyde groups 
exhibiting C=C and C=O stretching. Further peaks are seen at 1635.10cm-1 and 1632.54cm-1. 
This is attributed to skeletal vibrations representing a C=C stretch by the presence of an 
acetylenic compound whereby the band is more intensified in Figure 7.9a. Intensification of 
this bond in Figure 7.9a was largely attributed to formation of conjugated ketones due to 
crosslinking. Furthermore it was noted that a peak at 1034.83cm-1 was present in Figure 7.9a 
due to the presence of amino bonds (demarcated in the figure) by the addition of HA to the 
structure which is absent in the structure of Figure 7.9b. Thus from the observations made it 
was deduced that the process of crosslinking and addition of polymeric compounds provided 
greater intensity and conjugation to the molecular structure.  
 
Figure 7.9: Molecular vibrational transitions of a: the stimuli responsive system and b: the 
non stimuli responsive system 
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7.3.6. Thermodynamic Evaluation of the Optimized BTDS Device 
The DSC profiles for both the stimuli responsive and non stimuli responsive systems was 
obtained and is depicted in Figure 7.10. A distinct endothermic peak was observed for both 
formulations at 74.03°C and 102.67°C for the non stimuli responsive and stimuli responsive 
systems respectively. The presence of the peak relay to melting processes occurring at this 
point. A broad asymmetric melting peak characterised by Figure 7.10b as demarcated 
displayed a much quicker onset of melting at the temperature range indicated then the 
melting transitions occurring in Figure 7.10a of the stimuli responsive system. Furthermore it 
was noted that the endothermic melting peak observed was superimposed upon the glass 
transition temperature due to gradual enthalpy changes. From the temperature ranges 
indicated it was seen that the heat capacity required to cause a melting peak is greater for 
the stimuli responsive then the non stimuli responsive system. This was ascribed to the 
incorporation of a crosslinker to the system endorsing crosslinked bonds by intermolecular 
and intramolecular forces and linkages thus the heat energy required to cause a phase 
change such as melting is greater. Occurrence of this peak is attributed to polymorphism 
whereby melting occurs as a result of metastable modifications. Following this, an 
exothermic peak was then distinguished at 418.96°C and 258.65°C in the non stimuli 
responsive system contrasting to 236.52°C and 289.53°C in the stimuli responsive system. 
These temperatures obtained resembling an exothermic peak depicting cold crystallisation 
demonstrate a lower specific heat capacity for the stimuli responsive formulation thus the 
structure portrays a greater crystalline state in comparison to the control. A greater crystalline 
state of the structure designates that the system subsist to a greater molecular order and 
thus less molecular motion occurs between the particles thus the specific heat capacity 
required for amorphic phase change is less as depicted by the heat capacity temperatures 
obtained. Therefore it was deduced that the introduction of a crosslinker provides greater 
stability and molecular linking between molecules providing greater molecular order thus 
higher temperatures were required for thermal degradation. Furthermore ionic interactions 
between molecules further influence the enthalpy for thermal degradation of the system 
whereby a greater specific heat capacity was required for degradation of the stimuli 
responsive system.  
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Figure 7.10: Thermographic profiles of a: the stimuli responsive system, b: the non stimuli 
responsive system  
 
7.3.7. Topographical and Morphological determination of the Bioresponsive 
transdermal delivery system 
For optimal design of the wound healing device, tailoring the microstructure for improved 
structural performance is of utmost importance. This was performed by the introduction of 
crystallinity and crosslinking of molecular structures thus advancing the chemical and 
mechanical properties. Figure 7.11 depicts the surface morphological imagery of the non 
stimuli responsive system and stimuli responsive system whereby the effects of polymeric 
addition and crosslinker was observed. From the imagery obtained it was seen that Figure 
7.11b displays a greater fibril structure with a greater presence of fibrillogenesis in 
comparison to the control. Furthermore, interconnected porous sites were conspicuously 
seen which are attributed to the presence of a polymeric backbone presented by the addition 
of the crosslinker ADH and HA. It was clearly observed in Figure 7.11b that a more course 
molecular structure is attained due to the presence of ADH which lead to ionically associated 
domains and molecular cluster entanglements thus presenting with a greater polymeric 
backbone structure in comparison to the control thus improvising greater mechanical 
characteristics to the system with a more perceived and rigid structure. Figure 7.11a reveals 
the topographical surface imagery of the control whereby a clear split (tearing/cracking) was 
seen collectively with large porous sites as demarcated thus suggesting poor mechanical 
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attributes and a relatively weak structure in comparison to the optimized formulation due to 
the absence of a backbone structure.   
 
Figure 7.11: Surface topographical imagery of (a): Non stimuli responsive system and (b): 
Stimuli responsive system 
 
7.3.8. Evaluation of the Tensile Strength and Young’s Modulus of the Optimized 
System 
Young‘s Modulus can be described as the stress ratio coefficient of a substance when a 
stress is applied causing an alteration in the shape and length of the body of the specific 
object due to the force applied. The Young‘s Modulus and elasticity of the system provides 
an intricate indicator of the material stiffness. The elastic modulus provides an understanding 
of the materials ability to regain its original geometry when the imposed stress is removed. A 
highly elevated Young‘s Modulus value indicates a lower compliance material or stiffer 
material thus presenting with a lower elastic modulus (Dupps and Wilson, 2006). Figure 7.12 
and Table 7.4 represent the various physicomechanical characteristics of the systems. From 
the data obtained it was noted that the backing layer has the greatest Young‘s Modulus 
indicated by the linear portion of Figure 7.12C and thus the greatest strength and rigidity. 
This is essential and significant as the backing layer serves as the primary source of 
exposure to the outside foreign environment thus mechanical potency and strength is of 
utmost importance. A Young‘s Modulus of 3.92 E(MPa) was detected with a significantly 
greater tensile strength of 0.37N.mm2. The backing layer been the primary outer layer of the 
device is subjected to the greatest tensile stress, therefore requires the greatest magnitude 
of strength. Table 7.4 reveals a Young‘s Modulus of 1.22 and 0.86E(MPa) in the stimuli 
responsive and non stimuli responsive systems respectively thus presenting with lower 
tensile characteristics in contrast to the backing layer. Furthermore, the ultimate strength of 
the various components of the BTDS revealed the greatest strength in the backing layer at 
(a) (b) 
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0.15θμ(MPa) in contrast to 0.03 and 0.02 θμ (MPa) in the stimuli responsive and non stimuli 
responsive systems respectively. In addition, the stiffness, strength and rigidity of the system 
play a vital role in the healing process. Evan and co-workers (2013) have stated that several 
studies have established the occurrence of wound healing with scar formation when 
mechanical tension is applied, thus tension reduction systems are more adequate to promote 
healing endorsing differentiation, proliferation and fibrillogenesis. Therefore based on this 
ideology, a more rigid backing layer structure provides more advantageous properties to the 
wound healing process. The introduction of a polymeric component (HA) and crosslinker 
(ADH) providing crosslinking moieties to the structure provides a polymeric backbone to the 
structure and intermolecular linkages between the molecules thus endorsing the mechanical 
stability of the device as indicated in Table 7.4. The positive influence of molecular 
crosslinking is further substantiated by the topographical surface morphology as shown in 
Section 7.3.7 of this chapter and the enhanced conjugation and intensity between molecular 
bonds as indicated by the infrared spectra of Section 7.3.5. From the nanomapping profiles 
obtained in Figure 7.12a and 7.12b it was noted that a more defined linear portion is 
surveyed in Figure 7.12a thus suggesting a greater Young‘s Modulus. Furthermore Figure 
7.13 portrays the tensile strength profile revealing the mechanical characteristics of the 
system whereby it was noted that the stimuli responsive system shows a greater tensile 
strength of 0.265N.mm2 in disparity to the non stimuli responsive system displaying a tensile 
strength of 0.11N.mm2. Thus it was deduced that at the Young‘s Modulus and tensile 
strength obtained the stimuli responsive system portrays greater tensile characteristics then 
the non stimuli responsive system portraying enhanced stringency and at the same time 
displaying elastic properties making a suitable application for topical delivery whereas the 
non stimuli responsive system displays more feeble characteristics in terms of mechanics. A 
Young‘s Modulus of 1.22E (MPa) resembles an intermediate to moderate value thus avoiding 
the high rigidity and brittleness associated with a very high Young‘s Modulus value.   
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Figure 7.12: Nanomapping profiles revealing Young‘s Modulus (a) and fracture points (b) of 
A: Stimuli responsive system, B: Non stimuli responsive system, C: Backing Layer  
 
Table 7.4: Physicomechanical analysis revealing the various values for evaluation in terms 
of mechanical characteristics 
 Stimuli 
responsive 
system 
Non stimuli 
responsive 
system 
Backing 
Layer 
Young’s 
Modulus 
E(Map) 
1.22 0.86 3.92 
Yield 
Stress 
θγ(MPa) 
0.03 0 0.10 
Ultimate 
Strength 
θμ(MPa) 
0.03 0.02 0.15 
Ultimate 
Strain εμ 
0.036 0.024 0.079 
Tensile 
Strength 
(Nmm2) 
0.265 0.11 0.37 
 
A B 
C 
a a 
a 
b 
b 
b 
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Figure 7.13: Characteristic tensile strength profile 
 
7.3.9. Rheological Elucidation of the Stimuli Responsive and Non Stimuli Responsive 
Systems 
When a tensile strength or shear stress is applied to a substance, its ability to resist gradual 
deformation can be termed the viscosity of the substance. Intermolecular and intramolecular 
interactions occurring between molecules giving rise to collisions between neighbouring 
particles in a fluid at altering viscosities can be termed as a property of viscosity. The 
maximum amount of stress or strain applied to the polymeric system upon which degradation 
occurs can be expressed as its yield stress. The polymeric systems composed of hyaluronic 
acid components whereby entangled coil formation occurs resemble a viscous solution with 
shear thinning behaviour. An increase in the shear rate revealed a decrease in the shear 
viscosity. The rheological behaviour in terms of its steady shear viscosity is dependent and 
controlled by the molecular weight as well as network entanglement (Ambrosio et al., 1999). 
At increased shear rates, interruption of the molecular entanglements is more prominent 
leading to shear thinning behaviour but is more dominant in the uncrosslinked non stimuli 
responsive system. 
 
Oscillatory frequency studies revealed characteristics of the system in terms of its 
viscoelasticity whereby G‘(ω) the shear storage modulus and G‖(ω) the shear loss modulus 
was obtained. Energy stored within the system as well as the elasticity is characterised by G‘ 
whereas the G‖ parameter provides information regarding the heat energy dissipated as well 
as the viscous character of the system (Barbucci et al., 2000). Figure 7.14 reveal the stress-
Force (N)
Distance (m)
12
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strain frequency sweep profiles of the crosslinked stimuli responsive and non stimuli 
responsive systems. The viscous and elastic responses of these systems were detected 
through quantitative rheological evaluation whereby it was noted that the responses coincide 
and are related to the chemical structure and degree of crosslinking. Moreover the 
mechanical characteristics are also directly related and proportionate. From the profiles 
obtained it was noted that the elastic modulus is always higher than the viscous modulus in 
the non stimuli responsive (control) system as portrayed in Figure 7.14b, consequently 
depicting that the system possesses the features of ‗gel-like‘ structures. As the stress-strain 
shear rate frequencies increased, the storage modulus revealing shear thinning behaviour 
also increased, detecting that the system reflects strain independent behaviour only for small 
deformation regions. Within the non stimuli responsive uncrosslinked system no to minimum 
entanglement occurs amongst polymer chains as the macromolecules in the structure may 
be deemed individual flow units. The rheological behaviour of the crosslinked stimuli 
responsive system portrays a different profile to that of the unresponsive system. The elastic 
modulus furthermore transpires at a higher frequency range as noted in Figure 7.14a then 
that of the non stimuli responsive system. The system portrays viscoelastic properties 
whereby at lower frequencies they exhibit shear independent behaviour. The process of 
crosslinking and molecular entanglement lead to the formation of a stable network also 
characterised by the process of hydrogen bonding and ionic interactions with a subsequent 
decrease in the intrinsic mobility (Barbussi et al., 2000). The crosslinked stimuli responsive 
system revealed a greater initial viscous modulus followed by an elevated elastic modulus, 
increasing over time and frequency thus displaying greater viscoelastic properties then the 
non stimuli responsive system consequently exhibiting enhanced mechanical properties and 
chemical interactions. 
 
Figure 7.14: Pertinent rheological properties in terms of the G‘ and G‖ Modulus of a: Stimuli 
responsive system, b: non stimuli responsive system 
 
(a) (b) 
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7.4. Concluding Remarks 
The optimized device showed a rapid response for bioactive release. A bioactive release rate 
is a significant requirement as it indicates the stimuli responsive bioactive behaviour to 
inflammation. The optimized device system has been proven to have responsive behaviour 
and furthermore increase the residence time of release. The mechanical properties were also 
enhanced by the formation of the crosslinked linkages as well as a polyelectrolyte complex. 
As observed in the topographical surface imagery a more course molecular structure is 
configured leading to a molecular backbone infrastructure which directly attributed to the 
mechanical characteristics and chemical interactions of the system as perceived by the 
infrared spectra, Young‘s Modulus and viscoelastic characteristics by means of the elastic 
Modulus.  
 
Under the influence of Fenton‘s reagent, the system portrayed bioactive release in a more 
rapid manner whereas under normal saline conditions, bioactive release presented at a more 
dormant rate. Addition of ADH at 0.13%w/v improved the residence time of release thus 
maintaining the bioactive concentrates throughout the process of the wound healing cascade 
and preventing burst release rates. Furthermore the anionic and cationic nature of the 
various polymeric components of the system further influenced the release rates due to the 
formation of a polyelectrolyte complex enhancing system performance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
202 
 
CHAPTER 8 
IN VIVO ANALYSIS OF THE MULTI-COMPONENT INFLAMMATORY 
RESPONSIVE BIOACTIVE DELIVERY DEVICE 
The animals used in this study were approved by the Central Animal Services (CAS), Animal 
Ethics Screening Committee (AESC), University of Witwatersrand, Parktown, Johannesburg, 
South Africa. All experimental procedures were carried out in accordance with the AESC 
guidelines for the use and care of animals as pertained to the terms of Section 23 (1) (c) of 
the Veterinary and Para-Veterinary Professions Act (19 of 1982). (See Appendix 11.3) 
 
8.1. Introduction 
In vivo experimentation provides precise and supplementary information regarding the 
processes of what is occurring within the actual cell tissue or organism which may 
sometimes vary with in vitro experimentation as the physico-chemical properties in vivo are 
usually different from that of dilute aqueous solutions utilised to carry out the various in vitro 
tests (McConell. 1995). 
 
The activity of the wound healing device will be subjected to the presence of exudates, 
inflammation and the wound site itself, thus the results obtained of in vitro data will merely 
mimick  the in vivo environment and hence is not sufficient to provide accurate results and 
data. An in vivo model will provide optimal histopathological, pharmacokinetic and 
pharmacodynamic results. In addition observational data and more realistic clinical 
extrapolation can be successfully correlated. 
 
In vivo experimentation provides insight to possible risks or side effects with the use of the 
device, since biomaterials are biodegradable and biocompatible and should not be 
associated with any ill effects. It is unethical to conduct such a study directly on human 
subjects therefore the Sprague-Dawley Rat was the animal of choice that serves as a 
suitable model due to its availability, low cost, small size and it is widely used in the study of 
skin wound healing and the efficacy of different treatment modalities. Charerensriwilaiwat 
and co-workers, 2012 investigated a lysosome loaded chitosan based nanofibre mat by 
subjecting an incision of 0.8 cm2 at the back of the neck of all rats. In another study Ramli 
and Wong, 2011 evaluated the healing efficiency on the burn wound model in the rat by the 
use of heated deionised water on the dorsal area of the rats. This research focuses on 
conduction of a burn wound model and the subsequent healing process.  
 
The purpose of this research was to design and develop a ―smart‖ inflammatory responsive 
wound healing device intended to deliver the various bioactives to the targeted site at the 
determined time intervals significant to the wound healing cascade. Therefore, the device 
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structured of several components assembled in a manner best suited to the healing 
requirements as summarised in Figure 8.1. The device described was then employed for in 
vivo application to determine the healing success rates. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.1: Schematic overview of the componential architecture and formulation of the 
BTDS 
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8.2. Materials and Methods 
 
8.2.1. Materials 
Sprague Dawley Rats were utilised in this research and obtained from the Central Animal 
Services (CAS) as per the protocol in accordance with University of Witwatersrand animal 
services guidelines. All elementary gear used was of ultrapure grade and obtained from the 
Central Animal Services unit of the University of Witwatersrand. Dental syringe obtained from 
the dental department of the University of Witwatersrand and H-Dent dental needles (27GX1-
3/8‖) obtained from Hakusui Trading Co LTD. Osaka, Japan. 
 
8.2.2. Animal Husbandry 
The non-fasted rats were housed in groups of 5 initially and then in single cages for 
procedure purposes. The rats were provided with water and food in accordance with a 
standard rat diet ad libitum and maintained on a 12 hour light/12 hour dark cycle at a 
controlled temperature (+/-25°C). They were weighed weekly so as to indicate their general 
state of well being. Cage activity by means of observation for 1 hour periods daily was also 
carried out to assess their state of well being. Prior to in vivo experimentation, rats were 
acclimatised to laboratory conditions and held in vivarium for 7-14 Days. The South African 
Standard for care and use of animals for scientific purposes was followed to execute 
favourable housing conditions according to the relevant SOPs. 
 
8.2.3. In Vivo Experimental Design 
Thirty Sprague Dawley Rats within the weight range of 250-300mg were utilised within the in vivo 
animal study (Ethics clearance was obtained from the Animal Ethics Committee of the University 
of the Witwatersrand for this study, Ethics Clearance No 2013/24/05, see Appendix A). The rats 
were randomly assigned within six groups of five rats each (N=5 per group) whereby the 
experimental study consist of three experimental groups, a comparative group, control group and a 
placebo group. The various delivery systems were applied in accordance with the following criteria 
(Figure 8.2):  
 
Group A: Experimental Group: Nanofibrous Mats 
Group B: Experimental Group: Curcumin loaded films  
Group C: Comparative Group: Conventional System 
Group D: Control Group: Non Medicated Plain Gauze 
Group E: Experimental Group: Inflammatory responsive device 
Group F: Placebo Group: Non inflammatory responsive device 
 
205 
 
 
 
Figure 8.2: Photographic images pertaining to the administration of the various delivery 
systems whereby A is the inflammatory responsive device, B: nanofibrous mat, C: films 
loaded with curcumin, D: application of the conventional system, E: topical administration of 
non-medicated gauze and simple bandage and F: non inflammatory responsive device 
 
8.2.4. Preparation of the Wound Area 
Rats were made to lie dorsally whereby the hair of the upper back, dorsal region was 
removed by shaving using a sharp razor blade and disinfected using an alcohol swab. The 
rats were given jelly cubes medicated with Tramadol®, dosed at 4mg/kg 12 hours before the 
procedure and then twice a Day for a further 5 Days. All rats were premedicated with a dose 
of morphine 0.1ml/100g, 60 minutes prior to wound induction. Rats were anaesthetised in an 
Isofor gas chamber and an L-Block local anaesthesia using Xylotox® was induced once 
before creating the burn wound as indicated in Figure 8.3. (Ramli and Wong, 2007; Dr. 
Chetan Patel, Plastic surgeon in private practice running a study under the department of 
surgery, University of the Witwatersrand. Clearance certificate No.2010/48/04).   
 
8.2.5. In vivo Surgical Procedure: Full thickness Wound Model 
The burn wound was created as depicted in Figure 8.3 by using a metal probe with a 
diameter of 1.5cm that was heated to 99°C by insertion into boiling water and monitored 
using a mercury thermometer. Burn wounds were carried over a period of 10 seconds at a 
point that is 1.5cm‘s right laterally from the back midline towards the maxillary region of the 
rats and then covered with simple dry dressing to prevent the rats from scratching. After 48 
hours, Isofor was used as an inhalation anaesthetic agent for maintenance of anaesthetia and 
the resultant dry area surgically removed to create a severe burn wound model (Aoyagi et 
al., 2007). The shape, diameter and depth of the burn wound were determined in all animals 
prior to application of the test samples. All rats were given Ringers solution post procedure to 
B C
  A 
D E 
A 
F 
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avoid a hypovolemic shock. Throughout the preparation and surgical procedure the blood 
pressure and temperature was monitored using a BP monitor attached to the foot of the rats 
as seen in Fig 8.3 for all rats to ensure normality during experimentation. Wound dressings 
as depicted in Figure 8.2 were applied accordingly and held into place by self-adherent 
medical wrap and medical tape. All rats received an analgesic Tramadol® as necessary (Dr. 
Chetan Patel, Plastic surgeon in private practice running a study under the department of 
surgery, University of the Witwatersrand. Clearance certificate No. 2010/48). 
 
 
 
Figure 8.3: Surgical and preparatory procedure undertaken for burn wound induction  
 
8.2.6. Macroscopic Determination by Percentage Wound Closure Evaluation 
In order to determine the healing process during the experimentation period the wounds were 
photographed on Days 0, 5, 10, 15 and 20 post surgery. The Graphical Method was employed to 
determine the percentage (%) wound contraction by wound closure. This method involves the 
counting of the number of squares of retraced wound area or graph paper, to determine the wound 
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area reduction rate at different stages within the wound healing process. A ruler was used to 
determine the area of the wound site. The following formula was employed to determine the 
percentage (%) wound closure (Bindu et al., 2010).                                                 
% 𝐶𝑙𝑜𝑠𝑢𝑟𝑒 = 1 −  𝐴𝑑 𝐴𝑜  × 100                                                                       [Equation 8.1] 
Where  𝐴𝑜 = wound area on Day 0  
𝐴𝑑 = wound area on the corresponding Days  
 
8.2.7. Visual Comparative Analysis 
A visual comparison was carried out whereby photography of the wound site on the dorsal 
region of the rat together with a indicator was undertaken to determine the wound 
contraction over time at the specified time intervals in order to determine the degree of 
wound healing on the dorsal wounded area in the control, placebo, comparative and 
experimental groups. 
 
8.2.8. Histomorphological Examination to assess the Degree of Healing with the 
BTDS device 
Experimental progress was monitored over a period of 20 Days. A rat from each group was 
sacrificed on Day 0, 5, 10, 15 and 20 post surgery as summarised in Figure 8.4. The 
wounded tissue, healthy tissue surrounding the wound including the wound bed was 
excised and collected for histological evaluated. The excised tissue was fixed in 10% 
neutral buffered solution (Siritienthong et al., 2012). From each of the formalin-fixed skin 
specimens a cross section area of ulcerated skin was excised and collected for histolog ica l  
evaluated according to standard operating procedure PTA-his-SOP-27. After tissue 
processing, wax blocks were produced (PTA-his-SOP-28) and sections of 5 - 6μm were cut 
on a microtome (PTA-his-SOP-30). The sections that were produced were stained in an 
automated Haematoxylin and Eosin stainer (PTA-his-SOP-205) before microscopical 
examination. Wound healing progression on a cellular level in terms of re-epithelisation, 
inflammation and granulation was determined by topographical observations. 
 
8.2.9. Scores of Wound Healing Establishment as a Function of Time 
Based on the data accumulated over the 20 Day in vivo test period and evaluated by H&E staining 
a score was set in place and in accordance with previously published data (Sariethong et al., 
2012). Evaluation of the healing stages over time in terms of cell accumulation and granulation 
determination, variation of identified mediators and the degree of revascularization, epithelisation 
and keratinization was prepared (Siritienthong et al., 2012). Figure 8.4 provides a summary of the 
preparation and procedure methods undertaken for wound induction and healing evaluation. 
208 
 
 
Figure 8.4: Summary of the preparation and in vivo surgical procedure for wound induction 
followed by methods undertaken to determine wound healing evaluation 
  
8.3. Results and Discussion 
 
8.3.1. Gross Observation of Wound by Photographic Analysis 
The representative images of each group are depicted in Figure 8.5 whereby group A reveals the 
nanofibrous mat, group B is the film (curcumin loaded), group C is the conventional system, group 
D the control (non-medicated gauze), Group E is the inflammatory responsive system and Group F 
the ―placebo‖ is the non inflammatory responsive device. At Day 5 post injury, the wound was still 
dominant in all groups however healing progression had begun by the presence of slight 
granulation tissue present more so in group A. Day 10 to 15 post injury clearly illustrated greater 
healing progression in all groups but is more prevailing in group A and group B by the process of 
granulation and epithelisation. On Day 20, wounds treated with nanofibrous mats revealed close to 
a 100% wound closure in comparison to the other groups followed by films in group B. This 
phenomenon is correlated to the structure of the nanofibrous mat which mimicks the natural ECM 
of the wound site as well as the additive and synergistic advantageous properties of the 
biopolymers used.  
 
Figure 8.5 (ii) reveals digital photographic imagery of the experimental stimuli responsive device 
and the placebo, the non-stimuli responsive device. From the observation it was noted that wound 
healing activity transpired in both groups but is more dominant in the experimental stimuli 
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responsive group. Commencement of epithelisation can clearly be detected arising in a more rapid 
manner in Group E on Day 5 then in group F on Day 5 as the non-stimuli responsive device 
portrayed a greater degree of inflammation and slight granulation formation at this point. From an 
observatory point of view the healing progression was greatly advanced by Day 10 to 15 in both 
groups but remodelling is set in motion more notably in group E. Day 20 exhibited a close to 100% 
healing progression in group E and this can be attributed to the functioning of the nanofibrous mat 
as described above in this section as well as the enhanced function of the device attributed to its 
stimuli responsive nature. Furthermore the incorporation of hyaluronic acid serves as an 
advantageous attribute to the healing progression as it is a natural component found in the native 
ECM of the skin providing further healing properties which was omitted from the placebo group F. 
Group  A                     Group B                       Group C                    Group D 
 
 
 
 
                                        
 
 
 
 
         Day 5 
 
Day 10 
 
       Day 15 
 
 
Day 20 
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                                               Group  E                      Group F 
 
 
 
 
Figure 8.5: Photographic appearance of wounds (i) Group A: nanofibrous mat, Group B: 
Curcumin loaded film, Group C: Conventional system, Group D: Control, (ii) Group E: Stimuli 
responsive device, Group F: Non-stimuli responsive device  
 
8.3.2. Wound Size Reduction Analysis by Wound Closure 
Percentage wound closure was observed in all groups over the 20 Day period. Wounds 
treated with the nanofibrous mat disclose the greatest wound closure rate with the least scar 
formation in comparison to the simple non medicated gauze, conventional system and 
curcumin loaded films. The stimuli responsive system revealed a closure rate analogous to 
the nanofibrous mat though the healing progression occurs over a longer period of time as is 
in accordance with the phases of the wound healing cascade, thus the device will allow the 
         Day 5 
 
        Day 10 
 
         Day 15 
 
          Day 20 
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transpiration of healing over a prolonged period of time. Furthermore the rate of healing and 
closure rate was greater in the stimuli responsive system than the non-stimuli responsive 
system. Percentage wound closure rate on Day 20 revealed a wound closure rate of 99.94% 
for the wound healed with the nanofibrous mat, 94.88% for wounds treated with curcumin 
loaded films, 94.58% for wounds treated with non medicated gauze and 84.18% for wounds 
treated with the conventional system respectively. The stimuli and non-stimuli responsive 
devices depicted wound closure rates of 97.91% and 86.13% respectively. Figure 8.6 
displays the wound closure rate (WCR) of the various wound healing delivery systems over 
the period of 20 Days (i.e.: 5, 10, 15 and 20 Days). From further observation it was noted that 
the nanofibrous mat adhered well to the wound site, configuring a pseudo skin structure 
whereby a closure rate of 99.94% was obtained with minimum scar formation. The 
development of a wound dressing in a nanofibrous form greatly influenced the healing 
progression as a subordinate wound closure rate was obtained from the curcumin loaded film 
at 94.88% on Day 20. Additionally throughout the healing process wound closure was 
dominated by treatment with the stimuli responsive device and the nanofibrous mat as 
demonstrated in Figure 8.6. Thus it was deduced that structuring a wound healing delivery 
system that configures with the natural extracellular matrix of the skin, positively influences 
the healing progression. Moreover, the formation of a stimuli responsive device incorporating 
the nanofibrous system as described provides targeted bioactive release as well as ensures 
the healing progression occurs over an advanced period of time. Additionally, biopolymers 
used such as chitosan causes a release of N-acetylglucosamine by measured 
depolymerisation initiating collagen deposition at the wound site by the proliferation of 
fibroblasts further stimulating hyaluronic acid synthesis (Archana et al., 2013). The 
antioxidant and antimicrobial properties of curcumin further accelerated the healing 
progression and hindered scar formation. The stimuli responsive system composed of 
hyaluronic acid as a polymeric component in the device thus directly providing advantageous 
properties such as tissue regeneration influencing the wound closure rate by epithelisation 
and fibrillogenesis. 
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Figure 8.6: Percentage wound closure profile over the treatment 20 Day profile for Group A: 
Nanofibrous mat, Group B: curcumin loaded film, Group C: Conventional system, Group D: 
Control, Group E: Stimuli responsive system, Group F: Non-stimuli responsive system 
 
8.3.3. Histopathological Evaluation of the Wound Site  
An histological evaluation provides significant information regarding the condition of the  
inflicted wound site over time when topically treated with the various wound healing systems, 
i.e.: experimental groups (stimuli responsive system, nanofibrous mat and curcumin loaded 
film), control, placebo and conventional system. The H&E stained sections of healing wounds 
from the various groups under experimentation are illustrated in Figures 8.9-8.12 sectioned 
in accordance to the wound healing cascade occurring over the 20 Day period. 
 
8.3.3.1. Ulceration and Wound Healing of the Tested Sample Specimens 
Figure 8.7 reveals the presence of prominent ulcerative dermatitis in all group sections on 
Day 5 as depicted in Figure 8.7 a, c, d and f. This was exemplified by the presence of a 
hyperhaematoxylin stain showing the occurrence of thermal necrosis due to the implication of 
a burn wound. The stimuli and non-stimuli responsive systems revealed ulcerative 
dermatosis on Day 5 and Day 10 which relatively could also be experimentally induced as 
well. Prominent ulcerative dermatitis consisting of full-thickness ulceration with mild to 
minimal epithelisation has been recorded to continue throughout the 20 Day experimentation 
period in both the control and conventional groups including Day 15 and 20 as was seen in 
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the highly stained sections of Figure 8.7b and Figure 8.7g. Film application to the burn 
wound site resulted in the occurrence of only mild to moderate ulcerative dermatitis identified 
by the small ulcerated areas as demarcated in Figure 8.7e amid an advanced stage of 
regeneration and remodelling. Treatment with the nanofibrous mat resulted in complete re-
epithelisation whereby absolute healing of the ulcer occurred by Day 15 to 20.  
 
Figure 8.7i, 8.7j, and 8.7k depicts ulceration on Day 1 in the stimuli and non-stimuli 
responsive devices respectively whereby epidermal necrosis is more dominant in Figure 8.7k 
representative of ulceration and necrosis in the non-stimuli responsive device on Day 1. The 
necrotic tissue is prevalent in the image by the presence of a hyperhaematoxylin stain. The 
ulceration projected is referred to as epidermal necrosis and desquamation with exposure of 
the underlying dermis and superimposed secondary exudative inflammation. Figure 8.7h 
reveals the histological image of the non-stimuli responsive device on Day 20 demonstrating 
slight ulceration amid the epithelisation as demarcated in the figure which could possibly be 
experimentally induced. Severe ulcerative lesions were demonstrated in groups E and F from 
Day 1 to approximately Day 15 of the specimens but revealed a very mild to no grading by 
Day 20 of group E thus portraying an almost complete closure and healing progression in the 
stimuli responsive device. 
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Figure 8.7: Histopathological characteristics in terms of ulcerative dermatitis of (a) Control 
Day 0, (b) control Day 20, (c) nanofibrous mat Day 0, (d) Film Day 0, (e) Film Day 20, (f) 
conventional Day 0, (g) Conventional Day 20, (h) non-stimuli responsive Day 20, (i) stimuli 
responsive Day 1, (j) and (k) non-stimuli responsive Day 1 
 
8.3.3.2. Inflammation and Granulation of the investigated Specimens 
Figure 8.8 portrays the various H&E wound sections that depict the process of granulation 
and inflammation.  All groups revealed the commencement of the inflammatory process on 
Day 5. The base of the ulcer disclosed the formation of inflammatory infiltrates that was also 
identified at the dermal stroma. Infiltrates consisted of neovascularisation as demarcated in 
Figure 8.8 as well as polymorphonuclear leukocytes and mononuclear cells such as 
macrophages and lymphoplasma cells. On Day 5, granulating tissue appears to be more 
prominent in groups treated with the nanofibrous mat and curcumin loaded films whereas the 
control and conventional groups illustrate premature granulation formation whereby 
ulcerative dermatitis is still persistent in the control group on Day 5 as compared to the group 
a b c
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treated with the nanofibrous mat. The stimuli responsive and non-stimuli responsive device 
reveal the commencement of the inflammation and granulation phase by Day 5 although thin 
immature granulation tissue already begins to form by Day 1 of the stimuli responsive device 
as depicted by the image in Figure 8.8g. Slight inflammatory markers are still observed in the 
image of the stimuli responsive device amidst epithelisation as depicted in Figure 8.8h 
whereas granulation is noted on Day 15 in the non-stimuli responsive device demarcated in 
the figure (Figure 8.8i). Inflammation and granulation proportions appear to subdue by Day 
20 in the groups treated with stimuli responsive device, nanofibrous mat and curcumin 
loaded films and is graded as mild, however is more dominant and persist longer (up to 20 
Days) in the control categorized by the presence of thin immature granulation tissue and 
conventional group exhibiting inflammatory fibroplasia with moderate granulation tissue. The 
stimuli and non-stimuli responsive device reveal the instigation of inflammation at the base of 
the ulcer initially which appear to be exudative with the predominance of neutrophils in the 
early stages, while neovascularisation, granulation tissue development, infiltration of 
macrophages as well as fibroplasia are observed in the later stages. During the later stages 
of the healing process e.g. Day 20, the device reveals the presence of granulation tissue 
which is part of the normal healing process as well as extensive neovascularisation with 
domination of fibroblasts and collagen deposition was also noted.  
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Figure 8.8: Histopathological analysis depicting inflammation in (a) nanofibrous mat Day 5; 
(b) nanofibrous mat Day 10; (c) Film Day 5; (d) conventional Day 5; (e) conventional Day 10; 
(f) Control Day 5, (g) stimuli responsive device Day 1, (h) stimuli responsive device Day 15, 
(i) non-stimuli responsive device Day 15  
 
8.3.3.3. Epithelisation and Remodelling at the Wound Site over the 20 Day Period 
Epithelisation within the healing process of an induced burn wound refers to development, by 
the progression of re-epithelisation of the ulcerated surface of the wound. This is 
characterised by proliferation whereby fibroblast and collagen deposition transpire to 
instigate skin regeneration by the configuration of epithelium and endothelium cells 
(Diegelmanns and Evans, 2004). Epithelisation starts from the periphery with growth 
occurring towards the centre of the ulcer. Proliferation and epithelisation dominates and 
occurs significantly in the group treated with the nanofibrous mat. By Day 15 to 20 complete 
re-epithelisation of the wound ulcerated surface occurs whereby total surface coverage of the 
wound prevails as seen in the figure. Epithelisation was most prominent in the group treated 
with the nanofibrous mat and stimuli responsive device whereby dermal collagen deposition 
within the extracellular matrix forming an epithelial layer prevails. Only moderately advanced 
epithelisation in the curcumin loaded films occur by Day 15 to 20. Epithelisation was clearly 
detected on the periphery of the specimen as demarcated in the histological image of the 
stimuli responsive device as shown in Figure 8.9i. Furthermore mild epithelisation was 
detected in Figure 8.9l of the non-stimuli responsive device as indicated in the figure. 
a b c 
d
  a 
e f 
g h i 
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Premature mild epithelium occurred at the edges of the ulcer as depicted in the figure and is 
detected in the control and conventional groups whereby inflammatory infiltrates still 
dominate.  
 
Re-modelling refers to the final stage within the healing process whereby fibroblast activity 
involves the synthesis of collagen in the dermal stroma. Re-modelling entails the 
reorganisation of the newly synthesized collagen fibres to structure a further ordered lattice 
structure that has the potential to improve the tensile strength of the newly developed skin 
(Mackay and Miller, 2003). Siritienthong and co-workers refer to remodelling as thick 
vascular granulation tissue dominated by fibroblasts and extensive collagen deposition. 
Defects at this stage results in scarring and fibrosis. The representative images of the H&E 
wound sections in Figure 8.9 disclose prominent remodelling that is most pronounced in the 
stimuli responsive and nanofibrous group by Day 15. The results exhibit copious, compact 
and mature collagen type III fibres identified by the highly stained pink section on Day 15 of 
the nanofibrous mat treated wound. Furthermore on Day 15 curcumin loaded films reveal 
moderate remodelling from the granulation tissue. Mild ulceration is still present in the film 
treated group amidst the collagen deposition with fibroblast proliferation. Dominance of the 
remodelling stage was observed by the presence of collagen formation by Day 15 of the 
stimuli responsive device amidst the formulated granulation tissue. The haematoxylin stained 
fibril like structures clearly indicated the presence of collagen tissue with the occurrence of 
eosinically stained granulation tissue as can be seen in Figure 8.9h and 8.9j. Thus from the 
histomorphological image, wound healing progression was clearly detected on Day 15 of the 
stimuli responsive device as compared to Day 1 where apparent ulceration was noted as 
seen in Figure 8.6i. Prominent remodelling was surveyed by Day 20 of the stimuli responsive 
device as depicted in Figure 8.9k, however with the slight presence of fibrosis demarcated in 
the figure which is most likely to be due to an experimental error. Furthermore ulceration was 
also dominant in the conventional group on Day 15 to 20 which was furthermore 
distinguished in the photographic analysis. Re-modelling appeared to be mild to moderate by 
Day 20 and was graded as mild in the control group on Day 20. Interestingly, both the control 
and conventional groups disclose an increase in granulation and inflammatory intensity with 
time, however this prototype is in reverse with regards to the nanofibres and curcumin loaded 
films. The grading of epithelisation and remodelling intensifies with time. 
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Figure 8.9: Histogram revealing rate of epithelisation and remodelling in (a) nanofibrous mat 
Day 20; (b) nanofibrous mat Day 15; (c) films Day 15; (d) films Day 10; (e) conventional Day 
15; (f)control Day 15; (g) control Day 10; (h) stimuli responsive device Day 15; (i) stimuli 
responsive device Day 20; (j) stimuli responsive device Day 20; (k) stimuli responsive device 
Day 20; (l) non-stimuli responsive device Day 20   
 
8.3.4. Wound Healing Scores 
The wound healing score depicted in this chapter is designed on a score level of 8 stages 
depicting the various phases of healing that measures the progress of wound healing over 
time, whereby each score at the various stages represents wound tissue attributes produced 
by the applied system throughout the healing process. Table 8.1 (i), (ii), (iii) depicts the 
wound healing score of the wounds treated with the nanofibrous mat (group A), curcumin 
loaded film (group B), conventional system (group C) control (group D), stimuli responsive 
device (group E) and non-stimuli responsive device (group F). Significantly elevated healing 
          Mild 
epithelisation 
a b c 
d e f 
g 
Mild ulceration 
ulceration 
collagen 
h i 
j k l 
        
Epithelisation 
          Mild 
epithelisation 
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scores were obtained in the groups treated with the  stimuli responsive device and the 
nanofibrous mat followed by the curcumin loaded film as correlates to the morphological 
characteristics obtained in Section 8.3.4. Subordinate scores were obtained for the 
conventional and control group over the 20 Day period. Scores were graded on a scale of – 
to 3+ whereby – signifies negative, 1+ signifies mild, 2+ signifies moderate and 3+ signifies 
prominent. Prominent ulceration was noted at 3+ in all groups at the commencement of the 
study, but was then graded low at a negative score for the stimuli responsive device and the 
nanofibrous mat by Day 20, but was still prevalent at 3+ in the control and conventional 
groups by Day 20. The films and non-stimuli responsive device revealed a mild level of 
ulceration by Day 20 at 1+. Severe granulation and remodelling was portrayed to be the 
highest at levels ranging from 10-12 (as indicated in the footnotes) in both the stimuli 
responsive device and the nanofibrous system from Day 10 to 20 perceiving the greatest 
healing effects occurring in group A and E. Inflammation and granulation was the most 
prominent on Day 5 of all groups at a score level of 2+ and 3+ declining in score level of 
group A, B, E and F over time surpassed by epithelisation and remodelling heading towards 
complete wound closure. However, group C and D depicted an increase in inflammatory rate 
over time suggesting subordinate healing closure by Day 20.  
 
Table 8.1: Wound healing scores of the various groups where (i): Group A and B, (ii): Group 
B and C, (iii) Group D and E represented throughout the wound healing cascade 
Groups 
(i) 
A: Day 
0 
A: Day 
5 
A: Day 
10 
A: Day 
15 
A: Day 
20 
B: Day 
0 
B: Day 
5 
B: Day 
10 
B: Day 
15 
B: Day 
20 
Ulceration 3+ 3+ 2+ - - 3+ 3+ 2+ 1+ 1+ 
Epithelisation - - 2+ 3+ 3+ - - 2+ 2+ 2+ 
Inflammation/ 
Granulation 
- 3+ 2+ 2+ 1+ - 3+ 2+ 2+ 1+ 
Remodelling - 1+ 2+ 3+ 3+ - - 2+ 2+ 3+ 
Minimal 
Granulation 
          
Thin 
immature 
granulation 
      4    
Moderate 
granulation 
 7      9 9  
Severe 
granulation 
and collagen 
deposition 
  10 11 12     12 
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Groups 
(ii) 
C: Day 
0 
C: Day 
5 
C: Day 
10 
C: Day 
15 
C: Day 
20 
D: Day 
0 
D: Day 
5 
D: Day 
10 
D: Day 
15 
D: Day 
20 
Ulceration 3+ 3+ 3+ 3+ 3+ 3+ 3+ 3+ 2+ 3+ 
Epithelisation - - - 1+ 1+ - - 2+ 1+ 1+ 
Inflammation/ 
Granulation 
- 2+ 2+ 3+ 2+ - 2+ 3+ 3+ 3+ 
Remodelling - - 1+ 1+ 2+ - - 1+ 1+ 1+ 
Minimal 
Granulation 
 3     3    
Thin 
immature 
granulation 
         6 
Moderate 
granulation 
   7 9   8 8  
Severe 
granulation 
and collagen 
deposition 
          
 
Groups 
 (iii) 
E: Day 
0 
E: Day 
5 
E: Day 
10 
E: Day 
15 
E: Day 
20 
F: Day 
0 
F: Day 
5 
F: Day 
10 
F: Day 
15 
F: Day 
20 
Ulceration 3+ 3+ 2+ 1+ - 3+ 3+ 3+ 2+ 1+ 
Epithelisation - - - 2+ 3+ - - - 1+ 2+ 
Inflammation/ 
Granulation 
1+ 3+ 2+ 2+ 1+ - 3+ 3+ 2+ 2+ 
Remodelling - 1+ 2+ 3+ 3+ - 1+ 1+ 2+ 2+ 
Minimal 
Granulation 
2     1     
Thin 
immature 
granulation 
 5     4 4 5 6 
Moderate 
granulation 
  7 9 11      
Severe 
granulation 
and collagen 
deposition 
   10 11      
 
Footnotes: Scores were summarized as follows: - : Negative represents no cell accumulation, granulation or epithelisation; 1-3 
represented none to minimal cell accumulation and granulation tissue; 4-6 represented thin, immature granulation dominated by 
inflammatory cells but with few fibroblasts, capillaries or collagen deposition; 7-9 represented moderately thick granulation 
tissue, ranging from being dominated by inflammatory cells to more fibroblasts and collagen deposition, extensive 
neovascularisation; 10-12 represented thick, vascular granulation tissue dominated by fibroblasts and extensive collagen 
deposition 
 
8.4. Concluding Remarks 
In vivo morphological observations obtained indicate that treatment with nanofibrous wound 
dressings and more so incorporated as a stimuli responsive device achieved superlative and 
the fastest healing rates at a rate of 99.94% with comprehensive epithelial coverage and re-
modelling indicated by the presence of mature collagen fibres that presented at an earlier 
stage in contrast to the other systems. Results obtained revealed that healing was superior in 
both group A and E, then B and F in comparison to group C and D. This can be attributed to 
the incorporation of biopolymers such as chitosan to the wound dressing that promote the 
healing process. Chitosan provides advantageous properties to the remodelling of the ECM 
during the healing process (Gopal et al., 2014) and simultaneously sustains exceptional 
healing in combination with the incorporated biopolymers. Incorporation of hyaluronic acid as 
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found in the stimuli responsive device favours the healing process as it is a natural 
component of the ECM of the native skin thus advancing regeneration. Integration of 
nanobiotechnology to contour nanofibres that have the ability to mimick the skin structure 
further endorse the healing process. Advancements by instilling bioresponsive systems 
prolong the healing activity of the device, ensures targeted responsive release ensuring 
superior healing characteristics. Furthermore the process of crosslinking with genipin 
provides advantageous properties to the nanofibrous system such as greater tensile strength 
and flexibility, resistance to decomposition, advanced nanofibre uniformity and orientation as 
can be seen by the characterisation results from FTIR, XRD and SEM as discussed in 
Chapters 6 and 7 of this thesis. Thus, the combination of nanobiotechnology, bioresponsive 
systems, desired biopolymers and acquaintance to the cellular and subcellular events 
occurring within the wound healing cascade endow vast possibilities to advance wound care 
and treatment. 
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CHAPTER 9 
CONCLUSIONS, RECOMMENDATIONS AND FUTURE OUTLOOK 
 
9.1. Conclusions 
Within the African continent, thermal injuries and particularly childhood burns carry an 
extraordinary burden with ravaging consequences. An estimation of over a million individuals 
are burned annually on the African continent with an estimated mortality rate of 6 to 10% and 
a hospital admission rate of 18%. A survey carried out within the South African region 
revealed thermal injuries to be the most widespread origin of death due to external causes 
under the age of four years and the third universal basis for fatal injury casualties under the 
age of 18 (Rode et al., 2011). Within the United States it has been established that over 1.1 
million burn injuries require medical attention every year, approximately 4500 deaths are 
been reported and 20 000 burn injuries require medical attention annually whereby burns 
occur involving at least 25% of their total body surface (CDC Injury Prevention, USA). Based 
on the statistical thermal injury rates across the globe it can be noted that prevention, 
adequate healing management and efficient wound care are vital criteria‘s that need to be 
put in place and implemented effectively. 
 
Therefore, the BTDS device developed throughout this research has proven to be an efficient 
and effective means to manage wound care by the design of a biocompatible and 
biodegradable device that provides regulated bioresponsive bioactive release to the targeted 
wound site for the treatment and management of wounds in correspondence to the wound 
healing cascade. The effectiveness of the device has been exhibited through in vivo studies 
undertaken in the Sprague Dawley rat model exhibiting favourable outcomes for the stimuli 
responsive nanofibrous incorporated device.  
 
Based on the aims and objectives revealed in Chapter 1 of this thesis, conclusions regarding 
the device are established as follows: 
The study focused on the design of a topical delivery device for application on a targeted 
wound site in particular a wound caused by thermal injury. The most efficacious 
combinations of biopolymers, crosslinkers and bioactives was taken into consideration based 
on the pathophysiology, wound healing patterns and progressive course of injury to develop 
a novel conceptual device incorporating two major conceptions for wound bioactive delivery 
in accordance with inflammatory responsiveness. 
 
Within the goal for establishing targeted, prolonged and controlled release for the treatment 
of debilitating wounds is the design of a novel polymeric device designed on a foundation 
based on advances in nanotechnology incorporating an intelligent mechanism that focuses 
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on stimuli (inflammation) responsive behaviour. This was established by means of creating a 
componential device as described in this thesis in a logical step-wise manner integrating the 
various significant functions as a novel approach delivering the various bioactive therapeutic 
agents that include bioactives with wound healing properties. Antibiotics, anti-inflammatory 
and growth factors can also be incorporated as wound healing agents. Establishment of the 
device in a componential manner endows the exhibition of a potentially marketable product 
for convenient application and consumer mobility. 
 
Bioactive release from the BTDS on exposure to pathological (stimuli responsive) conditions 
and physiological (saline) conditions in vitro reveal a diverse pattern demonstrating 
prolonged bioactive release in the pathologically simulated exposed device. Under normal 
physiological conditions, elevated and continuous release patterns are seen irrespective of 
the presence on inflammatory infiltrates or not thus a greater propensity to toxicity, side-
effects and inefficient therapeutic outcomes. 
 
The research conversed throughout this thesis focused on the development of a device that 
exhibited characteristics mimicking the native skin and portraying a profile that is 
biodegradable, biocompatible, non-toxic, bioadherent and bioabsorbable. The formation of a 
nanofibrous mat with the use of biopolymers ensured the formation of a biostructure that 
mimicked the extracellular matrix (ECM) of the skin providing similar structural and 
physiological features as demonstrated in the in vivo studies of this thesis. Incorporation of 
hyaluronic acid, a natural component of the native ECM further enhanced this. 
 
Determination of characteristics in terms of the physicomechanical and physicochemical 
nature by evaluation of the Young‘s modulus, storage and loss modulus, viscosity and 
chemical transitions provided a vast outline regarding the properties of the system. Sufficient 
flexibility, strength and mobility were portrayed making the device a suitable configuration for 
topical application. 
 
9.2. Recommendations 
The present thesis provided information and statistical data regarding the successful 
fabrication and implementation of the BTDS device upon in vitro and in vivo analysis. 
Characterisation evaluation undertaken provided significant data regarding pharmaceutical 
and clinical significance. However, based on the stimuli responsive behaviour of the device 
and its inclination to provide therapeutic properties over a longer period of time it is 
suggested that in future, the animal based (in vivo) preclinical trial study carried out be 
prolonged over a longer period of time, over and above the twenty day limited time phase 
thus providing further information regarding the healing progress to the data attained thus far. 
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To ascertain added precise functionality of the device as a wound healing treatment 
application, further analysis should be conducted in human subjects to determine the efficacy 
of the stimuli responsive device. It is further recommended that various other marketed 
products available for thermal injuries be evaluated under the same conditions employing the 
same techniques for comparative purposes thus establishing the advantageous healing 
potential of the device in comparison to those therapeutic agents already available. 
 
Moreover, the device presented throughout this thesis can be employed for delivery of many 
other bioactives or potentially non-toxic drugs possessing wound healing properties, which 
include growth factors, mediators, antibiotics, antiseptics and inflammatories (NSAIDS). The 
ultimate goal for the development of the device, is to ensure marketability therefore 
introducing the novel system on the market. To ensure this scale-up procedures are of 
optimal importance. The present investigation is refined to acquisition of an optimal 
formulation and preclinical investigation thus it is relevant to consider product presentation 
and large scale manufacturing processes. Large scale manufacturing involves batch size 
amplification augmenting the device dimensions to fit the plant size as opposed to that 
produced in the laboratory, transfer of technology and integration of procedures (du Toit, 
2013). Of significant importance for the production of the BTDS device is the nanofibrous mat 
formation. Techniques and incorporates should be put in place to ensure speedy fabrication 
of fibres when using deionised water as a solvent thereby enhancing the conductivity.  
 
9.3. Future Outlook 
Within the pharmaceutical field many novel opportunities can be created with regards to 
wound healing and application of topical systems. The development of the novel device 
provides many novel prospects whereby new and creative innovative technologies can be 
employed and incorporated to advance the therapeutic outcomes demonstrating desirable 
release behaviour, therapeutic efficacy and prolonged action. The device can be applied to a 
wide variety of bioactives that include agents which can be polymeric possessing wound 
healing qualities, growth factors, anti-inflammatory and antibacterials amongst others. In the 
interest of intellectual property protection a patent was filed and the projection of the 
research is aimed towards licensing of the technology with a recognised pharmaceutical 
company that will allow for economical growth and clinical expansion of the developed 
device. Introduction of this technology within the South African infrastructure will provide 
opportunities in the international biotechnology sector thus minimising the importation of 
generic products (Choonara, 2009). 
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Boehringer Ingelheim Young Scientist Competition, 35TH Conference of the Acedemy of 
Pharmaceutical Sciences Publication 
Naeema Mayet, Pradeep Kumar, Yayha E. Choonara, Lisa C. du Toit, and Viness 
Pillay  
Synthesis of a Semi-Interpenetrating Polymer Network as a Bioactive Curcumin 
Film for Wound Healing 
Purpose: Wound healing and management has been proven to be challenging due to the 
fact that various extrinsic and intrinsic factors govern significant roles during the healing 
process. complex sequential cascade of events. Wounds occur on a daily basis and can 
result in a declined quality of life depending on the severity. The purpose of this study was to 
focus on the synthesis and characterisation of a natural polymeric system employing 
techniques such as the interpenetrating polymer network, cast and electrospinning. 
Methods: Using a statistically derived Box-Behnken Design Template, the paramount 
concentration of biopolymers was generated to produce 14 various formulations to fabricate 
wound healing films and nanofibrous mats.  These were then investigated in terms of their 
physicochemical, physicomechanical and biological properties by quantification by FTIR, 
DSC, Young‘s Modulus, In Vivo and In Vitro characterisation.  
Results: Chemical analysis by FTIR revealed greater shifts in wavelengths from 3260.11cm-1 
to 3278.79cm-1 when enhancements in crosslinking bridges is endorsed. Degradation of all 
systems occur between a temperature spectrum of 230 and 300°C upon thermodynamic 
evaluation revealing the presence of both crystalline and semi-crystalline behaviour. 
Structural morphological analysis illustrate relatively smooth, non porous and homogonous 
surface texture and nanofibres of varying diameters dependent upon the polymeric solution 
viscosity. Upon nanotensile mapping, variation in Young‘s Modulus was observed at 
4.25MPa providing flexibility whereas a higher Young‘s Modulus provides rigidity and 
stiffness. Further studies undertaken in terms of in vivo and in vitro reveal successful release 
of the bioactive compound curcumin, whereby an initial burst release was observed occurring 
within the first hour at 1.1mg in vivo and 2.23mg in vitro. Interestingly these results relate that 
the bioactive release rate from the system is greatly affected by the Lipophillic nature of the 
skin. Thus when exposed to the skin a superior release rate is seen improving the system 
performance. 
Conclusion: The novel semi-IPN film and nanofibres formulated, crosslinked and 
incorporated with a bioactive (curcumin) was developed in view to create an advanced, 
innovative  novel delivery system with the potential of wound healing that stimulates 
proliferation, differentiation and remodelling at the targeted sites. 
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School of Therapeutic Sciences Research Day 
 
Naeema Mayet, Viness Pillay, Yahya Choonara, Pradeep Kumar, Lisa C. du Toit 
 
An Inflammatory Bioresponsive Transdermal Delivery System as an 
Application for Wound Healing 
 
Novel prototype development and characteristic analysis of a complete prototyped device for 
wound healing incorporating a nanofibrous mat as well as a bioresponsive component to 
inflammation known as the ‗bioresponsive transdermal delivery system‘ (BTDS). The method 
utilised various natural biopolymers specific to the significant component of the device 
thereby employing a statistically derived Box-Behnken Design Template in order to 
implement optimisation of the predetermined pharmaceutical and therapeutic parameters to 
establish the optimal formula for fabrication. In vitro evaluation by determination of the 
bioresponsive nature was carried out in a stimulated inflammatory environment by utilisation 
of the Fentons reagent: Fe2+ + H2O2 → Fe
3+ + OH∙ + OH- whereby bioactive release rates 
were noted to be dependent upon the breakdown of the matrix by hydroxyl radicals. MDT for 
the bioactive release of curcumin depicted a value at 42.39 at a higher hyaluronic 
concentration and degree of crosslinkage whereas at lower concentrations MDT values at 
33.21 and 35.76 was depicted. Further evaluation in terms of chemical and mechanical 
characteristics indicates that the formulatory design meets the requirements for adequate 
wound healing. In vivo histological examination on the Sprague Dawley rat model revealed 
the healing progression whereby the presence of the nanofibrous mat elucidated a close to 
complete reepithelisation and remodelling of the wound site represented by thick, vascular 
granulation tissue dominated by fibroblasts and extensive collagen deposition. Therefore 
prototype device fabrication is exhibited in view to create an advanced, innovative novel 
delivery system with the potential of wound healing. 
 
Keywords: Wound healing, Bioactives, Stimuli Responsive 
 
 
 
 
 
 
 
 
 
262 
 
Conference of the Academy of Pharmaceutical Sciences, APSSA/SAAPI conference, 
“Today‟s Solutions for Tomorrow‟s Needs”. 
 
Naeema Mayet, Lisa C du Toit, Pradeep Kumar, Yahya E Choonara, Viness Pillay 
 
Synthesis of a Bioactive Nanofibrous Mat as an Application for Wound Healing 
 
Purpose: Nanofibres have become an advanced and intelligent form of drug delivery and 
tissue engineering. The present study focused on fabricating an optimal nanofibrous wound 
healing delivery device that is bioactive, non-toxic and mimicks the architecture of the native 
extracellular matrix (ECM) outlining ‗pseudoskin‘. 
Methods: Biopolymers such as chitosan and hypromellose loaded with curcumin were used 
synergistically providing healing properties in terms of angiogenesis and proliferation, 
antioxidant and antimicrobial effects. Crosslinking with genipin enhanced the 
physicomechanical, physicochemical and biological properties. Fibres were formulated 
employing the electrospinning technique and thereafter determination of the various 
parameters was carried out in terms of the various device characteristics. 
Results: We established that the nanofibrous mat revealed exceptional wound healing 
closure, epithelisation as well as type lll collagen deposition in contrast to the other systems 
investigated. Application of the systems were applied to a burn wound model whereby wound 
progression was evaluated on days 5, 10, 15 and 20 after wound induction. Results obtained 
revealed a significantly elevated rate in the nanofibrous treated group whereby the closure 
rate on day 20 disclosed a rate of 99.94% in contrast to 84.18% and 94.88%. The absence of 
ulceration and inflammation with severe collagen and granulation deposition is noted. 
Crosslinking lead to the formation of a uniform and denser structure with improved 
mechanical properties, stability and bioactive release whereby a permeated release rate of 
2.1016% was noted in contrast to normal release rate of 0.9457% of bioactive at 2 hours. 
Conclusions: The accelerated healing of the crosslinked nanofibrous mat can be directly 
attributed to its impersonation of the native skin structure, employment of bioactive polymers, 
biodegradability and biocompatibility. Thus the study conducted revealed that the 
nanofibrous mat serves as an optimal candidate for advanced wound care and management.  
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Naeema Mayet, Lisa C.du Toit, Pradeep Kumar, Yahya E. Choonara and Viness 
Pillay 
A Bioresponsive Transdermal Delivery System (BTDS) for Wound Healing 
Purpose: Development and characteristic analysis of a complete prototyped device for 
wound healing incorporating a nanofibrous mat as well as a bioresponsive component to 
inflammation. First novel prototype developed as an inflammation bioresponsive device for 
superior wound healing incorporating a nanofibrous mat  
Methods: The method utilised various natural biopolymers specific to the significant 
component of the device. Using a statistically derived Box-Behnken Design Template, the 
paramount concentration of biopolymers was generated to produce 15 various formulations 
each to fabricate wound healing nanofibrous mats as well as the lyophilised inflammatory 
dependent matrix. The technique entailed the process of electrospinning for nanofiber 
formation as well as blending and lyophilisation for the inflammatory responsive component. 
Prototype component characteristics were then determined in terms of morphological 
analysis, mechanical, chemical, in vitro and in vivo analysis. 
Results:  Elucidation of the various polymeric and crosslinker concentrations greatly 
influenced the properties and characteristics of the system.  An endorsement in intensity and 
conjugation is noted by the FTIR spectra whereby greater shifts in wavelengths from 
3260.11cm-1 to 3278.79cm-1 is noted when enhancements in crosslinking bridges is 
undertaken. Structural morphological analysis revealed the synthesis of smooth, cylindrical, 
uniformly aligned nanofibres without the presence of nanobeads as well as the formation of a 
lyophilised matrix having a tough backbone structure at higher concentrations. Upon 
nanotensile mapping, variation in Young‘s Modulus was observed at 4.25MPa providing 
flexibility whereas a higher Young‘s Modulus provides rigidity and stiffness to the structure. 
Determination of the bioresponsive nature was carried out in a stimulated inflammatory 
environment by utilisation of the fentons reagent: Fe2+ + H2O2 → Fe
3+ + OH∙ + OH- . Results 
amongst the experimentally derived formulations revealed the reliance of bioactive release 
on the hyaluronic acid concentration and degradation by hydroxyl radicals present. MDT 
results obtained depicted a value at 42.39 at a higher hyaluronic concentration and degree of 
crosslinkage whereas at lower concentrations MDT values at 33.21 and 35.76 was depicted. 
In vivo histological examination revealed the healing progression whereby the presence of 
the nanofibrous mat illucidated a close to complete reepithelisation and remodelling of the 
wound site represented by thick, vascular granulation tissue dominated by fibroblasts and 
extensive collagen deposition. 
 Conclusions: A validated fabrication of the prototype device providing the necessary 
therapeutic, physical, chemical and biological requirements in view to create an advanced, 
innovative novel delivery system with the potential of wound healing that stimulates 
proliferation, differentiation and remodelling at the targeted sites. 
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